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Abstract 
 
Single-cell DNA analysis is not routinely carried out in a forensic setting as it is considered 
unreliable due to challenges associated with DNA amplification, contamination and profile 
interpretation. In light of the development of increasingly sensitive techniques, the question of 
the reliability of single-cell DNA analysis in terms of both processing and interpretation is 
addressed in the first part of this thesis. Optimising all stages of the DNA analysis process has 
provided a sensitive method which facilitates the successful outcome of a useable profile from 
single-cells. Although no consensus profile can be generated for this sample type, interpretation 
guidelines have been set to enable the robust analysis of single cells. It has been concluded that 
single-cells can be reliably amplified and profiled for forensic purposes. 
Both DNA and textile fibres have a proven track record in forensic casework yet their analysis is 
rarely combined. As an application of the aforementioned single-cell DNA analysis, this project 
explores the possibility that when fibres are transferred from one surface to another, they could 
also be acting as a vector for the wearer’s own DNA, through cells that have adhered to the fibre 
surfaces. Fluorescent staining and microscopy is used to detect the cells in situ on the fibre 
surface, which are then recovered and processed for DNA using the previously optimised single-
cell analysis methods, along with a newly developed DNA assay designed for the amplification 
of low DNA template samples. The results of this study have demonstrated that cells can be 
visualised in situ on the fibre surface and that there is potential for cell transfer to occur. It has 
been concluded however, that from a casework point of view, targeting transferred fibres for 
cells may not be the best approach as it is time consuming and has not been shown to be effective 
in this study.  
The final part of this thesis is focused on the efficacy of massively parallel sequencing (MPS) 
technology for samples that are expected to be severely degraded due to age or exposure to a 
hostile environment. The ability of both the recently launched Illumina ForenSeq™ DNA 
Signature Prep Kit for nuclear DNA markers and an in-house method for the sequencing of 
degraded mitochondrial DNA, have been tested to determine if MPS offers a more 
comprehensive evaluation of degraded material than the traditional PCR-CE methods. The 
results of the ForenSeq kit have demonstrated the effectiveness of its low molecular weight STR 
and SNP markers for amplifying low template, degraded DNA samples, with alleles amplified 
using less than 20 pg total DNA input. This kit has also therefore shown application in the field 
of bioarchaeology, as it can provide the biological sex of the sample, biogeographic ancestry 
information and also aids detection of sample/control contamination. The in-house mitochondrial 
DNA assay resulted in the successful amplification and sequencing of samples for which no 
nuclear DNA was amplified. The high depth of read coverage in these samples, average of 
18,000, allowed for the identification of even low level variants.  
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1.1 Forensic science 
Forensic science is the use of a scientific approach for the investigation, evaluation and 
communication of evidence pertaining to the criminal justice system. One of the first 
recorded cases of forensic investigation can be traced anecdotally back to early China, 
during which an early form of entomology was used to identify from a number of sickles the 
one that had been used as the murder weapon; it was the only one to attract flies, thus 
indicating the presence of blood (Sung, 1981).  
There are many reported uses of forensic science over the following centuries, for example 
the use of fingerprints to prevent relatives claiming the pension of deceased military persons, 
and the use of toxicology to detect arsenic poisoning in a murder trial in 1883 (Tilstone, 
2006). It was not until the early 20th century however, that the first police lab was opened in 
Lyon, France, by Edmond Locard. It is Locard’s principle of exchange, whereby he 
describes how evidence of the perpetrator will be left at the scene or that traces from the 
scene will be taken away on their being (Locard, 1920), which remains the underpinning 
principle of forensic criminal casework. 
Forensic science is continually evolving in order to meet the requirements of modern day 
society; the 21st Century has already seen the rapid expansion of areas such as digital based 
forensics and those related to terrorism. The nature of not only criminal or civil 
investigations in their traditional sense, but also areas such as disaster victim identification 
and bio-archaeological investigations ensures that a wide range of different disciplines can 
be applied and encompassed under the forensic science umbrella, each with its own set of 
analytical methods and techniques used to answer the questions posed by the investigation.  
Whilst the UK courts do not have a specific set of standards for the admissibility of 
scientific evidence in court (Ireland, 2015), the impact and challenge to forensic science 
following the Daubert v. Merrell Dow Pharmaceuticals ruling (1993) and the U.S. initiative 
to strengthen Forensic Science (National Research Council (U.S.). Committee on Identifying 
the Needs of the Forensic Science Community. et al., 2009, Butler, 2015b) have been felt 
internationally (Ireland, 2015). The emphasis is now placed firmly on the fundamental 
science that underlies forensic analysis, with a comprehensive assessment of the capabilities 
and limitations of the varying analytical techniques required before confidence in any result, 
both positive and negative, can be communicated. Although forensic Deoxyribonucleic Acid 
(DNA) analysis has, since its inception, been subjected to rigorous testing and validation (as 
reviewed in (Saks and Koehler, 2005) and (Butler, 2015b)), and so is held up as the ‘gold 
standard’ of forensic disciplines in this context, the fast pace of development in this field 
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along with the increasingly sensitive techniques employed, demand continuous improvement 
and evaluation for use in forensic casework.  
1.2 Forensic DNA analysis 
In 1984 Sir Alec Jeffreys first demonstrated the use of multiple minisatellite regions as a 
method by which two individuals could be distinguished, a technique he termed ‘DNA 
fingerprinting’ (Jeffreys et al., 1985). Minisatellites are loci that can consist of up to 
approximately one thousand tandem repeat units, each one being made up of 10 -100 bp 
(Jeffreys et al., 1985). Multi-locus probes hybridised with conserved core sequences across 
many minisatellite loci which, when combined with southern blotting, allowed for the 
visualisation of the multiple DNA bands that made up the individual’s DNA fingerprint 
(Jeffreys et al., 1985). The potential for the application of this technique in a forensic context 
was quickly recognised (Gill et al., 1985) and along with the developed single-locus probes, 
which allowed for the targeting and visualisation of a single locus at a time to facilitate 
interpretation, formed the earliest type of DNA analysis utilised in criminal casework; the 
infamous Colin Pitchfork case, which saw not only the identification and conviction of the 
offender in 1987, but also the first exoneration of an individual based upon DNA evidence 
(reviewed in (Jobling and Gill, 2004)). Efforts were made to collect data on the observed 
frequency of alleles within differing populations so that the discriminatory power of a DNA 
profile could be assessed and the advent of the polymerase chain reaction (PCR) by Kary 
Mullis (Saiki et al., 1988), together with the introduction of short tandem repeats (STRs) 
(Weber and May, 1989) and development of the Sanger sequencing (Sanger et al., 1977, 
Butler et al., 2004) technology, prompted rapid advancement in the area of forensic genetics.  
1.2.1 Short tandem repeats 
STRs differ from minisatellites in that they have fewer repeat units of lengths of between 2-6 
nucleotides (Kimpton et al., 1993), producing an overall shorter length of target fragment 
(Figure 1.1). The shorter target size, and the ability to design primers close to the target 
region (mini-STRs), facilitates amplification of smaller quantities of DNA template resulting 
in an increase in assay sensitivity relative to the use of minisatellites; an important advantage 
for forensic DNA analysis given the type of material often available for analysis.  
The ability to visualise amplified DNA fragments through the use of fluorescent tags added 
during PCR, facilitated multiplex reactions enabling additional markers to be analysed 
simultaneously, thus improving the discriminatory value of the assay. The use of capillary 
electrophoresis (CE) allows for the separation and fluorescent detection of the PCR products, 
with the lower molecular weight DNA fragments passing through the detection window 
earliest (Butler et al., 2004). The inclusion of a DNA fragment size standard with every 
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sample along with the use of an allelic ladder (Butler et al., 1995, Butler et al., 2004), 
enabled the unambiguous identification of alleles at all loci, thus enabling the application of 
a standardised nomenclature system (Olaisen et al., 1998) allowing the comparison of data 
between labs and importantly, the introduction of the National DNA Database (NDNAD) in 
the United Kingdom (UK) in 1995 (Werrett, 1997). The ability to search against DNA 
profiles both from previous offenders and crimestains from unsolved crimes, enabled 
perpetrators to be identified and crimes to be linked together in a way that had not 
previously been possible, highlighting the contribution of DNA analysis to the criminal 
justice system.  
Approximately 3% of the human genome consists of STRs (Lander et al., 2001), often 
located in the promotor regions of genes (Sawaya et al., 2013) as well as at the terminal 
regions of the chromosomes (Misawa, 2016). The complexity of the repeat units varies 
between markers with loci categorised as ‘simple’, in that the sequence is made up of 
identical repeating units, ‘compound’, where at least two repeat units are present, and 
‘complex’, in which multiple types of repeat units are interspersed with additional bases 
(Urquhart et al., 1994) as shown in Figure 1.1. The complex loci are generally associated 
with an increase in the distinguishing capability at that locus (Gill et al., 1997a).  
An investigation into the use of fourteen STR loci, arranged into three possible multiplexes 
was carried out by Kimpton et al. in order to assess suitability for their inclusion in the first 
STR Quadplex used in forensic DNA analysis (Kimpton et al., 1993, Kimpton et al., 1994). 
This was based on their predicted discriminatory power, well-matched amplification 
conditions for multiplexing, compatible allele fragment sizes and the ability to generate 
distinct alleles for accurate sizing. The use of tetra- or penta- nucleotide repeat units rather 
than di- or tri- nucleotide repeats was also considered in order to reduce the frequency of 
associated stutter peaks. Stutter peaks are a common and unavoidable artifact that results in 
the appearance of additional peaks exactly one or more repeat units less than the true allele 
peak or, less frequently in the plus one repeat unit position (Walsh et al., 1996), which is 
thought to arise during DNA synthesis as a consequence of the polymerase ‘slipping’ off the 
template strand (see Section 3.1); reducing the occurrence of these stutter peaks aids 
interpretation of the resulting DNA profile.  
Since the early markers were identified, the completion of studies such as the Human 
Genome Project, has increased the number of STR loci that may be potentially useful in a 
forensic context. The maximum size of the DNA target is a defining feature of newly 
selected loci in order to ensure that maximum information can be obtained from low 
quantity/ poor quality samples. This must however, be balanced with a high number of
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D 
Figure 1.1 Overview of the structure of short tandem repeats. A – Simple STRs are made up of identical repeating units with alleles six and eight shown in the 
example above. B – Compound STRs are made up of at least two different repeat units shown above in two different shades of blue. The total number of repeat units 
are counted to give the allele number; alleles eight and nine above. C- Complex STRs are made up of multiple types of repeat units are interspersed with additional 
bases with only the various repeat units counted to give the allele number  (Urquhart et al., 1994). D - Primers are used to target the region of interest with the STR 
between them, with the number of repeats at each locus determining the total length of the DNA fragment. 
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associated alleles and a high degree of heterozygosity in order to maintain the discriminatory 
power of the assay. A summary of this information for loci currently used in the UK is 
provided in Table 1-1. The mutation rates for commonly used forensic STR loci has been 
shown to be approximately 9.78 x 10-4 mutations per locus per generation, with those loci 
having a higher value of heterozygosity also have a higher mutation rate than those with a 
lower heterozygosity value. FGA for example has a heterozygosity value of 0.8671 and a 
mutation rate of approximately 1.98 x 10-3 (Caucasian), whilst TH01 has a heterozygosity 
value and mutation rate of 0.7802 and 0.02 x 10-3 respectively (Caucasian) (Sun et al., 2014). 
Following a recent genome wide study of STR loci, the overall germline mutation rate has 
been calculated as approximately 7.6 x10-5 mutations per locus per generation 
(Fungtammasan et al., 2015); the lower mutation rates in STRs selected for forensic analysis 
facilitate their efficacy for use in kinship analysis Other factors affecting STR mutation rates 
include repeat unit length and sequence, ethnicity, gender and age (Fungtammasan et al., 
2015, Sun et al., 2014).  
Finally, all selected loci must be amenable to multiplexing in terms of both primer 
compatibility and positioning on the chromosome relative to other loci in order to avoid 
genetic linkage. By ensuring that any loci on the same chromosome are separated by 
millions of base pairs the risk of both being inherited together through recombination during 
meiosis is eliminated. This means that loci are independent of one another and can therefore 
be used to calculate the profile frequency by way of the product rule (Carracedo, 1998, 
Coble and Butler, 2005).  
1.2.2 Single nucleotide polymorphisms  
In addition to the length mutations observed with STRs, single nucleotide polymorphisms 
(SNPs) are also utilised for forensic investigation. SNPs arise from a single point mutation in 
the genome resulting in a change to the expected nucleotide present. Following an in-depth 
study of data generated as part of the 1000 genomes project (The Genomes Project, 2015), a 
total of approximately 38 million SNPs have been identified throughout the genome, with an 
average of 3.6 million SNPs detected per individual (Sudmant et al., 2015)  
Traditionally the focus of identity markers for forensic purposes has been on the use of  
STRs, as the biallelic nature of the majority of SNPs results in the requirement for a high 
number of loci to be analysed in order to obtain a comparable power of discrimination to 
relatively few STR loci, i.e. approximately fifty SNPs is equivalent to approximately twelve 
STRs (Gill, 2001). More recently, however, identity SNPs (iSNPs) are being included 
alongside STRs in assays developed for PCR-massively parallel sequencing (PCR-MPS) 
7 
 
techniques (Section 1.3.3), in order to take advantage of their short fragment sizes, which 
facilitates amplification in low quality forensic material. 
SNPs have been demonstrated as highly informative markers for indicating both 
biogeographic ancestry (Frudakis et al., 2003, Shriver et al., 2003) and phenotypic 
characteristics, such as hair and eye colour (Liu et al., 2009, Walsh et al., 2013) of an 
individual under investigation. SNPs are also the marker type utilised for the analysis of 
mitochondrial DNA (mtDNA) as described in the following section. 
Table 1-1 Summary of STR locus information. The chromosome location of each STR 
locus included in the NGM Amplification Kit is given, along with the minimum and 
maximum fragment sizes at that locus across the range of alleles observed. Information 
adapted from (Biosystems, 2015). All loci are shown to have high heterozygosity values 
of >0.7 (AllST*R – Autosomal Database (allstr.de), Qualitype GmbH, Germany) allowing 
for greater variability within the population.  
Locus 
Chromosome 
location 
Minimum 
fragment 
size 
Maximum 
fragment 
size 
Allele 
range 
Heterozygosity 
value  
D10S1248 10q26.3 72.0 127.0 8-18 0.7470 
vWA 12p13.31 149.0 214.3 11-24 0.8077 
D16S539 16q24.1 223.6 277.6 5-15 0.7783 
D2S1338 2q35 281.6 356.0 15-28 0.8756 
D8S1179 8q24.13 117.9 174.9 8-19 0.8094 
D21S11 21q11.2-q21 178.8 249.8 24-38 0.8299 
D18S51 18q21.33 259.5 347.5 7-27 0.8764 
D22S1045 22q12.3 76.0 120.0 8-19 0.7198 
D19S433 19q12 122.3 166.3 9-17.2 0.7534 
TH01 11p15.5 176.4 221.1 4-13.3 0.7802 
FGA 4q28 221.6 372.0 17-51.2 0.8671 
D2S441 2p14 74.5 113.4 9-16 0.7403 
D3S1358 3p21.31 114.4 168.4 12-19 0.7979 
D1S1656 1q42.2 170.0 224.0 9-20.3 0.8951 
D12S391 12p13.2 225.0 287.0 14-27 0.8933 
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1.2.3 Mitochondrial DNA 
It was first demonstrated in 1966 that in contrast with the linear nature of the nuclear 
genome (Watson and Crick, 1953), the mitochondrial genome (mtGenome), shown in  
Figure 1.2, has a circular structure (van Bruggen et al., 1966, Nass, 1966). The Sanger 
method was used by Anderson et al. in 1981 (Anderson et al., 1981) to sequence the first 
human mtGenome, which consisted of 16,569 bp. This published sequence, widely known 
as the Cambridge Reference Sequence (CRS), was then revised (rCRS) and updated by 
Andrews et al. in 1999 (Andrews et al., 1999) to correct for eleven original sequencing 
errors.  
 
Figure 1.2 Diagram showing overview of the mtGenome. The double-stranded 
mtGenome contains thirty-seven genes coding for fourteen tRNAs (t) (areas encoding 
multiple tRNAs indicated in bold), two rRNAs and twelve polypeptides on the heavy strand, 
and eight tRNAs and one polypeptide on the light strand (Anderson et al., 1981). The control 
region contains three hypervariable sections between nucleotide positions 16024 and 576. 
The mtGenome is intertwined with core mtDNA binding proteins, primarily the structural 
Mitochondrial Transcription Factor (TFAM) (Kaufman et al., 2007), to form spherical 
nucleoids (Nass, 1969). This mtDNA/protein complex is thought to form a dense core, so 
compactly formed that access is limited from other matrix proteins (Brown et al., 2011). 
Surrounding this core are multi-functional factors that interact with the core through protein-
protein interactions (Brown et al., 2011). Kukat et al. utilised immunofluorescence together 
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with stimulated emission depletion (STED) microscopy to determine the average diameter 
across 38,777 mammalian nucleoids as 102 ± 0.3 nm, approximately 70 nm without the 
antibody attached (Kukat et al., 2011). The quantity of nucleoids per mitochondrion (1 – 
2000 nucleoids) and the mtGenome copy number per nucleoid (1 – 15 copies) have been 
debated over the years (Brown et al., 2011, Iborra et al., 2004, Legros et al., 2004, Satoh and 
Kuroiwa, 1991, Kukat et al., 2011, Cavelier et al., 2000), but a consistent average of 1.4 
copies of the mtGenome in each nucleoid was observed by both the 1991 paper of Satoh & 
Kuroiwa (Satoh and Kuroiwa, 1991)  and 2011 work of Kukat et al. (Kukat et al., 2011). 
There was however, a five-fold difference in total estimated mtDNA copy number per cell, 
with averages of approximately 500 copies and 2720 respectively, presumably due to the 
development of superior microscopy techniques in the last two decades allowing better 
resolution for the 70 nm diameter nucleoid structures (Kukat et al., 2011). The high copy 
number and nucleoid structure contributes to its ability to better withstand the effects of 
DNA degradation than nuclear DNA, as discussed further in Section 1.2.4.3.  
It was established in 1980 that, aside from rare incidences of paternal inheritance (Schwartz 
and Vissing, 2002), human mtDNA is inherited maternally (Giles et al., 1980) although the 
actual mechanisms behind how the mtDNA is inherited are still under investigation it has 
been demonstrated that mitochondria in the spermatozoa do enter the oocyte at fertilisation 
(Ankel-Simons and Cummins, 1996). As discussed by Carelli, there are two prevailing 
theories that account for the elimination of the paternal mitochondria following conception. 
The ‘dilution model’ works on the assumption that the ratio of copies of paternal to maternal 
mtDNA is approximately 1:15,860, thus resulting in the masking of the paternal mtDNA. 
The second theory supports the active elimination of the paternal mitochondria possibly 
through ubiquitination of mitochondria in the sperm, selective mitophagy or direct 
degradation (Carelli, 2015). As summarised by Brogenhagen, it is also not yet clear whether 
it is the entire nucleoid, potential containing multiple copies of the mtGenome, or an 
individual mtGenome within the nucleoid that actually constitutes the genetic unit of 
inheritance (Bogenhagen, 2012). The elucidation of these mechanisms will improve 
understanding on how both germline and somatic variants are inherited. 
1.2.3.1 mtDNA variants 
The human mtGenome is evolving at approximately six to seventeen times the rate of nDNA 
(Brown et al., 1979, Wallace et al., 1987, Miyata et al., 1982) resulting in the presence of 
both point and length mutations. Due to this relatively high rate of mutation, along with the 
cellular abundance of mtDNA, instances of heteroplasmy can arise whereby divergent 
versions of the mtGenome can be present within the same cell (Holt et al., 1988). The rate at 
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which heteroplasmy occurs has been shown to vary dependent upon the area of the 
mtGenome in question (Pesole et al., 1999), with the synonymous sites evolving at a faster 
rate than the non-synonymous positions (Pesole et al., 1999), and the tissue type of the host 
cell (Naue et al., 2015, Calloway et al., 2000). Recent studies using next generation 
sequencing (NGS) have recorded heteroplasmy in approximately a quarter of individuals 
sampled when using a minor allele detection setting of ≥ 10% of the total number of base 
calls at a given position (Li et al., 2010, King et al., 2014a, Ramos et al., 2013, Just et al., 
2015). Setting the variant detection threshold at ≥ 0.2% however, suggests that heteroplasmy 
may be more prevalent than previously thought as the ultra-deep sequencing of two mtDNA 
amplicons revealed that all thirty-four individuals sampled, had at least one heteroplasmic 
site present (Payne et al., 2013); seven of these (~21 %) would have been detected had the 
threshold been set at 10%, which is consistent with other papers.  
The improvement in the ability to detect low level variants using NGS technologies has also 
been illustrated recently by Bintz et al. (Bintz et al., 2014) when in addition to their target 
mtDNA sequence, a nuclear mitochondrial sequences (NumtS) (Lopez et al., 1994) was also 
detected. NumtS are fragments of the mtGenome that become incorporated into the nuclear 
genome during the repair of damaged DNA (Blanchard and Schmidt, 1996, Ricchetti et al., 
2004). There are currently over seven hundred of these fragments documented (Calabrese et 
al., 2012, Dayama et al., 2014) that, once integrated into the nuclear genome, evolve at a 
slower rate than the mtGenome and so have use in phylogenetic studies (Zischler et al., 
1995a). The potential to misinterpret a NumtS for a genuine mtDNA sequence has been 
demonstrated (Zischler et al., 1995b) and sample haplotypes, particularly low level 
heteroplasmic sites, should be checked against known NumtS variants (Calabrese et al., 
2012, Dayama et al., 2014)  before final designation.  
Historically the control region (CR), also known as the displacement loop (D-loop), has been 
the target of interest for forensic geneticists due to the high mutation rate, estimated at 
2.5/site/Myr (Parsons et al., 1997). The CR is the largest non-coding segment of the 
mtGenome (Anderson et al., 1981) and includes three hypervariable sections (HVS). 
Amplification and sequencing of HVSI or HVSI/II for haplotype comparisons is common 
practice as these regions are considered mutational hotspots (Jazin et al., 1998) and therefore 
highly informative, as well as offering a target that is practical for Sanger sequencing. The 
maternally inherited nature of the mtGenome results in an expected inability to differentiate 
between relatives in the maternal line. In addition to this and unlike the nuclear genome, the 
mtGenome is a single-linked molecule and so the frequencies observed for SNPs in the 
genome cannot be assessed individually, but as a whole haplotype (Parsons and Coble, 
2001). 
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Mitochondrial haplotypes are generated by sequencing either a targeted region of the 
mtGenome or its entirety for a direct comparison with the rCRS. Deviations from the rCRS 
are recorded according to the guidelines published by the DNA Commission of the 
International Society of Forensic Genetics (ISFG) (Parson et al., 2014, Carracedo et al., 
2000) as detailed in appendix 8.1. The mtDNA haplotype profiles of two samples can be 
compared with one another resulting in an inclusion, exclusion or inconclusive result 
(Carracedo et al., 2000). The absence of a heteroplasmic site should not be used to exclude 
an individual due to the potential for differences within and between cell types (Calloway et 
al., 2000, Naue et al., 2015), but conversely the presence of a heteroplasmic site may 
increase the strength of the evidence (Parson et al., 2014, Carracedo et al., 2000). Match 
probability and likelihood ratios can then be derived from datasets compiled in databases 
such as EMPOP (Parson, 2015), or those containing more relevant localised population data 
(Parson et al., 2014) to assess the significance of a match between a reference sample and 
the sample in question.  
It has now been recommended by the ISFG DNA Commission that the entire control region, 
i.e. nucleotide positions 16024 – 576, should be sequenced as a minimum for forensic 
analysis (Parson et al., 2014) in order to maximise the potential to discriminate between two 
individuals or assign haplogroups based on markers outside of the HVSI/II fragments 
(Parson et al., 2014). Further to this however, it has been demonstrated that if the whole 
mtGenome is sequenced then distinct haplotypes can be observed in over 90% of randomly 
sampled individuals (Just et al., 2015, King et al., 2014a).    
The uniparental inheritance of mtDNA, along with its high rate of mutation has been 
exploited by both population geneticists for use in tracking the worldwide migration of the 
human population, and by forensic geneticists for use in kinship analysis, through which 
familial relationships can be established. A landmark study in 1992 by Excoffier et al. 
(Excoffier et al., 1992) outlined a framework for mapping and establishing genetic distance 
between mitochondrial haplotypes. A year later, seventeen Native American populations 
were consigned to the first four haplogroups (A-D) based on their mitochondrial haplotype.  
In the last two decades the haplotypes and haplogroups of individuals from around the world 
have been published in hundreds of papers (most recent review (Kivisild, 2015)), which 
have contributed towards the assembly of a comprehensive phylogenetic tree (van Oven and 
Kayser, 2009, Van Oven, 2015). Based on the presence or absence of the population specific 
polymorphisms used to construct this tree, an individual’s haplotype can be used to assign 
their haplogroup and thus determine their ancestral biogeographic origins. This information 
can be particularly useful within a forensic context in inferring the ethnicity and thus some 
phenotypic characteristics of an unknown suspect.  
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The multi-copy nature of the mtGenome within every cell offers two further avenues for use 
in forensic DNA analysis in the form of an alternative source of DNA in samples that either 
inherently contain little or no nDNA such as keratinous tissues (Parson et al., 2015, Higuchi 
et al., 1988, Anderson et al., 1999) or, of particular interest for this study, samples in which 
the quantity or quality of nuclear DNA (nDNA) is in question, i.e. nDNA is expected to be 
severely degraded due to spatiotemporal effects or quantification results indicate a low 
concentration/absence of nDNA; this is explored further in chapter five. 
1.2.4 Optimal biological forensic samples  
The biological samples types collected during the course of a forensic investigation can vary 
widely, as can the quantity and quality of DNA contained within them. An ideal sample for 
forensic DNA analysis will contain a high quantity of good quality DNA, such as may be 
found in a fresh blood or saliva sample. Once extracted, such a sample can be diluted to 
acquire the optimal quantity for the forensic DNA kits (approximately 0.5 ng – 2 ng DNA), 
and the longer DNA fragments associated with good quality DNA should result in the 
amplification of even high molecular weight loci, thus generating a full DNA profile. 
Reference samples taken directly from an individual will invariably yield optimal DNA, the 
exceptions being hair samples taken by force and samples taken from a decomposing corpse. 
A significant advantage of optimal DNA is that having a higher starting quantity allows for 
multiple testing to be carried out on the same extract, thereby increasing the amount of 
information that can be acquired. 
1.2.5 Sub-optimal DNA 
As reviewed recently by Butler (Butler, 2015a) forensic DNA analysis is now moving into 
an era of growth and into one of what he terms ‘sophistication’, whereby the use of 
techniques including those with higher sensitivity and greater depth of information will be 
introduced into casework. In order to achieve this, these technologies must be evaluated to 
ascertain their capabilities and limitations for use with forensic material, particularly for that 
which is sub-optimal.  
1.2.5.1 Low template DNA 
‘Touch’ DNA samples (van Oorschot and Jones, 1997) are the most prevalent form of 
ltDNA sample collected in forensic casework as they inherently contain very few nucleated 
cells (Kita et al., 2008), however sub-optimal samples that would usually be considered as a 
good source of DNA, but are aged or have been subjected to harsh environmental 
conditions, may also yield relatively low quantities of  DNA. With a development in 
technology, along with the improvement in sensitivity of the related chemistries, there is 
now the capability to recover, extract and amplify DNA from even the most challenging of 
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forensic material. There has been much discussion amongst the forensic genetics community 
regarding what defines a DNA sample as being low template, with DNA quantity frequently 
favoured using upper threshold figures of either 100 pg (Whitaker et al., 2001, Forster et al., 
2008) or 200 pg (Budowle et al., 2009a, Gill et al., 2008), equivalent of approximately 
thirty-four and sixty-four times the mass of a haploid genome (approximately 3 pg).   
Gill and Buckleton (Gill and Buckleton, 2010) argue that it is impractical to define a 
threshold for low template DNA based on quantity because it does not necessarily reflect the 
quality of the DNA within the sample, i.e. stochastic effects of PCR may be evident for the 
high molecular weight (HMW) loci whilst the low molecular weight (LMW )are unaffected 
within the same profile, or in the case of a mixed sample, a number of individuals may all be 
contributing to the overall DNA quantification value.  
1.2.5.2 Degradation of DNA 
The degradation of DNA in apoptosis, the predominant form of programmed cell death, is 
characterised by the cleavage of chromosomal DNA initially into HMW fragments of 50 - 
300 kb (Oberhammer et al., 1993). This is followed by subsequent cleavage into LMW 
fragments, producing a DNA ladder effect with intervals of approximately 200 bp when 
visualised on an agarose gel (Wyllie et al., 1980, Widlak et al., 2000). As reviewed by 
Samejima & Earnshaw (Samejima and Earnshaw, 2005) more than twenty nucleases have 
been identified as having varying degrees of involvement in DNA cleavage during 
apoptosis. One such enzyme primarily active in mammals is Caspase-activated DNase (CAD) 
(human homologue known as Caspase-activated nuclease), which exists as an inactive 
complex with it’s chaperone, Inhibitor of CAD (ICAD) (Enari et al., 1998), in the nucleus of 
the cell (Lechardeur et al., 2000). A cell autonomous nuclease, CAD is predominantly 
involved in the degradation of LMW DNA (Widlak et al., 2000) but a role in HMW DNA 
fragmentation has also been demonstrated in some cell types (Zhang et al., 2000). Once 
ICAD has been removed, the scissor-like structure of the CAD homodimer (Woo et al., 2004) 
targets the phosphodiester bonds and cleaves the double stranded DNA (dsDNA) located in 
the inter-nucleosomal space (Widlak et al., 2000) creating nucleosomal units, which are 
approximately 200 bp in length. The mechanisms for the fragmentation of DNA through 
apoptosis have been extensively investigated; there is still very little understanding of the 
process of DNA digestion in both regulated (RCD) and accidental cell death (ACD) (Mizuta 
et al., 2013).  
Hydrolysis of the N-glycosyl bond (Drohat and Maiti, 2014) that connects the nucleobase 
with the sugar/phosphate backbone, is catalysed by a monofunctional glycosylase that 
results in cleavage of the base to leave an abasic site (Lindahl and Karlstro.O, 1973, Lindahl 
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and Nyberg, 1972, Loeb and Preston, 1986). Due to the relative instability of this bond, 
hydrolysis at this site occurs readily with approximately 10,000 abasic sites created each day 
per cell (Lindahl and Nyberg, 1972). This process is often referred to as ‘depurination’ as it 
has been demonstrated that the rate of loss of cytosine and thymine (1.5 x 10 -12 s-1) (Lindahl 
and Karlstro.O, 1973) is only 5% that of the loss of the purines, guanine and adenine (3.0 x 
10-11 s-1) (Lindahl and Nyberg, 1972). Bifunctional glycosylases also act to catalyse the 
hydrolysis of N-glycosidic bond using an amine nucleophile from the enzyme itself creating 
an intermediate Schiff base, which then allows for the β-elimination of the phosphodiester 
backbone at the 3’ end of the abasic site causing single strand nicks (Drohat and Maiti, 2014) 
and consequently further fragmentation of the DNA (Briggs et al., 2007, Ginolhac et al., 
2012).  
The formation of interstrand DNA cross-links between abasic sites and opposing nucleotides 
was first described in 1964 (Freese and Cashel, 1964). The reaction, which has only recently 
become fully understood, involves the aldehyde group of the abasic site interacting with the 
exocyclic N2-amino group of an opposing guanine base (Dutta and Gates, 2006, Catalano et 
al., 2015) or the N6-amino group of adenine (Price et al., 2014) to form an interstrand DNA 
cross-link (Dutta and Gates, 2006, Catalano et al., 2015). If left unrepaired, this type of 
cross-link can cause cell death to occur in a eukaryotic cell (Grossmann et al., 2001).   
Hydrolytic (Orlando et al., 2013) or nitric oxide-induced (Wink et al., 1991) deamination 
causes a direct change in the sequence of cellular DNA through the removal of the amine 
group of the base. Deamination by hydrolysis is most frequently observed as a transition 
from cytosine to uracil (5.8 x 10-13 s-1) (Duncan and Miller, 1980) or 5-methylcyctosine to 
thymine (2.6 x 10-13 s-1) (Shen et al., 1994, Duncan and Miller, 1980), whilst the transition 
from adenine to hypoxanthine (Shapiro and Klein, 1966, Lindahl and Nyberg, 1974, Duncan 
and Miller, 1980) only occurs at approximately 2-3% of the purines (Karran and Lindahl, 
1980). Conversely, nitric oxide-induced deamination more readily occurs in purine bases 
such as the transition from guanine to xanthine (Caulfield et al., 1998). The transition of one 
base to another in the DNA sequence can result in the incorrect nucleotide being 
incorporated into the daughter strand during replication. For example, the deaminated 
cytosine base uracil will go on to pair with adenine following which, during subsequent 
replication, adenine will in turn pair with thymine generating a C→T point mutation 
(Duncan and Miller, 1980).  
Damage to DNA can also be caused by oxidation reactions involving reactive oxygen 
species (ROS) (Feig et al., 1994), such as the superoxide anion (O2
2-), the highly reactive 
hydroxyl radical (HO.), Hydrogen peroxide (H2O2) and the singlet oxygen (
1O2). These can 
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be formed as a by-product of normal cellular metabolism (Freeman and Crapo, 1982), a 
result of ionising or ultra violet (UV) radiation (Peak and Peak, 1989, Zhang et al., 1997, 
Ravanat et al., 2001) or through the metabolism of exogenous chemicals (Cooke et al., 2003). 
Oxidation can also occur by the loss of one electron from the nucleobase ring causing a 
charge that will make its way along the double helical structure of the DNA strand until it 
becomes trapped and results in damage to the DNA base (Kanvah et al., 2010). The site at 
which this reaction occurs is determined by the localised DNA sequence (Kanvah et al., 
2010), but it has been widely shown that guanine is preferentially oxidised due to both its 
low ionisation potential (Steenken and Jovanovic, 1997, Fleming et al., 2015) and the steric 
effects of the chemical structure (Carter et al., 1996). The oxidation of guanine to form 8-
oxo-7,8-dihydroguanine (8-OxoG) is the most frequently observed oxidative lesion with 1 in 
40,000 8-OxoG sites present in the human genome (Shigenaga et al., 1990), 10% of which 
result in a G→T transversion site (Hanes et al., 2006). 
In addition to this, the absorption of UV light by the double bonds in pyrimidine bases can 
lead to cyclobutane pyrimidine dimers (Setlow, 1966, Mouret et al., 2006) whereby adjacent 
pyrimidine bases are covalently linked to form TT, CT, TC or CC base pairings, or 6-4 
photoproducts (Mitchell and Nairn, 1989, Ravanat et al., 2001), which involve a single 
covalent bond between two carbon atoms in the ring. In each type of pyrimidine dimer 
lesion, the intrastrand bonding of molecules results in disruption to the DNA helical 
structure, which will prevent DNA replication unless repaired (Rastogi et al., 2010).  
In addition to the aforementioned mechanisms of DNA degradation, consideration must also 
be given to the potential for further degradation or loss of DNA as a direct result of 
laboratory processing and sample storage. During the preparation of some samples, 
particularly bone and teeth, it may be necessary to physically cut and grind the specimen 
prior to DNA extraction which may cause DNA fragments to shear or degrade due to friction 
or the heat produced, which is thought to cause double-strand breaks in the DNA leading to 
an increase in fragmentation (Purschke et al., 2010). 
Although extremely difficult to quantitate, it is thought that the physical manipulation of the 
samples, for example through pipetting or vortexing, during DNA isolation can cause 
shearing of the DNA due to hydrodynamic breakage (Bowman and Davidson, 1972, 
Davison, 1959, Yoo, 2011). The fragmentation of DNA through use of a vortex however, 
has recently been refuted by Rossmanith et al. (2011) who did not observe any significant 
difference in the quantity of DNA recovered between two samples, one of which had been 
routinely vortexed over the course of a month (Rossmanith et al., 2011). The qPCR target 
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was however, only 274 bp and so may not reflect the level of degradation to the larger DNA 
fragments. 
Storage of DNA extracts at -20 ˚C or -80 ˚C, along with freeze-thaw cycles over this period, 
results in the formation of ice crystals, which have been shown to physically shear and 
therefore further fragment the DNA (Ross et al., 1990, Shao et al., 2012). The effects of 
freeze/thaw cycles were observed in longer genomic DNA fragments (Shao et al., 2012, 
Rossmanith et al., 2011), i.e. greater than 100,000 bases (Shao et al., 2012), but not in 274 
bp PCR amplicons, even after twenty freeze-thaw cycles (Rossmanith et al., 2011), 
suggesting that extracts containing degraded DNA would not be at further risk of 
fragmentation if stored frozen.  
1.2.5.3 Mitocondrial DNA versus nuclear DNA 
The multi-copy nature of the mtGenome within every cell offers two further avenues for use 
in forensic DNA analysis in the form of an alternative source of DNA in samples that either 
inherently contain little or no nDNA such as keratinous tissues (Parson et al., 2015, Higuchi 
et al., 1988, Anderson et al., 1999) or, of particular interest for this study, samples in which 
the quantity or quality of nDNA is in question, i.e. nDNA is expected to be severely 
degraded due to the effects of age and/or environment, or quantification results indicate a 
low concentration/absence of nDNA.  
It has been estimated that nDNA may degrade approximately twice as fast as mtDNA 
(Allentoft et al., 2012), and so mtDNA can often be amplified from samples in which nDNA 
cannot (Schwarz et al., 2009, Krings et al., 1997). The ability of mtDNA to persist for a 
longer period of time than nDNA in forensic samples is thought to be due to a number of 
contributing factors. As previously mentioned the number of copies of the mtGenome 
present in human cells can be in the thousands thus resulting in an increased chance of 
mtDNA recovery and amplification relative to the nuclear genome, of which there is just one 
copy (Robin and Wong, 1988). Not only does the circular nature (van Bruggen et al., 1966, 
Nass, 1966) of the mtGenome provide resistance to exonuclease activity (Shokolenko et al., 
2013) that linear nDNA (Watson and Crick, 1953) is susceptible to, but the compact protein-
packaged core of the nucleoid (Kaufman et al., 2007, Nass, 1969, Brown et al., 2011, Lo et 
al., 2011) may offer a degree of protection to the mtGenome(s) within it. Support for this 
structural defence is  provided by Foran (2006) who demonstrated that in whole tissue 
mtDNA showed less signs of degradation than nDNA, but when a sample of that same tissue 
was homogenised the mtDNA was shown to degrade at a quicker rate than the nDNA 
(Foran, 2006). 
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The early demonstrations that mtDNA persisted for a longer duration than nDNA (Krings et 
al., 1997), along with the phylogenetic and biogeographical information that could be 
obtained from this genome, made it the ‘go to’ marker for any sample that was suspected to 
be degraded; investigators were not willing to risk a negative result in the pursuit of nDNA. 
The entire DNA analysis workflow has however, been developed over time from DNA 
recovery right through to data analysis, and so the potential to extract and successfully 
sequence nDNA has increased. In addition to this, an improved understanding of the 
mechanisms behind DNA degradation has led to the design of a wide range of highly 
informative markers which maximise the information obtained from every sample.   
1.3 Forensic DNA amplification kits  
1.3.1 PCR-CE STR kits 
The first reported assay was made up of just four STR markers (Kimpton et al., 1993, 
Kimpton et al., 1994). However, this was quickly replaced by the Second Generation 
Multiplex (SGM), containing six STRs and Amelogenin (Sullivan et al., 1993) for 
identification of sex. SGM had a match probability of <5-6, significantly reduced from its 
predecessor, which had a match probability of approximately <10--4 (Jobling and Gill, 2004). 
The match probability is calculated using allele frequency tables, which are based on the 
frequency with which a particular allele is observed at a specific locus in different 
populations around the world (based largely upon reference data sets). The allele frequencies 
for each present allele are used to calculate the genotype frequency at each locus using 
Hardy Weinberg. The resulting genotypes are then multiplied together (product rule) to 
obtain the match probability; the probability that two DNA profiles from unrelated 
individuals will match by random chance (Balding and Nichols, 1994). As more loci are 
included in an assay, the ability to discriminate between two individuals increased, resulting 
in a decrease in the match probability.  
The SGM assay was further advanced through the addition of four new STRs (SGM Plus), 
which resulted in a reduction in the match probability of the assay to just <10-13 (Jobling and 
Gill, 2004). The ten STR loci included in the SGM Plus kit are D3S1358, vWA, D16S539, 
D2S1338, DS81179, D21S11, D18S51, D19S433, TH01 and FGA. Introduced into forensic 
casework in 2000, the SGM Plus kit, a product of Applied Biosystems, was utilised by all 
forensic providers in the UK for loading to the NDNADB until 2014. Although the 
calculated match probability values for SGM Plus were so low that it was commonly 
reported as a standard ‘less than 1 in billion’, the Prüm Treaty and its subsequent adoption 
by the EU Council (Union, 2008) requires that an exchange of DNA profile information 
within Europe is possible and so the NDNAD was updated to include the European Standard 
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Set (ESS) of loci (Gill et al., 2006b, Gill et al., 2006a), and three ‘DNA 17’ kits were 
developed and approved for forensic use in England, Wales and Northern Ireland. 
1.3.1.1 DNA 17 assays 
In an opening of the forensic market, there are three DNA 17 kits that have been approved 
for loading to the NDNAD; NGM Select (Applied Biosystems) (Green et al., 2013), ESI 17 
(Promega) (Tucker et al., 2011) and Investigator ESS Plex SE (Qiagen) (Qiagen, 2015a). All 
three of these kits incorporate Amelogenin, the same ten loci from the previous SGM Plus 
kit and an additional six loci, D10S1248, D22S1045, D2S441, D1S1656, D12S391 and 
SE33, which loci include the European standard set of twelve STR markers (Gill et al., 
2006b). Although all kits utilise the same STR loci, the differing primer binding sites and 
chemistries result in slight variations in amplification sensitivity and also potential 
discordance between results for the same sample (Tomas et al., 2014). An example of a 
DNA 17 assay is shown in Figure 1.3. 
 
Figure 1.3 Example of a DNA 17 kit. The chart is a representation of the loci included in 
the Applied Biosystems NGM Select kit (Biosystems, 2015), and the allele size range for 
each locus. The different colours represent the colour of the fluorescent dye attached to the 
respective primer sets. Those loci with a discriminatory value have been designed where 
possible in the low molecular weight range (< 200 bp).  
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1.3.1.2 Alternative assays 
Aside from those kits developed for loading to the NDNAD, there are numerous additional 
assays that have been developed over the years. Whilst many have been developed for 
loading to the national databases of countries outside of the UK or for non-database 
identification, there are kits which have been developed for use in specific circumstances. 
AmpFℓSTR® MiniFiler for example, includes only eight low molecular weight loci, and so is 
often used for amplification of samples that are expected to be degraded/inhibited (Mulero et 
al., 2008). PCR assays such as AmpFℓSTR® Identifiler Direct (Wang et al., 2011) and 
Promega’s ESX/ESI systems (Tucker et al., 2012a, Tucker et al., 2011) have been developed 
for use in direct PCR, whereby the sample is added directly to the PCR tube without pre-
isolation of the DNA (Section 3.1), and so have a higher tolerance for the  potentially 
increased presence of PCR inhibitors. AmpFℓSTR® YFiler has been designed to target 
seventeen STRs on the Y-chromosome only (Mulero et al., 2006), which is particularly 
useful in cases with a high background level of female DNA such as in sexual assault 
casework. In more recent years SNP assays have been developed for compatibility with 
capillary electrophoresis (CE) instruments, including those for determining hair and eye 
colour; most notably HIrisPlex which contains a total of twenty-four SNPs (Walsh et al., 
2013). 
1.3.1.3 Limitations of PCR-CE 
Despite the success of the aforementioned PCR-CE kits for DNA profiling in forensic 
science, there are some significant limitations to this method. The number of multiplexed 
DNA fragments of the same or overlapping size that can be analysed at any one time using 
CE, is restricted due to constraints on the number of different dyes (currently a maximum of 
six) that can be detected by the instrument itself.  
Current forensic DNA amplification assays rely on the use of fragment length analysis rather 
than the sequence of the STR itself. It is known that SNPs can occur within the STR repeat 
units or flanking regions, resulting in isoalleles (Section 5.1) that could enable further 
distinction between two individuals or help resolve DNA mixtures. 
Due to the limitations on the number of loci able to be detected using CE, along with the 
necessity of specific allelic ladders, it is extremely complex to multiply differing marker 
types for simultaneous analysis. Consequently multiple amplification reactions are required; 
each one consuming part of what may be a very limited DNA extract.  
The introduction of massively parallel sequencing (MPS) has alleviated or resolved the 
aforementioned limitations associated with CE fragment analysis, thereby facilitating the 
20 
 
development of a new generation of multiplex amplification assays for use in forensic 
casework. 
1.3.2 Massively Parallel Sequencing 
The development of MPS was originally driven by the need to reduce both the time and 
financial costs associated with Sanger sequencing for large scale genomic study (Collins et 
al., 2003), however this multifaceted technology has found numerous additional and diverse 
applications across the spectrum of genetics, including in clinical diagnostics (Jones, 2015), 
molecular ecology (Ekblom and Galindo, 2011) and functional genomics (Morozova and 
Marra, 2008). The fields of forensic science and bioarchaeology are no exception to this as 
the potential is explored to develop both novel approaches to their work or for opportunities 
to make improvements on traditional techniques in order to generate a better quality and 
quantity of results. 
1.3.2.1 Development of platforms 
The first MPS platform, released by 454 Life Sciences in 2005 (Margulies et al., 2005) was 
based upon the use of pyrosequencing. This method uses a DNA library which is first 
prepared by randomly fragmenting double-stranded DNA (dsDNA) and ligating specialised 
adaptors to each strand; the DNA is then denatured and captured by beads so that each bead 
has one, single-stranded DNA fragment attached to it. The DNA fragments are then 
amplified in-situ using emulsion PCR, resulting in beads that have 10 million copies of their 
DNA fragment attached. The beads are then transferred onto a slide that contain wells 55 µm 
deep (Margulies et al., 2005), enough to hold a single DNA bead and smaller beads 
containing the immobilised enzymes need for the pyrosequencing reaction to occur. During 
sequencing, the reagents flow past the open side of the vertically held slide, allowing them to 
diffuse into the wells to surround the beads. As a dNTP is incorporated into the sequence by 
a DNA polymerase, a nucleotide dependant quantity of pyrophosphate is released, which is 
then transformed to ATP, in the presence of adenosine 5’ phophosulfate by ATP sulfurylase. 
ATP then converts luciferin to oxyluciferin, resulting in the generation of photons that are 
detected by a charge coupled device camera on the closed side of the wells. Apyrase is 
utilised to digest remaining dNTPs and then the reaction is repeated.  
This first sequencing by synthesis technology demonstrated the capability to simultaneously 
sequence over 300,000 DNA fragments (approximately 100-110 bases) of a Mycoplasma 
genitalium genome, with 96% accuracy in a single run of four hours (Margulies et al., 2005), 
representing a 100-fold improvement on the Sanger sequencing technology. Just three years 
later, the extent to which MPS was having already having an impact on the field of genomics 
was demonstrated when the first human genome sequenced using this technology was 
21 
 
published, taking just two months to complete (Wheeler et al., 2008), a feat that had 
previously required a worldwide collaboration and over a decade in time using the Sanger 
technique (Collins et al., 2004).   
In the years following the release of the 454 system (purchased by Roche but recently 
discontinued) several MPS platforms have been developed, improving performance in terms 
of run speed, read length, sample capacity, accuracy and quality.  
Developed by the same designer, the technology underlying the Ion Torrent (now owned by 
Thermo Scientific) PGM™ and Proton™ series platforms, is principally the same as the 
previously described 454 system. The difference between these two technologies is that 
where the 454 system relies on photon detection resulting from the incorporation of a 
nucleotide, the Ion Torrent platforms uses semiconductor sequencing which measures the 
release of protons. The released proton causes a change in the well pH which is detected as a 
difference in potential across a metal oxide layer that is placed between the bottom of the 
well and the sensor plate, thus negating the requirement for scanning with a camera and so 
decreasing the time taken per run (Rothberg et al., 2011). The Ion Torrent PGM™, released 
in 2010, is currently the quickest bench top sequencer commercially available with the of the 
longest read length capacity of 400 nucleotides (van Dijk et al., 2014a). The Proton™, Ion 
Torrents latest benchtop platform, has been designed for high-throughput use with the 
capacity to produce up to 10 Gb of data on 200 bp reads in less than four hours 
(Technologies, 2015). Both the 454 and Ion Torrent systems have been shown to be prone to 
errors in homopolymeric regions of the DNA sequence (Loman et al., 2012, Margulies et al., 
2005).   
The Sequencing by Oligo Ligation Detection (SOLiD®) sequencing chemistry (Thermo 
Scientific) introduced in 2007, is again very similar to the 454 system, using beads and 
emulsion based PCR for target amplification. Rather than dispensing the beads into wells 
however, the template DNA undergoes a 3’ modification which enables a covalent bond to 
be formed between the bead and a glass slide. Primers are hybridised to the adaptors that 
were added during library DNA preparation and then four fluorescently labelled di-base 
probes are used in a ligation reaction. When a probe is complementary to the template DNA, 
it hybridises and is then ligated, prior to fluorescent detection and imaging. The dye is then 
cleaved off with silver ions to liberate a 5’ phosphate group and the process is repeated for 
the required number of cycles. The synthesised DNA strand is removed and a new primer is 
then hybridised, offset by one nucleotide base and the steps repeated so that each base across 
the sequence is read twice (Technologies, 2013, Mardis, 2008). The key advantage of this 
system is its high base calling accuracy of 99.85% after filtering (Liu et al., 2012) however 
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due to its short read length of 35 nucleotides and long run time this platform is not widely 
used for research. The introduction of the SOLiD® Wildfire system in 2013, has sought to 
rectify these short comings as the DNA library amplification is now carried out directly on a 
flow chip using isothermal amplification rather than the previous bead/emulsion PCR system 
(Ma et al., 2013), thus increasing the read length to 75 nucleotides whilst decreasing both the 
preparation/run times by a quarter (Technologies, 2012).    
Illumina’s sequencing by synthesis technology, acquired from Solexa in 2007, is the basis 
for their MiSeq, NextSeq, HiSeq and HiSeq X series sequencing platforms (Illumina, 2014b). 
DNA libraries are pooled, denatured and added to the flow cell where single-stranded DNA 
will hybridise with complimentary adaptor sequences. A DNA polymerase is used to 
synthesise a complimentary strand of DNA which is attached to the flow cell and the 
original template is then washed away. The oligo at the free end of the remaining DNA 
strand then hybridises with a complimentary adaptor on the flowcell to form a bridge and a 
new strand of DNA is synthesised. The dsDNA is denatured, resulting in two independent 
strands that are anchored to the flowcell, which then each undergo bridge amplification until 
a cluster comprising of up to one thousand copies of the original template is generated. All 
reverse strands are cleaved and washed away, all 3’ ends on the oligo lawn and DNA 
fragments are blocked and a sequencing primer is added to the flowcell, which hybridises to 
the template DNA. All four fluorescently labelled, reversible terminators are added to the 
flowcell and the one which is complimentary to the template will be incorporated by the 
DNA polymerase, whilst the remaining terminators are washed away. The fluorescent label 
acts as a polymerase terminator and, using total internal reflection fluorescent imaging with 
two lasers, the incorporated nucleotide can be identified. The fluorescent tag is then cleaved 
to allow for the addition of the next nucleotide (Illumina, 2010). This cycle of incorporation, 
washing and cleaving repeats of up to 300 bases (Illumina, 2014b). 10 million clusters per 
square centimetre of the flow cell means that billions of reads can be taken per run.  
Using the HiSeq X platform, Illumina is the first company to meet the $1000 human genome 
(van Dijk et al., 2014a), which achieved using two flowcells, each with a capacity for 3 
billion reads of 2 x 150 bp lengths, generating up to 1.8 Tb  in less than 3 days (Illumina, 
2014b). Illumina are widely acknowledged as the current leaders in the MPS market 
(Metzker, 2010, Quail et al., 2012, van Dijk et al., 2014a), with >90% of all the worlds 
current sequencing data generated using their platforms (Illumina, 2014b). This is most 
likely due to the fact that although other platforms can be more accurate (Technologies, 
2013), quicker (Technologies, 2015) or have longer maximum read lengths (Bayley, 2015), 
the Illumina platforms represent a balance between all these variables. The limitation with 
technology primarily lies in the use of two lasers, red and green; each of which is required to 
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differentiate between two dyes, A/C and G/T respectively that have similar emission profiles. 
Schirmer et al. (Schirmer et al., 2015) used 16S bacterial data to demonstrate that the 
nucleotide substitution errors occur with increasing frequency towards the end of each read 
and that read 2 has a significantly higher error rate. It was proposed that the increase in 
errors at the end of the read sequences is due to an accumulation of phasing and dephasing 
events, which results in a loss of cluster signal (Schirmer et al., 2015). This also means that 
variable clustering density on the flowcell or a DNA library lacking in complexity can result 
in a loss of base calling accuracy or the inability to demultiplex the sequences (van Dijk et 
al., 2014a, Schirmer et al., 2015).   
A significant development in MPS was the introduction of technologies that no longer 
required a DNA amplification step as part of the protocol for whole genome or de novo 
sequencing. The removal of PCR associated artifacts and amplification bias (Hart et al., 
2010) results in sequences that are truly reflective of their endogenous state, in terms of both 
sequence fidelity and the numbers observed.  
The HeliScope™ Single Molecule Sequencer (SMS) (SeqLL, Woburn, MA, USA) was the 
first technology to be commercially released that does not include a PCR enrichment step in 
the protocol. Briefly, extracted DNA is cleaved into fragments of 100-200 bp in length and a 
poly-A universal priming sequence is added to the end of each strand. A fluorescently 
tagged adenosine nucleotide is then added to the end of the poly-A sequence and the DNA 
fragments are loaded onto the flow cell for hybridisation with oligo-T universal capture sites. 
The surface of the flow cell is illuminated and the incorporated fluorescent adenosine 
enables the position of every strand recorded by CCD camera. The template label is then 
removed and a DNA polymerase plus one type of fluorescently tagged nucleotide is added to 
the flow cell and then subsequently washed away to remove any excess. The flow cell is 
again illuminated and images capture the positions of the strand that have incorporated the 
additional nucleotide. The fluorescent tags are removed and the step is repeated for each 
type of nucleotide for the required number of cycles with every DNA strand to being 
sequenced independently (Hart et al., 2010). The HeliScope™ SMS was the first single 
molecule sequencing technology to be used to sequence a human genome in 2009 
(Pushkarev et al., 2009), achieving 90% alignment to the reference genome. One of the 
biggest advances introduced by the HeliScope™ SMS is the ability to directly sequence 
RNA molecules through the use of a reverse transcriptase enzyme rather than a DNA 
polymerase, thus negating the requirement for prior conversion to cDNA (Ozsolak et al., 
2009).  
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The development of the PacBio RS II Real-Time (SMRT®) DNA Sequencing System 
(Menlo Park, CA, USA) in 2010 represented another step forward in MPS as it was the first 
SMS platform with the ability to record the DNA sequence in real time (Eid et al., 2009). 
This is accomplished using an array of up to seventy-five thousand 29Φ polymerase 
molecules (Schadt et al., 2010), each one of which is immobilised on a glass surface within a 
nano-photonic zero-mode waveguide (ZMW) (a 43-50 nm hole within a 100 nm metal film) 
(Levene et al., 2003). Nucleotides, which are fluorescently labelled on the phosphate chain 
of the nucleotide rather than the base (Korlach et al., 2003), are passed over the ZMWs and 
down to the polymerase molecule by diffusion. The size of the ZMW restricts its 
illumination to the bottom 30 nm; therefore any nucleotides above this level will not be 
detected (Levene et al., 2003). As a nucleotide is incorporated by the polymerase it 
fluoresces and the signal is recorded before the phosphate chain and the fluorescent tag are 
cleaved. The use of this nanotechnology based approach enables the polymerase to work 
without the interruptive steps of nucleotide flushing/washing, signal recording and 
fluorescent tag cleaving, which results in an increase in the length of reads, approximately 
twenty thousand nucleotides, and also a significant reduction in the time take to complete a 
sequence (Levene et al., 2003, Eid et al., 2009, Schadt et al., 2010).  
Nanotechnology has also been employed by Oxford Nanopore Technologies (Oxford, 
Oxfordshire, UK) in their three instruments the GridION™, PromethION™ and MinION™. 
As alluded to in the name, the recently launched MinION™ is a hand held device and is the 
only portable device currently commercially available. This technology utilises the negative 
charge of DNA to draw each strand through a 1 nm protein nanopore, which is set in a 
synthetic polymer membrane containing several hundred nanopores (Bayley, 2015). An 
enzyme sits above the nanopore, separating the DNA, which allows a single strand to then 
be drawn through the centre of the nanopore. The DNA strand blocks part of the ion current 
as it moves through the pore, causing a disruption in the current that is characteristic of the 
nucleotides present, thus allowing the sequence of the passing DNA strand to be identified. 
The DNA library is prepared so that each dsDNA molecule has a hairpin at one end so that 
as one strand is sequenced, the opposite strand is then drawn through the nanopore for 
sequencing also (Clarke et al., 2009).  
The serious limitation shared by all current SMS technologies is in the high error rate of raw 
reads ~ 5% (HeliScope) and 15% (PacBio) in, particularly for the detection of insertions and 
deletions (indels), which can make sequence alignment extremely complex. In an attempt to 
sequence the genome of the lambda phage, just 10% of the raw reads mapped to the 
reference genome (Mikheyev and Tin, 2014), even when using the Basic Local Alignment 
with Successive Refinement (BLASR) tool, which has been developed to accommodate the 
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longer read lengths and the high instances of indels found in SMS technologies (Chaisson 
and Tesler, 2012). It has been suggested that the high number of indels observed in the 
MinION™ data may be due to signal errors caused by an uneven movement of the DNA 
strand as it passes through the pore (Mikheyev and Tin, 2014). Whilst these technologies 
have found application for rapid clinical tests (Quick et al., 2015, Jones, 2015), they are 
unlikely to replace the PCR based methods for de novo sequencing until the sequencing 
becomes more robust (Laver, 2015, Mikheyev and Tin, 2014).  
1.3.2.2 Library preparation 
Library preparation is the first step in the process irrespective of the sequencing platform to 
be used and is crucial in determining the quality of the sequencing data generated (van Dijk 
et al., 2014b, Schirmer et al., 2015). Many protocols use either mechanical shearing or 
enzymatic cleavage to randomly fragment the DNA strands (Knierim et al., 2011) followed 
by a PCR step which allows for the platform specific adaptors to be attached. Specific 
indexes can also be incorporated at this point in cases where multiple samples are processed 
together. In the case of Illumina platforms, paired-end sequencing allows for the use of a 
dual index system whereby DNA fragments have an index at each end of the DNA strands to 
be sequenced (Syed et al., 2009) increasing the number of samples that can be multiplexed 
together. A size selection or PCR clean up step can then be utilised to remove any unused 
primers/adaptors from the reaction prior to sequencing. The use of a PCR step during DNA 
library preparation results in amplification bias (Dabney and Meyer, 2012) that is reflected 
in the resulting sequence data, particularly evident in samples that are not GC neutral (van 
Dijk et al., 2014b). It has been shown that the choice of DNA polymerase can affect the 
extent of bias observed (Dabney and Meyer, 2012), as can the inclusion of additives such as 
betaine, which reduces the bias seen when amplifying GC rich genomes (Aird et al., 2011, 
van Dijk et al., 2014b).  
A pair-ended, dual index system developed by Kozich et al. (Kozich et al., 2013) for 
sequencing of amplicons from the bacterial 16S region has circumvented the requirement for 
the fragmentation of DNA, instead employing a one-step PCR during which the DNA 
extract is amplified using primers which include one of the two platform specific flowcell 
adaptors (in this case the Illumina MiSeq), a unique sample index and the target region. The 
forward and reverse primers each carry different index sequences, which together create a 
unique sample identifier. Removing the requirement for a second PCR step, which would 
usually be required to attach the flowcell adaptors, reduces the potential for PCR artifacts 
and can be customised for any target sequence. 
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Illumina’s TruSeq DNA PCR-Free Library Preparation Kit uses ligation to attach adaptors to 
sample DNA, thus eliminating the PCR bias at this stage of sample preparation. The 
suggested DNA input for this technique is relatively high at a minimum input of 25 ng 
required, however it has been demonstrated that this kit can be effective with as little as 6 ng 
of amplified STR product (Zeng et al., 2015). 
1.3.2.3 Target enrichment techniques 
Target enrichment techniques allow for the DNA sequencing of areas of the genome of 
specific interest to be analysed, thus optimising the amount of information obtained for the 
cost/time required for processing and data analysis. Historically, this role has been fulfilled 
by PCR, but difficulties in designing efficient large-scale multiplex reactions particularly 
non-specific and preferential amplification, limit the capability of most PCR techniques to 
take full advantage of MPS. Micro-droplet PCR however, alleviates some of these issues 
through the separation of DNA template and PCR reagents into single-plex reaction droplets 
(Tewhey et al., 2009).  
An alternative to PCR is the use of molecular inversion probes (MIP) which are made up of 
a synthetic single (Nilsson et al., 1994) or double (Yoon et al., 2015) oligonucleotide strand 
that has a highly specific sequence region at each end. These regions hybridise both 
upstream and downstream of the target, which is then copied and incorporated into a circular 
DNA molecule by polymerase and ligase enzymatic activity (Nilsson et al., 1994). An 
exonuclease is then used to digest any linear background DNA, thus increasing the 
proportion of the target sequence, which can then be amplified prior to sequencing. This 
technique has been particularly successful in targeting exons in the genome for DNA 
analysis (Porreca et al., 2007) with up to 50,000 exons enriched simultaneously in a 55,000 
multiplex reaction (Turner et al., 2009), and also in DNA methylation studies (Deng et al., 
2009, Diep et al., 2012).  
Hybridisation capture is a target enrichment method that uses target specific 
oligonucleotides which are immobilised on a microarray platform (Albert et al., 2007) or in 
solution using a biotinylated probes and beads system (Gnirke et al., 2009). Any non-
specific DNA is then washed away, thus enriching the regions of interest and once isolated, 
the target sequences are then released from the probes and eluted ready for MPS. The key 
advantage of both MIP and hybridisation methods is the capability to enrich large target 
fragments of DNA in a more efficient way than PCR based techniques, in that it can be 
completed in a single reaction using as little as 3 µg of DNA (Mamanova et al., 2010). 
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Microfluidic droplet enrichment for targeted sequencing (MESA) is a novel technique 
recently been published by Eastburn et al. (Eastburn et al., 2015), which eliminates the 
requirement for either PCR or hybridisation techniques. Utilising droplets to encapsulate 
DNA molecules, the 50-200 kb target sequences are identified by amplification of 
approximately 100 bps with a highly specific Taqman assay. The Taqman identified 
sequences are then separated from those droplets without the target sequence by 
dielectrophoretic sorting when the fluorescent tag is detected. The collected DNA target 
sequences are then released from the oil based droplets and the amplified section is removed 
from the DNA fragment enzymatically, prior to sequencing (Eastburn et al., 2015). This 
technique allows for the enrichment of longer target sequences than PCR or hybridisation 
methods and resulted in a 13-fold enrichment of a 200 kb DNA target. The relatively high 
DNA input requirement of 100 ng however, will again need to be reduced for utilisation 
with forensic samples.            
1.3.2.4 Use of MPS for Human Identification 
The investigation governed nature of forensic DNA analysis requires a focused approach, 
exploiting highly informative markers in order to answer questions posed during the inquiry. 
Sequencing of large regions, or indeed the whole human genome is therefore a redundant 
endeavour in terms of the added value of the additional information, as well as the time and 
monetary considerations. There are two notable exceptions to this type of approach; firstly, 
the recently demonstrated distinguishing capability in haplotype when the whole mtGenome 
is sequenced (Just et al., 2015, King et al., 2014a) as discussed in Section 1.2.3 and secondly 
is the use of whole nuclear genome mapping by MPS to differentiate between monozygotic 
twins based on rare polymorphisms, who would otherwise be indistinguishable from one 
another (Weber-Lehmann et al., 2014). 
The markers traditionally utilised in forensic casework are currently undergoing 
development and evaluation for use on the MPS platforms, as well as the rigorous validation 
processes that accompany any new technology for forensic application. In addition to a 
limited read capacity, the number of multiplexed DNA fragments of the same or overlapping 
size that can be analysed using capillary electrophoresis is restricted due to constraints on 
the number of different dyes that can be detected by the instrument. 
For the majority of sequencing work, depth of coverage refers to the average coverage per 
base across a run, whereas targeted sequencing for forensic applications relies on the actual 
amplicon or base count for comparison between alleles/loci and for the accurate 
identification of the present variants. The minimum depth of coverage that can be used to 
accurately identify the allele/variant calls in a profile will determine the number of loci that 
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can be multiplexed in one reaction, which in turn impacts on the number of samples that can 
be processed in one run (Eduardoff et al., 2015). Investigations into the depth of coverage 
required for forensic analysis found that for single source profiles, 13x – 40x coverage 
(Quail et al., 2012, Eduardoff et al., 2015, King et al., 2014a) is sufficient to accurately 
identify variant mutations. 
In an early study on the use of MPS for STR sequencing, Bornman et al. (Bornman et al., 
2012) demonstrated a >99% confidence in allele designation using a depth of coverage of 
18,500 reads. This figure however was generated using the limited 150 base single read 
sequences available on the Illumina MiSeq platform at the time of this study and is therefore 
likely to be grossly over-estimated using updated chemistry. A more recent study using 454 
pyrosequencing found that a depth of coverage of 160 reads was sufficient to accurately 
designate alleles (Fordyce et al., 2011) whilst another set filters to 1% of the total read count 
(Van Neste et al., 2012). Work to determine the minimum depth of coverage required for 
accurate STR allele designation is still on-going (Zeng et al., 2015) and will be platform, 
chemistry, marker and locus dependant.  
Aside from the ability to multiplex markers and samples, one of the significant advantages to 
using MPS for forensic analysis is that rather than a profile based on fragment size analysis, 
the actual sequence of the STR is obtained. Numerous isoalleles (Heinrich et al., 2005, 
Rockenbauer et al., 2014, Gelardi et al., 2014, Dalsgaard et al., 2014) as well as SNP sites in 
the flanking regions of the repeat structures (Divne et al., 2010) have already been 
documented, which provide the capability to distinguish between two individuals with the 
same allele call for a locus, thus increasing the discriminatory value of the allele and also 
aiding the deconvolution of mixtures. The allele sequence may also prove particularly useful 
for distinguishing stutter from the true allele in situations where one allele is a single repeat 
less than the other (Zeng et al., 2015).                                                                                              
Gelardi et al. (Gelardi et al., 2014) proposed a nomenclature system for isoalleles to 
facilitate consistency across the field. Firstly, the standard locus name is listed followed by 
the length of the STR divided by the length of the individual repeating unit. The sequence 
and number of each repeat unit(s) is then added and lastly any flanking region variants are 
listed, using rs numbers where possible (Gelardi et al., 2014). For example two differing 
versions of D3S1358 locus allele 14 would be written as 
D3S1358[14]TCTA[1]TCTG[3]TCTA[10] and D3S1358[14]TCTA[1]TCTG[1]TCTA[12] 
(Gelardi et al., 2014). In order to better accommodate variants in the flanking regions of the 
STR target, it has been suggested that additional information for each variant be included in 
the format; locus, allele, chromosome: position and reference genome (Gettings, 2015), 
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which carries the advantage of limiting discrepiences as reference genomes are updated. 
Alternatives to this bracketed approach have also been suggested by Gettings et al. (Gettings, 
2015) including the use of the complete MPS generated string sequence which could also 
allow for recording of platform, chemistry etc. utilised for sequencing. Whilst the transition 
to MPS technologies requires a thorough investigation into the most apposite method for 
recording the generated sequence data, the development of new nomenclature systems will 
inevitably result in inconsistency amongst data sets as individuals use their own preference. 
Progress in this area is quickly needed so that publication of guidelines by a standardising 
body such as ISFG can be issued to ensure uniformity.  
Data analysis is currently a substantial constraint on the introduction of MPS for use in 
routine casework. A lack of end to end analysis software and the sheer quantity of data 
produced by any MPS run has resulted in the utilisation of developed or adapted ad hoc 
workflows, which can make it very difficult to assess the data quality and also complicates 
data comparison between groups, due to differing parameters or nomenclature. The 
development of multiple Y-SNP phylogenies is one example of this, whereby the once 
ubiquitous Y-Chromosome Consortium tree has been superseded by several differing trees 
as new data sets are released (Larmuseau et al., 2015). 
The ability to multiplex a variety of markers of the same size is a significant advantage of 
MPS over the traditional PCR-CE methodologies for the processing of degraded forensic 
samples. Smaller amplicons have a better success rate in samples containing sub-optimal 
DNA and so a larger quantity of markers will maximise the information available from these 
sample types.  
1.3.3 MPS forensic multiplex kits 
There are currently a limited number of commercially produced forensic assays available for 
use with MPS technology. Both Illumina and Thermo Scientific have developed kits 
exclusively for use with their own platforms, whilst Promega have developed a series of 
assays for use with the Illumina MiSeq platform. A summary of the number and type of 
markers utilised by each is provided in Table 1-1. The Ilumina ForenseqTM DNA Signature 
Prep Kit clearly is ahead of the rest of the market in terms of the variety of markers analysed 
and the number of markers included for analysis.  
1.3.3.1 MiSeq FGx Forensic Genomics System  
The release of the ForenSeq™ DNA Signature Prep Kit (Illumina, 2015a), which has been 
developed by Illumina for use exclusively with their MiSeq FGx Forensic Genomics System 
(Illumina, 2015b) is the first assay which exploits the marker multiplexing capability of 
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MPS. This kit contains two primer sets; set A contains autosomal, X and Y STRs and 
identity SNPs, whilst phenotypic and ancestry informative SNPs are additionally included in 
set B, as summarised in Table 1-2.  
87 (56%) of the markers used in primer set A and 149 (64%) of those included in set B are 
below 150 bp in size (Table 1-3). If the DNA fragment length has degraded to less than 200 
bp (Wyllie et al., 1980), then 119 and 190 loci in primer sets A and B respectively should 
still be amenable to DNA amplification, depending on the degree of degradation, 
representing a substantial improvement in terms of the potential for results when compared 
with the amplification kits currently used in forensic casework. For example, only eight out 
of seventeen loci in the AmpFℓSTR® NGM™ Kit and seven out of nine loci of the 
AmpFℓSTR® MiniFiler™ Kit loci (designed specifically for degraded samples) fall below 
200 bp.  
In line with the traditional amplification kits, the suggested DNA input for this kit is 1 ng 
(Illumina, 2015a) and although, due its recent launch date, there is very little information 
available on DNA sensitivity tests, Børsting & Morling (Borsting and Morling, 2015) did 
make reference to having obtained results from a DNA input of 50 pg. This figure was given 
with the caveat that data were still being processed but if this is indeed the case then, given 
the 5 µl volume (Illumina, 2015a) allowed in the first PCR set-up then the minimum DNA 
concentration that would be required is 10 pg / µl, a figure below that considered for low 
template DNA forensic samples. It should be noted however, that no information was 
provided as to quality of the resulting DNA profile at this low DNA input.   
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Table 1-2 Summary of commercial forensic kits currently or soon to be available for use with MPS platforms. The two kits containing mtDNA include 
primers for ten overlapping sections of the control region and PowerSeq™ Auto/Mito/Y is the first commercial kit to contain both STRs and mtDNA targets.  
Company Kit name Platform 
Marker type  (number of targets) 
Reference 
STRs Y-STRs X-STRs 
Identity 
SNPs 
Ancestry 
SNPs 
Phenotypic  
SNPs 
mtDNA 
Thermo 
Scientific 
HID-Ion AmpliSeq™ 
Identity Panel 
Ion Torrent PGM 
platform 
   (169)    
(Borsting et al., 2014, 
Eduardoff et al., 2015, 
Seo et al., 2013) 
Thermo 
Scientific 
HID-Ion AmpliSeq™ 
Ancestry Panel 
Ion Torrent PGM 
platform 
    (165)   (Churchill et al., 2015) 
Thermo 
Scientific 
Ion Torrent™ HID 
STR 10-plex assay 
Ion Torrent PGM 
platform 
(9)       (Fordyce et al., 2015) 
Promega 
PowerSeq™ Auto 
System 
MiSeq MPS 
platform 
(23)       (Zeng, 2015) 
Promega PowerSeq™ Mito 
MiSeq MPS 
platform 
      (10) (Downey, 2015) 
Promega 
PowerSeq™ 
Auto/Mito/Y 
MiSeq MPS 
platform 
(22) (23)     (10) (Downey, 2015) 
Illumina 
Inc. 
ForenSeq™ DNA 
Signature Prep Kit 
MiSeq FGx 
Genomics System 
(27) (24) (7) (95) (56) (22)  (Illumina, 2015a) 
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Table 1-3  Maximum amplicon size of markers included in ForenSeq™ DNA Signature 
Prep Kit adapted from (Illumina, 2015a). 
 Maximum amplicon size (bp)  
Marker type <100 100-150 151-200 >200 Total 
Identity SNPs 24 53 17 1 95 
Autosomal STRs 0 8 10 9 27 
Y STRs 0 2 4 18 24 
X STRs 0 0 1 6 7 
Phenotypic SNPs 3 8 4 7 22 
Ancestry SNPs 18 33 5 0 56 
 
1.3.3.2 Mitochondrial DNA analysis 
Illumina have also made available a protocol for mtDNA D-loop amplification (Illumina, 
2013) or use with the MiSeq benchtop platform, including a list of suggested primers that 
have been adapted for duplex tagging, whereby two versions of each primer set are used in 
the reaction so that consensus between them can be checked. This method helps to maintain 
the true ratio of nucleotide bases in heterogeneous mixtures, which may otherwise become 
skewed as a result of bias during amplification and sequencing (Schmitt et al., 2012). Two 
overlapping amplicons are used, spanning the HVSI (nucleotide position 15997-16401) and 
HVSII (29–408) regions, with each set targeting a region of between 236-256 bp. While this 
has been demonstrated as a successful approach for forensic sample types meeting the 
mtDNA input requirement of 1 ng (Davis et al., 2015), the minimum fragment size of 236 bp 
may be an optimistic target for highly degraded DNA.  
It is essential that the capabilities and limitations of this generation of newly developed, 
commercially available assays are explored, as well as those ‘in-house’ developed methods 
for forensic application, as these data will help inform the forensic community as they 
discuss the potential for the introduction of MPS into casework. 
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1.4 Aims and objectives 
1.4.1 Aim 
The overall aim of this thesis is to explore the use of enhanced experimental strategies for 
the analysis of sub-optimal biological material that is encountered during forensic 
investigations. This aim will be addressed as two areas of research; the first of which will be 
an investigation into underexploited low-template DNA (ltDNA) sources in forensic 
casework. The second will focus on sample types that are expected to yield severely 
degraded DNA. Novel, existing and emerging laboratory strategies will be utilised to fulfil 
these aims.  
1.4.2 Objectives 
Historically, the use of single-cell analysis within a forensic context is rarely carried out due 
to challenges associated with DNA amplification, contamination prevention and data 
interpretation. Over the last decade, in addition to the availability of increasingly sensitive 
DNA profiling kits our knowledge and understanding of the factors affecting amplification 
in low DNA template samples has developed. The first part of this research aims to 
investigate the analysis and interpretation of DNA derived from single-cells in order to 
determine their efficacy for use in forensic casework.  
The second part of this research will investigate an application of single-cell DNA analysis 
within a forensic context through testing of the hypothesis that when textile fibres are 
transferred from one surface to another, they could also be acting as a vector for the wearer’s 
own DNA, via cells that have adhered to the fibre surfaces. If proven, this would offer 
forensic scientists a method by which transferred fibres could be targeted to obtain a DNA 
profile, with the two evidence types being utilised alongside one another in forensic 
casework.  
The focus of the final part of this thesis is directed towards teeth and bone that is expected to 
contain severely degraded DNA due to either age or exposure to a hostile environment. The 
value of massively parallel sequencing techniques for degraded DNA, through the targeted 
sequencing of both nuclear DNA markers and regions of the mitochondrial genome will be 
tested, using traditional PCR-capillary electrophoresis techniques as a point of comparison.   
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2. Materials & methods 
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2.1 Anti-contamination measures 
Personal protective equipment was worn at all times during sample preparation, DNA 
extraction and PCR set-up; this included a hairnet, facemask, gloves, oversleeves and a 
dedicated labcoat. All pre-PCR sample manipulations were carried out inside a UV cabinet 
within a restricted access laboratory that post-PCR material did not enter. The laboratory 
was deep cleaned approximately every 4-6 weeks using a 10% (w/v) Sodium hypochlorite 
solution. As a minimum, all bench surfaces were cleaned using 10% (w/v) Sodium 
hypochlorite and the preparation hood was treated with UV light for 10 min before and after 
every use. DNA free disposable equipment was used where possible, including the use of 
pre-sterilised, aerosol-resistant filter tips to prevent contamination of the pipettes. Plates and 
tubes were treated with UV light for a minimum of 10 min in a UV Crosslinker box at an 
exposure output of approximately 999.9 J/cm2. All other equipment was wiped using 10% 
(w/v) Sodium hypochlorite solution and then, where possible, treated in a UV Crosslinker 
box for a minimum of 10 min (999.9 J/cm2). Where possible, solutions were prepared 
immediately prior to use in order to reduce the risk of contamination and, if not DNA-free 
were then treated with UV light for a minimum of 10 min (999.9 J/cm2). 
Negative controls were introduced during DNA extraction, DNA quantification and pre-PCR 
set-up and processed exactly as the samples, in order to detect any DNA contamination. All 
post-PCR manipulations were carried out in a dedicated area, wearing a dedicated labcoat 
and disposable gloves.   
Use of the Upright Leica DM5000 B Fluorescent Microscope System was in an isolated 
cubicle within a multi-user room. This area was cleaned down using 10 % (w/v) Sodium 
hypochlorite and PPE, including a disposable labcoat, was worn at all times. All equipment 
was cleaned and samples prepared in the dedicated pre-PCR lab as previously described.  
2.2 Additional measures for ancient DNA 
In addition to the above the pre-PCR laboratory was deep cleaned using a 10% (w/v) 
Sodium Hypochlorite solution immediately prior to the start of work and then after DNA 
extraction was completed. The lab was also deep cleaned between the processing of different 
samples. Equipment that was not DNA-free was soaked in a 10% (w/v) Sodium 
Hypochlorite solution, rinsed with DNA-free water and then treated in a UV Crosslinker box 
for a minimum of 20 min (999.9 J/cm2). In addition to the previously described PPE, two 
pairs of gloves were worn at all times, with the outer set changed at regular intervals.  
During the period when ancient DNA samples were being extracted, no other samples were 
processed in the pre-PCR lab and lab access was restricted to only the operator.  
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2.3 Equipment, consumables & suppliers  
2.3.1 Company information 
Company Company information 
BioRad Hemel Hempstead, United Kingdom 
CS Cleaver Scientific Ltd Rugby, UK 
DREMEL® Mount Prospect, IL, USA 
Edge BioSystems Gaithersburg, MD, USA 
Eppendorf Hamburg, Germany 
Faraday Scientific Ltd Sheffield, UK 
GE Healthcare Chalfont, UK 
Geospiza, Inc. Seattle, WA, USA 
Gilson, Inc.  Middleton, WI, USA 
Grant Shepreth, UK 
Integrated DNA Technologies Coralville, IA, USA 
Illumina Inc. San Diego, CA, USA 
J&M Analytik AG Essingen, Germany 
KDP Tools Ltd Devon, UK 
Killer Ink Ltd Liverpool, UK 
Kimberly-Clark Professional Kent, UK 
Labnet International Inc. Woodbridge, NJ, USA 
Leica Microsystems Wetzlar, Germany 
Linde Group Munich, Germany 
Orange-Sol Companies Gilber, AZ, USA 
Pal International Ltd Lutterworth, UK 
Promega Corporation Madison, WI, USA 
Qiagen Venlo, Limburg, Netherlands 
Main Man supplies Ltd Cradley Heath, UK 
Merck Millipore Billerica, MA, USA 
Microsoft  Redmond, WA, USA 
Molecular Bio-Products, Inc. San Diego, CA, USA 
Sarstedt Nümbrecht, Germany 
Scenesafe Ltd Essex, UK 
Scientific Laboratory Supplies Hessel, Yorkshire, UK 
Sellotape® Cheshire, UK 
Shurtape® Hickory, NC, USA 
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Sigma Aldrich St. Louis, MO, USA 
Sigma Laborzentrifugen GmbH Osterode am Harz, Germany 
Silverline Tools Ltd Somerset, UK 
Spex CertiPrep  Metuchen, NJ, USA 
Swann-Morton® Sheffield, UK 
Syngene Cambridge, UK 
TCS Biosciences Ltd Buckingham, UK 
Thermo Fisher Scientific Oyster Point, CA, USA 
TWD TradeWinds, Inc. Pleasant Prairie, WI, USA 
UVP Upland, CA, USA 
VELP Scientifica Usmate, Italy 
WA Products (UK) Ltd Essex, UK 
Waldemar Knittel Glasbearbeitungs Braunschweig, Germany 
3M™ Bracknell, UK 
 
2.3.2 Commercial kits  
Kit name Company 
Catalogue  
number 
Alexa Fluor 488 Goat Anti-mouse SFX Kit Thermo Fisher Scientific A31620 
AmpFℓSTR® SGM Plus® PCR 
Amplification Kit 
Thermo Fisher Scientific 4307133 
AmpFℓSTR® NGM™ PCR Amplification 
Kit 
Thermo Fisher Scientific 4415020 
AmpFℓSTR® Identifiler® Direct PCR 
Amplification Kit 
Thermo Fisher Scientific 
4467831 
 
AmpFℓSTR® Yfiler® PCR Amplification Kit Thermo Fisher Scientific 4359513 
AmpFℓSTR® MiniFiler® PCR Amplification 
Kit 
Thermo Fisher Scientific 4373872 
BigDye® Terminator v1.1 Cycle Sequencing 
Kit 
Thermo Fisher Scientific 
4337449 
 
CC5 Internal Lane Standard 500 Promega DG1521 
ForensicGEM® Tissue ZyGEM FT10200 
GeneScan™ 500 ROX™ dye Size standard Thermo Fisher Scientific 401734 
GeneScan™ 500 LIZ™ dye Size Standard Thermo Fisher Scientific 4322682 
Hyperladder™ 50bp Bioline BIO-
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33054 
PERFORMA® DTR Gel Filtration Cartridges Edge BioSytems 
42453 
 
PowerPlex® ESX 16 System Promega DC6711 
PowerPlex® ESI 16 System Promega DC6771 
QIAamp DNA Mini Kit Qiagen 51304 
QIAGEN Multiplex PCR Kit Qiagen 206143 
QIAquick PCR Purification Kit Qiagen 28104 
Quantifiler® Duo DNA Quantification Kit Thermo Fisher Scientific 4387746 
Quantifiler® Trio DNA Quantification Kit Thermo Fisher Scientific 4482910 
Qubit® dsDNA HS Assay Kit Thermo Fisher Scientific Q32854 
QuickStep™2 PCR Purification Kit (Single 
cartridges) 
Edge BioSystems 33617 
SYBR® Green PCR Master Mix Thermo Fisher Scientific 4309155 
 
2.3.3 Reagents 
Reagent Company 
Catalogue  
number 
Agarose for electrophoresis Sigma Aldrich A5304 
Ammonium acetate molecular biology ≥ 98% Sigma Aldrich A1542 
AmpFlSTR® Control DNA 007 Thermo Fisher Scientific - 
AmpFlSTR® Control DNA 9947A Thermo Fisher Scientific - 
Boric acid for electrophoresis Sigma Aldrich B7901 
Calcium chloride  
Anhydrous, BioReagent 
Sigma Aldrich C5670 
Chloroform:isoamyl alcohol (24:1) Sigma Aldrich C0549 
Cytokeratin 10 Monoclonal Antibody, Mouse 
(VIK-10) 100 µg/ 200 µl  
Thermo Fisher Scientific 395300 
DAPI, dilactate ≥ 98% (HPLC) Sigma Aldrich D9564 
5X DNA Loading Buffer Blue Bioline 
BIO-
37045 
DPBS, no calcium, no magnesium Gibco 14190 
DPX Mountant for histology Sigma Aldrich 06522 
Eosin Y (1% aqueous) TCS Biosciences HS250 
Ethanol Sigma Aldrich E7023 
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Ethylenediaminetetraacetic acid BioULTRA, 
anhydrous, ≥ 99% (titration) 
Sigma Aldrich EDS 
Genetic Analyzer 10X Buffer with EDTA  Thermo Fisher Scientific 402824 
Guanidine Thiocyanate Thermo Fisher Scientific AM9422 
Haematoxylin Harris Modified (no acetic acid) TCS Biosciences HS351 
Hi-Di™ Formamide  Thermo Fisher Scientific 4311320 
Hydrochloric Acid  ACS reagent, 37% Sigma Aldrich 258148 
Liquid Nitrogen Linde Group - 
Paraformaldehyde powder 95% Sigma Aldrich 158127 
Phenol:chloroform:isoamyl alcohol (25:24:1) Sigma Aldrich 77617 
POP-4® Polymer for 3130/3130xl Genetic 
Analyzers 
Thermo Fisher Scientific 4363752 
2-Propanol (isopropanol) BioReagent for 
molecular biology ≥  99.5% 
Sigma Aldrich I9516 
Proteinase K powder Thermo Fisher Scientific AM2544 
NucBlue® Fixed Cell ReadyProbes® Reagent Thermo Fisher Scientific R37606 
Scenesafe FAST™ Box Scenesafe K545 
Silicon dioxide ~ 99%, 0.5-10 µm (approx. 
80% between 1-5 µm) 
Sigma Aldrich S5631 
Sodium chloride for molecular biology ≥ 98% 
(titration) 
Sigma Aldrich S3014 
Sodium hydroxide ACS reagent, ≥ 97.0%, 
pellets 
Sigma Aldrich 221465 
Sodium hydroxide solution BioUltra, for 
molecular biology, 10 M in H2O 
Sigma Aldrich 72068 
Sodium dodecyl sulfate Sigma Aldrich 436143 
Sodium hypochlorite  Fisher Scientific 10553864 
SYBR® Safe DNA Gel Stain Thermo Fisher Scientific S33102 
Sticky Stuff Remover Orange-Sol Companies - 
Triton™ X-100  Sigma Aldrich X100 
Trizma base for molecular biology,  ≥ 99.8% 
(T) 
Sigma Aldrich 93362 
Water Molecular Biology Grade Reagent Sigma Aldrich W4502 
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2.3.4 Equipment & consumables 
Equipment  Company 
Catalogue  
number 
ART Pre-Sterilised Aerosol Resistant Tips  Molecular BioProducts - 
Aura™ Particulate Respirator 9320 3M™ 
GT5000731
65 
Capillary Array 36 cm for 3130 Thermo Fisher Scientific 4333464 
CFX96 Touch™ Real-Time PCR Detection 
System 
BioRad 185-5196 
CL-1000 Ultraviolet Crosslinker box UVP 95-0174-02 
Cobex Sheet 175 mm 4" x 6" WA Products 
B20912-
100 
Deburring and Engraving Set 30Pc KDP 
KDPHB26
5 
Deckglaser crystal clear glass coverslip 
Waldemar Knittel 
Glasbearbeitungs 
GG-1212 
DNA Free Swab Scenesafe Ltd K650 
Dremel® 8200 (8200-2/45) DREMEL® 
F0138200J
E 
Dremel®  Flexible Shaft  (225) length 1070 
mm 
DREMEL® 
26150225J
A 
Drum Sanding Kit 10 Piece 
 
Silverline Tools 675272 
Gilson Pipetman Classic™ Gilson 
F167500/3
00 
Hard-Shell® Low-Profile Thin-Wall 96-
Well Skirted PCR Plate  
BioRad HSP-9641 
Heater block Grant - 
Sellotape Double-sided Tape 15 mm x 5 m 
with Dispenser 
Sellotape® - 
Falcon Conical 50 ml PP Centrifuge Tubes 
Bagged 
Scientific Laboratory 
Supplies 
352070 
Falcon Petri Dish 60 X 15 mm Standard 
Style Petri dishes 
Scientific Laboratory 
Supplies 
351007 
Ink Precision Bug Pin Sterile Stainless Steel 
Tattoo Needles Round Liners  
Killer Ink 50-08RL 
Innova®44 incubator  Eppendorf M1282-
41 
 
0002 
Kimtech Science® A7 Disposable Lab Coats 
Kimberly-Clark 
Professional 
1137935 
Kimtech Science® Purple Nitrile 24 cm 
gloves 
Kimberly-Clark 
Professional 
90627 
KIMCARE® Medical Wipes - Interfolded / 
White 
KIMCARE® Medical 3020 
MicroAmp® Fast Optical 96-Well Reaction 
Plates 
Thermo Fisher Scientific 4358297 
MicroAmp® Fast Reaction Tube with Cap, 
0.1 ml 
Thermo Fisher Scientific 4358297 
MicroAmp® Fast-Tube Strip tube 0.1 ml Thermo Fisher Scientific 4358293 
MicroAmp® Optical 8-Cap Strip Thermo Fisher Scientific 4323032 
MicroAmp® Optical Adhesive Film Thermo Fisher Scientific 4311971 
Microbox Precision Drills 20Pc KDP  
KDPDR07
4 
Microcon YM-30 centrifugal filter device 
Ultracel-30 membrane 
Merck Millipore 
MRCF0R0
30 
Microgard™ 2500 disposable oversleeves Sigma Aldrich 
Z679283-
50PR 
Microscope slides plain, size 25 mm x 75 
mm 
Sigma Aldrich S8902 
Microseal® 'C' Optical Seals  BioRad MSC-1001 
Spectrafuge™ Mini Laboratory Centrifuge Labnet International Inc. C1301 
MiSeq Desktop Sequencer Illumia - 
Mob Cap  Pal® International D93 
MSP400 UV-Vis Range 
Microspectrophotometer 
J&M Analytik AG - 
NanoDrop® Spectrophotometer ND-1000 Thermo Fisher Scientific - 
Plate Septa, 96-well Thermo Fisher Scientific 4315933 
PowerPac™ Basic Power supply BioRad 164-5050 
Qubit® 2.0 Fluorometer  Thermo Fisher Scientific Q32866 
Qubit® Assay Tubes, 0.5 ml Thermo Fisher Scientific Q32856 
Shurtape JLAR Clear to the core Tape 2’’ x 
72 yds   
Shurtape® - 
SIGMA 1-14 Microfuge Sigma L.GmbH 10014 
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Spex CertiPrep 6750 Freezermill Spex CertiPrep - 
Sterile disposable forceps TWD TradeWinds DF8988P-S 
Surgical scalpel Sterile Stainless Steel Blade 
No.10A 
Swann-Morton® 0302 
Syngene G:BOX Gel Doc  Syngene - 
Upright Leica DM5000 B Fluorescent 
Microscope System 
Leica Microsystems - 
UV Sterilisation Cabinet CS Cleaver Scientific 
CSL-
UVCAB 
Vented Diamond Cutting Disc Kit 6-Piece 
22 mm 
Silverline Tools 719813 
Veriti® 96-Well Fast Thermal Cycler  Thermo Fisher Scientifc 4375305 
Wizard Vortex Mixer  VELP Scientifica F202A0175 
Warrior Blue Powderfree Nitrile Glove Main Man Supplies 
0117SNDP
F 
Whatman® Grade 1 filter paper GE Healthcare 1001-0155 
Micro tube 1.5 ml SafeSeal Sarstedt 72.706.400 
Microcentrifuge Tubes 2.0 ml, graduated, 
flat cap, pre-sterilised 
Molecular BioProducts 3453 
3130 Genetic Analyzer Thermo Fisher Scientific  - 
7500 FAST Real Time PCR System Thermo Fisher Scientific 4351106 
 
2.3.5 Software 
Software  Company  
Finch TV Version 1.4.0 Geospiza Inc. 
Genemapper® ID version 3.2 Thermo Fisher Scientific 
GeneSys.Ink software  Syngene 
Genetic Analyzer Data Collection Software version 3.0 Thermo Fisher Scientific 
Leica Application Suite Software Version 4.3.0 Leica Microsystems 
Microsoft Excel 2010  Microsoft 
ND-1000 Version 3.8.1 Thermo Fisher Scientific 
ONYX Software Faraday Scientific 
SeqScape Version 5.2 Thermo Fisher Scientific 
7500 Software version 2.0.6. 
 
Thermo Fisher Scientific 
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2.4 Sample preparation 
2.4.1 Reagent preparation 
All chemicals and reagents were stored at room temperature for a maximum of 2 years 
unless otherwise stated. Any purchased reagents that were kept frozen were first separated 
into aliquots of an appropriate volume to avoid freeze-thaw cycles.  
2.4.1.1 DAPI stock solution 
To prepare a 1 mg/ml stock of DAPI solution, 10 mg of DAPI dilactate powder was added to 
10 ml of Molecular Biology Grade (MBG) water  and inverted several times to mix. 500 µl 
of stock solution was aliquoted into 0.5 ml tubes and stored at -20 °C until required.   
2.4.1.2 DAPI working solution 
 A 1 in 10,000 working solution of DAPI dilactate was prepared by adding 4 µl of 1 mg/ml 
stock solution to 39.996 ml of sterile DPBS in a 50 ml Falcon tube. The tube was covered in 
aluminium foil and inverted several times to mix.  
2.4.2 Reference buccal swab samples 
Reference samples for operators and volunteers involved throughout this project were taken 
by swabbing the inside surface of both cheeks using a single DNA-free swab. The swab was 
then stored at -20 ºC until required for further work. 
2.4.3 Buccal cell harvesting 
The head of the buccal swab was placed into a 1.5 ml tube with 500 µl of MBG water and 
vortexed for 15 sec. The swab head was then carefully removed and discarded using forceps 
and the sample centrifuged for 3 min at 14,000 x g in a SIGMA 1-14 Microfuge. All of the 
supernatant was removed and another 500 µl of MBG water was added to the pellet, which 
was resuspended by vortexing for 15 sec. The sample was centrifuged as described 
previously and the supernatant removed. The cell pellet was then resuspended in 30 µl of 
MBG water.  
2.4.3.1 Sample applied directly onto microscope slide 
5 µl of the cell suspension was pipetted onto a microscope slide and allowed to air dry prior 
to staining. 5 µl of MBG water was used in place of the cell suspension to act as a negative 
control for the staining process. All prepared samples were placed into a DNA clean Petri 
dish ready for staining. 
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2.4.3.2 Sample applied onto J-LAR® tape 
A microscope slide was prepared by placing one strip of double-sided tape at both ends and 
removing the protective covering. A strip of J-LAR tape was then secured to the slide 
adhesive side up, using the double-sided tape strips. 5 µl of the cell suspension was pipetted 
onto the J-LAR tape and allowed to air dry prior to staining. 5 µl of MBG water was used in 
place of the cell suspension to act as a negative control for the staining process. Prepared 
samples were placed into a DNA clean Petri dish ready for staining. 
2.4.4 Fibre tapes 
Five microscope slides were prepared by placing one strip of double-sided tape at both ends 
and removing the protective covering. The fibre tape to be stained was carefully peeled off 
its acetate and then positioned horizontally across the slides, secured in place using the 
double-sided tape. A disposable 10A scalpel was then used to separate the slides, which 
were each placed into a DNA clean Petri dish ready for staining with the appropriate dye.  
2.4.5 Bone samples 
2.4.5.1 Bone 
The Vindolanda femur bone sample (see Chapter 5) was prepared by removing a section of 
approximately 3 cm x 2 cm. This was accomplished by first using a junior hacksaw to make 
two parallel cuts perpendicular to the bone surface and then using a Dremel® 8200 series 
hand tool with a Dremel® Flexible shaft attached, fitted with a Silverline Vented Diamond 
Cutting Disc to cut along the length as shown in Figure 2.1. The section was then removed 
using sterile forceps and placed in a container whilst the area was cleaned down. 
Approximately 1-2 mm was removed from every bone surface using the Dremel® hand tool 
with a Silverline sanding band attachment and the area was then cleaned down again. Once 
completed the bone section was cleaned thoroughly using two DNA-free swabs, the first 
with a 5% (w/v) sodium hypochlorite solution and the second with MBG water. The bone 
section was cut into pieces of less than 1 cm x 1cm, using the Dremel® hand tool with a 
vented diamond cutting disc attachment. Bone pieces were then soaked in a 5% (w/v) 
sodium hypochlorite solution and rinsed with MBG water. The sections were allowed to air 
dry for approximately 15 min and were then placed into a UV Crosslinker box at an 
exposure output of 999.9 J/cm2. Samples were treated with UV light for 20 min and then 
turned over 180º and treated for an additional 20 min. The cleaned sections were then placed 
into a DNA clean 50 ml Falcon tube and stored at room temperature until required. This 
cleaning process is an amalgamation of a number of published protocols (Rohland and 
Hofreiter, 2007, Kemp et al., 2007, Bouwman and Brown, 2005). 
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Figure 2.1 Image to illustrate removal of section from an intact bone sample. 
 
2.4.5.2 Teeth 
The entire outside surface of a tooth was cleaned using a DNA-free swab soaked in a 5% 
(w/v) sodium hypochlorite solution and then with a second swab using MBG water. The 
tooth was then soaked in a 5% (w/v) sodium hypochlorite solution for 10 minutes, rinsed 
using MBG water and then allowed to air dry. The tooth was then placed into a UV 
Crosslinker box set at an exposure output of 999.9 J/cm2 for 20 min on one surface and then 
turned over 180º for an additional 20 min. The cleaned tooth was then placed into a DNA 
clean 50 ml Falcon tube and stored at room temperature until required.   
2.4.5.3 Removal of dentin and cementum from teeth 
In order to preserve the outside casing so that the sample could be returned for display in the 
museum, some samples were obtained by removing the dentin and cementum from the 
inside surface of the tooth. In order to access the dentin/cementum the top section was first 
removed by slicing the crown away using a Dremel® 8200 series hand tool with a Dremel® 
Flexible shaft attached, along with a Silverline Vented Diamond Cutting Disc attachment. 
The tooth root section was placed on to a DNA clean sheet of acetate and a variety of 
Dremel® accessories were then utilised to remove as much of the inside surface material as 
possible from the tooth without damaging the surface (Figure 2.2). Both drill and engraving 
bits were used with the size and shape being determined by the size and shape of the 
tooth/roots. The powder generated through drilling was collected into a DNA clean 50 ml 
Falcon tube using a sterile disposable 10A scalpel blade and stored at room temperature until 
required. This cleaning process is an amalgamation of a number of published protocols 
(Rohland and Hofreiter, 2007, Kemp et al., 2007, Bouwman and Brown, 2005). 
Horizontal cuts made along length using Dremel® 
Perpendicular cuts made using a junior hacksaw 
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Figure 2.2 Example of tooth casing with all inner material removed. Use of this method 
allowed for the preservation of the casing for return to the museum so that it could be put 
back on display. 
 
2.4.5.4 Freezermill 6750 
Either a bone or tooth sample was placed into a grinding vial and sealed with a magnetic rod 
in the centre. The grinding vial was then placed into liquid nitrogen inside a Spex CertiPrep 
6750 Freezermill, which was used to grind the entire sample to a fine powder using a 
program of a 15 min pre-cool, followed by three cycles of 2 mins of grinding and 2 mins of 
cooling. The sample powder was then transferred from the grinding vial to a DNA clean 50 
ml Falcon tube and stored at room temperature until required for further processing.   
2.5 Staining of cells 
2.5.1 Histological staining 
The sample of cells was removed from its Petri dish and placed onto a staining rack. Enough 
Haematoxylin (Harris modified) was applied to cover the sample and allowed to incubate for 
2 min at room temperature. Sterile DPBS was used to rinse the sample three times and Eosin 
Y (1% v/v) was then used to cover the sample and left in place for 30 sec. Sterile DPBS was 
again used to rinse the sample. Samples were stained immediately prior to imaging with a 
high-powered light microscope using x 100 and x 400 magnification.  
2.5.2 Fluorescent staining 
All fibre/cell samples stained with a fluorescent dye were imaged using an Automated 
Upright Leica DM5000 B Fluorescent Microscope System with Leica Application Suite 
Software Version 4.3.0.  
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2.5.2.1 NucBlue® Fixed Cell ReadyProbes® Reagent 
NucBlue® Fixed Cell ReadyProbes® Reagent was applied directly from the bottle until the 
sample was covered. The sample Petri dish was covered with aluminium foil for a 30 min 
incubation at room temperature. Samples were then removed from the Petri dish and rinsed 
three times with sterile DPBS followed by MBG water. Samples were then placed back into 
the Petri dish, which was again covered in aluminium foil. Staining was carried out 
immediately prior to microscope imaging.  
2.5.2.2 DAPI 
A P1000 pipette was used to cover the sample with approximately 300 µl of a working 
solution of DAPI dilactate. The lid was replaced and the Petri dish covered with aluminium 
foil and incubated at room temperature for 1 hour. Samples were removed from the Petri 
dish and rinsed three times with sterile DPBS followed by MBG water. Samples were then 
placed back into the Petri dish, a coverslip applied using DPX if required, and then wrapped 
in aluminium foil until use. Staining was carried out immediately prior to microscope 
imaging.  
2.6 Single-cell work 
Double-sided tape was placed in two strips at either end of a pre-cleaned microscope slide 
and the protective covering removed. Strips of J-LAR tape were then secured to the slide 
adhesive side up, using the double-sided tape strips. A disposable 10A scalpel was used to 
cut squares of J-LAR tape/ Scenesafe FAST™ minitapes approximately 1 mm x 1 mm 
which were secured to the slide, again adhesive side up, by placing onto the J-LAR strips as 
shown in Figure 2.3.  
 
 
   
 
 
Figure 2.3 Preparation of J-LAR/ FAST™ minitapes to be used for the transfer of 
single-cells. This set up allowed for easy access to the adhesive squares whilst working, 
preventing the occurrence of contamination. 
 
J-LAR/ FAST™ tape 
adhesive side up 
Double-sided tape 
NOT TO SCALE 
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The required number of 0.1 ml individual capped MicroAmp® Fast Reaction Tubes  were 
prepared for cell transfer by placing 1 µl of sticky stuff adhesive remover (SSR) mixed with 
MBG water in the bottom centre of the tube. Both the prepared tubes and microscope/tape 
slides were then treated with UV light for 10 min in a CL-1000 Ultraviolet Crosslinker box 
at an exposure output of 999.9 J/cm2.   
The single-cell of interest was carefully removed from its surface using a micro-needle with 
a tip diameter of 0.25 mm, and transferred directly onto the adhesive surface of an upturned 
square of J-LAR tape. The tape section was immediately viewed under the fluorescent 
microscope to confirm transfer and an image captured if required. A pair of DNA clean 
forceps was used to then remove the tape section from the slide and transfer it directly into 
the 1 µl of MBG water in a 0.1 ml capped tube. 
2.7 DNA extraction 
2.7.1 Reagent preparation 
2.7.1.1 0.45/0.5 M EDTA 
13.15/14.61 g of EDTA powder was added to 80 ml of MBG water and inverted several 
times to mix. Sodium hydroxide pellets were added to dissolve the solid EDTA and adjust 
the pH to 8.0, MBG water was then added to a final volume of 100 ml. 
2.7.1.2 Proteinase K reconstitution buffer  
To prepare a 50 mM Tris-HCl pH 8.0, 10 mM CaCl2 reconstitution buffer, 1.21 g of Trizma 
base was added to 150 ml of MBG water and adjusted to pH 8.0 using 0.1 M HCl. 0.22 g of 
CaCl2 was then added and the solution was inverted several times to mix before topping up 
to a total volume of 200 ml with MBG water.  
2.7.1.3 Proteinase K 10 mg/ml 
0.1 g of Proteinase K (Pro K) powder was added to 10 ml of Pro K reconstitution buffer and 
inverted several times to mix.  
2.7.1.4 8M HCl 
To prepare a 8M HCl solution, 0.68 ml 37% HCl was placed in a DNA clean 1.5 ml tube 
and made up to a final volume of 1 ml using MBG water.  
49 
 
2.7.1.5 5 M Ammonium acetate  
38.54 g of ammonium acetate was added to 80 ml of MBG water and inverted several times 
to mix. Once dissolved, additional MBG water was added to a final volume of 100 ml to 
provide a 5 M solution. 
2.7.1.6 Extraction solution  
To prepare 10 ml of extraction solution, 0.25 ml of Pro K (10 mg/ml) was added to 9.75 ml 
of 0.45 M EDTA and inverted to mix (Rohland and Hofreiter, 2007).  
2.7.1.7 Binding buffer  
To prepare 400 ml of binding buffer (5 M GuSCN, 25 mM NaCl, 50 mM Tris) 0.58 g NaCl, 
2.42 g Trizma and 236.32 g GuSCN were added to 300 ml of MBG water and inverted to 
mix. The flask was placed in warm water, with periodic mixing, until fully dissolved and 
then made up to a final volume of 400 ml using MBG water (Rohland and Hofreiter, 2007).  
2.7.1.8 Silica suspension  
4.8 g of silicon dioxide was suspended in 40 ml of MBG water and allowed to settle for 1 
hour in a DNA clean 50 ml Falcon. 39 ml of the suspension supernatant was then transferred 
to a fresh tube and the remaining settled silica discarded. The suspension was allowed to 
sediment for a further 4 hours before 35 ml of the supernatant was removed and discarded. 
48 µl of 8M HCl was added to the pellet, which was then vortexed to mix (Rohland and 
Hofreiter, 2007).  
2.7.1.9 Washing buffer  
100 ml of washing buffer (125 mM NaCl, 10 mM Tris, 1 mM EDTA, 50% (v/v) EtOH) was 
prepared by adding 0.73 g NaCl, 0.12 g Trizma and 222 µl EDTA [0.45 M] to 50 ml MBG 
water, which was then topped up with EtOH to a final volume of 100 ml and inverted to mix 
until fully dissolved (Rohland and Hofreiter, 2007).  
2.7.1.10 Extraction Buffer  
50 ml of extraction buffer (0.5 M EDTA pH 8.0, 0.5% (w/v) SDS, 0.1 mg/ml Pro K) was 
prepared by adding 0.25 g SDS and 0.5 ml Pro K (10 mg/ml) to 35 ml of EDTA [0.5 M] and 
inverting several times to mix. The solution was heated gently until fully dissolved and then 
MBG water was added to a final volume of 50 ml (Bouwman and Brown, 2005).  
2.7.1.11  TE buffer  
To prepare 100 ml TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) 0.12 g Trizma and 222 µl 
EDTA [0.45 M] was dissolved in 100 ml of MBG water.  
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2.7.2 Reference samples 
2.7.2.1 Buccal swab using QIAamp® DNA mini kit 
Following the manufacturers instructions (Qiagen, 2015b), either the sample swab head, or a 
DNA-free swab for use as an extraction negative control, was removed from the shaft and 
placed into a 1.5 ml plastic tube containing 400 µl of PBS and 400 µl of AL buffer. 20 µl of 
Pro K (10 mg/ml) was then added and the sample was vortexed for 15 sec to mix. The 
sample was incubated for 10 min 56 °C in a dry heater block. The tube was very briefly 
vortexed and the swab head removed and discarded. 400 µl of absolute ethanol was added to 
the tube, which was again vortexed for 15 sec. 675 µl of the sample was transferred to the 
centre of a QIAamp Mini spin column and centrifuged in a SIGMA 1-14 Microfuge at 4722 
x g for 1 min. The collection tube was then emptied and the step repeated using the 
remainder of the sample mixture. The collection tube was replaced and 500 µl AW1 buffer 
was added to the centre of the silica column. The column was centrifuged for 1 min at 4722 
x g and the collection tube containing the filtrate was discarded and replaced. 500 µl AW2 
buffer was then added to the centre of the spin column which was centrifuged at 14462 x g 
for 3 min. The filtrate was discarded and the spin column centrifuged for an additional 1 min 
to ensure that any remaining AW2 buffer was removed and the column was then transferred 
into a 1.5 ml tube. 60 µl of AE buffer was added to the centre of the silica membrane and the 
tube was then left to incubate with the cap closed for 3 min. The sample was centrifuged for 
1 min at 4722 x g and the column was discarded; the eluate was retained and stored at -20 °C 
until required for further use.  
2.7.3 Single-cells 
2.7.3.1 ForensicGEM® Tissue  
A mastermix of ForensicGEM® Tissue extraction reagents was prepared in a 1.5 ml tube  
for the number of samples to be processed, containing 0.6 µl 10X Gold Buffer, 0.3 µl 
prepGEM enyme and 4.1 µl of MBG water per sample. For ltDNA samples (<0.1ng/µl) the 
volumes were as follows: 0.5 µl 10X Gold Buffer, 0.25 µl prepGEM enyme and 3.25 µl of 
MBG water per sample. The mastermix was vortexed for 15 sec and 5 µl (4 µl for the low 
template DNA assay) was dispensed into each sample tube, pipetting up and down several 
times to mix. An equivalent amount of mastermix was added to an unused sample tube for 
use as an extraction negative control. All reagents and samples were kept on ice throughout 
the preparation period. Samples were incubated for 10 min at 75 °C, followed by 5 min at  
95 °C on a Veriti® 96-Well Fast Thermal Cycler to deactivate the prepGEM enzyme. 
Samples were placed on ice and immediately prepared for PCR as described in Section 2.9. 
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2.7.4 Bone samples 
2.7.4.1 Phenol chloroform  
Protocol based on Kemp et al. (Kemp et al., 2007). 2 ml of 0.5 M EDTA (pH 8.0) was added 
to 0.5 g of powdered bone/tooth sample in a 50 ml Falcon tube and inverted several times to 
mix. EDTA only, was transferred to an additional 50 ml Falcon tube to act as a negative 
extraction control throughout processing. Samples were then placed into sealed bags and 
incubated in an Innova®44 incubator at 20 °C for 24-36 hours, rotating at 100 rpm to in 
order to agitate gently. Throughout the incubation, samples were periodically checked and 
inverted to remove any sediment from the bottom of the tube. 300 µl Pro K (10 mg/ml) was 
then added and samples were inverted to mix and placed back into sealed bags in the 
incubator at the increased temperature of 65 °C. Samples were removed after a four-hour 
period and then centrifuged at 5000 x g for 2 minutes in a Sigma 3-18KS Centrifuge. The 
supernatant was transferred to a fresh 50 ml falcon tube and an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) was added and inverted several times to mix. 
Samples were centrifuged at 1665 x g for 5 min and the aqueous phase was transferred to a 
fresh tube. An equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) was added to 
each sample and the previous step repeated. An equal volume of chloroform:isoamyl alcohol 
(24:1) was then added to each of the samples, which were vortexted to mix and then 
centrifuged again for 3 min at 1665 x g. The aqueous phase was again transferred to a fresh 
tube and a one half volume of 5 M ammonium acetate was added to each sample and 
vortexed briefly to mix. An equal volume of room temperature isopropanol was then added 
to each sample, vortexed and left to incubate at room temperature for ten hours.  
The following day the DNA was pelleted by centrifuging the samples at 1665 x g for 30 min 
and the supernatant was then removed and discarded. The sample pellet was allowed to air 
dry at room temperature for approximately 15 min prior to resuspension in 50 µl of MBG 
water. The extracted DNA was stored at -20 °C until required for further work.  
2.7.4.2 Silica column  
Protocol based on Bouwman and Brown (Bouwman and Brown, 2005) using reagents from 
the PCR Purification Kit (Qiagen). 1.5 ml of extraction buffer was added to 0.5 g of 
powdered bone/tooth sample in a 50 ml Falcon tube and inverted several times to mix. An 
equivalent amount of extraction buffer was added to an additional Falcon tube for use as an 
extraction negative control throughout processing. Samples were placed in sealed bags and 
put into an Innova®44 incubator at 56 °C for 24 – 36 hours, rotating at 100 rpm to agitate 
gently. Throughout the incubation, samples were periodically checked and inverted to 
remove any sediment from the bottom of the tube.  Samples were centrifuged in a Sigma 3-
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18KS Centrifuge at 693 x g for 5 min and the supernatant transferred into a fresh Falcon 
tube containing 3.75 ml PB buffer (Qiagen) and the samples were then vortexed to mix. 750 
µl of sample/PB buffer mix was added to a Qiaquick column, which was then centrifuged in 
a SIGMA 1-14 Microfuge for 1 min at 14,462 x g and the filtrate discarded. This step was 
repeated until the entire sample had passed through the column and the collection tube was 
replaced. 750 µl of buffer PE (Qiagen) was then added to the sample column, centrifuged for 
1 min at 14,462 x g and the collection tube replaced. The column was centrifuged for an 
additional 2 min to ensure that the PE buffer was completely removed from the sample. The 
column section was transferred to a 1.5 ml tube and 50 µl of buffer EB (Qiagen) added to the 
centre of the silica membrane. Samples were left to incubate for 10 min at room temperature 
and were then centrifuged at 14,462 x g for 1 min. The eluate was retained and stored at -20 
°C until required for further analysis.    
2.7.4.3 Silica suspension  
Protocol based on Rohland and Hofreiter (Rohland and Hofreiter, 2007). 10 ml of extraction 
solution was added to 0.5 g of powered bone/tooth sample in a 50 ml Falcon tube and 
inverted several times to mix. 10 ml of extraction solution was also added to an additional 50 
ml Falcon tube to act as a negative control throughout the extraction process. Samples were 
placed inside sealed bags and placed in an Innova®44 incubator at room temperature for 24 – 
36 hours, rotating at 100 rpm to agitate gently. Throughout the incubation, samples were 
periodically inverted to remove any sediment from the bottom of the tube. The temperature 
of the incubator was increased to 56 °C for one hour prior to the removal of the samples 
which were then centrifuged for 2 min at 5000 x g in a Sigma 3-18KS Centrifuge. The 
supernatant was transferred to a fresh 50 ml Falcon tube containing 40 ml binding buffer and 
inverted several times to mix. The silica suspension was briefly vortexed to resuspend and 
100 µl was added to the sample/binding buffer mix. The sample was inverted to mix and 
then the pH was adjusted using 8M HCl to pH 4.0. Samples were then sealed into bags and 
placed back into the incubator for an additional 3 hours at room temperature with a rotation 
of 100 rpm. Once the incubation period had completed, samples were centrifuged for 2 min 
at 5000 x g and the supernatant removed but retained in a fresh tube until after 
quantification. 1 ml binding buffer was added to the sample and the silica pellet resuspended 
by pipetting up and down several times. The silica/binding buffer mix was then transferred 
to a 2 ml tube and centrifuged at 16,000 x g for 30 sec in a SIGMA 1-14 Microfuge, the 
supernatant was removed and 1 ml of washing buffer added to the sample. The silica pellet 
was resuspended and then the sample was centrifuged at 16,000 x g for 30 sec. The 
supernatant was again removed and the wash step repeated a second time. The supernatant 
was removed as completely as possible and the pellet allowed to air dry with the lid open for 
53 
 
10 min. 100 µl TE buffer was added to resuspend the pellet, which was then left to incubate 
for 10 min. The sample was centrifuged for 3 min at 16,000 x g and the supernatant 
transferred to a fresh tube, being careful not to disturb the silica pellet. An additional 100 µl 
TE buffer was added and the step repeated once more to give a total extract volume of 200 
µl which was stored at -20 °C until required.  
2.7.4.4 Microcon® Centrifugal filter device  
A Microcon YM-30 centrifugal filter device with an Ultracel-30 membrane was utilised to 
combine and concentrate multiple DNA extracts from the same sample into approximately 
60-80 µl. This was done by adding up to 0.5 ml of DNA extract to the membrane in the 
sample reservoir and centrifuging the vial for 7 min at 10,000 x g. The sample reservoir was 
then reversed and placed into a fresh vial and centrifuged for 3 min at 1000 x g. The sample 
reservoir was discarded and the retenate retained. Samples were then stored at -20 °C until 
required. 
2.8 Quantification 
2.8.1 Reagent preparation 
2.8.1.1 Primer resuspension buffer 
To prepare 100 ml of primer resuspension buffer (10 mM Tris, 0.1 mM EDTA pH 8.0)    
0.12 g Trizma and 22.2 µl of EDTA [0.45 M] was added to 80 ml of MBG water and 
inverted several times to dissolve. MBG water was then added to a final volume of 100 ml  
2.8.1.2 Primer preparation 
All lyophilised primers were resuspended to a 100 µM or 10 µM stock solution by adding 
the required volume primer suspension buffer directly to the primer tube. This was then 
vortexed for 15 sec to completely resuspend the pellet. Primer stocks were stored at either -
20 ºC or -80 ºC. 
10 µl of 100 µM primer stock was added to 90 µl MBG water in a 1.5 ml tube to obtain a 
working solution at 10 µM. Diluted primers were vortexed for 15 sec to mix thoroughly.  
2.8.2 NanoDrop® Spectrophotometer ND-1000  
The NanoDrop® Spectrophotometer ND-1000 with software ND-1000 Version 3.8.1 was 
used for the quantification of DNA in reference samples, which had an expected 
concentration exceeding 5 ng/µl. The sampling arm and lower measurement pedestal were 
both cleaned using water and then 1.5 µl of water was placed onto the lower pedestal to 
initialise the instrument. The pedestal was then wiped and 1.5 µl of AE buffer (Qiagen) was 
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used as a blank sample in order for the level of background absorbance to be recorded. After 
cleaning, 1.5 µl of DNA extract was transferred to the lower pedestal and the sample 
absorbance measured and recorded. Quantification was carried out in triplicate and an 
average of the result taken for use in dilution calculations prior to PCR.  
2.8.3 Quantifiler® Duo and Trio DNA Quantification Kits 
Nuclear DNA in low template or ancient DNA samples was quantified using either the 
Quantifiler® Duo (Quant Duo) or Trio (Quant Trio) kits. Both kits were set-up in 
MicroAmp® Fast Optical 96-Well Reaction plate and processed on a 7500 FAST Real Time 
PCR System with 7500 Software version 2.0.6. 
2.8.3.1 Template DNA preparation 
A serial dilution was prepared using (Quant Duo) DNA Standard (male genomic DNA, 200 
ng/µl) and (Quant Duo) Dilution Buffer as shown in Table 2-1 to generate a standard curve 
for absolute quantification of the unknown samples. In a similar manner, a serial dilution for 
Quant Trio was prepared using Quantifiler® THP DNA Standard (male genomic DNA, 100 
ng/µl) and Quantifiler® THP Dilution Buffer as shown in Table 2-2 In a slight modification 
of the manufacturer’s instructions, six standards were prepared as opposed to the 
recommended five, in order to try and capture any samples with a DNA concentration of less 
than 0.005 ng/µl. A fresh set of standards was prepared prior to each run.  
Table 2-1 Preparation of DNA standards for the Quantifiler® DUO DNA 
Quantification Kit 
Standard 
Final 
concentration 
(ng/µl) 
Volume of previous 
sample (µl) 
Volume of 
dilution buffer 
(µl) 
Dilution 
factor 
1 50.00 *10 30 4X 
2 16.70  10 20 3X 
3 5.60  10 20 3X 
4 1.80  10 20 3X 
5 0.60  10 20 3X 
6 0.21  10 20 3X 
7 0.07  10 20 3X 
8 0.02  10 20 3X 
*10 µl of Quantifiler® Duo DNA Standard stock  
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Table 2-2 Preparation of DNA standards for the Quantifiler® Trio DNA 
Quantification Kit 
Standard 
Final 
concentration 
(ng/µl) 
Volume of previous 
sample (µl) 
Volume of 
dilution buffer 
(µl) 
Dilution 
factor 
1 50.000 *10 10 2X 
2 5.0000 10 90 10X 
3 0.5000 10 90 10X 
4 0.0500 10 90 10X 
5 0.0050 10 90 10X 
6 0.0005 10 90 10X 
*10 µl of Quantifiler® THP DNA Standard stock  
All DNA extracts to be quantified were thoroughly mixed by vortex for 15 sec and then 2 µl 
of sample was transferred to the reaction plate in either duplicate or triplicate. 2 µl of MBG 
water was added in duplicate to the reaction plate to act as the no template control (NTC) for 
the real-time PCR. 
2.8.3.2 Reaction set-up 
A mastermix of the relevant PCR mix and primer mix was prepared for the number of 
samples to be analysed as shown in Table 2-3. 23 µl (Quant Duo) or 18 µl (Quant Trio) of 
mastermix was then dispensed into each sample well to give a total reaction volume of 25 µl 
or 20 µl respectively, and the plate was sealed with a MicroAmp® Optical Adhesive Film. 
Table 2-3 Quantifiler® Duo/Trio DNA Quantification Kit reaction set-up 
Kit Reagent Volume per sample (µl) 
Quant Duo Quantifiler® Duo Primer Mix 10.5 
 Quantifiler® Duo Reaction Mix 12.5 
 Total 23.0 
Quant Trio Quantifiler® Trio Primer Mix 8.0 
 Quantifiler® Trio Reaction Mix 10.0 
 Total 18.0 
 
2.8.3.3 PCR run conditions 
The real-time PCR was programmed to run for 40-cycles as per the manufacturer’s 
instructions for each kit as shown in Figure 2.4 and Figure 2.5.   
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Figure 2.4 Quantifiler® Duo DNA Quantification Kit amplification conditions. An 
initial incubation was carried out at 50 ºC for 2 min followed by a second incubation for 10 
min at 95 ºC. The DNA then underwent 40-cycles consisting of a DNA denaturation step for 
15 sec at 95 ºC followed by an anneal/extend step for 1 min at 60 ºC. At the end of cycle an 
image was captured in order monitor the level of fluorescence in real time.   
 
 
 
Figure 2.5 Quantifiler® Trio DNA Quantification Kit amplification conditions. An 
initial incubation was carried out for 2 min at 95 ºC. The DNA then underwent 40-cycles 
consisting of a DNA denaturation step for 9 sec at 95 ºC followed by an anneal/extend step 
for 1 min at 60 ºC. At the end of cycle an image was captured in order monitor the level of 
fluorescence in real time.   
 
2.8.3.4 Analysis 
Data analysis for both kits was carried out using the integrated 7500 Software v2.0.6 and 
Microsoft Excel 2010. Results were accepted if the standard curve had a R2  value >0.98.  
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2.8.4 In-house mtDNA real-time PCR assay 
An in-house SYBR green assay was designed as described in Section 5.4 to quantify the 
amount of mitochondrial DNA present in sample DNA extracts.  
2.8.4.1  Template DNA preparation 
A synthetic DNA fragment (Integrated DNA Technologies, Coralville, IA, USA) was used 
in lieu of extracted DNA as described in Section 5.4 to prepare samples for the standard 
curve, which were set-up using the volumes outlined in Table 2-4 immediately prior to each 
run. A 20 µl aliquot of dsDNA fragment stock was taken from -80 °C storage, allowed to 
defrost on ice and then mixed by vortex for 15 sec; this tube formed standard 1. 990 µl of 
MBG water was added to each of four 1.5 ml tubes and labelled accordingly. 10 µl of 
standard 1 was transferred into standard 2, which was then vortexed for 15 sec to mix 
thoroughly and this step was repeated for subsequent standards. 2 µl of each standard was 
transferred into a Hard-Shell® Low-Profile Thin-Wall 96-Well Skirted PCR Plate in 
duplicate.  
All DNA extracts to be quantified were thoroughly mixed by vortex for 15 sec and 2 µl of 
each sample was then transferred to the reaction plate in either duplicate or triplicate. 2µl of 
MBG water was added in duplicate to the reaction plate to act as the NTC for the real-time 
PCR.  
Table 2-4 Preparation of DNA standards for in-house real time mtDNA assay 
Standard Final copy 
number/µl 
Volume of 
previous sample 
(µl) 
Volume of 
MBG water 
(µl) 
Dilution 
factor 
1 5*10
9
 
#
20 - 1X 
2 5*10
7
 10 990 100X 
3 5*10
5
 10 990 100X 
4 5*10
3
 10 990 100X 
#
20 µl of synthetic dsDNA fragment stock [5*10
9
 copies/µl] 
2.8.4.2 Reaction set- up 
SYBR® Green PCR Master Mix reagent kit along with the primers (Integrated DNA 
Technologies, Coralville, IA, USA) listed in Table 2-5 were used to set-up the reactions in a 
total volume of 10 µl as shown in Table 2-6. The reaction plate was sealed using Microseal® 
'C' Optical Seals and samples were amplified using a CFX96 Touch™ Real-Time PCR 
Detection System with the program shown in Figure 2.6.  
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Table 2-5 Primer sequences used for in-house real time PCR mtDNA assay 
Primer Sequence 5ˈ – 3  ˈ
F9638 CACCTGAGCTCACCATAGTCT 
R9772 GAAATGGTGAAGGGAGACTCG 
 
Table 2-6 Reaction set-up for in-house real time PCR mtDNA assay 
Reagent [Initial] [Final] 
Volume per 
sample (µl) 
SYBR® Green PCR Master Mix 2X 1X 5 
Primer F9638 10 µM 0.3 µM 0.3 
Primer R9772 10 µM 0.3 µM 0.3 
MGB water - - 2.4 
  Total 10 
 
 
 
Figure 2.6 Amplification conditions for in-house real time PCR mtDNA assay PCR. An 
initial incubation for 3 min at 98 ºC was followed by 40-cycles, consisting of a DNA 
denaturation step for 10 sec at 95 ºC, followed by an anneal/extend step for 30 sec at 60 ºC. 
At the end of cycle an imaged was captured in order monitor the level of fluorescence in real 
time. The temperature was then increased in increments of 5 °C every 5 sec and an image 
take to produce the melt curve. 
 
2.8.5 Qubit™ protocol 
A Qubit® 2.0 Fluorometer was used to measure the quantity of double-stranded DNA in a 
DNA extract using a Qubit™ dsDNA HS Assay Kit. 
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A working solution was prepared by adding X µl of Qubit™ dsDNA HS reagent to X*198 µl 
of Qubit™ dsDNA HS buffer, where X is the number of samples plus standards to be 
analysed.  
The standards were prepared by pipetting 190 µl into two 0.5 ml Qubit® Assay Tubes and 
adding 10 µl of either Qubit™ dsDNA HS standard 1 (0 ng/µl) or 2 (100 ng/µl). The 
standards were vortexed to mix and left to incubate for 2 min in the dark, at room 
temperature. The dsDNA High Sensitivity option was selected on the Qubit® Fluorometer, 
followed by the option to calibrate and standard 1 was inserted into the sample holder for 
measurement. When complete, this step was repeated for standard 2 and the standard curve 
accepted or rejected.  
198 µl of the prepared working solution was added to a 0.5 ml clear-walled tube and 2 µl of 
DNA extract was then added and vortexed to mix. Samples were incubated for 2 min at 
room temperature in a dark environment and then quantified in turn. 
2.9 DNA amplification 
2.9.1 Commercial kits 
2.9.1.1 DNA template preparation 
Each sample to be amplified was vortexed for 15 sec to mix and the required volume of 
DNA extract was transferred to a 0.1 ml MicroAmp® Fast-Tube Strip tube and sealed with a 
MicroAmp® Optical 8-Cap Strip. 007 or 9947A Control DNA was added, either directly or 
pre-diluted with MBG water, to give a total DNA input of 0.5 ng for a 28-cycle program or 
0.05 ng for a 34-cycle program. An equivalent volume of MBG water was added to one tube 
for the PCR negative control. 
2.9.1.2 Reaction set-up 
The required volume of each PCR reagent summarised in Table 2-7 for the number of 
samples to be processed was transferred to a DNA clean 1.5 ml tube and vortexed for 15 sec 
to mix. The appropriate volume of mastermix was then dispensed into each of the sample 
tubes, including the PCR positive and negative samples, pipetting up and down to mix. 
Samples were briefly vortexed and placed in a mini-microcentrifuge for 5 sec to ensure all 
liquid was removed from the lid.    
The sealed PCR tubes were then placed on a Veriti® 96-Well Fast Thermal Cycler and 
amplified using the manufacturer’s instructions for PCR run conditions as described in Table 
2-8. 
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Table 2-7 Summary of the PCR set-up, cycle number and size standards required for commercial amplification kits 
Amplification kit Application Cycle 
number 
Reaction 
mix (µl) 
Primer 
mix (µl) 
AmpliTaq 
Gold (µl) 
DNA template/  
MGB water (µl) 
Reaction 
volume (µl) 
Control 
profile 
Size 
standard 
AmpFℓSTR® SGM Plus® 
PCR Amplification Kit 
Buccal samples 
Low template samples 
28 
34 
5.25 2.75 0.25 5 12.5 007 500 ROX 
AmpFℓSTR® SGM Plus® 
PCR Amplification Kit 
Single-cells 34 6.3 3.3 0.3 *6 15 007 500 ROX 
AmpFℓSTR® NGM™ PCR 
Amplification Kit 
Buccal samples 28 5.0 2.5 N/A 5 12.5 007 500 LIZ 
AmpFℓSTR® NGM™ PCR 
Amplification Kit 
Low template samples 
Single-cells 
30/34 10.0 5.0 N/A 10 25 007 500 LIZ 
AmpFℓSTR® Identifiler® 
Direct PCR Amplification Kit 
Single-cells 34 12.5 12.5 N/A 
#
N/A 25 9947A 500 LIZ 
AmpFℓSTR® Yfiler® PCR 
Amplification Kit 
Low template samples 34 9.2 5.0 0.8 10 25 007 500 LIZ 
PowerPlex® ESX 16 System Low template samples 
Single-cells 
30/34 5.0 2.5 N/A 17.5 25 007 CC5 
PowerPlex® ESI 16 System Low template samples 
Single-cells 
30/34 5.0 2.5 N/A 17.5 25 007 CC5 
*PrepGEM extraction reagents added                                                                                                                                 
#
1µl of control DNA added for PCR positive sample  
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Table 2-8 Summary of PCR run conditions required for commercial kits 
Amplification kit Initial denaturation Denature Anneal Extend Final extension Hold 
Cycle 
number 
AmpFℓSTR® SGM Plus® PCR Amplification Kit 
95 °C 
11 min 
94 °C 1 
min 
59 °C    1 
min 
72 °C 
1 min 
60 °C 
45 min 
4 °C 
∞ 
28/34 
AmpFℓSTR® NGM™ PCR Amplification Kit 
95 °C 
11 min 
94 °C 
20 sec 
59 °C 
3 min 
60 °C 
10 min 
4 °C 
∞ 
28/30/34 
AmpFℓSTR® Identifiler® Direct PCR 
Amplification Kit 
95 °C 
11 min 
94 °C 
20 sec 
59 °C     2 
min 
72 °C 
1 min 
60 °C 
25 min 
4 °C 
∞ 
28/34 
AmpFℓSTR® Yfiler® PCR Amplification Kit 
95 °C 
11 min 
94 °C 
1 min 
61 °C 
1 min 
72 °C 
1 min 
60 °C 
80 min 
4 °C 
∞ 
28/34 
PowerPlex® ESX/ESI 16 System 
96 °C 
2 min 
94 °C 
30 sec 
59 °C 
2 min 
72 °C 
90 sec 
60 °C 
45 min 
4 °C 
∞ 
30/34 
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2.9.2 Low-template DNA assay 
2.9.2.1 Template DNA preparation 
DNA extracts were vortexed for 15 sec to mix and 5 µl of each sample was transferred to a 
0.1 ml MicroAmp® Fast-Tube Strip tube, which was sealed with a MicroAmp® Optical 8-
Cap Strip. 007 Control DNA was pre-diluted to give a total DNA input of 0.05 ng and an 
equivalent volume of MBG water was added to one tube for the PCR negative control.  
Single-cell samples were briefly vortexed and then centrifuged in a mini-microcentrifuge for 
5 sec to remove any liquid from the tube cap.  
2.9.2.2 Reaction set-up 
Qiagen’s Multiplex PCR Kit was used to set-up reactions in a total volume of 15 µl using 
the fluorescently tagged primers (Integrated DNA Technologies, Coralville, IA, USA) listed 
in Table 2-9. Primers were resuspended and diluted as described in section 2.8.1.1. The 
mastermix was prepared by transferring the required volume for the number of samples to be 
processed into a DNA clean 1.5 ml tube, as described in Table 2-10 and vortexing for 15 sec 
to mix. 10 µl of mastermix was then dispensed into each of the sample tubes, including the 
PCR positive and negative samples, pipetting up and down to mix. Samples were vortexed 
and placed in the mini-microcentrifuge for 5 sec to ensure all liquid was removed from the 
lid.    
The sealed PCR tubes were then placed on a Veriti® 96-Well Fast Thermal Cycler and 
amplified using the run conditions shown in Table 2-11.   
Table 2-9 Primer sequences used for in-house ltDNA amplification assay 
Primer  Sequence 5' – 3' Reference 
D10S1248_F NED-TTA ATG AAT TGA ACA AAT GAG TGA G (Coble and 
Butler, 
2005) 
D10S1248_R GCA ACT CTG GTT GTA TTG TCT TCA T 
PENTA_E_F* 6FAM-TGG GCG ACT GAG CAA GAC TC (Butler et 
al., 2003) PENTA_E_R GGT TAT TAA TTG AGA AAA CTC CTT ACA 
Amelo_F PET-CCC TGG GCT CTG TAA AGA ATA GTG (Sullivan 
et al., 
1993) 
Amelo_R ATC AGA GCT TAA ACT GGG AAG CTG 
D12S391_F VIC-TCT CCA GAG AGA AAG AAT CAA CAG GA (Guo et al., 
2014) D12S391_R* CCT CCA TAT CAC TTG AGC TAA TTC C 
* Primer modified 
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Table 2-10 PCR set-up for in-house ltDNA amplification assay 
Reagent [Initial] [Final] 
Volume per 
sample (µl) 
Qiagen 2X Buffer 2X 1X 7.5 
Primer mix 4.5 µM (each) 0.3 µM (each) 1 
Q solution 5X 0.5X 1.5 
  Total volume 10 
 
Table 2-11 PCR amplification conditions for in-house ltDNA assay 
Initial 
denaturation 
Denature Anneal Extend 
Final 
extension 
Hold 
Cycle 
number 
95 °C 
15 min 
94 °C 
30 sec 
59 °C 
90 sec 
72 °C 
1 min 
60 °C 
30 min 
4 °C 
∞ 
34 
 
2.9.3 Mitochondrial DNA amplification 
2.9.3.1 Template DNA preparation 
Samples were vortexed for 15 sec to mix and 5 µl was then transferred to a 0.1 ml 
MicroAmp® Fast-Tube Strip tube, which was sealed with a MicroAmp® Optical 8-Cap 
Strip. 5 µl of pre-diluted 007 Control DNA was added to one tube, to give a total DNA input 
of 0.05 ng, as a PCR positive control and an equivalent volume of MBG water  was added a 
tube for the PCR negative control. 
2.9.3.2 Reaction set-up 
Individual mastermixes were prepared for each primer set by transferring the required 
volume of each reaction component into a DNA clean 1.5 ml tube as summarised in Table 
2-12 to Table 2-17. All primers (Integrated DNA Technologies, Coralville, IA, USA) listed 
in Table 2-18 to Table 2-20, were resuspended and diluted as previously described in 
Section 2.8.1.1. The positions of the Edson primer sets listed in Table 2-18 are shown in 
Figure 2.7. Each mastermix was vortexed and 15 µl transferred to the appropriate tubes to 
give a total reaction volume of 20 µl.  
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Table 2-12 PCR set-up for mtDNA HVSI primer sets A-C and HVSII sets E, H & J 
Reagent [Initial] [Final] 
Volume per 
sample (µl) 
Buffer II 10X 1X 2 
MgCl2 25 mM 3 mM 2.4 
Forward Primer 10 µM 1 µM 2 
Reverse Primer 10 µM 1 µM 2 
dNTP mix 25 mM (each) 0.2 mM (each) 0.16 
BSA 10 mg/ml 1 mg/ml 2 
Taq 5 U/µl 1 U 0.2 
MBG water - - 4.24 
 Total mastermix volume 15 
 
Table 2-13 PCR set-up for mtDNA HVSI primer set D 
Reagent [Initial] [Final] 
Volume per 
sample (µl) 
Buffer II 10X 1X 2 
MgCl2 25 mM 2 mM 1.6 
Forward Primer 10 µM 1.5 µM 3 
Reverse Primer 10 µM 1.5 µM 3 
dNTP mix 25 mM (each) 0.2 mM (each) 0.16 
BSA 10 mg/ml 1 mg/ml 2 
Taq 5 U/µl 1 U 0.2 
MBG water - - 3.04 
 Total mastermix volume 15 
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Table 2-14 PCR set-up for Illumina D-loop protocol primer mix MI 
Reagent [Initial] [Final] 
Volume per 
sample (µl) 
10X buffer II 10X 1X 2 
Primer mix 0.25µM (each) 0.04 3.2 
dNTPs 25mM (each) 0.4mM (each) 0.32 
Taq 5U/µl 1U 0.2 
MgCl2 25mM 6mM 4.8 
MBG water - - 2.48 
Q solution 5X 0.5X 2 
 Total mastermix volume 15 
 
Table 2-15 PCR set-up for Illumina D-loop protocol primer mix MII 
Reagent [Initial] [Final] 
Volume per 
sample (µl) 
10X buffer II 10X 1X 2 
Primer mix 0.25µM (each) 0.05 4 
dNTPs 25mM (each) 0.6mM (each) 0.48 
Taq 5U/µl 1U 0.2 
MgCl2 25mM 6mM 4.8 
MBG water   1.52 
Q solution 5X 0.5X 2 
 Total mastermix volume 15 
 
Table 2-16 PCR set-up for Illumina D-loop protocol primer mix MIII 
Reagent [Initial] [Final] 
Volume per 
sample (µl) 
10X buffer II 10X 1X 2 
Primer mix 0.25µM (each) 0.05 4 
dNTPs 25mM (each) 0.6mM (each) 0.48 
Taq 5U/µl 1U 0.2 
MgCl2 25mM 7mM 5.6 
MBG water   2.72 
 Total mastermix volume 15 
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Table 2-17 PCR set-up for Illumina D-loop protocol primer mix MIV 
Reagent [Initial] [Final] 
Volume per 
sample (µl) 
10X buffer II 10X 1X 2 
Primer mix 0.25µM (each) 0.05 4 
dNTPs 25mM (each) 0.4mM (each) 0.32 
Taq 5U/µl 1U 0.2 
MgCl2 25mM 5mM 4 
MBG water   2.48 
Q solution 5X 0.5X 2 
 Total mastermix volume 15 
 
Table 2-18 Primer sequences for HVSI, II & III amplicons using Edson primer sets 
(Edson, 2004) for samples to be analysed using the 3130 Genetic Analyzer 
HVSI Primer ID Primer Sequence 5' - 3' 
Set A F15989 CCC AAA GCT AAG ATT CTA AT 
 R16158 TAC TAC AGG TGG TCA AGT AT 
Set B F16112 CAC CAT GAA TAT TGT ACG GT 
 R16251 GGA GTT GCA GTT GAT GT 
Set C F16190 CCC CAT GCT TAC AAG CAA GT 
 R16322 TGG CTT TAT GTA CTA TGT AC 
Set D F16268 CAC TAG GAT ACC AAC AAA CC 
 R16410 GAG GAT GGT GGT CAA GGG AC 
Set E F034 GGG AGC TCT CCA TGC ATT TGG TA 
 R159 AAA TAA TAG GAT GAG GCA GGA ATC 
Set H F220 TGC TTG TAG GAC ATA ATA AT 
 R389 CTG GTT AGG CTG GTG TTA GG 
Set J F403 TCT TTT GGC GGT ATG CAC TTT 
 R569 GGT GTA TTT GGG GTT TGG TTG 
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Figure 2.7 Image to show position of Edson primer sets used. This primer set has been 
designed to generate overlapping amplicons which are suitable for amplification of degraded 
DNA. The exact positions of primer sets A-E, H and J and the primer sequences are listed in 
Table 2-18.  
 
Table 2-19 Primer sequences for HVSI amplicons A-D [4] for samples to be analysed 
on the MiSeq Desktop Sequencer 
HVSI Primer 
Id 
Primer Sequence 5' - 3' 
S
e
t 
A
 
AF1 AATGATACGGCGACCACCGAGATCTACACCGCTGATTCATGC
ATTGCCCAAAGCTAAGATTCTAAT 
AF2 AATGATACGGCGACCACCGAGATCTACACAGGCGATTCATGC
ATTGCCCAAAGCTAAGATTCTAAT 
AF3 AATGATACGGCGACCACCGAGATCTACACGCGGTATTCATGC
ATTGCCCAAAGCTAAGATTCTAAT 
AR1 CAAGCAGAAGACGGCATACGAGATAATACACCTGAGTCGTGT
ACTACAGGTGGTCAAGTAT 
AR2 CAAGCAGAAGACGGCATACGAGATTTTTCACCTGAGTCGTGT
ACTACAGGTGGTCAAGTAT 
S
e
t 
B
 
BF1 AATGATACGGCGACCACCGAGATCTACACGTGACATTCATGC
ATATCACCATGAATATTGTACGGT 
BF2 AATGATACGGCGACCACCGAGATCTACACCCCTAATTCATGC
ATATCACCATGAATATTGTACGGT 
BF3 AATGATACGGCGACCACCGAGATCTACACAGGTCATTCATGC
ATATCACCATGAATATTGTACGGT 
BR1 CAAGCAGAAGACGGCATACGAGATCACTTACTTGAATATCCG
GAGTTGCAGTTGATGT 
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BR2 CAAGCAGAAGACGGCATACGAGATATGCTACTTGAATATCCG
GAGTTGCAGTTGATGT 
S
e
t 
C
 
CF1 AATGATACGGCGACCACCGAGATCTACACCCTGTATTCATAC
ATAGCCCCATGCTTACAAGCAAGT 
CF2 AATGATACGGCGACCACCGAGATCTACACCGATCATTCATAC
ATAGCCCCATGCTTACAAGCAAGT 
CF3 AATGATACGGCGACCACCGAGATCTACACGTCCAATTCATAC
ATAGCCCCATGCTTACAAGCAAGT 
CR1 CAAGCAGAAGACGGCATACGAGATGGTAAACCTGAGTCGCCT
GGCTTTATGTACTATGTAC 
CR2 CAAGCAGAAGACGGCATACGAGATGATTCACCTGAGTCGCCT
GGCTTTATGTACTATGTAC 
S
e
t 
D
 
DF1 AATGATACGGCGACCACCGAGATCTACACCTGGTATTCATGC
ATATCACTAGGATACCAACAAACC 
DF2 AATGATACGGCGACCACCGAGATCTACACGCATCATTCATGC
ATATCACTAGGATACCAACAAACC 
DF3 AATGATACGGCGACCACCGAGATCTACACGGAACATTCATGC
ATATCACTAGGATACCAACAAACC 
DR1 CAAGCAGAAGACGGCATACGAGATATTCCACTTGAATATATG
AGGATGGTGGTCAAGGGAC 
DR2 CAAGCAGAAGACGGCATACGAGATAAGGAACTTGAATATATG
AGGATGGTGGTCAAGGGAC 
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Table 2-20 Primer sequences for Illumina protocol D-loop amplification 
HVSI Primer Id Primer Sequence 5' - 3' 
S
e
t 
M
I 
F15997‐A  TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCACCATT
AGCAC CCAAAGCT 
F15997‐B  GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCACCAT
TAGCA CCCAAAGCT 
R16236‐A  TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCTTTGGA
GTTGCA GTTGATG 
R16236‐B  GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTTTGG
AGTTGC AGTTGATG 
S
e
t 
M
II
 
F16159‐A  TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTACTTGA
CCACC TGTAGTAC 
F16159‐B  GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTACTTG
ACCAC CTGTAGTAC 
R16401‐A  TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTGATTTC
ACGGA GGATGGTG 
R16401‐B  GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTGATTT
CACGGA GGATGGTG 
S
e
t 
M
II
I 
F29‐A  TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGTCTAT
CACCC TATTAACCAC 
F29‐B  GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGTCTA
TCACC CTATTAACCAC 
R285‐A  TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGGGTTT
GGTGG AAATTTTTTG 
R285‐B  GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGGGT
TTGGTGG AAATTTTTTG 
S
e
t 
M
IV
 
F172‐A  TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGATTATTT
ATCGCA CCTACGT 
F172‐B  GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATTATT
TATCGC ACCTACGT 
R408‐A  TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCTGTTAA
AAGTG CATACCGCCA 
R408‐B  GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTGTTA
AAAGTG CATACCGCCA 
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The sealed PCR tubes were then placed on a Veriti® 96-Well Fast Thermal Cycler and 
amplified using the PCR run conditions shown in Table 2-21 with the annealing 
temperatures specified in Table 2-22. 
This set-up was used for samples going on to be sequenced by both the 3130 Genetic 
Analyzer and the MiSeq Desktop Sequencer. Reaction set-up for samples to be sequenced 
by the MiSeq using the Edson set of primers modified with flowcell adaptors, as explained 
in more detail in Section 5.3.6.7. 
Table 2-21 PCR run conditions for mtDNA HVS amplification ‘X ºC’ denotes the 
annealing temperature for each of the HVS primer sets as described in Table 2-22 
 
Table 2-22 Target fragment size and annealing temperatures for amplifications of 
mtDNA primer sets HVSI A-D (both Edson and modified Edson sets), HVSII E, H & J 
(Edson) and Optimised Illumina D-loop protocol sets MI-MIV 
Primer Set Target size (bp) Annealing temperature °C 
HVSI Set A 169 52 
HVSI Set B 139 53 
HVSI Set C 132 55 
HVSI Set D 142 59 
HVSII Set E 125 56 
HVSII Set H 169 46 
HVSIII Set J 166 58 
MI 239 59 
MII 242 60 
MIII 256 59 
MIV 236 59 
 
Initial 
denaturation 
Denature Anneal Extend 
Final 
extension 
Hold 
Cycle 
no. 
95 °C 
10 min 
94 °C 
30 sec 
X °C 
1 min 
72 °C 
1 min 
60 °C 
7 min 
4 °C 
∞ 
35 
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2.10 PCR clean-up  
2.10.1 QuickStep™2 PCR Purification Kit  
To prepare PCR products for clean-up using the QuickStep™2 PCR Purification Kit, MBG 
water was added to each sample so to a final total volume of 20 µl. The SOPE resin was 
vortexed briefly to mix and 4 µl added to each sample, pipetting up and down several times 
to mix. The samples were left to incubate at room temperature for 5 min whilst the Performa 
Gel Filtration Cartridges were placed in a SIGMA 1-14 and centrifuged at 850 x g for 3 min. 
The columns were then transferred to fresh 1.5 ml tubes and the SOPE/sample mixture 
transferred to the centre of the column gel bed. Samples were then centrifuged at 850 x g for 
3 min, the columns discarded and the eluates retained. Samples were stored at -20 °C until 
required for further processing.  
2.11 Sequencing reaction 
2.11.1 BigDye® Terminator v1.1 Cycle Sequencing Kit 
2 µl of purified PCR product from each sample was transferred into a 0.1 ml MicroAmp® 
Fast-Tube Strip tube and sealed with a MicroAmp® Optical 8-Cap Strip. 2 µl of MBG water 
was added to one tube for a sequencing negative control. 
The appropriate primers (Integrated DNA Technologies, Coralville, IA, USA) and PCR 
reagents included in the BigDye® Terminator v1.1 Cycle Sequencing Kit were briefly 
mixed by vortex and a mastermix was prepared in a 1.5 ml tube for each individual primer 
as shown in Table 2-23. The mastermix was mixed for 15 sec by vortex and 8 µl was then 
dispensed into each sample tube. Samples were placed on a Veriti® 96-Well Fast Thermal 
Cycler and amplified for 25-cycles using the program shown in Table 2-24.  
 Table 2-23 Sequencing reaction set-up for BigDye® Teminator kits 
Reagent [Initial] [Final] 
Volume per 
sample (µl) 
Ready Reaction Premix 2.5X 0.5X 2 
BigDye Sequencing Buffer 5X 0.5X 1 
Primer (either forward or reverse) 10 µM 1 µM 1 
MBG water - - 4 
 Total mastermix volume 8 
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Table 2-24 Sequencing reaction run conditions for BigDye® Terminator kits 
Initial 
denaturation 
Denature Anneal Extend Hold Cycle no. 
96 °C 
1 min 
96 °C 
10 sec 
50 °C 
5 sec 
60 °C 
75 sec 
4 °C 
∞ 
25 
 
2.12 Sequencing reaction clean-up 
2.12.1 PERFORMA
®
 DTR Gel Filtration Cartridges 
The required number of PERFORMA® DTR Gel Filtration Cartridges were placed in a 
SIGMA 1-14 Microfuge centrifuge at 750 x g for 2 min (850 x g for 3 min for BigDye® 
Teminator v 3.1 Cycle Sequencing Kit) and the columns transferred to a fresh kit tube. The 
entire sample was transferred to the centre of the gel bed and the columns centrifuged at 750 
x g for 2 min (850 x g for 3 min for BigDye® Teminator v 3.1 Cycle Sequencing Kit). The 
columns were then discarded and the eluates retained. Samples were stored at 4 °C until 
required for further processing.  
 
2.13 DNA profile visualisation 
2.13.1 Reagent preparation 
2.13.1.1  TBE buffer 
To prepare 1 litre of a 5X TBE buffer stock solution 54 g of Trizma, 27.5 g boric acid and 
20 ml of 0.5 M EDTA pH 8.0 was added to 900 ml of deionised water and inverted several 
times to dissolve. Deionised water was added to a final volume of 1 L and the solution was 
stored at room temperature for a maximum of 6 months. 
A 1 in 5 dilution in deionised water was carried out to prepare a 1X working solution of 
TBE buffer. The solution was stored at room temperature for a maximum of 6 months. 
2.13.1.2 3% agarose gel 
To prepare a 3% (w/v) agarose gel, 1.5 g of agarose powder was added to 50 ml of 1X TBE 
buffer and heated in a microwave for approximately 90 sec until melted. The gel was 
allowed to cool at room temperature for 2 min and 5 µl of SYBR®Safe and gently swirled to 
mix. The gel was poured into a cassette mould holding either an 8 or 15 well comb and left 
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to set under aluminium foil for 20 min. Once set, the comb was removed from the gel and 
the cassette transferred to a gel tank, which was then covered in 1X TBE buffer.  
Samples were prepared by adding 5 µl of PCR product into a 1.5 ml tube and adding 1 µl of 
5X Loading Buffer Blue (Bioline), pipetting up and down to mix. The sample/loading buffer 
was then transferred into one of the gel sample wells; this was repeated for samples. 5 µl of 
Hyperladder™ 50 bp was added to the wells on the left and right of the samples. The tank 
was sealed and the electric current applied for 40 min at 120 V.    
Products were visualised and captured using a Syngene G:BOX Gel Doc with integrated 
GeneSys.Ink software.  
2.13.2 Applied Biosystems 3130 Genetic Analyzer  
2.13.2.1  Fragment analysis 
To process samples for fragment analysis on the 3130 Genetic Analyzer, a size standard mix 
was prepared in a 1.5 ml tube containing either 8.5 µl or 8.7 µl of Hi-Di™ Formamide and 
0.5 µl or 0.3 µl of GeneScan™ 500 ROX™ or 500 LIZ™ dye Size Standard respectively. 
The size standard mix was briefly vortexed and 9 µl was then dispensed into the number of 
required wells of a 96-well plate. 1 µl of the sample PCR product was then added to each 
well. For Promega ESI/ESX 16 kits, 10 µl of Hi-Di™ Formamide was mixed with 1 µl of 
CC5 Internal Lane Standard 500 and 11 µl transferred to the reaction plate per well.  
The appropriate allelic ladder for the amplification kit used in PCR was vortexed to mix and 
1 µl was added to a well at a ratio of one ladder for every two runs. 
A plate septum was used to seal the plate and was then placed on a Veriti® 96-Well Fast 
Thermal Cycler for 3 min at 95 °C, prior to being put on ice to snap cool for 5 min. The plate 
was then secured in the plate adaptor and placed onto the 3130 machine for processing using 
a 36-cm length capillary array with POP-4. 
Genetic Analyzer Data Collection Software v 3.0 was used to set-up the plate sample sheet 
using the appropriate run module with parameters as described in Table 2-25. The sample 
sheet was then linked to the plate and the run initiated. 
 
 
 
 
74 
 
Table 2-25 3130 Genetic Analyzer run module capillary electrophoresis parameters 
Run module Oven 
temp 
(ºC) 
Injection 
voltage 
(kV) 
Injection 
time  
(sec) 
Run 
voltage 
(kV) 
HIDFragmentAnalysis36_POP4_1 60 3 5 15 
HIDFragmentAnalysis36_POP4_1_LI 60 3 15 15 
UltraSeq36_POP4_1 55 1.2 10 15 
 
2.13.2.2  Sequencing analysis 
To prepare for sequencing analysis of samples on the 3130 Genetic Analyzer, 8 µl of Hi-
Di™ Formamide was dispensed into the required number of wells on a MicroAmp® Optical 
Reaction Plate. Samples were briefly vortexed to mix and 2 µl was then transferred to the 
reaction plate, pipetting up and down several times to mix. The reaction plate was then 
sealed with a plate septum, secured in the plate adaptor and placed onto the 3130 machine. 
A new plate was created, named and ‘sequencing analysis’ selected. Sample names were 
inputted onto the sample sheet and the run module UltraSeq36_POP4_1, with the parameters 
as shown in Table 2-25, was selected. The KB basecaller mobility file 
KB_3130_POP4_BDTv1.1/3.1 was used and set to remove bases from the end until fewer 
than 4 bases out of 20 have QVs < 20.  The sample sheet was then linked to the plate and the 
run commenced.  
2.13.3 Data analysis 
2.13.3.1  Fragment analysis 
Files produced by the 3130 run collection software were imported into Genemapper® ID 
version 3.2 for analysis. DNA fragments were first sized relative to the appropriate size 
standard for the commercial kit as shown in Table 2-7, and then alleles designated by 
comparison with the appropriate ladder. Table 2-26 outlines the analysis settings used for all 
amplification kits. As no ladder was available for the in-house developed ltDNA assay, all 
alleles were sized by comparison to GeneScan™ 500 LIZ™ dye Size Standard and the 
alleles designated manually as described in Section 3.3.6 
2.13.3.2  Sequencing analysis 
Files created by the 3130 run collection software and KB base caller were imported into 
SeqScape Version 5.2 software and then the resulting ABI format chromatogram files were 
opened and analysed using Finch TV Version 1.4.0.  
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Table 2-26 GeneMapper ID v 3.2 Analysis settings 
Amplification kit 
used 
 Panel set Bin set Peak amplitude 
threshold 
Size standard 
AmpFℓSTR® SGM 
Plus® 
Reference 
Low-template 
AmpFLSTR_Panels_v1 AmpFLSTR_Bins_v1 
50 
25 
CE_F_HID_GS500 
AmpFℓSTR® 
NGM™ 
Reference 
Low-template 
AmpFLSTR_NGM_v1 NGM_bins_v1 
50 
25 
CE_G5_HID_GS500 
AmpFℓSTR® 
Identifiler® Direct 
Reference 
 
Low-template 
IdentifilerDirect_GS500_Panels_v1 IdentifilerDirect_GS500_Bins_v1 
50 
 
25 
CE_G5_HID_GS500 
AmpFℓSTR® 
Yfiler® 
Reference 
Low-template 
AmpFLSTR_YFiler_Panel_v2 YFiler_v2 
50 
25 
CE_G5_HID_GS500 
PowerPlex® ESI 16 
System 
Reference 
Low-template 
Promega_ESI_16 Promega_ESI_16_bins 
50 
25 
CC5_ILS_GS500 
PowerPlex® ESX16 
System 
Reference 
Low-template 
Promega_ESX_16 Promega_ESX_16_bins 
50 
25 
CC5_ILS_GS500 
ltDNA Assay 
Reference 
Low-template 
ltDNA v1.1 NA 
50 
25 
CE_G5_HID_GS500 
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2.14 Fibre spectral profile visualisation 
2.14.1 Microspectrophotometer 
The fibre of interest was mounted on a microscope slide using DPX with a Deckglaser 
crystal clear glass coverslip and left for at least 1 hour to set before analysis. For fibres 
examined in the UV range, glycerol was used to mount the sample under quartz coverslips.  
The slide was placed onto the microscope stage of a TIDAS MSP800 UV-Vis Range 
Microspectrophotometer, which was set with the following parameters for acquisition: scan 
type – Absorbance, start wavelength – 380 nm, end wavelength – 700 nm, integration time – 
600 ms, no. of averages – 10, binning – 1, dark current – selected. The measurement window 
was aligned alongside the fibre and a background spectrum recorded. The measurement 
window was then positioned over the fibre of interest, which was orientated in a vertical 
direction and ten measurements were recorded along the fibre length, which were then 
averaged prior to comparison between spectra from different fibres. Data was analysed and 
visualised using integrated ONYX software. 
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3. Single-cell DNA analysis 
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3.1 Introduction  
LtDNA analysis is carried out routinely in forensic casework, particularly on so-called 
‘touch DNA’ samples; however the sensitivity required for such work often results in the 
amplification of background DNA in addition to the target DNA, thus resulting in mixed 
DNA profiles. Whilst under some circumstances, i.e. with clear major/minor contributors, a 
mixture can be resolved; often the complexity of these profiles renders them uninterpretable. 
The use of individual single-cells as a DNA source would minimise the potential for DNA 
mixtures; however this type of analysis is seldom carried out in forensic casework.   
The analysis of DNA extracted from single nucleated cells was first reported by Li et al. in 
1988 (Li et al., 1988) who used the then relatively new technique of PCR to amplify two 
genetic loci from both a single sperm cell and a diploid cell. It was not until almost a decade 
later that the potential for use of forensic analysis of single-cell DNA was first explored and 
reported by Findlay et al. (Findlay et al., 1997), who amplified at least four out of six STR 
markers in approximately two thirds of the two hundred and twenty six buccal cells tested. 
Whilst these results looked promising for application in forensic science the authors noted 
the requirement for a robust interpretation strategy due to both the stochastic effects that are 
associated with processing ltDNA extract and allele drop-in/contamination events, which 
were observed in 17% of their results. Allele drop-in is a sporadic contamination events 
thought to be a result of amplification of atmospheric DNA or potentially cell-free DNA that 
is adhered to the surface of the cell.  
In order to interpret any DNA profile, a peak amplitude threshold (PAT) describing the 
minimum peak heights in relative fluorescent units (RFU) will be used, which for the 
identification of allelic peaks against the background noise signal (Budowle et al., 2009b). 
Minimum peak heights of 50 RFU and 150 RFU for heterozygous and homozygous peaks 
respectively have been demonstrated as suitable PAT thresholds for standard DNA profiles 
generated using 28-cycle PCR (Gill et al., 1997b). For ltDNA samples a nominal minimum 
threshold of 25 RFU is frequently utilised (Cowen et al., 2011) in order to obtain the 
maximum amount of information from each sample.  
Once all peaks of interest have been identified, characteristics such as stutter peaks, 
heterozygous balance between peaks within a locus, balance across all the loci, allelic drop-
out and allelic drop-in must all be considered (Gill et al., 1997b).    
Stutter peaks are a common and unavoidable artifact that results in the appearance of 
additional peaks exactly one or more repeat units less than the true allele peak or, less 
frequently, in the plus-one repeat unit position (Walsh et al., 1996). It is thought stutter 
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peaks arise during DNA synthesis as a consequence of the polymerase ‘slipping’ off the 
template strand, thus causing the two DNA strands to separate slightly, which due to 
misalignment upon reannealing results in the newly synthesised strand consisting of one 
repeat unit shorter than the original template (Levinson and Gutman, 1987, Strand et al., 
1993). To account for those stutter peaks that are one repeat unit longer than the template 
DNA strand, it is thought that the extending strand may loop out during synthesis, which 
will then act as a template in the next round of amplification (Walsh et al., 1996). A number 
of factors have been shown to effect the occurrence of stutter peaks including repeat unit 
length (Walsh et al., 1996, Klintschar and Wiegand, 2003), the longest stretch of 
uninterrupted tandem repeats within the allele (Bright et al., 2014, Klintschar and Wiegand, 
2003) and the primary DNA sequence (Aponte, 2015, Walsh et al., 1996, Schlotterer and 
Tautz, 1992). The degree to which the stutter peak is present will be determined 
predominantly by the cycle number and frequency with which the slippage event occurs. As 
demonstrated recently by Aponte et al. (Aponte, 2015), the frequency and range of stutter 
increased by up to approximately 3% and 5% respectively when using MPS as compared 
with CE, most likely due to the additional amplification during sequencing.  
Stutter peaks must be considered with care as they can be interpreted as true alleles, 
therefore indicating a mixed profile, or incorrectly discounted from the profile thereby 
implying results from a single DNA source, when in fact it is mixed (Walsh et al., 1996, 
Clayton et al., 1998). Stutter peaks are identified through calculation of the stutter ratio (SR) 
in peak height/area (RFU) between the true allele peak and the suspected stutter peak using 
the following equation according to Gill et al. (Gill et al., 2000a): SR = stutter peak φ / allele 
φ (‘n’) + φ (‘n+1’), where ‘φ’ is peak area in RFU and ‘n’ is the allele peak minus the 
additional adenine base. The proportion of stutter (SP) observed at each locus is calculated 
using the equation SP = number of loci which stutter/total number of loci. Using the original 
SGM assay it was shown that stutter peaks were under 15% (0.15) of the true allele height 
(Gill et al., 1997b), and this threshold is often still used for the designation of stutter peaks if 
more precise, locus specific figures are not available through extensive validation work 
(Gibb et al., 2009). For ltDNA samples however it has been demonstrated that the stutter 
ratio value is increased due to stochastic variation of PCR; Whitaker et al. (Whitaker et al., 
2001), for example, observed stutter peaks that were as high as 0.40 for alleles with a peak 
area of < 10 000 RFU.   
The ratio in peak height or area (RFU) between two peaks at heterozygous loci is referred to 
as the heterozygous balance (Hb). If the starting quantity of DNA is optimal for the 
amplification kit used, then the amplification rate of both alleles at a locus should be 
consistent and therefore Hb = 1. When the starting quantity of DNA is sub-optimal however, 
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random selection will increase the probability that one allele is amplified to a greater extent 
than the other during the early cycles of PCR (Garvin et al., 1998, Ray et al., 1996). As the 
number of copies of this allele increases with each cycle, there are relatively fewer copies of 
the second allele, which is then visualised as imbalance in the peak height at the locus, 
becoming more severe as the Hb value draws towards zero (allelic drop-out). An increase in 
the number of PCR cycles, a method often used to enhance the amplification of ltDNA 
samples (Section 3.1), will exacerbate this effect, resulting in a higher frequency of observed 
heterozygous imbalance (Gill et al., 2000b). Hb by peak area can be calculated using either 
Hb = lower φ allele/ higher φ allele or Hb = LMW allele φ / HMW allele φ (Gill et al., 
2000a). The latter of these equations provides additional information in that a result over Hb 
> 1, indicates preferential amplification of the LMW allele and H < 1 of the HMW allele.  
An association between the mean peak area (RFU) and the variation in peak asymmetry at a 
locus has been demonstrated by Whitaker et al. (Whitaker et al., 2001) using loci that have 
peaks with an area >10,000 RFU, Hb min = 0.63 Hb max = 1.59, whilst loci with peaks 
<10,000 are expected to have more variation, Hb min = 0.58 Hb max = 1.89.  
The difficulty that arises more frequently in ltDNA profiles is the potential to incorrectly 
assign a locus as homozygous, when in actuality there may only be a single peak present as a 
result of allele drop-out. The consequences of this in casework are potentially serious as if 
the reference profile is heterozygous for a particular locus, and the crimestain is mistakenly 
designated homozygous, then the true offender might be excluded as the DNA source. To 
address this issue, a ltDNA threshold can be determined from a known source of DNA as the 
minimum peak height at which the drop-out of a second allele can be excluded, thus 
identifying a single peak as a homozygote (Gill et al., 2009).    
Allelic drop-in is the term used to describe the presence of one or two alleles, which have 
occurred independently as a result of the fragmented chromosomal DNA that is ubiquitous 
in the environment (Gill and Buckleton, 2010). Allelic drop-in is inescapable when working 
with methods and technologies that have been designed to detect even minute traces of 
DNA. The presence of more than two alleles is indicative of a likely contamination event 
rather than random allelic drop-in and it is important not to confuse the two concepts.  
It was first theorised by Navidi et al. (Navidi et al., 1992) and later tested by Taberlet et al. 
(Taberlet et al., 1996) that the use of a ‘multiple tubes approach’ would enable a more 
complete set of DNA results, a process widely known as consensus profiling. Consensus 
profiling requires a minimum of two amplifications from the same DNA extract, the profiles 
for which can then be compared and only alleles that are observed at least twice are recorded 
(Cowen et al., 2011). This approach somewhat alleviates the interpretation of artifacts such 
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as high stutter peaks and allele drop-in, as the stochastic effects of PCR are random by 
nature and so any two profiles, even from the same DNA extract, will exhibit differences. 
The conservative nature of this method results in a higher degree of confidence when 
analysing ltDNA profiles as demonstrated by Cowen et al. (Cowen et al., 2011), who found 
that the number of drop-in alleles was reduced by at least 95% when all alleles had to be 
observed twice.      
It is not possible to generate a consensus profile in the traditional sense from a single-cell 
DNA source as in having only two copies of the genome (diploid cells), multiple 
amplifications will result in differing regions of the DNA template being randomly 
amplified. It is however possible to amplify multiple single-cells in independent reactions, 
and then to generate consensus across the samples. Allele dropout has been shown to effect 
single-cell DNA amplification at a rate of approximately 10% per locus (Findlay et al., 1998, 
Findlay et al., 1997). Due to the random nature of the preferential amplification of one allele 
over another in ltDNA samples (Garvin et al., 1998, Ray et al., 1996), misinterpretation of a 
heterozygous locus as homozygous due to allele dropout can be reduced by the amplification 
and DNA profiling of multiple individual single-cells to provide consensus profiles. For 
example Garvin et al. (Garvin et al., 1998) demonstrated that when using a total of eight 
single-cells (four loci DNA profiles), a locus would be incorrectly designated as a 
homozygote in just 0.017% of cases where allelic dropout was observed at 62% per cell.   
In order to try and assuage some of the stochastic effects of PCR, thereby improving the 
quality of the resulting DNA profile, varying modifications to standard PCR and CE 
protocols have been researched.  
A number of modifications to the stage of DNA amplification have been shown to increase 
PCR sensitivity and thus the ability to detect and interpret DNA profiles generated from 
minimal quantities of starting DNA template. The most effective of these is to increase the 
number of cycles in the PCR program from the standard number of 28-cycles up to a total of 
34-cycles, either in one program (Findlay et al., 1997) or as two sequential amplifications 
referred to as 28 + 6 cycles (Kloosterman and Kersbergen, 2003). Due to the increased 
presence of stochastic effects resulting from PCR using ltDNA, increasing the number of 
PCR cycles above 34 has been shown offer no additional advantages (Gill et al., 2000b).  
A reduction in the volume of reagents used for PCR has shown to increase the sensitivity 
with which low level template DNA can be detected as it increases the ratio of DNA to 
reaction components (Gaines et al., 2002, Proff, 2006, Li, 2009, Leclair et al., 2003). For 
example, a volume of 5 µl or 10 µl  were shown to be most effective in increasing PCR 
sensitivity when using the AmpFℓSTR® Profiler Plus™ Kit (Gaines et al., 2002) with 22% 
82 
 
and 32% of expected alleles recovered respectively, whilst no amplification was observed 
using reaction volumes of 15, 20 and 50 µl.  
Direct PCR allows for the addition of the forensic material straight to the amplification 
reaction (Mercier et al., 1990); whilst there are associated reductions in time and cost using 
this method, importantly for ltDNA samples the potential for loss of DNA or introduction of 
contamination during the extraction process is eliminated. The addition of extraction 
reagents either to the PCR components (Goldenberger et al., 1995) or as a step prior to 
amplification (carried out in the same reaction tube), can facilitate cell lysis and therefore the 
release of DNA to increase PCR efficiency. A disadvantage of this method is the potential 
for PCR inhibitors to be added into the amplification reaction along with the sample. The 
effect of this is alleviated somewhat due to the inclusion of buffers and enzymes with a 
higher tolerance for inhibitors in kits such as Applied Biosytems AmpFℓSTR® Identifiler® 
Direct PCR Amplification Kit (Wang et al., 2012, Wang et al., 2011) and Promega’s 
PowerPlex® 18D System (Oostdik et al., 2013), as well as the direct-PCR compatible 
extraction reagents (Park et al., 2008). It has also been shown that some standard 
amplification kits, designed for use with an extraction step, may also be used effectively for 
direct PCR (Hall and Roy, 2014).  
PCR enhancers are components added to the PCR reagents that may improve the efficiency 
of amplification, particularly for DNA templates with a high GC content (Henke et al., 1997, 
Jensen et al., 2010), a high number of homopolymeric regions (Fazekas et al., 2010) or 
localised repeat sequences (Haqqi et al., 2002), and can also increase the stringency with 
which the reaction occurs, reducing the presence of stochastic effects such as stutter 
(Marshall et al., 2015). The effectiveness of betaine, a commonly used PCR enhancer, for 
ltDNA samples has been demonstrated by Marshall et al. (Marshall et al., 2015) who 
observed an increase in PCR yield for samples with a starting DNA quantity of 100 pg or 25 
pg, using both AmpFℓSTR® Identifiler and Identifiler Direct amplification kits and also an 
‘in-house’ two-locus assay.    
In addition to modifications during PCR, optimisation of post-PCR processes has also shown 
effective in increasing the sensitivity with which DNA can be detected.   
During electrokinetic injection, negatively charged primers and ions will compete with DNA 
for uptake by the electrodes prior to capillary electrophoresis, thereby limiting the quantity 
of DNA available for visualisation. The use of post-PCR clean-up methods to remove these 
additional PCR components from the sample, have shown to result in an increase in peak 
height (RFU) (Smith and Ballantyne, 2007, Forster et al., 2008), thus assisting interpretation 
of present alleles on the generated electropherogram. The advantage in utilising post-PCR 
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methods over modifications during pre-PCR stages, is the reduced risk of sample 
contamination using amplified DNA (Smith and Ballantyne, 2007); however, the reaction 
volume used for amplification must be considered as there is potential for sample loss during 
this stage. Additionally the use of a highly deionised form of formamide for sample injection 
will reduce competition from ions during electrokinetic injection and increase DNA uptake 
into the capillaries (Butler et al., 1995).   
Adjusting the electrokinetic injection voltage or length of time for which the voltage is 
applied will facilitate the uptake of DNA for capillary electrophoresis and so an associated 
increase in peak height RFU is observed (Westen et al., 2009, Forster et al., 2008, Cowen et 
al., 2011). This can be particularly useful to increase the height of potential allelic peaks 
above the analytical threshold, which under standard conditions would not have been 
recorded in the results. Cowen et al. (Cowen et al., 2011) were able to demonstrate that 
amplified DNA may be present but left undetected, as shown when up to 50% of dropped-
out alleles were detected following CE at 4 kV for 30 s as compared with the standard CE 
settings of 3 kV for 10 s.    
In some circumstances however, the nuclear DNA within the sample will have degraded to 
such an extent that any amplification and subsequent information obtained is limited. 
Mitochondrial DNA is known to persist better than nuclear DNA and so offers an alternative 
for forensic investigation as previously discussed in Section 1.2.4.3.    
Despite the interpretation issues discussed above, there are two substantial advantages to 
single-cell profiling; the reduced risk of obtaining a mixed DNA profile and the ability to 
obtain forensic DNA information from any biological material.  
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3.2 Aims and objectives 
The use of individual single-cells in forensic casework is limited due to concerns regarding 
difficulties associated with reliable DNA amplification, potential for contamination and 
interpretation challenges due to both the expected exacerbation of stochastic effects 
associated with any ltDNA sample and inability for a consensus profile to be generated. The 
aim of this part of this thesis is to investigate the analysis and interpretation of DNA derived 
from individual single-cells to determine their efficacy for use in forensic casework.  
The objectives of this study are to first develop an effective method for the visualisation and 
recovery of single-cells for DNA analysis that does not cause inhibition for downstream 
processing, and which can be carried out efficiently and under DNA anti-contamination 
conditions. The use of the AmpFℓSTR® SGM PCR Amplification Kit (SGM Plus), as the 
commercial kit utilised for loading to the NDNAD at the commencement of this study, will 
be optimised in order to maximise the information obtained from the DNA template 
available in a single diploid cell, approximately 6 pg. Once an optimal process has been 
determined, data will be generated to evaluate parameters for interpretation, i.e. stutter 
percentages etc. in order to assess challenges relative to published work on other ltDNA 
samples. In light of the recent transition to DNA 17 amplification kits for loading to the 
NDNAD, a preliminary look at the performance of three commercially available kits, 
AmpFℓSTR® NGM PCR Amplification Kit and the PowerPlex® ESX 16 and ESI System, 
will be carried out to assess their performance against SGM Plus. Finally, in addition to this, 
an ‘in-house’ assay will be developed targeted for amplification of ltDNA samples to 
determine if the use of fewer low molecular weight loci will improve amplification 
reliability in single-cell levels of DNA.    
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3.3 Materials and methods  
All single-cell DNA and assay development work for this project was approved by the 
Northumbria University Ethics Committee under the reference number RE25-10-121294. 
3.3.1 Inhibition tests 
50 pg of 007 DNA was added to twenty-eight 0.1 ml PCR tubes and an equivalent volume of 
MBG water was transferred to an additional six PCR tubes for negative controls. A square of 
UV-treated J-LAR tape or Sellotape, approximately 0.2 x 0.2 mm, was placed into each of 
three DNA-containing tubes and two water-containing tubes. In order to facilitate the release 
of the single-cell from the tape, two different adhesive removers, Sticky Stuff Remover 
(SSR) and Brava® Adhesive Remover (AO), were tested at volumes of 1 µl, 2 µl or 3 µl; 
added in triplicate to PCR tubes containing DNA. SSR is currently used by the FBI as an 
adhesive remover to recover textile fibres from under fibre tapes for further analysis (R. 
Palmer 2013 pers. comm. 8th February). Data on the components in the SSR solution is 
limited to hydrocarbons, n-alkanes, isoalkanes, cyclics and aromatics (De-Solve-it, 2012). 
Brava® Adhesive Remover is used by individuals who have a stoma, to remove any 
adhesive from the surface of the skin without causing damage (Coloplast, 2013); no 
information is available on the contents. The remaining four DNA samples and two water 
samples were used as control samples and PCR negatives respectively. In all cases the 
volume was made up to a total of 6 µl using MBG water. SGM Plus reagents were added to 
all samples and amplified for 34-cycles as described in Section 2.9.1. All SGM Plus PCR 
products were then visualised and analysed as described in Sections 2.13.2.1 and 2.13.3.1. 
3.3.2 PCR volume trial 
Single-cells and a tape negative control were prepared and transferred into a 0.1 ml PCR 
tube containing 1 µl of SSR and SGM Plus reagents were then added to each tube as 
described in Table 3-1 to give final reaction volumes of 5, 10, 15, 20 & 25 µl. Samples were 
amplified for 34-cycles according to manufacturer’s instructions as detailed in Section 2.9.1. 
All SGM Plus PCR products were then visualised and analysed as described in Sections 
2.13.2.1 and 2.13.3.1.  
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Table 3-1 SGM Plus component volumes for each reaction volume tested 
Reaction 
Volume (µl) 
SGM reaction 
mix (µl) 
SGM Plus 
primer set (µl) 
Taq polymerase 
(µl) 
MBG 
water (µl) 
5 2.1 1.1 0.1 1.7 
10 4.2 2.2 0.2 3.4 
15 6.3 3.3 0.3 5.1 
20 8.4 4.4 0.4 6.8 
25 10.5 5.5 0.5 8.5 
 
3.3.3 Initial ForensicGEM extraction trial 
Six individual single-cells and a tape negative control were prepared and transferred into a 
0.1 ml PCR tube containing 1 µl of SSR. A mastermix prepared on ice, containing 0.6 µl 
10X Gold Buffer, 0.3 µl prepGEM enzyme and 4.1 µl of MBG water was then added to each 
sample to give a total extraction volume of 6 µl. Samples were incubated on a Veriti® 96-
Well Fast Thermal Cycler for 10 min at 75 °C, followed by 5 min at 95 °C to deactivate the 
prepGEM enzyme. Samples were then placed on ice and SGM Plus reagents added to each 
sample as described in Section 2.9.1. These results were then compared with three single-
cells which had been amplified without the use of the ForensicGEM reagents as a control. 
All SGM Plus PCR products were visualised and analysed as described in Sections 
2.13.2.1and 2.13.3.1.  
3.3.4 Single-cell DNA profiles 
The donor volunteer for buccal cells used in this experiment was chosen based on his SGM 
Plus DNA profile as he was heterozygous at nine of the ten STR loci and also shared 
minimal alleles with the operator, facilitating detection of sample contamination. 
A buccal sample was cell harvested as described in Section 2.4.3, with the additional wash 
step added to the protocol in order to remove all salivary fluid from the cell samples, and 
prepared for staining with haematoxylin and eosin as described in Sections 2.4.3.2 and 2.5.1. 
Fifty single-cells were then recovered and prepared as described in Section 3.3.3. All SGM 
Plus PCR products were visualised and analysed as described in Sections 2.13.2.1 and 
2.13.3.1, using both a standard and extended capillary electrophoresis injection time.  
3.3.5 Assay comparison  
Buccal samples were prepared as described in Section 2.4.3 and transferred directly to a 
microscope slide for staining with haematoxylin and eosin as explained in Sections 2.4.3.2 
and 2.5.1. Forty individual cells were collected and transferred into 0.1 ml PCR tubes for 
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treatment using ForensicGEM reagents as detailed above (Section 3.3.3). Each of the 
amplification kits to be tested, AmpFℓSTR® NGM PCR Amplification Kit (NGM), 
PowerPlex® ESX 16 System (ESX), and PowerPlex® ESI 16 System (ESI), were added to 
ten cells and amplified according to the manufacturer’s instructions as summarised in 
Section 2.9.1.  
The final ten cells were amplified using an ‘in-house’ developed assay (Section 3.3.6) for 
ltDNA (ltDNA assay) as described in Section 2.9.2. All PCR products were visualised and 
analysed using the kit relevant reagents and protocols as described in Sections 2.13.2.1 and 
2.13.3.1.  
3.3.6 Development of an in-house low-template DNA amplification assay 
In order to try and improve the reliability of the amplification results for single-cell DNA 
analysis it was thought that a miniSTR kit with shorter target fragment sizes might result in a 
more consistent result. In the absence of funding for a commercially available kit, an in-
house ltDNA assay was designed and optimised. The requirements of the assay were to 
multiplex loci that have a relatively small fragment size, as this facilitates amplification as 
discussed in Section 1.2.1, but with a high degree of variability to enable identification of 
the donor source wherever possible. 
It was decided to include just four target STR loci in this assay, one in each of the 6-FAM, 
VIC, NED and PET dye lanes to allow for flexibility in primer design whilst keeping all loci 
at a minimal size. The fifth dye lane was then used to accommodate the LIZ-labelled size 
standard in order to size DNA fragments and identify alleles following PCR. 
A number of resources were utilised to determine which STR loci would be ideal candidates 
for inclusion in the multiplex, including published literature, particularly (Butler et al., 2003, 
Coble and Butler, 2005, Hill et al., 2008, Guo et al., 2014), and databases such as the ALlele 
FREquency Database (ALFRED) (Osier et al., 2001) and the ALLST*R autosomal STR 
database (Götz, 2015). Parameters such as allele range, fragment size, power of 
discrimination and heterozygosity value amongst the British population were considered 
during selection. Loci D10S1248, D12S391 and Penta E were chosen as suitable STR 
markers, in addition to which Amelogenin was included for sex determination.  
D10S1248 (Coble and Butler, 2005) is an ideal locus for inclusion in this multiplex for the 
purposes of sensitivity as the allele range spans only 44 bp and by using primer binding sites 
immediately adjacent to the repeating region, the total target fragment size can be kept 
minimal (Coble and Butler, 2005), thus facilitating locus amplification in both low-template 
and degraded DNA samples. For this reason, as well as a relatively high power of 
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discrimination (PD) value of 0.87 (sample size of 2949 individuals) amongst twenty-six 
countries from the European Union (Welch et al., 2012), D10S1248 was proposed as an 
addition to the European standard set of loci (ESS) in 2006 (Gill et al., 2006a). D12S391 is a 
tetranucleotide STR (Lareu et al., 1996) that has over fifty different alleles (Butler, 2012) 
and was also recommended as an addition to the ESS of loci in 2006 due to a high PD value 
of 0.97 (sample size of 2949 individuals) amongst the same twenty-six countries from the 
European Union (Gill et al., 2006b, Welch et al., 2012). Finally Penta E (Schumm, 1998), 
which is located on chromosome 15, was selected for inclusion in the multiplex as this locus 
has a wide range of alleles and therefore a high power of discrimination. As Penta E is not 
widely utilised in Europe, there is little data available; however, the PD value for the UK is 
given as 0.98 (sample size of 156 individuals) (Götz, 2015). Partially due to its 
pentanucleotide nature, Penta E exhibits very low levels of stutter <2% (Schumm, 1998) 
relative to tetranucleotides, which will facilitate interpretation in the presence of the 
stochastic effects associated with low-template and degraded DNA material. The high 
heterozygosity values for D10S1248, D12S391 and Penta E of 0.76, 0.89 and 0.90 
respectively (Götz, 2015) will also aid identification of source DNA, even in the presence of 
allele dropout. Calculating the match probability using the product rule as previously 
described in section 1.3.1, the probability of an unrelated individual having the same DNA 
profile as that generated using the ltDNA assay for the 007 control, was calculated as 
approximately 1 in 51,000 (allele frequencies obtained from (Götz, 2015).  
Primer sequences were initially obtained from published literature (see Table 3-2) and 
checked for multiplex compatibility using both NetPrimer 
(http://www.premierbiosoft.com/netprimer/index.html, last accessed 24/05/2015) and the 
NIST Autodimer tool (Vallone and Butler, 2004). Due to a difference in melting temperature 
(Tm) across the primer sets of 11.5 °C, the Penta E forward and D12S391 reverse primers 
were redesigned using Primer-BLAST (Ye et al., 2012) resulting in a decrease in the Tm 
range to 6.5 °C.  
 
The fluorescent intensity of the NED and PET dyes is low, approximately 2.5x and 4x less 
respectively, relative to the 6-FAM and VIC dyes and so, to balance the peak heights across 
the profile, these two dyes were coupled with the two smallest fragment targets of 
Amelogenin and D10S1248, as the LMW targets are preferentially amplified, therefore 
accounting for some of the intensity defect. Each dye was attached to the forward primer of 
each locus set as shown in Table 3-2. The primer concentration was also increased for the 
two smaller-sized loci during the initial testing; however, this did not affect the peak height 
balance between the loci. A diagram depicting the final assay layout is shown in Figure 3.1.  
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Figure 3.1 Overview of positions of loci included in the ltDNA amplification assay 
relative to the size standard in base pairs (bp) in orange colour. Each set of primers was 
tagged with a different fluorescent tag to allow for detection on the 3130 Genetic Analyzer; 
loci are shown in the colour related to the attached dye. 
 
Primers were set-up for DNA amplification using the Qiagen Multiplex PCR kit that 
includes a buffer containing K+ and NH4+, which together facilitate the specific and stable 
hybridisation of primers to the DNA template, enabling an efficient extension of the DNA 
strand (Qiagen, 2010). A series of experiments were conducted in order to optimise the 
assay to ensure maximum sensitivity, including the annealing temperature tested at            
58-60 °C, primer concentrations 0.1–0.5 µM (each) and inclusion of an additional unit of 
HotStar Taq DNA Polymerase. The addition of the Q-solution additive included in the 
Qiagen Multiplex PCR Kit, which is designed to increase assay tolerance to the annealing 
temperature range across the primer sets, was also tested. Results were determined using 
relative peak heights and the overall quality of the EPG, i.e. presence of PCR artefacts, using 
007 control DNA at a total input of 50 pg. The following conditions were determined as 
optimal for this assay; a primer concentration of 0.3 µM (each), the addition of Q solution to 
the reaction mixture and an annealing temperature of 59 °C. Alleles were designated using 
their fragment size (see appendix 8.2) relative to the included size standard. An example of a 
ltDNA assay profile is shown in Figure 3.2. 
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Figure 3.2 Example of EPG for ltDNA profile generated from a total DNA input of 50 
pg using 007 control DNA. Alleles at STR loci Penta E, D12S391 and D10S1247 have 
been sized relative to a size standard (not shown) and designated using expected allele sizes 
(see appendix 8.2). Alleles at Amelogenin were also sized relative to the size standard and 
designated X or Y based on expected fragment size. 
 
A serial dilution was set-up using 007 control DNA at total DNA inputs of approximately 
100 pg, 50 pg, 25 pg, 13 pg, 6 pg and 3 pg, in order to test the sensitivity of the assay under 
optimised conditions; reactions were set-up in triplicate as described in Section 2.9.2.1.  
 
An minimum average of 96% of the expected alleles were amplified down to a total DNA 
input of 25 pg, shown in Figure 3.3. Successful amplification of alleles was also observed in 
all samples at DNA inputs of approximately 13 pg, 6 pg and 3 pg, with averages of 79%, 
63% and 38% of expected alleles observed respectively.  
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Figure 3.3 Summary of sensitivity test results for the ltDNA assay showing successful 
amplification of alleles (grey) and allele drop out (pale grey) at each individual locus for 
decreasing total DNA inputs, from 100 pg – 3 pg. Tests were carried out in triplicate with all 
results shown.  
 
 
 
 
DNA input Penta E D12S391 D10S1428 Amelogenin 
100 pg 
        
        
        
50 pg 
        
        
        
25 pg 
        
        
        
13 pg 
        
        
        
6 pg 
        
        
        
3 pg 
        
        
        
 
Triplicate 
92 
 
Table 3-2 Summary of primer information for the four loci included in the ltDNA amplification assay. Two of the primers, D12S391 (reverse) and 
Penta E – (forward) were redesigned for this multiplex (denoted by *) 
 
Locus 
Genbank 
accession 
Primer set Repeat motif 
Fragment size 
range (bp) 
Allele range Reference 
D10S1248 AL391869 
NED-TTAATGAATTGAACAAATGAGTGAG 
GCAACTCTGGTTGTATTGTCTTCAT 
GGAA (simple) 79-123 8-19 
 (Coble and 
Butler, 2005) 
D12S391 G08921 
PET-TCTCCAGAGAGAAAGAATCAACAGGA 
GCCATATCACTTGAGCTAATTCCTCTAATA 
AGAT/AGAC 
(compound) 
145-195 15-27.2 
(Guo et al., 
2014)* 
Penta E AC027004 
6FAM-GGCGACTGAGCAAGACTC 
GGTTATTAATTGAGAAAACTCCTTACA 
AAAGA (simple) 73-168 5-24 
(Butler et al., 
2003)* 
Amelogenin 
M55418 
M55419 
VIC-CCCTGGGCTCTGTAAAGAATAGTG 
ATCAGAGCTTAAACTGGGAAGCTG 
 
NA 
106 
112 
X 
Y 
(Sullivan et 
al., 1993) 
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3.4 Results 
3.4.1 Inhibition tests  
Allele peak area (RFU) was recorded at each locus and compared against a control sample to 
determine if the addition of either adhesive tape or adhesive remover to the sample tube 
resulted in PCR inhibition. Of the two tapes tested, J-LAR tape did not appear to affect peak 
area (AV 24471 RFU, SD 12397 RFU) when compared with the control sample (AV 20241 
RFU, SD 9729 RFU), whilst a decrease in peak height relative to the control was observed 
across the DNA profile for Sellotape (AV 9051 RFU, SD 4927) as shown in Figure 3.4. 
In order to facilitate release of the single-cell from the tape two adhesive removers were 
tested for indication that PCR would be inhibited if added to the sample tube. No PCR 
inhibition was observed in the presence of 1 µl SSR (AV 15482 RFU, SD 7203 RFU) 
relative to the control sample (Figure 3.5) however, the addition of 2 µl and 3 µl resulted in 
complete inhibition of the PCR. All volumes of AO resulted in complete PCR inhibition 
with no DNA amplification observed. Data for charts included in appendix 8.3. 
 
Figure 3.4 Peak area of alleles at each locus following addition of adhesive tape into 
sample tube during PCR as compared with a control sample. Tests were carried out in 
triplicate and the average peak area (RFU) for each amplified allele in the DNA profile is 
shown for Sellotape (red) J-LAR tape (green). The average results for a control sample 
(black) tested without the addition of adhesive tape is also shown for comparison. A 
decrease in the average peak area across all loci, relative to the control sample is seen for the 
Sellotape indicating PCR inhibition, whilst the peak area of alleles J-LAR tape was 
comparable with the control sample. 
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Figure 3.5 Peak area of alleles at each locus following addition of 1 µl SSR into sample 
tube during PCR as compared with a control sample. Tests were carried out in triplicate 
and the average peak area (RFU) for each amplified allele in the DNA profile is shown for   
1 µl SSR (red) and a control sample (black), which was amplified without the addition of an 
adhesive remover for comparison. Although a slight decrease in peak area can be seen at 
some loci, no significant difference in the results was observed. 
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3.4.2 Amplification reaction volume trial 
Single-cells were prepared in triplicate and amplified using SGM Plus reagents, in reaction 
volumes of between 5 – 25 µl on a 34-cycle PCR program. The average DNA results 
summarised in the chart below (Figure 3.6) indicate that 15 µl is the most effective reaction 
volume for single-cell DNA amplification, whilst 5 µl was least effective in these 
experiments. Data for chart included in appendix 8.4.  
 
Figure 3.6 Effect of PCR volume on the average number of expected alleles amplified 
from individual single-cells using a 34-cycle PCR.  The fewest expected amplified alleles 
was observed in 5 µl (2%), followed by 10 µ (23%), 20 µl (26%), 25 µl (35%) and finally 
the highest number of expected alleles were amplified in 15 µl (43%). 
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3.4.3 Initial ForensicGem extraction trial 
The use of the ForensicGem reagents, including the incubation period prior to the addition of 
the SGM Plus reagents was shown to increase the average number of expected alleles 
amplified by 19%. 
3.4.4 Single-cell overall results 
Fifty individual single-cells were prepared and amplified from the same buccal source for 
34-cycles and then visualised using capillary electrophoresis at both standard and extended 
injection times. Of the fifty resulting DNA profiles using a standard injection time, thirty-
eight partial profiles were obtained, of which 61% had at least five alleles present (Figure 
3.7). No amplification was observed for eleven samples and one result was excluded from 
the data set due to evidence of contamination as more than two unexpected alleles were 
present as set out in Gill and Buckleton (Gill and Buckleton, 2010). Increasing the CE 
injection time resulting in the amplification of an additional DNA profile contain at least 
five alleles. Data for chart included in appendix 8.5. 
 
Figure 3.7 Summary of DNA profile results; using a standard CE injection the following 
results were observed: 23 partial profiles with more than four alleles, 15 partial profiles with 
four or less alleles, 11 of samples with no amplification observed and 1 sample in which 
contamination was evident. For the extended CE injection the number of samples where no 
amplification was present was reduced to 10, and the number of partial profiles with more 
than four alleles was increased to 24. 
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3.4.5 Amplified alleles 
The number of alleles amplified at each locus was plotted as a percentage of the maximum 
number of alleles across all forty-nine DNA profiles, with loci arranged in ascending order 
of molecular weight. As shown in Figure 3.8 as the amplicon size increases, the frequency 
with which the allele is amplified decreases. The exception to this is vWA, excluded from 
chart, as it is the only homozygous locus in the donor’s DNA profile and was observed in 
51% and 53% of single-cell DNA profiles for standard and enhanced CE conditions 
respectively. 
The amplicon size (bp) was plotted against peak height (RFU) for each of the observed 
alleles amplified in the forty-nine single-cell DNA profiles (Figure 3.9), for both standard 
and extended CE injection times. When the injection time was increased by a period of ten 
seconds, the peak heights increased by an average factor of 3 (SD 0.3) relative to the 
standard injection time. A slight decline can be seen in the peak height as the size of the 
amplicon increased, which is more pronounced when using the extended injection time. Data 
for charts included in appendix 8.6 and 8.7. 
 
Figure 3.8 Relationship between the molecular weight of each locus with the number of 
times an allele was observed for both standard and increased CE injection times. As the 
molecular weight of the amplicon size at each locus increased, the percentage of alleles 
amplified can be seen to decrease.  
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Figure 3.9 Relationship between amplicon size (bp) and peak height (RFU) for both 
standard and increased capillary electrophoresis injection time. As the amplicon size 
increases a slight reduction in peak height is observed. 
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3.4.6 Heterozygous balance 
Heterozygous balance (Hb) was assessed using the allelic peak areas (φ) (combining the ‘n’ 
and ‘n+1’ peaks where present) of 83/90 loci, for standard/increased CE injection time, 
according to the following equation as described by Gill et al. (Gill et al., 2000a),                          
Hb = LMW allele φ / HMW allele φ. The results were plotted as two scatterplots shown in 
Figure 3.10 and Figure 3.11, for those loci with an average peak height ≤10,000 RFU and 
>10,000 RFU respectively. Under standard CE conditions 51% of loci had a value of           
Hb ≥0.6, average Hb = 0.6 (SD 0.22), and a Hb range of 0.84, whilst using the enhanced CE 
settings resulted in values of 49% Hb ≥0.6, average Hb = 0.59 (SD 0.26), with the range       
Hb = 0.91. The increased injection time did not result in a significant decrease in 
heterozygous imbalance (P = 0.99). In cases where the maximum peak area was below 
10,000 RFU, a total of 44% of loci had a value of Hb ≥0.6 (both standard and increased 
settings) whereas 57% of loci for which the maximum peak area exceeded 10,000 RFU had 
values of Hb ≥0.6. Irrespective of peak area, all loci except D3 and D16 had a median value 
of Hb > 1, thus indicating a slight tendency towards preferential amplification of the LMW 
allele. Amplification of D2 did not result in the presence of both alleles in any sample. Data 
for charts included in appendix 8.8, and statistics calculations are included in appendix 8.12. 
 
Figure 3.10 Relationship between heterozygous balance and maximum peak area, 
where area is under 10,000 RFU for both standard and increased injection times. No 
relationship is observed between the heterozygous balance for alleles with a peak area of 
<10,000 RFU for either injection time. 
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Figure 3.11 Relationship between heterozygous balance and maximum peak area, 
where area exceeds 10,000 RFU for both standard and increased injection times. Only 
four data points for loci where the peak area >10,000 RFU were recorded for a standard CE 
injection.  
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3.4.7 Locus dropout 
Of a possible 429 loci, complete drop-out was observed at 46% of loci using a standard CE 
injection and 47% when using an increased injection time. The increased injection time did 
not result in a significant decrease in the level of locus dropout observed, with a P value of 
0.95 (see appendix 8.12 for details). The loci with the highest proportion of locus drop-out 
are D2 and D16, whilst D19 has the lowest as shown in Figure 3.12. Two instances were 
recorded following an increased injection time during CE, for which alleles were detected at 
loci that had previously been recorded as dropped out using the standard setting. In both 
cases the allele could not be designated in the first instance due to poor morphology/peak 
height, which was improved following the enhanced injection time, see  
Figure 3.13. Data for charts included in appendix 8.9. 
 
Figure 3.12 Frequency at which complete locus dropout was observed at each locus 
using both standard and increased CE injection times. Values at loci were the same, 
except for at D19 and FGA where the percentage is slightly reduced. 
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Figure 3.13 Images showing EPG of alleles for D19 (left) and FGA (right) for both 
standard (top) and increased (below) injection times during CE. It can be seen that under 
the standard injection times the peaks could have been mistaken for baseline noise on the 
electropherogram, however with the increase in injection time the morphology of the peak in 
each case becomes more distinct. 
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3.4.8 Allele dropout 
The frequency of allelic drop-out was recorded for each locus in addition to which, if the 
allele was the lower or higher molecular weight allele at that locus was also noted (Table 
3-3). Allelic drop-out was observed at 31% of all heterozygous loci; this was reduced to 29% 
using the increased injection during CE. The use of the increased injection time at CE did 
not result in a significant decrease in the level of allele dropout observed, P = 0.61 (see 
appendix 8.12). There was no bias towards the higher or lower molecular weight alleles 
using the standard injection, 50% for each, whilst the increased injection time resulted in a 
slight bias towards drop-out of the lower molecular weight (LMW) allele at 53%, than the 
higher molecular weight (HMW) allele at 47%.  
The increase in injection time resulted in a reduction of 2% in allelic drop-out. In five out of 
six of the observed alleles the low peak area, relative to the previously present first allele, 
lead to severe imbalance (see Figure 3.14) as reflected with Hb values as follows: D2 0.12, 
D8 0.14, D21 15.43 and D18 15.37.  
Figure 3.15 shows the peak heights (RFU) of the homozygous locus vWA and the remaining 
allele for loci at which allelic drop-out has occurred. The maximum peak height of the 
present allele, where the other has dropped out is 708 RFU and 1827 RFU for standard and 
increased injection times respectively. Data for charts included in appendix 8.9. 
Table 3-3 Summary of allelic drop-out results at all heterozygous loci for both standard 
and increased injection times 
Locus Number of times allele dropped out 
 Standard Enhanced 
 Total LMW HMW Total LMW HMW 
D3 13 1 12 13 1 12 
D16 6 6 0 6 6 0 
D2 9 3 6 8 5 3 
D8 17 10 7 16 9 7 
D21 11 5 6 10 5 5 
D18 13 8 5 11 8 3 
D19 15 8 7 15 8 7 
THO1 10 7 3 10 7 3 
FGA 15 8 7 14 7 7 
AMEL 10 4 6 10 4 6 
Total 119 60 59 113 60 53 
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Figure 3.14 Images showing EPG of imbalanced alleles at D21 (left) and D8 (right) for 
both standard (top) and increased (below) injection times during CE. Due to the level of 
preferential amplification during PCR, the imbalance between allele peaks is extreme with 
dropout occurring under a standard injection time (D21). With the increase in injection time 
however, the smaller allele is detected. 
 
 
Figure 3.15 Peak height (RFU) of both homozygous alleles and, in cases where allelic 
drop-out has occurred, the peak height of the remaining allele, under both standard 
and increased CE injection times.  
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3.4.9 Stutter peaks 
The relative area of stutter peaks (SR) was assessed using the allelic peak areas (φ) 
(combining the ‘n’ and ‘n+1’ peaks where present) according to the following equation as 
described by Gill et al. (Gill et al., 2000a),  SR = stutter peak φ / allele φ (‘n’) + φ (‘n+1’). 
Stutter peaks (-4 bp) were observed for 27% of the 272 alleles observed using a standard CE 
injection time (Figure 3.16), which increased to 65% (of 281 alleles) when the increased CE 
injection time was applied (Figure 3.17). The increase in injection time did not result in a 
significant increase in the level of stutter observed (P = 0.86). 64% of the stutter peaks 
observed using the standard injection times were seen to decrease in stutter ratio following 
the use of enhanced CE settings. 88% and 92% of stutter peaks had a stutter ratio value of 
≤0.15 for standard and increased injection times respectively (P = 0.15), whilst the 95th 
percentile value for stutter ratio in each case was SR ≤0.20 and ≤0.19. As the peak area of 
the allele peak decreased, the stutter ratio was seen to increase as shown in Figure 3.18. The 
maximum stutter ratio observed where the true allele peak area < 10 000 RFU was at 
0.33/0.32, and values at >10 000 RFU were 0.13/0.29, for standard/increased CE settings 
respectively. No stutter peaks greater in area than the true allele were observed in this 
dataset. Data for charts included in appendix 8.10 and statistics results are included in 
appendix 8.12. 
 
Figure 3.16 Stutter ratio by peak area for each STR locus using a standard CE 
injection time 
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Figure 3.17 Stutter ratio by peak area for each STR locus using an increased CE 
injection time 
 
Figure 3.18 Stutter ratio by area relative to peak area of true allele for standard and 
increased CE injection times – outlier removed from THO1 with peak area of >70,000 
RFU 
 
 
 
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
D3 VWA D16 D2 D8 D21 D18 D19 THO1 FGA
S
tu
tt
er
 r
at
io
 b
y
 p
ea
k
 a
re
a
 
Locus 
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0 10000 20000 30000 40000 50000
S
tu
tt
er
 r
at
io
 b
y
 p
ea
k
 a
re
a
 
True allele peak area (RFU) 
Standard CE
injection time
Increased CE
injection time
107 
 
3.4.10 Assay comparison 
A comparison was carried out to assess the performance of three commercial kits; 
AmpFℓSTR® NGM PCR Amplification Kit (NGM), PowerPlex® ESX 16 System (ESX) 
and PowerPlex® ESI 16 System (ESI), and an ‘in-house’ developed assay for ltDNA was 
also evaluated. 
Two samples were excluded from the data set; firstly one from the ESI data on the basis that 
more than two unexpected alleles were observed in the DNA profile thereby indicating the 
presence of contamination, and secondly from the ESX dataset as a full profile was obtained 
from one sample, the peak areas for which were at least double that of all other samples, thus 
suggesting that a higher starting quantity of DNA was present in the PCR tube. No 
amplification was observed for one single-cell using the ESX assay and for two cells using 
all other assays. 
The average result for the number of expected alleles amplified per cell was taken 
(excluding those results showing no amplification) with the following results: ESX 75%, 
ltDNA assay 51%, NGM 49%, SGM Plus 46% and ESI 28% (Figure 3.19). Using the ESX 
assay, over 85% of the expected alleles were obtained from each of four single-cells, an 
example of the EPG for which is shown in Figure 3.20. 
The random match probabilities (RMP), that is the frequencies with which the generated 
DNA profile would be expected to occur in the population, were calculated using the online 
European STRbASE (Parson, 2003, Gill et al., 2003, Welch et al., 2012) with the results 
summarised in Table 3-4. Both the minimum and average RMP generated from the single-
cell results for all assays exceeded the 1 in a billion number which is used as the ceiling 
figure in forensic casework. The ltDNA assay was not included at this point as the database 
used does not currently hold the allele frequencies for locus Penta E. Data for charts 
included in appendix 8.11. 
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Figure 3.19 Percentage of alleles amplified from each individual single-cell tested as a 
percentage of the total number of alleles possible for the kit utilised. The mean value for 
each kit is represented by the red coloured marker with the values as follows: SGM 37%, 
NGM 39%, ESX 67%, ESI 22% and the ltDNA assay 42%. 
 
Figure 3.20 Example EPG of partial profile generated from a single-cell using ESX-16 
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Table 3-4 Average and minimum random match probabilities (RMP) for assays as 
calculated using STRbASE (Parson, 2003) 
Assay Average RMP Minimum RMP 
SGM Plus 2.81E-15 2.81E-16 
NGM 4.95E-17 5.18E-18 
ESI 16 2.64E-13 2.64E-14 
ESX 16 1.01E-21 1.34E-22 
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3.5 Discussion 
In order to evaluate the efficacy of individual single-cells as a source for forensic DNA 
analysis, a method by which each cell could be recovered from a surface and transferred into 
a PCR tube was developed. In the absence of an automated system such as laser 
microdissection (Di Martino et al., 2004a, Di Martino et al., 2004b), it was found most 
effective to stain the cells in situ using haematoxylin and eosin, and then under a high-
powered microscope at x100 magnification to manually recover the individual cell using 
ultra-fine micro needles. The length of the needle allowed for its manoeuvring under the 
objective, whilst a tip width of just 0.25 mm facilitated the precision manipulation of each 
single-cell, in addition to which each disposable needle arrives pre-sterilised using ethylene 
oxide and so can be used with minimal risk of DNA contamination. Once recovered from 
the surface of interest, the cell was transferred to a UV-treated square of adhesive tape 
approximately 2 x 2 mm, for examination under the microscope at x200 magnification in 
order to confirm both the transfer of the cell from the needle point and also to ensure that 
only one cell was present to make certain that any DNA amplification observed could be 
attributed to just one cell. It was determined that placing the tape/cell into 1 µl of sticky stuff 
remover (SSR) that had been pre-pipetted into the PCR tube, was able to facilitate release of 
the single-cell from the adhesive during amplification, without causing inhibition during 
PCR. 
It has been demonstrated previously that reducing the reaction volume can increase the PCR 
sensitivity thereby generating in a better quality DNA profile. The results of this study 
suggest that 15 µl is the most effective reaction volume for single-cell DNA amplification, 
contradicting previous research which has suggested that use of a smaller volume is more 
effective (Gaines et al., 2002). This is most likely due to the requirement to include SSR in 
the PCR tube in order to ensure that the cell is effectively released from the adhesive tape; in 
the 10 µl and 5 µl reactions the concentration of SSR may have inhibited the PCR thus 
resulting in the amplification of relatively fewer of the expected alleles. The use of a volume 
of 15 µl also allowed for the ForensicGEM extraction reagents to be utilised, occupying 6 µl 
of the total volume, with the SGM Plus amplification reagents making up the remaining 9 
µl. Discovered in the 1980’s by Morgan and Daniel (Bergquist et al., 1987) the neutral 
proteinase, derived from Bacillus sp. is included in the ForensicGEM kit, facilitates cell lysis 
through the breakdown of proteins into soluble peptides, therefore making the DNA 
template more accessible to the amplification reagents during PCR. An increase of 
approximately 20% was observed in the average number of expected alleles amplified when 
ForensicGEM was used as compared with single-cells amplified without the use of the 
extraction enzyme. As discussed in Section 3.1, the use of direct PCR decreases the number 
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of transfer steps necessary during extraction, thus reducing the risk of contamination and, 
particularly pertinent for single-cell work, the potential for sample loss. 
Across all forty-nine generated DNA profiles, a total of 314 alleles were observed under a 
standard CE injection setting, and 324 alleles using the increased injection time. 
The frequency with which alleles were observed at each locus was shown to correlate with 
the molecular weight; as the molecular weight of the loci increased, the number of times an 
allele was observed at a particular locus was shown to decrease. This can be explained 
through preferential amplification, the effects of which are known to be exacerbated in 
ltDNA samples. With the exception of vWA as the only homozygous locus, Amelogenin, 
D19 and D3 were found to amplify most frequently observed in over 40% of the DNA 
profiles, whilst D2 was present in just 11%.  
As the size of the amplicon fragment increased, a decline in the peak height could be 
observed. Although this trend is one of the hallmarks of degraded DNA, in this study all 
single-cells were prepared from a fresh buccal source and so is likely related to the reduced 
frequency of amplification observed of the LMW loci. The use of an increased injection time 
during CE resulted in an average increase in peak height (RFU) by a factor of three, which is 
expected given that the injection time was increased by a factor of three from the standard 
setting of, 3 kV for 5 s (15 kV), to the enhanced setting of 3 kV for 15 s (45 kV).  
It has been demonstrated that as the area of peak decreases below 10,000 RFU, the 
heterozygous balance (Hb) at each locus is subject to more variation (Whitaker et al., 2001). 
As 95% of all amplified alleles had a peak area <10,000 RFU when using the standard CE 
injection time, the results of this study reflect this, with no correlation observed between the 
average peak area and Hb value; this is also observed when the peak height remains at 
<10,000 RFU following an increased CE injection time. Further analysis of those loci for 
which Hb < 0.2 found that in all bar one of these cases an allele that had previously been 
recorded as dropped out under standard injection times was detected with the increased 
injection time, as the previously present peak area was also enhanced by the additional 
injection time, the difference between the two allele peaks resulted in severe imbalance at 
the locus (see Section 3.1). As the peak height exceeds 10,000 RFU, there was an increase of 
over 10% in the number of loci with Hb> 0.6 and almost 15% in those with Hb> 0.5, relative 
to those with a peak area  <10,000 RFU. 
In this study, using standard CE injection settings, it was found that 27% of observed alleles 
had an associated stutter peak present, which is consistent with the observations of Whitaker 
et al. (Whitaker et al., 2001) of 30%. The stutter ratios calculated for both standard and 
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enhanced CE injection times showed that 88% and 92% of stutter peaks had a stutter ratio 
value of ≤0.15, which is often the standard figure used for interpretation (Gill et al., 2000a), 
whilst the 95th percentile value for stutter ratio in each case was SR ≤0.20 and ≤0.19. The 
maximum stutter ratio observed for this dataset was 0.33, which falls within figures 
observed by both Whitaker et al. at 0.40 (Whitaker et al., 2001), and Petricevic et al. at 0.57 
(Petricevic et al., 2010) as part of their validation studies. Also consistent with these studies 
is the observation that with a decrease in allele peak area, the stutter ratio was seen to 
increase. This is demonstrated when the peak area is divided; the maximum stutter ratio 
observed where the true allele peak area <10 000 RFU was at 0.33/0.32, and values at       
>10 000 RFU were 0.13/0.29, for standard/increased CE settings respectively.  
Locus drop-out was observed at just under half of the possible loci across all samples. This 
is markedly higher than results published using low concentrations of extracted DNA, for 
which less than 8% locus dropout was recorded (Petricevic et al., 2010, Whitaker et al., 
2001). This is possibly due to the higher quantities of DNA utilised in these papers and 
included in their calculations, for example 6.25/12.5 pg (Petricevic et al., 2010) and 12.5/25 
pg (Whitaker et al., 2001) thus reducing the frequency of locus drop-out observed. The locus 
exhibiting the highest frequency of drop-out was D2, which was also observed by Petricevic 
et al. (Petricevic et al., 2010) and Whitaker et al. (Whitaker et al., 2001), who also noted that 
the increased injection time had minimal impact on the proportion of locus dropout. As the 
SGM Plus assay is a multiplex PCR kit, it is probable that the efficiencies with which the 
different STR loci amplify will vary and may account for the relatively higher amount of 
drop-out exhibited by locus D2 (Petricevic et al., 2010).  
Allelic drop-out was observed in 31% and 29% of all heterozygous loci for the standard and 
increased CE injection times respectively. No bias with regard to the drop-out of either the 
LMW or HMW alleles was observed using standard CE settings, whilst a slight tendency 
towards drop-out of the LMW alleles was noted using the extended injection time. These 
results concur with those of Whitaker et al. (Whitaker et al., 2001) who observed a slight 
bias towards LMW drop-out and Petricevic et al. (Petricevic et al., 2010) who found a slight 
tendency towards HMW drop-out but noted no significant difference from the Whitaker data 
set.  
The use of an extended CE injection time resulted in a 2% decrease in the proportion of 
allelic drop-out observed, however the additional alleles that were designated (D2, D8, D21, 
and D18) resulted in peak imbalance with values of  Hb < 0.15 and Hb >15. The usefulness 
of these additional alleles is therefore limited, as in the absence of prior DNA profile 
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knowledge such a severe imbalance could be interpreted as the presence of a low level 
mixture.  
In order to determine an approximate value for the ltDNA threshold as defined by Gill et al. 
(Gill et al., 2009) the peak heights of the remaining allele at all heterozygous loci for which 
the second allele fell below the lower limit of detection (25 RFU), were analysed and 
determined to be 750 RFU and 1850 RFU for standard and increased injection times 
respectively. If the peak height of a single allele at a locus exceeds this value then the peak 
can be designated as homozygous. Using these thresholds, 28% of the alleles amplified for 
vWA using the standard injection, and 32% using the increased injection, would have been 
designated as homozygous without prior knowledge of the expected result. 
Both the ESX and ESI assays have been shown to perform with equivalent success during 
validation tests with approximately 27% of expected alleles amplified using 7.8 pg extracted 
DNA template (Tucker et al., 2012a, Tucker et al., 2011). The results for the ESI assay with 
an average of 28% of the expected alleles amplified from a single-cell in this study are 
consistent with those observed using the extracted DNA, however the ESX results far 
exceeded the validation results with an average of 75% of alleles observed. Given that these 
samples were prepared at the same time and using the same source, the discrepancy between 
the two kits cannot be accounted for, unless perhaps the ForensicGEM reagents provided 
more favourable conditions for the ESX chemistry than the ESI assay chemistry.    
It has been demonstrated through direct comparison that the more recently developed ESI 
amplification kit is more sensitive than the SGM Plus (Tucker et al., 2012b), which at first 
glance would appear inconsistent with the results of this study with averages of 28% and 
46% expected alleles amplified for the two kits respectively. However, aside from the 
additional number of loci targeted by the ESI assay, as part of this study the SGM Plus kit 
has been optimised for use in terms of the PCR volume utilised, use of ForensicGEM 
extraction reagents and inhibition tests, which the ESI kit has not been subjected to. This in 
itself demonstrates the value of optimising even a commercially available kit when it is to be 
used for a specific purpose; this may also explain why the NGM kit performed little better 
than its predecessor.  
A full DNA profile, which was generated using the ESX amplification kit, was excluded 
from analysis as, whilst almost complete DNA profiles (>85%) were observed in four other 
samples, the peak area (RFU) was at least double that observed on all other EPGs, indicating 
the presence of a higher quantity of starting DNA material. As all samples were prepared 
under the microscope using stained cells and cell transfer checked, it is possible that more 
than one cell was present, for example if cells were directly situated on top of one another, 
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and so multiple transfer was not detected, or the cell transferred may have been at the end 
stage of mitosis, prior to cytokinesis, therefore containing twice the DNA template. The 
capability to generate a full profile from such a small starting quantity of DNA demonstrates 
the impressive sensitivity of this assay.   
The ‘in-house’ ltDNA assay was developed using just three STR markers and Amelogenin 
to determine if reducing the targets for amplification would improve the reliability of PCR 
for such a low level of template DNA. Whilst the results produced were comparable with 
those of the commercial assays (excluding ESX), the reduced number of loci did not 
improve the reliability of the assay thus, given the loss of discrimination, does not carry any 
advantage over assays that contain more, HMW loci. 
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3.6 Conclusions 
The described method for the recovery of individual single-cells provides an effective and 
efficient means by which a cell can be detected and transferred from its surface to a PCR 
tube without sample loss. The use of the ForensicGEM extraction reagents facilitates cell 
lysis prior to amplification and allows for the use of a one-tube step with SGM Plus reagents 
added directly to the tube for PCR.  
Overall, the results for the amplification of DNA from individual single-cells demonstrate 
that the frequency and intensity of artifacts resulting from the stochastic effects of PCR are 
comparable with those observed from using extracted ltDNA samples and can, therefore, be 
interpreted using the same parameters. In the absence of a consensus profile, the use of an 
increased injection time during capillary electrophoresis can aid interpretation of peaks and 
artifacts that are around the minimum peak amplitude threshold. Although the use of an 
increased injection can help in some instances such as resulting in a reduction in the level of 
locus and allele dropout observed; this was not found to be significant with all P values 
exceeding 0.1.  
The use of single-cells as a DNA source could be of crucial importance in cases where very 
little biological evidence is identified, providing a source of intelligence for investigators, or 
as an alternative technique to identify a single contributor in cases where a complex 
mixtures is obtained.  
Following initial results, Promega’s ESX-16 amplification assay, used in conjunction with 
ForensicGEM extraction reagents, appears to be particularly effective for amplification of 
DNA from individual single-cells. 
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4. Cell transfer via textile fibres  
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4.1 Introduction 
The concept that the transfer of textile fibres between two (or more) surfaces as possible 
means to link the victim(s), suspect(s) and scene(s) involved in a crime, has been described 
in literature for almost a century (Locard, 1920). Through mapping the fibre transfers that 
have occurred during a criminal incident, movement and interaction between individuals and 
scenes can be established, which can help investigators by supporting or refuting the version 
of events given by those involved.  
Despite the demonstrated utility of fibre evidence in casework, there is still a general 
perception that analysis is time consuming, costly and without much return in terms of 
evidentiary value, often leading to fibre evidence being under-utilised by investigators. 
Extensive research across the field, including the use of block colour (Grieve et al., 2005, 
Palmer et al., 2009, Biermann, 2007), population (Roux and Margot, 1997, Palmer and 
Oliver, 2004, Watt et al., 2005, Grieve et al., 2003), target (Cook et al., 1997, Jones and 
Coyle, 2011, Kelly and Griffin, 1998, Wiggins et al., 2004), transfer and persistence studies 
(Akulova et al., 2002, Grieve and Biermann, 1997b, Palmer and Polwarth, 2011, Roux et al., 
1999, Salter and Cook, 1996, Kidd and Robertson, 1982, Palmer and Burch, 2009), is 
helping to demonstrate and reinforce the value and reliability of fibre evidence for both 
intelligence purposes and for use in court; dismissing, for example, the notion that two fibres 
of the same type and colour cannot be distinguished in the majority of cases.  
A landmark three-part study in 1975 by Pounds & Small, although preliminary, is the first 
detailed account of the factors influencing the transfer and persistence of textile fibres 
(Pounds and Smalldon, 1975c, Pounds and Smalldon, 1975a). They proposed that the textile 
fibres are transferred to a second surface through three distinct mechanisms; fibres that are 
loose on the outside surface of the garment, those that are drawn out of the fabric as a result 
of friction, and those that are fragmented during the contact (Pounds and Smalldon, 1975b). 
It has been demonstrated that the transfer of fibres between two surfaces is dependent upon a 
number of factors such as the nature of both the donor and the recipient surfaces, the length 
of contact time and pressure applied during the event (Pounds and Smalldon, 1975a, Kidd 
and Robertson, 1982, Grieve and Biermann, 1997b, Roux et al., 1999, Palmer and Burch, 
2009). Following a transfer event however, it has been shown that the percentage of fibres 
lost from the recipient surface is consistent irrespective of the surface type, displaying an 
exponential decay with increasing time (Pounds and Smalldon, 1975c, Akulova et al., 2002, 
Palmer and Polwarth, 2011, Roux et al., 1999). Understanding the characteristics of transfer 
and persistence for fibre evidence facilitates the forensic scientist in forming their 
expectations regarding the likelihood of evidence recovery given a set of circumstances.  
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Several techniques are available for the recovery of textile fibres and other debris from the 
recipient surface to which they have been transferred, including the use of forceps 
(Schotman, 2015), shaking/scraping techniques (Pounds, 1975, Lowrie and Jackson, 1991) 
and polystyrene rods (Keutenius et al., 2013). Whilst these techniques have been shown to 
be effective methods for the recovery of fibres in some circumstances, they can be time 
consuming, may present a contamination risk (Roux et al., 2001) and additional information 
on the location of fibre populations over the surface of the item is lost. 
Care must be taken during recovery as fibre contamination can occur between items, through 
direct contact or indirectly via the examiner, as well as from unrelated background fibres in 
the examination area. Roux et al. (Roux et al., 2001) suggested the use of separate 
examination rooms where possible for related items, the use of a disposable covering over 
the benchtop during examination and that a disposable lab coat be worn by the examiner, in 
order to minimise the risk of contamination. 
Tape lifting has been the method of choice for fibre recovery in many laboratories (Wiggins, 
2001) since it was first proposed by Frei-Sulzer in 1951 (Keutenius et al., 2013). Following 
the recovery of transferred fibres from an item, an initial examination of the fibre tapes is 
conducted under a low-powered microscope. If no source material has been identified, then 
fibre populations of possible interest are searched for and used to inform the investigation. If 
a potential source material has been identified, then tapes are searched for target fibres that 
are possible matches based on similar colour and morphology. Following detection, fibres of 
interest are removed from the fibre tape and mounted under a coverslip using a medium such 
as Phytohistol (Grieve and Deck, 1995) or Entellen (Wiggins and Drummond, 2007) on a 
glass microscope slide for further examination.  
Comparison microscopy allows for the observation of two fibres immediately adjacent to 
one another in the same field of view. This enables a direct comparison of colour and 
morphological detail under white, polarised and fluorescent light sources. The use of 
comparison microscopy is in itself a highly discriminating tool for fibre examination and can 
be utilised to quickly exclude fibres from the investigation (Palmer et al., 2009). Fibres that 
cannot be distinguished from one another using microscopy are then analysed using 
microspectrophotometry (MSP), which provides the forensic analyst with the ability to 
objectively discriminate colour between two fibres based on their absorption spectra 
(Robertson and Grieve, 1999). It has been demonstrated that by extending the analysis into 
the UV range, further discrimination between fibres is possible, for example, the 
discriminatory power for non-denim blue cotton fibres was found to increase by 7% (Palmer 
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et al., 2009) and 9% (De Wael, 2015) to a value of 0.98 following additional analysis in the 
UV range.  
 
The recovery of DNA from fibre tapes is usually attempted only if visible cellular material 
such as skin flakes are present and a specific connection is sought or, most commonly, in 
cold casework where the available evidence is limited. The chemical structure of differing 
fibre types is expected to affect the strength of the interaction between the fibre and 
carbohydrates on the cellular membrane, or directly with cell-free DNA, depending on their 
functional groups (Seah et al., 2004). For example, the hydroxyl groups on the repeating 
cellulose units of cotton will form strong hydrogen bonds that enable a relatively stable 
binding with DNA/cell membrane, whereas weaker dipole-dipole interactions are formed 
with polyester carbonyl and cyano groups (Linacre et al., 2010, Mulligan et al., 2011). It is 
has been suggested that the varying strengths of these interactions may account for the 
observed ability to amplify DNA from some fabrics such as cotton and nylon with more 
success than from others such as polyester (Seah et al., 2004, Linacre et al., 2010). The 
results for one study did not show any significant difference between cotton and polyester 
(Mulligan et al., 2011), however this study differed from the previous two in that the focus 
was on fibres as a method for DNA retrieval, i.e. for swabbing. Sethi et al. (Sethi, 2013) 
used cotton and polyester fabrics to carry out simulated ‘grabbing’ incidents, but were 
unable to amplify DNA from the ‘assailant’ due to the low quantities of DNA (< 18 pg/µl) 
recovered.   
 
The current methods used in casework to obtain a transferred DNA profile involve either the 
cutting or swabbing of fibre tapes for DNA extraction (May, 2009). Having tested methods 
for the recovery of DNA from fibre tapes using five different swabbing solvents and a total 
of seven extraction methods, May and Thomson (May, 2009) found that the use of xylene to 
swab the fibre tape followed by a Chelex™ DNA extraction was the most effective method 
in recovering DNA. Although it has been demonstrated that DNA can be successfully 
recovered in this manner, these methods do have two significant disadvantages; the potential 
for the loss of fibre evidence, and that it is likely that a DNA mixture will be obtained, with 
the donor’s profile at risk of being completely obscured in a very high wearer DNA 
background. The loss of both of these evidence types will be detrimental to the investigation. 
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4.2 Aims and objectives 
It is hypothesised that when textile fibres are transferred from a donor to a recipient, the 
fibres themselves may be acting as a vector for the transfer of nucleated cells from the donor 
garment and could therefore be targeted to obtain a DNA profile. If possible, this would 
provide a more refined technique for the recovery of DNA from fibre tapes, increasing the 
successful detection and amplification of the donor’s DNA, even in the presence of a high 
level of background recipient (wearer) DNA. The aim of this chapter is to test this 
hypothesis, whilst ensuring that all methods have no detrimental effect on either the 
subsequent fibre analysis or DNA processing, thus allowing the two evidence types to be 
investigated alongside one another. 
The objectives of this study are to first demonstrate that nucleated cells can be seen in situ 
on the surface of textile fibres and that once located, can be recovered for single-cell DNA 
analysis utilising the methods developed in the previous chapter. Any techniques used for 
visualisation of the nucleated cells will require testing for compatibility with downstream 
DNA and fibre analysis processes. The extent to which nucleated cells are present on the 
outside surface of clothing items will then be investigated in order to determine the potential 
for transfer via the fibre surface. Finally, fibre transfer experiments will be used to 
demonstrate the transfer of nucleated cells on the surface of textile fibres. 
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4.3 Method development and results 
This project had been conducted with ethical approval from the Northumbria University 
Ethics committee under reference number RE25-10-121294. Volunteers were provided with 
information sheets and requested to sign consent forms prior to participation in the study; 
copies of which are included in appendix 8.12.  
The methods and results sections for this chapter are presented together in order to 
effectively reflect and describe the development of the methods involved, with sections 
clearly marked as either ‘experiment’ or ‘method development’ as appropriate.   
4.3.1 Visualisation of cells in situ on the fibre surface (method 
development) 
In order to demonstrate the transfer of single-cells on the surface of textile fibres, a method 
by which the cells could be visualised in situ was first developed.  
4.3.1.1 Testing of fluorescent dyes for staining of cells in situ on fibre tapes 
For the initial proof of concept work, it was decided that a DAPI-based dye would be an 
ideal candidate stain, as it will fluoresce nuclear DNA without the requirement of additional 
fixing reagents, thus limiting manipulations and therefore potential loss of sample, as well as 
impact on downstream DNA/Fibre analyses. Two DAPI solutions were considered; DAPI 
dilactate is supplied as a powder which was added to MBG water to obtain a concentrated 
stock at 1 mg/ml (see Section 2.4.1.1), which was then diluted further in sterile DPBS prior 
to use, and NucBlue® ReadyProbes® Reagent which is a ready to use DAPI solution.  
4.3.1.2 Determining optimum DAPI dilactate dilution for staining cells 
Buccal cells were prepared as described in Section 2.4.2 and 2.4.3 and then a diluted sample 
was transferred to a microscope slide and allowed to air dry as outlined in Section 2.4.3.1. A 
1 in 2 serial dilution of DAPI dilactate (hereafter referred to as DAPI) was carried out using 
sterile DPBS to prepare 1 in 2500, 1 in 5000, 1 in 10000 and 1 in 20000 solutions. Samples, 
including a negative MBG water control, were stained in situ on the microscope slide as 
described in Section 2.5.2.2. Cells were then examined under a Leica DM5000 B 
Fluorescent Microscope System using filter A (excitation filter BP 340-380, emission filter 
LP 425) and also using differential interference contract microscopy. 
As shown in Figure 4.1, the nuclear DNA is visible at even the lowest DAPI concentration; 
however, it was noted that at this 1 in 20000 dilution there were cells present that had not 
stained as intensely. The 1 in 10000 DAPI dilution (Figure 4.1C) was determined as the 
most effective concentration to use for this study as the nuclear DNA was clearly visible in 
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all cells as compared with the DIC images, and this low concentration is less likely to effect 
the downstream fibre/DNA analyses then the higher concentrations (Figure 4.1A and B). No 
fluorescence was observed for any of the negative controls. 
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Figure 4.1 Images of buccal cells stained with a DAPI solution at 1 in 2500 (A) 1 in 5000 
(B) 1 in 10000 (C) and 1 in 20000 (D) taken under the Leica DM5000 B fluorescent 
microscope at x200 magnification with filter A (left) and as overlaid with DIC images taken 
(right). All scale bars show 100 µm. 
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4.3.1.3 Testing DAPI and NucBlue® for PCR inhibition 
A buccal swab was obtained from a volunteer, which was extracted using the QIAamp® 
DNA mini kit as described in Section 2.7.2.1 and then quantified using the NanoDrop® 
Spectrophotometer ND-1000 as outlined in Section 2.8.2. The DNA extract was diluted to a 
concentration of 0.1 ng/µl with MBG water and 5 µl was added to each of the required PCR 
tubes for a total DNA input of 0.5 ng, whilst 5 µl of MBG water was added to a tube for the 
PCR negative control. A 1 in 2 serial dilution of DAPI was prepared in sterile DPBS for 
testing of 1 in 1250, 1 in 2500, 1 in 5000, 1 in 10000 and 1 in 20000 DAPI solutions. 1 µl of 
sterile DPBS, NucBlue® or diluted DAPI was then added to PCR tubes in duplicate and 1 µl 
of water was added to both the positive and negative control samples. A mastermix of 
AmpFℓSTR® SGM Plus® reagents was then prepared as described in Section 2.9.1.2 and    
9 µl added to each tube for a total reaction volume of 15 µl. Amplification was carried out 
using a Veriti® thermal cycler following the 28-cycle program outlined in Section  2.9.1.2. 
The electropherograms (EPGs) for each reaction were examined for indications that 
inhibition had occurred during the PCR, such as locus or allele dropout and a reduction in 
the peak heights, particularly in the high molecular weight (HMW) loci (Opel et al., 2010).  
The NucBlue® solution was tested as it is a ready-to-use, DAPI based solution, which can 
be stored at room temperature and can be directly applied to the sample. Complete dropout 
at locus D21S11 was observed in both duplicate reactions indicating specific inhibition at 
this locus as shown in Figure 4.2. The specificity of this inhibition suggests an interaction 
between the DAPI and the DNA sequence of this STR itself or its associated primers (Opel 
et al., 2010), because if it were as a result of  interactions with the Taq polymerase directly 
or other components of the reaction mix, then indications of inhibition would be expected at 
more, or all loci in the multiplex. Inhibition at this locus was also observed for the most 
concentrated DAPI at a 1 in 1250 dilution. In this case peak heights were reduced but 
present, suggesting that there may be a component in the NucBlue® reagent that is 
exacerbating the interaction between the DAPI dye itself and  the DNA sequence which is 
preventing PCR at this location.  
Inhibition was only observed in the most concentrated DAPI solution tested (1 in 1250 
dilution) where, aside from the aforementioned inhibition at D21S11, a reduction in the 
HMW alleles relative to the control sample was observed as shown in Figure 4.3. No 
indication of PCR inhibition was observed however for the 1 in 5000 dilution and as a 1 in 
10000 solution will be used in this study, it has been demonstrated that the DAPI dye 
preparation is compatible with downstream DNA processing.   
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Figure 4.2 Example of EPG for NucBlue® solution showing complete locus dropout at 
D21S11, circled in red. Peaks are observed at all other loci, which are all clearly visible 
with good peak heights. 
 
 
Figure 4.3 EPG examples for PCR inhibition tests with DAPI at 1 in 20000, 1 in 5000 
and 1 in 1250 dilutions. A reduction in peak height relative to the control was observed at 
locus D21S11 and HMW loci D2S1338 and D18S51, shown circled in red. 
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4.3.1.4 Effect of DAPI staining on MSP 
Ten fibres were soaked in PBS or a DAPI solution of 1 in 1000, 1 in 5000 or 1 in 10000, and 
mounted on a microscope slide using glycerol and a quartz coverslip as described in Section 
2.14. In addition to this, ten unstained control fibres were also prepared in the same way for 
comparison of absorption spectra generated using the J & M TIDAS MSP 800™ (UV–vis) 
microspectrophotometer (MSP) in order to determine if staining the fibres with a DAPI 
solution would affect the downstream fibre MSP analysis. Three readings in the UV-vis 
range were taken along the length of each fibre, which were then averaged. The stained 
fibres were then compared with the unstained control fibre spectra as shown in Figure 4.4. 
As these spectra were taken using cotton fibres, some natural variation would be expected; it 
appears that the staining has not adversely affected the spectral profile of the fibre.  
 
Figure 4.4 Spectra generated for fibres stained with DAPI at 1 in 1000 (red), 1 in 5000 
(blue) and 1 in 10000 (green) dilutions, and control fibres (shown in black) using MSP 
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4.3.2 Demonstration of cells on outer surface available for transfer 
(experiment) 
4.3.2.1 Demonstration of cells on outer surface available for transfer – materials 
and methods 
Five volunteers were recruited and asked to wear an item of upper washed clothing, i.e. 
cardigan or jumper, of their own. Following at least six hours of wear, the garment was 
removed by the volunteer and placed into a bag, which was then sealed.  
The outside front surface of each garment was then fibre taped in three sections,  upper right 
front/right sleeve, upper left front/left sleeve and lower right/left using one strip of J-LAR 
tape per section, which was secured on an acetate sheet. The garment details were recorded 
as shown in Table 4-1.   
Table 4-1 Summary of garment information for each of the five participants 
Volunteer Garment type Fibre type 
1 Orange/peach coloured wool style jumper Unknown 
2 Blue/green coloured zip up cardigan 100% acrylic 
3 Blue coloured cardigan without fastenings 96% viscose, 4% elastane 
4 Navy coloured cardigan with ¾ length sleeves 70% viscose, 30% nylon 
5 Burgundy coloured long sleeve top 100% cotton 
 
Fibre tapes were prepared and stained for examination as described in Section 2.4.4 and 
2.5.2.2. The prepared microscope slides were then examined using an upright Leica 
DM5000 fluorescent microscope under x100 - x200 magnification. Each tape section was 
searched and the number of nucleated cells observed on each tape was recorded as the 
number of cell ‘events’, i.e. a single-cell or a cluster of cells equates to one event each, and 
the total number of cells in each event; an approximation was recorded for clusters in which 
not all cells could not be counted individually.   
4.3.2.2 Demonstration of cells on outer surface available for transfer - results 
In order to demonstrate the presence of cells on the outer garment surface and thus the 
availability of cells for transfer, the outside front surface of the tops of five volunteers were 
fibre taped. The tapes were stained with DAPI for examination under the high-power 
fluorescent microscope and the number of nucleated cells was counted. Both single-cells and 
cell clusters were observed on tapes taken from all volunteers, examples of which are shown 
in Figure 4.5 to Figure 4.7. The number of cell events and an approximate value for the total 
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cell count, i.e. taking into account all cells within a cluster, were recorded as shown in 
Figure 4.8. The number of cell events observed was between 672-2198 and the total number 
of cells within the range 1748-4410. The average number of cells observed per cell event for 
each volunteer is two, except for one volunteer with an average of four. The mode and 
median for all five volunteers is one, demonstrating that although clusters of cells increase 
the cell count, single-cells were observed more frequently.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Examples of stained cells observed in situ on fibre tapes using a high-
powered fluorescent microscope. All scale bars show 100 µm. 
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Figure 4.6 Examples of stained cells observed in situ on fibre tapes using a high-
powered fluorescent microscope. All scale bars show 100 µm aside from the bottom two 
right hand panels for which the scale bar shows 2 mm. 
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Figure 4.7 Examples of stained cells observed in situ on fibre tapes using a high- 
powered fluorescent microscope. All scale bars show 100 µm aside from the top two right 
hand panels for which the scale bar shows 2 mm. 
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Figure 4.8 Bar chart showing both the number of cell events and the total cell count for 
each participant. The total cell count includes those clusters of cells that were 
frequently observed. 
 
4.3.3 Demonstrating cell transfer – two-way transfer (experiment) 
4.3.3.1 Demonstrating cell transfer – two-way transfer  - materials and methods  
Six, 100% cotton long sleeved-tops, three purple and three green, were purchased on 
separate days. The tops were grouped by colour and washed in separate machines, using a 
biological washing powder in an attempt to remove exogenous DNA from the surface. The 
tops were allowed to air dry in a DNA clean environment and then all outside surfaces were 
taped to remove foreign fibres and adhering cellular material, before being sealed in bags 
prior to use. Six participants were recruited and split into three pairs, each individual within 
the pair was provided with either a green or purple coloured top. Participants were requested 
to wear the provided top for a minimum of eight hours whilst carrying out their normal daily 
activities. Immediately prior to meeting each individual was asked to wear a hairnet, 
facemask, disposable gloves and over-sleeves to prevent the transfer of DNA through means 
other than contact between garments. The participants were then asked to hug for a two 
minute period, one minute with arms around the shoulders and one minute with arms around 
the waist, following which the tops were immediately placed in separate bags and were 
sealed until examination. 
Fibre taping was carried out on separate, non-subsequent days for each of the tops and inside 
different examination hoods, which had been cleaned using 10% (v/v) sodium hypochlorite 
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solution and then lined with brown paper. The front outside surface of each top was fibre 
taped using J-LAR  tape with a 1:1 taping method and each tape was then secured and sealed 
on an acetate sheet.   
All tapes were searched for transferred fibres using a low powered microscope on x25 
magnification. Fibres of interest were then recovered by cutting around the fibre using a 
scalpel and removing the J-LAR tape section using forceps. Microscope slides were 
prepared by securing a strip of J-LAR tape adhesive side up using double-sided sticky tape 
and treating with UV light for ten minutes. The J-LAR tape section containing the fibre of 
interest was then secured adhesive side up on a microscope slide for staining with DAPI. 
The removed sections of fibre tape were prepared and stained with DAPI for examination as 
described in Section 2.4.4 and 2.5.2.2. The prepared microscope slides were then examined 
using an upright Leica DM5000 fluorescent microscope under x100-x200 magnification. 
The surface of each recovered fibre was searched for nucleated cells and once located, an 
image of the cell or cluster of cells in situ was captured using the microscope camera. The 
cell(s) was then removed from the fibre surface utilising a micro-needle and transferred 
under the microscope onto a fresh section of J-LAR tape, and then into an individual 0.1 ml 
PCR tube containing 1 µl of sticky stuff remover (SSR) as described in Section 2.6. The 
associated fibre was then recovered from the J-LAR tape section using SSR and mounted on 
a microscope slide using DPX and a coverslip as outlined in Section 2.14.1, for further fibre 
analysis should a positive PCR result be obtained. 
Samples were prepared using ForensicGEM® Tissue extraction reagents and then set-up for 
direct, 34-cycle PCR using the AmpFℓSTR® SGM Plus® PCR Amplification Kit as 
described in Sections 2.7.3.1 and 2.9.1.2 respectively. PCR products were visualised and 
analysed as outlined in Sections 2.13.2.1 and 2.13.3.1.  
4.3.3.2 Demonstrating cell transfer – two-way transfer - results 
Between 640-1300 transferred fibres were recovered from each of the six individuals who 
participated in the two-way transfer experiments (Figure 4.9). A total of forty-five cell 
events were observed in which a nucleated cell or cluster of cells was associated with the 
surface of the transferred fibre. These were imaged in situ and then recovered for DNA 
profiling, some examples of which are shown in Figure 4.11 and Figure 4.12. As shown in 
Figure 4.10, seventeen of the forty-five samples resulted in successful amplification of 
DNA, with sixteen of these being attributed to background wearer DNA, one of which was a 
full profile obtained from a cluster of six nucleated cells shown in Figure 4.13. The 
remaining DNA profile could not be attributed to either of the participants involved in the 
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transfer, or to any person involved with this study. No DNA amplification was observed for 
twenty-eight of the samples. Data for chart included in appendix 8.14.  
 
Figure 4.9 Number of transferred fibres recovered from each participant’s garment 
 
 
Figure 4.10 Amplification results obtained for a total of forty-five cells recovered from 
the surface of textile fibres 
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Figure 4.11 Examples of partial SGM Plus DNA profiles obtained from a single-cell 
recovered from the surface of a textile fibre. Each four image panel shows the cell in situ 
on the fibre surface under white (top left) and fluorescent (top right)t light, an image of the 
cell on a section of tape prior to transfer into a PCR tube (bottom left) and the resulting 
SGM Plus EPG. All scale bars in the top panel show 100 µm, and those in the bottom panel 
show 2 mm. 
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Figure 4.12 Examples of partial SGM Plus DNA profiles obtained from a single-cell 
(top panel) and a cluster of cells (bottom panel) recovered from the surface of a textile 
fibre. Each four image panel shows the cell(s) in situ on the fibre surface under white (top 
left) and fluorescent (top right)t light, an image of the cell(s) on a section of tape prior to 
transfer into a PCR tube (bottom left) and the resulting SGM Plus EPG. All scale bars show 
100 µm. 
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Figure 4.13 A full SGM Plus DNA profile obtained from a cluster of six cells recovered 
from the surface of a textile fibre. The cells ares shown in situ on the fibre surface under 
white (top left) and fluorescent (top right) light, an image of the cells on a section of tape 
prior to transfer into a PCR tube (bottom left) and the resulting SGM Plus EPG. All scale 
bars show 100 µm. 
 
4.3.4 Further method development 
Following analysis of the results from the two-way transfer experiment, see Section 4.3.3.2, 
it was determined that modifications to the DNA analysis protocol would be required prior 
to the commencement of the next transfer experiment; specifically on the medium used for 
transfer of the single-cell into the PCR tube.   
4.3.4.1 Effect of increased time of cell exposure to SSR  
In order to ascertain the effect of prolonged SSR exposure on the amplification of DNA in 
ltDNA samples, buccal cells were prepared as described in Sections 2.4.2 and 2.4.3. Cells 
were stained using haematoxylin and eosin as described in Section 2.5.1. Ten buccal cells 
were transferred in duplicate to pre-prepared J-LAR tape sections as described in Section 
2.4.3.2. It was decided that ten buccal cells would allow the effect of SSR exposure on a low 
DNA template to be assessed whilst ensuring successful amplification for analysis. The J-
LAR tape sections were transferred to a 0.1 ml PCR tube with 1 µl of SSR and left to 
incubate at room temperature. At hourly intervals, an additional two samples were prepared 
and transferred into SSR until the final sample, which was prepared for PCR immediately 
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following transfer into the SSR. All samples were then prepared and amplified using 34-
cycle SGM Plus® amplification as described in Sections 2.7.3.1  and 2.9.1.2.   
Shown in Figure 4.14, as the length of cell exposure time to the SSR increased over one hour 
a decrease in the average peak heights at all loci was observed. To determine if SSR could 
be removed from the amplification tube entirely, an experiment was set-up to test the 
effectiveness of FAST™ minitapes rather than J-LAR as the vector for transfer of the single-
cell into the PCR tube. As the layer of adhesive on the Scenesafe FAST™ minitapes is 
relatively thin, it was tested to see if water could replace SSR in the PCR tube without 
affecting the amplification reliability. Data for chart included in appendix 8.15. 
 
Figure 4.14 Results of DNA profiles generated from cell samples exposed to SSR for an 
increasing length of time. Average peak heights for all ten SGM Plus STR loci are shown 
at hourly time increments. 
 
4.3.4.2 Effectiveness of FAST™ minitapes with MBG water 
A buccal sample was prepared as described in Sections 2.4.2, 2.4.3 and 2.4.3.2, and then 
stained using a 1 in 10000 diluted DAPI solution as outlined in Section 2.5.2.2. Under the 
fluorescent microscope a single-cell was placed on a pre-prepared section of FAST™ 
minitapes (Chapter 2.5) and then transferred into a 0.1 ml PCR tube containing 1 µl of MBG 
water. This was carried out in triplicate and then repeated again using 1 µl of SSR. The same 
steps were taken using J-LAR tape for the cell transfer in order for the results to be 
compared. All samples were then prepared and amplified using 34-cycle SGM Plus® 
amplification as described in Sections 2.7.3.1and 2.9.1.2. 
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As determined in the previous chapter, SSR is required to facilitate the release of the single-
cell from the layer of adhesive on the J-LAR tape, for amplification of the DNA. Figure 4.15 
shows that the use of sections of FAST™ minitapes for cell transfer into the PCR tube, 
rather than J-LAR tape results in a more consistent amplification of DNA. Furthermore SSR 
does not appear to be required for release of the cell from the thinner layer of the FAST™ 
minitapes adhesive. Data for chart included in appendix 8.16. 
 
Figure 4.15 Methods for single-cell transfer to a PCR tube results showing the number 
of observed alleles amplified from a single-cell (in triplicate) following use either J-LAR 
tape or FAST™ minitape with SSR (grey) or water (dark grey). 
The subsequent one-way transfer experiments were carried out using the modified protocols. 
4.3.5 Demonstrating cell transfer – one-way; part A (experiment) 
4.3.5.1 Demonstrating cell transfer – one-way; part A – materials and methods 
Three green coloured, long sleeved tops (95% cotton, 5% elastane) and three black coloured 
long sleeved tops, 100% cotton, were purchased on separate days. As described previously, 
the tops were grouped by colour, washed in separate machines using a biological washing 
powder and then fibre taped to remove any exogenous DNA and fibres respectively. A strip 
of J-LAR tape was applied five times across the front surface of each of the three black 
coloured recipient tops, which was then stained with a 1 in 10000 dilution DAPI solution 
and examined under the high powered fluorescent microscope for nucleated cells as 
described in Sections 2.4.4 and 2.5.2.2. No nucleated cells were observed on any of these 
control tapes.    
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Three volunteers were recruited at random to act as the fibres/DNA donors whilst one 
individual was recruited to act as the recipient in all three transfer experiments. The donor 
participant was asked to wear the provided green top for at least eight hours whilst carrying 
out their normal daily activities, and then given a hairnet, face mask, disposable gloves and 
oversleeves to wear immediately prior to contact. The recipient was provided with a hairnet, 
facemask, disposable gloves and a crime scene suit, which was worn underneath the black 
cotton recipient garment as shown in Figure 4.18. The two participants were then asked to 
hug for two minutes, in the same manner as previously described. At the end of the contact 
period, the recipient garment was immediately taken off and sealed in a bag until 
examination. 
4.3.5.2 One-way transfer study; part A - results 
The number of transferred fibres recovered from the recipient garments following contact 
was approximetly 630-720 as shown in Figure 4.16.   
In once instance, a cluster of three cells was observed to be associated with a transferred 
fibre shown in Figure 4.17. The cells were recovered from the fibre surface for DNA 
analysis, however no amplification was observed.  
 
Figure 4.16 Number of transferred fibres recovered from the recipient garment 
following contact with the donor for part A (particpants 1-3) and part B (participant 4) 
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Figure 4.17 Images of nucleated cells in situ on the surface of a transferred fibre as 
viewed under both white (left) and fluorescent (right) light sources. Both scale bars show 
100 µm. 
4.3.6 Demonstrating cell transfer – one-way; part B (experiment) 
4.3.6.1 Demonstrating cell transfer – one-way; part B – materials and methods 
This part of the experiment was set-up exactly as described for part A, however a male 
individual who had taken part in the initial part of this study was selected to act as the 
fibre/DNA donor  using the same burgundy coloured, long sleeved, 100% cotton top that he 
had previously worn. The participant was asked to wear this top for a minimum of sixteen 
hours over a two day period prior to transfer, shown in Figure 4.18.  
All work was carried out exactly as described for the two-way transfer experiment up until 
the point at which a cell sample was to be recovered from the surface of a fibre. 
The cell(s) was then removed from the fibre surface utilising a micro-needle and transferred 
under the microscope onto a fresh section of FAST™ minitapes, and then into an individual 
0.1 ml PCR tube containing 1 µl of MBG water as described in Section 2.6. The associated 
fibre was then recovered from the J-LAR tape section using SSR and mounted on a 
microscope slide using DPX and a coverslip as outlined in Section 2.14.1, for further fibre 
analysis should a positive PCR result be obtained. 
Samples were prepared using ForensicGEM® Tissue extraction reagents and then set-up for 
direct, 34-cycle SGM Plus® amplification as described in Section 2.7.3.1 and 2.9.1.2. PCR 
products were visualised and analysed as outlined in Sections 2.13.2.1 and 2.13.3.1. 
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Figure 4.18 Photographs taken during one-way transfer experiment of the recipient 
prior to transfer (right) and during contact (left). 
 
4.3.6.2 One-way transfer study; part B -  results 
A total of 760 transferred fibres were recovered from the fibre tapings taken from the 
receipient’s gament following contact. There were no cell events observed to be associated 
with any of these transferred fibres. Following this, four fibre tapes corresponding to the 
upper front chest area of the recipient top were selected and swabbed for DNA. The results 
for the positive and negative controls for these samples were as expected, however no DNA 
amplification was observed for any of the sample fibre tapes. 
4.3.7 DNA extraction directly from tapes (experiment) 
4.3.7.1 DNA extraction directly from tapes – materials and methods 
Four fibre tapes were selected for further DNA analysis, which had been taken from the 
upper front sections of the recipient garment. Each tape was carefully peeled off its acetate 
and swabbed using xylene to remove the adhesive and concentrate the sample onto the swab 
head as described in (May, 2009). A positive control was set-up by pipetting 10 x 1 µl of 
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buccal cells which had been cell harvested from a buccal swab as described in Section 2.4.3, 
onto a strip of J-LAR tape, which was allowed to air dry before being sealed on acetate. The 
negative control was a strip of plain J-LAR tape secured on a sheet of acetate. Both controls 
were then treated as the sample fibre tapes. 200 µl of xylene was added to each of the tubes, 
which were vortexed and then left with open lids overnight in a fume hood until the xylene 
had evaporated. The four tapes, alongside the positive and negative controls, were then 
extracted using a Chelex™ extraction and were set-up for PCR amplification using the 
AmpFℓSTR® NGM™ PCR Amplification Kit as outlined in Section 2.9.1.2. PCR products 
were visualised and interpreted as described in Sections 2.13.2.1 and 2.13.3.1. 
4.3.7.2 DNA extraction directly from tapes – results 
Although positive and negative results were as expected for this method, no DNA 
amplification was observed for any of the four tested fibre tapes as described above.  
4.3.8 Persistence of single-cells in fibre tapes (experiment)  
4.3.8.1 Persistence of single-cells in fibre tapes - material and methods 
Using the same cell harvested sample as described in Section 3.3.4, 1 µl droplets of cells 
were transferred to a strip of UV-treated J-LAR tape, at intervals of approximately 5 cm and 
allowed to air-dry in a DNA clean environment. The strip of J-LAR tape was then secured to 
a sheet of UV-treated acetate and left at room temperature for a period of 24 months. 
Samples were then prepared for staining with haematoxylin and eosin as described in 
Sections 2.4.3.2 and 2.5.1, amplified using SGM Plus reagents, see Section 2.9.1.2 and all 
PCR products were visualised and analysed as described in Sections 2.13.2.1 and 2.13.3.1. 
4.3.8.2 Persistence of single-cells in fibre tapes - results 
In order to demonstrate the ability to amplify DNA from individual single-cells following a 
prolonged storage at room temperature, buccal cells were recovered for DNA analysis after a 
period of 24 months. Of the ten cells recovered, nine resulted in partial DNA profiles with 
the no amplification observed for the remaining sample. The number of alleles observed per 
single-cell ranged between three and seventeen alleles; the results were compared with the 
number of alleles observed from the previous fifty-cell experiment as these cells, from the 
same donor, were prepared on the day of sampling (day 0), shown in Figure 4.19. The range 
of alleles observed from the single-cells following the 24 month period of storage, was the 
same as that observed for those cells prepared on the same day as sampling (both datasets 
having a mean value of 8 alleles) indicating that the two-year storage of cells on a fibre tape 
does not cause a consistent reduction in the number of alleles amplified. To determine if a 
reduction in HMW loci was observed following the 24 month period, results were compared 
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with those of the fifty-cell DNA results carried out in Section 3.4.4. As shown in Figure 
4.20, although the percentage of alleles is seen to decrease as the molecular weight of the 
allele increases, the results follow the same trend as observed for the freshly prepared cell 
samples, supporting the persistence of the DNA in these single-cells without consistent signs 
of degradation of even the HMW loci. Data for chart included in appendix 8.17. 
 
Figure 4.19 Comparison of alleles amplified at each locus in single-cell DNA profiles 
for both control cells (day 0) and following a 24 month storage period. Mean values for 
both data sets are shown with a red marker. 
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Figure 4.20 Comparison of alleles amplified at each locus in single-cell DNA profiles 
for both control cells and following a 24 month storage period. A decrease in the 
amplification of HMW alleles can be seen for both time periods. 
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4.4 Discussion 
It is thought that during the period over which an item of clothing is worn, nucleated cells 
are being continuously deposited on the outside surface, as it is known that DNA can be 
transferred onto fabric through contact with the skin (Linacre et al., 2010, Daly et al., 2012), 
i.e. when adjusting sleeves or wiping hands, or via saliva aerosols whist talking (Rutty et al., 
2003, Port et al., 2006). The results of the first part of this study confirmed the presence of 
nucleated cells on the outer layer of upper garments with an average of approximately 1300 
cell events, being observed on fibre tapings for each volunteer. Given that the entire outside 
front surface of each top was taped, this number of cells is relatively low but does 
demonstrate that nucleated cells are present and therefore available for transfer to a recipient 
surface.  
The presence of individual single-cells on the surface of the textile fibres was prevalent, 
however numerous clusters of cells were also observed for each participant. These clusters, 
particularly those made up of over thirty cells, were observed wrapped around the fibre 
surface, which is expected to facilitate their transfer with the fibre to a recipient surface. In 
addition to this, the increased quantity of template DNA within the group of cells will aid 
DNA amplification during PCR. It is probable that the cellular clusters are present as a result 
of saliva aerosols rather than from contact with skin, as very few nucleated cells and no 
clusters of more than eight cells were observed during previous examination of touch DNA 
samples under a high-powered microscope (data not included in this study), which is also 
supported by observations in (Alessandrini et al., 2003) and (Kita et al., 2008). Although 
outside of the scope of this study, RNA profiling could be used to determine if saliva is in 
fact the source of these cellular clusters. 
As cotton is the most frequently encountered relevant fibre type (Watt et al., 2005, Grieve 
and Biermann, 1997a, Houck, 2003, Palmer and Oliver, 2004, Marnane et al., 2006, Roux 
and Margot, 1997, Cantrell et al., 2001, Fong and Inami, 1986, Palmer and Burch, 2009), all 
items purchased for use in the transfer experiments were at least 95% cotton, and selected 
for their ability to shed well in order to maximise fibre transfer. In addition to this, all donor 
tops were selected to be either green or purple in colour, as both are less frequently observed 
in the population (Houck, 2003, Grieve et al., 2003), thus reducing the chance that fibres 
unrelated to the study were misidentified during the initial examination under the low 
powered microscope.  
The transfer experiments themselves used were set-up to reflect those used in fibre transfer 
and persistence studies (K. Sheridan 2014 pers. comm. 4th, June), with the addition of DNA 
anti-contamination precautions integrated into the methodology. A total of ten transfer 
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experiments were conducted over the course of this study, which resulted in the recovery 
and examination of just fewer than nine thousand individual fibres. Less variability in the 
number of transferred fibres recovered between experiments was observed following the 
one-way experiments than the two-way transfers. This may be due to the fact that the same 
individual acted as the recipient in each of the four transfer events, thereby partially 
standardising the pressure applied during the contact period.  
Just over a third of the cell samples tested resulted in partial wearer DNA profiles, with 
between one to sixteen alleles (average of six) amplified per sample. One full profile was 
obtained from a cluster of six cells, approximately 37 pg DNA, which is consistent with the 
earlier sensitivity test results (Chapter 3) carried out using pristine 007 control DNA.  
Just under half of the cell samples processed following the two-way transfer study resulted 
in no amplification, which may be as a result of the SGM Plus kit’s limit of sensitivity for 
single-cell analysis if the DNA is sub-optimal, however it was also noticed that the time 
taken to examine the fibre surfaces under the fluorescent microscope, image, recover and 
transfer cells to the PCR tube, was by far in excess of that taken during the initial single-cell 
studies carried out in Chapter 3. On further investigation it was demonstrated that the SSR 
was in fact having an increasingly detrimental effect on the ability to amplify the DNA as 
the length of time of cell exposure was increased and therefore may have contributed to 
these results. As it has been shown in initial studies that the SSR does not cause PCR 
inhibition at the low volume of 1 µl used in each reaction (see Section 3.4.1), it is likely that 
the SSR is interacting with the DNA template over the increased timeframe, either through 
binding with the DNA or causing degradation to occur. The SSR was originally added into 
the PCR tube to facilitate the release of the single-cell off the J-LAR tape section and so a 
several methods for transfer of the cell(s) to the PCR tube were investigated. The use of 
FAST™ minitapes, which are typically employed for collecting touch DNA samples from 
exhibits, was shown to be an effective substitute for the J-LAR tape, due to the relatively 
thin layer of adhesive on the tape, which has been shown to release cells easily for DNA 
extraction (Hansson, 2009, Verdon et al., 2014). As a result of this, all further testing was 
conducted using MBG water in place of the SSR, which was shown to be effective when 
used in conjunction with the FAST™ minitapes. 
Following the number of wearer DNA profiles obtained from the two-way transfer study, it 
was decided that in order to demonstrate the transfer of cells from the donor garment, a one-
way transfer experiment would be utilised, whereby the recipient garment was prepared to 
minimise the presence of background cells and fibres. The following three transfer 
experiments resulted in only one cell event, which did not result in DNA amplification. In a 
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final attempt to demonstrate the transfer of cells via the fibre surface a volunteer, who took 
part in the earlier potential for cell transfer experiment and had a top that shed fibres well 
and also had the highest cell count, was asked to wear his top again for a minimum of 
sixteen hours over a two day period. This was part of the experiment was designed with the 
intention of maximising the potential for nucleated cells to be present on the outside surface 
of the garment and therefore increase the chance of transfer to the recipient. However, no 
cell events associated with transferred fibres were observed.  
As only one cell event was observed in the one-way transfer studies, two possible 
explanations were considered that may account for the absence of observed cells; firstly that 
as only the sections of J-LAR tape containing the fibre of interest were stained and examined 
under the fluorescent microscope, cells may be present over the remainder of the fibre tape, 
or secondly that there is little or no transfer of DNA to the fibre tapes as a direct result of 
contact between two items of clothing. In order to further explore this, fibre tapes were 
selected from the recipient garment used in the final experiment and swabbed for DNA 
according to current practice in operational casework (May, 2009).   
The contact scenario used for the latter part of this study was set-up to maximise the 
potential for DNA transfer, and in the absence of any background DNA to obscure the 
results, no amplifiable DNA was recovered from any of the swabbed fibre tapes. This could 
be a result of the precautions taken during this study to ensure that DNA transfer could only 
take place as a direct result of contact between the donor and recipient garments which, 
although preliminary, suggests that when DNA is recovered from fibre tapes, it may in fact 
have been transferred to the recipient garment through means other than surface-surface 
contact, i.e. via direct contact with the skin during an altercation or even from deposits of 
saliva following a verbal exchange. As such, recovering DNA from the surface of a garment 
should not be taken as proof of direct contact in the absence of other evidence.  
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4.5 Conclusions 
The use of DAPI as a DNA stain, together with fluorescence microscopy, has been shown to 
be an effective method by which single-cells can be visualised in situ on the surface of 
textile fibres. Using a microneedle, it is possible to manually recover detected cells to a 
section of adhesive FAST tape for transfer directly into a PCR tube, thus ensuring that the 
sample is not lost. It has been demonstrated that the inclusion of DAPI and FAST™ 
minitapes in the PCR does not inhibit DNA amplification, nor does the DAPI adversely 
affect the MSP spectral profile, allowing for further analysis of the fibre if required.  
It has been demonstrated that nucleated cells are present on the outside surface of an 
individual’s upper clothing and as such represent a source of DNA for possible transfer to a 
recipient surface.  
Whilst it has been demonstrated that nucleated cells can be visualised in situ on fibre tapes 
and recovered for DNA analysis without adversely affecting subsequent fibre analysis, the 
results of this study suggest that if fibres are in fact acting as a vector for the transfer of 
DNA then they do so rarely and as such, specifically targeting transferred fibres for an 
associated DNA profile is unlikely to yield a result.  
From a forensic casework point of view, the use of staining, examining and recovering cells 
from the whole fibre tape may prove a favourable alternative to the current methods 
employed in forensic casework of swabbing or cutting the fibre tape for DNA extraction, 
which would have the dual advantages of preserving the fibre evidence as well as reducing 
the background debris and adhesive that would allow for a more efficient DNA extraction or 
a direct PCR.    
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5. Massively parallel sequencing 
approaches to degraded DNA 
analysis 
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5.1 Introduction 
Forensic samples are no longer ‘living’ and so, having lost their innate DNA repair 
capabilities an accumulation of DNA damage in the cells occurs (Lindahl, 1993). Regardless 
of its localised or ubiquitous nature, the degradation of DNA in any forensic sample has the 
potential to impede efforts to generate reliable data. The successful amplification of targeted 
regions of DNA is dependent upon the ability of the polymerase enzyme to access the DNA 
template and synthesise the new strand; damage to the DNA template can partially or 
completely inhibit this process. If amplified product is obtained, then consideration must be 
given to the veracity of any data obtained as base modifications and polymerase chain 
reaction (PCR) artefacts may have become incorporated into the DNA sequences. 
The first generation Sanger sequencing instruments are rapidly becoming superseded by the 
use of massively parallel sequencing (MPS) platforms across the biological sciences. The 
development of MPS was originally driven by the need to reduce both the time and costs 
associated with Sanger sequencing (Sanger et al., 1977) for large scale genomic study 
(Collins et al., 2003), however this multifaceted technology has found numerous additional 
and diverse applications across the spectrum of genetics, including in clinical diagnostics 
(Jones, 2015), molecular ecology (Ekblom and Galindo, 2011) and functional genomics 
(Morozova and Marra, 2008). The fields of forensic science and bioarchaeology are no 
exception to this as the potential is explored to develop both novel approaches to their work 
or for opportunities to make improvements on traditional techniques in order to generate a 
better quality and quantity of results from sub-optimal samples. 
The investigation-governed nature of forensic DNA analysis requires a focused approach, 
exploiting highly informative markers in order to answer questions posed during the inquiry. 
Sequencing of large regions, or indeed the whole human genome, is therefore a redundant 
endeavour in terms of the added value of the additional information, as well as the time and 
monetary considerations. There are two notable exceptions to this type of approach; firstly, 
the recently demonstrated distinguishing capability in haplotype when the whole mtGenome 
is sequenced (Just et al., 2015, King et al., 2014a) as discussed in Chapter 1, and secondly is 
the use of whole nuclear genome mapping by MPS to differentiate between monozygotic 
twins based on rare polymorphisms, who would otherwise be indistinguishable from one 
another (Weber-Lehmann et al., 2014). 
As discussed in detail in Section 1.3.3, the markers traditionally utilised in casework are 
currently undergoing development and evaluation for use on the MPS platforms, in addition 
to the rigorous validation processes that accompany any new technology for application in a 
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forensic context, with the long-term potential to entirely replace the current PCR-CE 
techniques in forensic casework.   
One of the significant advantages to using MPS for forensic analysis is that rather than a 
profile based on fragment size analysis, the actual sequence of the STR is obtained. 
Numerous isoalleles (Heinrich et al., 2005, Rockenbauer et al., 2014, Gelardi et al., 2014, 
Dalsgaard et al., 2014) as well as SNP sites in the flanking regions of the repeat structures 
(Divne et al., 2010) have already been documented, which provide the capability to 
distinguish between two individuals with the same allele call for a locus, thus increasing the 
discriminatory value of the allele and also aiding the deconvolution of mixtures. The allele 
sequence may also prove particularly useful for distinguishing stutter from the true allele in 
situations where one allele is a single repeat shorter than the other (Zeng et al., 2015).  
The ability to multiplex a variety of markers of the same size is a significant advantage of 
MPS over the traditional PCR-CE methodologies for the processing of degraded forensic 
samples. The extent of DNA fragmentation due to cell death mechanisms or strand breaks 
caused by DNA hydrolysis, will ultimately determine the quantity and quality of DNA 
template that is available for DNA extraction and the potential for successful amplification. 
Targeting markers suitable for degraded DNA, i.e. SNPs, mini-STRs and mtDNA (see 
Chapter 1), will facilitate DNA amplification, enabling the maximum amount of information 
to be obtained from the remaining DNA.   
Bioarchaeological interest in a particular set of skeletal remains, with queries around sex, 
identity, ancestry and phenotypic characteristics have shown to benefit from a forensic 
approach to the DNA analysis. 
The first successful project involving this type of historical DNA work include the 
identification of five members of the Romanov family in 1994 (Gill et al., 1994) followed by 
the remaining two children in 2008 (Coble et al., 2009). The initial work was carried out 
using Amelogenin, five tetrameric STR markers and mtDNA analysis of the HVSI region, 
which enabled the identification of the Tsar, Tsarina and three of their children from the nine 
present skeletons. Further work was then able to confirm two skeletons found in an 
additional grave as the missing daughter and son of the Tsar and Tsarina. Updated DNA 
analyses were carried out for all members of the family, using the AmpFℓSTR® 
Identifiler™, MiniFiler™ and YFiler™ PCR Amplification Kits to confirm the identity of 
Tsar Nicholas II as well as the results from the previous study.  
The investigation into skeletal remains excavated in 2012, which were alleged and 
subsequently confirmed to be those of King Richard III (King et al., 2014b) utilised a variety 
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of DNA markers and following protocols for ancient DNA analysis, carried out in two 
laboratories for independent verification. Whole genome sequencing of mtDNA from the 
skeletal sample and also two maternal relatives (separated by 19/21 generations) for 
comparison, was carried out on both the Illumina HiSeq2000 and Ion Torrent PGM MPS 
platforms. Phenotypic characteristics were also investigated by targeting HlrisPlex SNPs, the 
results of which inferred that the subject had a 96% chance of having blue-coloured eyes and 
a 77% chance of blonde-coloured hair. Both of the above examples demonstrate the value of 
using a variety of marker types in order to provide a comprehensive DNA evaluation, thus 
increasing confidence in the results obtained. Although this information has clear application 
in field of forensics, it must be noted that many phenotypic characteristics, such as hair, eye 
and skin colour, can to varying degrees be altered by the individual, with their appearance no 
longer reflecting their genetics. 
It has been hypothesised that the reason behind the preservation of DNA in skeletal remains 
is due to its affinity for binding with calcium phosphate apatite minerals (Lindahl, 1993) and 
collagen I (Mrevlishvili and Svintradze, 2005b), which form the inorganic and organic 
components of the structural matrix respectively. Corroboration for the adsorption of DNA 
on apatite has been provided in 2001 by Okazaki (Okazaki et al., 2001) and more recently 
(2014) by Grunenwald (Grunenwald et al., 2014), who both concluded that there is a strong 
affinity between the phosphate groups of the DNA backbone and the calcium ions in the 
apatite. Collagen molecules cluster together to form fibrils, which are required to provide 
structural support in bone materials (Rho et al., 1998). It is thought that DNA is incorporated 
into the centre of these fibrils, forming a stable nanostructure with the collagen molecules 
(Pidaparti et al., 2009, Mrevlishvili and Svintradze, 2005a).  
Within the bone matrix, a network of cross-linked, fully hydrated collagen fibrils is formed, 
the alignment of which results a series of regularly interspersed gap zones (Rho et al., 1998). 
The mineralisation process is initiated in these gaps through the formation of hydroxyapatite 
platelets, which then progresses throughout the fibril network via the formation of 
hydroxyapatite crystals that encapsulate the fibrils, including the DNA component, and 
develop in size to fill the interfibrillar space (Campos et al., 2012). Extracellular DNA that is 
present within the interfibrillar space as a result of cell death processes, chemical 
degradation or microbial activity, may become trapped through adsorption with the 
hydroxyapatite crystallites, effectively facilitating their preservation (Campos et al., 2012).  
Although DNA can be extracted from both the apatite and collagen fractions independently 
(Campos et al., 2012), the relationship between the two appears to be complex, with 
collagen potentially acting to shield the apatite-adsorbed DNA (Götherström, 2002, Roberts 
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et al., 2002), as the loss of DNA in the collagen faction also correlates with a loss in the 
mineral fraction (Campos et al., 2012). As proposed by Campos (Campos et al., 2012), if the 
collagen/DNA fibril molecules were to degrade, i.e. though microbial activity (Child, 1995), 
then apatite crystals located in the interfibrillar gap zones would also then be exposed to 
degradation. It appears therefore probable that the preservation of DNA is principally 
dependent upon the integrity of the bone matrix. 
Each tooth is made up of pulp, a soft tissue, and three structural components, enamel, dentin 
and cementum, which are made up of 97%, 70% and 45% mineral respectively (Brudevold 
et al., 1960). All four of these components contain both DNA and mtDNA, which have been 
shown to degrade differentially post mortem (Higgins et al., 2015). Due to the mineral 
encapsulated cementocytes in the cementum and odontocytes in the dentin, the DNA in 
these two components invariably persists for a longer period of time than the pulp tissue 
(Malaver and Yunis, 2003, Higgins et al., 2015).  
There are numerous examples in which the ability of DNA to persist for longer periods of 
time in environments that have a cooler climate has been demonstrated (Burger et al., 1999, 
Hoss et al., 1996, Higgins et al., 2015). Whilst it has been shown that the structure of the 
bone itself does not undergo any significant structural changes under 250 ˚C (Etok et al., 
2007), the rate of depurination, one of the predominant forms of DNA degradation in post 
mortem samples, has been shown to be temperature dependent (Lindahl and Nyberg, 1972). 
This knowledge, along with localised modern and historical temperature data, allows the 
thermal age of a sample, i.e. the extent of DNA degradation expected if the temperature is at 
10 ˚C, to be calculated. The estimated thermal age has been shown to be a better indicator of 
the state of DNA preservation in a sample than the actual age (Smith et al., 2003). 
The availability of water within the localised environment is known to increase the rate of 
DNA degradation, as damage from hydrolytic activity, particularly depurination and 
deamination is frequently observed in degraded samples (Hedges and Millard, 1995, 
Nielsen-Marsh and Hedges, 2000, Bollongino et al., 2008).  
Although the release of hydroxyapatite crystals into the surrounding environment provides 
bone material with an effective buffering capacity within the range pH 3-9 (Bada et al., 
1980), if the acidity of the burial environment exceeds this level, the bone matrix has been 
shown to break down (High, 2015). Whereas it has been demonstrated that slightly alkaline 
conditions, such as limestone environments (Burger et al., 1999) favour DNA preservation.  
The exposure to sunlight or more specifically UVA and UVB light, will vary depending on 
the individual circumstances surrounding death, e.g. if the skeletal remains were in the open 
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environment, as well as excavation and storage. The absorption of light photons by 
nucleotides, particularly pyrimidines, can lead to a variety of oxidation reactions, including 
the formation of 8-OxoG and other hydantoins (Peak and Peak, 1989, Zhang et al., 1997, 
Ravanat et al., 2001, Hoss et al., 1996). 
Finally, bioerosion of bone material as a result of microbial activity, particularly the 
breakdown of collagen by collagenase/protease-producing bacteria (Child, 1995) will also 
detrimentally effect the preservation of DNA within bone material (Campos et al., 2012).  
The greatest challenge faced for the analysis of degraded samples, especially for ancient 
specimens, is the potential for any extracted DNA to have come from a source other than the 
target. Aside from a couple of examples of exceptional DNA preservation (Meyer et al., 
2012, Reich et al., 2010), it has been shown in a number of studies that on average a 
degraded DNA extract consists of 95-99.9% exogenous DNA and just 0.1-5% target DNA 
(Burbano et al., 2010, Meyer et al., 2014, Fu et al., 2013).  
Nine criteria for ensuring the authenticity of ancient DNA results were proposed by Cooper 
and Poinar (Cooper and Poinar, 2000) in an effort to standardise data evaluation, these 
include that pre-amplification work is carried out in a physically isolated area, that 
appropriate negative controls are utilised throughout processing and a minimum of two 
independent and sequential extractions of each sample should be carried out, by two 
different laboratories; although with archaeological specimens this may not always be 
feasible due to limited sample availability. At least two DNA amplifications should also be 
carried out for each extract in order to generate consensus sequences that will help identify 
PCR artefacts arising from stochastic variation, and that an inverse relationship should be 
observed between the amplification strength and the PCR product size. 
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5.2 Aims and objectives 
DNA material contained within human skeletal remains that has severely degraded as a 
result of temporal or environmental factors can represent a significant challenge for forensic 
DNA analysis. MPS techniques are proposed as a significant a step forward in terms of the 
quantity and reliability of information that can be obtained from samples and as such, should 
offer advantages for analysis of these sample types. The aim of this chapter is to investigate 
the efficacy of MPS techniques for degraded DNA through the targeted sequencing of both 
DNA markers and regions of the mtDNA genome, using traditional PCR-CE techniques as a 
point of comparison.   
The initial objective of this study is to identify the most effective method of extracting DNA 
from the skeletal remains, assessing both the DNA quantity and quality through the use of 
qPCR techniques. In the absence of a commercially available kit, an ‘in-house’ assay for the 
quantification of mtDNA will be developed and tested for use with these samples. DNA 
extracts will then be subjected to both PCR-CE and two PCR-MPS techniques, using 
Illumina’s suggested protocol for amplification of the control region of the mtGenome and 
their recently launched ForenSeq™ Signature Prep Kit for DNA, in order to assess the 
capability of the latter to provide a more comprehensive evaluation of the degraded DNA 
samples.  
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5.3 Materials and methods 
5.3.1 Samples 
Two different sample sets were used as part of this study in order to look at both the effect of 
age and of environment in the analysis of DNA using MPS techniques.  
5.3.1.1 Brazil 
To investigate the use of MPS for the sequencing of highly degraded DNA, twenty samples 
(labelled LAFR01–LAFR20) were obtained through a collaborative project with the 
Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of 
São Paulo, Brazil. These samples were taken from the skeletal remains of twenty individuals 
excavated from the Cemetery of Bom Pastor in Ribeirão Preto. This cemetery was used as a 
burial site for individuals of either unknown identity or those who did not have means for 
other arrangements. Due to the site been sold, the graves were excavated and the remains 
donated to the Ribeirão Preto Medical School.  
The weather conditions in Ribeirão Preto, for the time period 2000-2012 had an average 
high temperature of 26 ºC, with an average of 124 mm rainfall over 10.8 days a month 
(www.worldweatheronline.com, accessed 18/07/2015). These samples were of particular 
interest as the heat and humidity in Brazil creates a hostile environment for DNA, therefore 
it was expected that any DNA remaining in the skeletal samples would be severely 
degraded. As such, mtDNA sequencing was the primary target of this study although some 
nDNA analysis was also carried out.  
These samples included a section of the femur from twenty different individuals that had 
been buried 11-14 years previously. In addition to this, a tooth sample was also provided for 
samples LAFR02, 07, 09, 11 and 20. Ethical permission for this project has been granted by 
both the University of São Paulo Ribeirão Preto Medical School and Northumbria 
University Ethics Committee (copy included in appendix 8.18).  
5.3.1.2 Vindolanda Trust 
Positioned on the old Stanegate Road, approximately a mile south of Hadrian’s Wall, 
Vindolanda is an archaeological dig site dating back to the early Roman occupation (Birley, 
2009). Throughout this period, the infrastructure of Vindolanda was subjected to frequent re-
building projects, resulting in the construction of at least nine distinct forts. As one fort was 
demolished, the ground was prepared for new structures by filling and covering with up to 
40 cm of turf or clay, creating layers in which any debris was protected from both oxygen 
and surface water (Birley, 2009). These unique conditions have consequently enabled 
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Vindolanda to yield some of the best preserved exhibits from across the entire Roman 
Empire (Birley, 2007). 
Two samples have been obtained from the Vindolanda Trust for DNA analysis; sample 
‘V12-35N 29180’ Femur and sample ‘SF8658 – Tooth from Human Skull’. The Femur bone 
was recovered during excavation of a fort ditch, which has been dated to circa 110CE. The 
tooth sample, a molar removed from the jaw bone, was taken from a skull that has been 
dated to 208-211CE. Permission for the destruction of the samples for DNA analysis was 
obtained from the Vindolanda Trustees in December 2014 (copy included in appendix 8.19).  
5.3.2 Sample preparation  
5.3.2.1 Brazil bones & teeth 
The Brazil samples were prepared by cleaning and pulverising the entire pre-cut section of 
bone sample or tooth as described in Section 2.4.5. The samples were prepared sequentially, 
in two batches as shown in Table 5-1, with a full clean-down of the preparation area in 
between each sample.  
5.3.2.2 Vindolanda femur 
A 3 cm x 2.3 cm section of the femur was removed immediately adjacent to the area that had 
previously been removed by York University as shown in Figure 5.1. All surfaces were 
sanded, cleaned and treated with UV light to remove any exogenous DNA prior to 
pulverisation using a freezer mill as described in Section 2.4.5. A total of 6.9 g of powdered 
sample was collected.  
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Figure 5.1 Images illustrating preparation of femur sample. 5.1A – image of Vindolanda 
femur sample, 5.1B – close up of section removed previously by York University, 5.1C – 
section removed, 5.1D – removed section cleaned and sanded to remove exogenous DNA, 
5.1E – section cut into small pieces prior to pulverisation in freezermill, 5.1F – bone sample 
powdered. 
 
5.3.2.3 Vindolanda tooth  
The tooth was cleaned and treated with UV light in order to remove any foreign DNA from 
the outside surface. In an effort to preserve the tooth casing, the tooth was drilled as 
described in Section 2.4.5.3; 0.26 g of powdered sample was collected (Figure 5.2).  
In a second attempt to obtain nuclear DNA, the entire tooth surface was re-cleaned and 
pulverised as detailed in Section 2.4.5, resulting in 1.12 g of sample powder 
 
 
159 
 
D 
A B 
C 
 
Figure 5.2 Images of the Vindolanda tooth sample. 5.2A – image of excavated skull prior 
to removal of the tooth sample (taken from http://www.vindolanda.com/educate/artefacts), 
5.2B-side profile 5.2C – top section of crown, 5.2D – tooth case section post removal of 
inner material. 
5.3.2.4 Control sample - Cervus elaphus 
Tooth and bone samples from a Red deer (Cervus elaphus) were cleaned and prepared in 
exactly the same way as the human samples, one for each preparation batch and labelled as 
‘Negative A’. This sample was used as a process control and to monitor for the presence of 
any human contamination throughout processing.  
5.3.3 DNA extraction 
5.3.3.1 Reference buccal swabs 
The reference buccal samples required for this work were collected as described in Section 
2.4.2 and extracted using the QIAamp® DNA mini kit as described in Section 2.7.2.1.  
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5.3.3.2 Brazil bones and teeth 
Samples 005B, 007B, 011B, 013B and 020B were extracted using phenol chloroform 
(method 1), silica column (method 2) and silica suspension (method 3) approaches, 
following the protocols detailed in Section 2.7.4. Samples 002T, 007T, 009B, 009T, 012B, 
017B were extracted using method 1 only, samples 011T and 020T were extracted using 
only method 2, samples 001B-004B, 006B, 008B, 010B, 014B-016B, 018B and 019B were 
extracted using only method 3 as summarised in Table 5-1. 
5.3.3.3 Vindolanda samples  
Two sequential extractions of the pulverised femur were carried out, each one using a total 
of 3 g of bone powder, labelled ‘Extraction 1’ and ‘Extraction 2’. The 3 g of bone powder 
was further split into six samples of 0.5 g, each of which was extracted as described in 
Section 2.7.4.3. Extracts were each eluted in 200 µl of TE buffer and were then combined 
and concentrated into approximately 60-80 µl, using a Microcon YM-30 centrifugal filter 
device, described in Section 2.7.4.4.   
The first tooth extraction, consisting of 0.26 g of material removed from the inside surface of 
the casing, was extracted as outlined in Section 2.7.4.3. Volumes of the extraction solution 
and binding buffer were reduced to 6 ml and 24 ml respectively; all other volumes remained 
the same. 
The pulverised whole tooth sample was split into two samples of 0.55 g and extracted in the 
same manner as the femur sample. Due to the limited quantity of sample, it was not possible 
to carry out a second independent extraction of this sample.  
5.3.3.4 Negative control 
A reagent negative control, labelled as ‘Negative B’ was set-up using an equivalent volume 
of digestion buffer as that added to the sample powder, and was then treated in exactly the 
same way as the samples throughout processing. This control was used to monitor any 
contamination of the DNA extraction reagents or occurring as a result of sample 
manipulation during processing. 
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Table 5-1 Summary of the sample details and preparation, extraction methods and amplification kit used for samples received from Ribeirão Preto, 
Brazil 
Internal 
Sample 
reference 
Post 
mortem 
interval 
(years) 
Sex Batch 
Phenol 
chloroform 
(method 1) 
Silica 
column 
(method 2) 
Silica suspension 
(method 3) 
AmpFℓSTR® 
NGM™ PCR Kit 
mtDNA HVSI 
‘in-house’ 
MiSeq assay 
ForenSeq DNA 
Signature Kit 
001B 14 (Male) 2       
002B 14 Male 2       
002T 14 Male 1       
003B 14 Male 2       
004B 14 Male 2       
005B 12 Male 1   *    
006B 12 Male 2       
007B 12 Female 1   *    
007T 12 Female 1       
008B 11 Male 2       
009B 11 Male 1       
009T 11 Male 1       
010B 11 Male 2       
011B 11 Male 1  *     
011T 11 Male 1       
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012B 8 (Female) 1       
013B 12 Male 1  *     
014B 12 Male 2       
015B 12 Female 2       
016B 12 Male 2       
017B 12 Male 1       
018B 11 Male 2       
019B 10 Female 2       
020B 10 Male 1  *     
020T 10 Male 1       
*denotes which DNA extract was used for NGM profile generation where multiple extractions were carried out 
Sex listed in brackets reflects a conflict in assigning biological sex between the ante mortem and post mortem examinations with the ante mortem result provided 
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5.3.4 DNA quantification 
5.3.4.1 Nuclear DNA 
The nuclear DNA recovered from the Brazil bone and tooth samples 001-020, along with the 
two Vindolanda femur extracts and the Vindolanda tooth extract were each quantified in 
triplicate, using the Quantifiler® Trio DNA Quantification Kit as detailed in Section 2.8.3.  
The degradation index (DI) was used to assess the level of DNA degradation in each of the 
samples. This was calculated using the formula:  
𝐷𝐼 =  
𝑆𝑚𝑎𝑙𝑙 𝑎𝑢𝑡𝑜𝑠𝑜𝑚𝑎𝑙 𝑡𝑎𝑟𝑔𝑒𝑡 [𝐷𝑁𝐴] (𝑛𝑔 / µ𝑙) 
𝐿𝑎𝑟𝑔𝑒 𝑎𝑢𝑡𝑜𝑠𝑜𝑚𝑎𝑙 𝑡𝑎𝑟𝑔𝑒𝑡 [𝐷𝑁𝐴] (𝑛𝑔 / µ𝑙)
 
The level of degradation for each sample was then categorised according to Vernarecci et al. 
as indicated by the DI value; < 1-1.5 no degradation, 1.5-4 mildly degraded, 4-10 degraded 
and >10 severely degraded (Vernarecci et al., 2015). 
An internal positive control (IPC) was run with each sample, which is a synthetic sequence 
of DNA that is not found in nature. If the expected Ct value of the IPC is delayed, this is 
indicative of the presence of inhibitors within the sample that are affecting DNA 
amplification. Samples were flagged as showing signs of PCR inhibition if their IPC value 
exceeded the mean Ct value for all of the standards in the run plus a variance of two, as 
suggested in the manufacturer’s guidelines. 
Sex was only assigned in samples where the total DNA concentration (short target) was 
determined to be >2 pg/µl. The sex was assigned as male when the average DNA 
concentration of the Y target exceeded that of the total DNA (short target) concentration. In 
cases where the average total DNA concentration (short target) is greater than the average 
value for male DNA (Y target), then the sample was determined to be single source only if 
the mean ± the standard deviation, for the two targets overlapped. If the two values did not 
overlap, i.e. the total DNA concentration exceeds the male DNA concentration; a mixed 
source of male/female DNA was then recorded. Where there was no amplification of the Y 
target observed, the sample was recorded as female.  
The red deer negative controls were quantified using both the Quantifiler® Trio Kit, in order 
to detect any present human DNA and also the Qubit® 2.0 Fluorometer, along with the 
Qubit™ dsDNA HS Assay Kit as detailed in Section 2.8.5, to confirm a positive extraction 
result. The Nanodrop-1000 was used to quantify the DNA concentration of all reference 
samples required for this work in this section as described in Section 2.8.2 .  
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5.3.5 Mitochondrial qPCR assay 
5.3.5.1 Assay design 
In the absence of a commercially available kit, an in-house quantitative-PCR (qPCR) SYBR-
Green assay for the quantification of mitochondrial DNA was designed and optimised for 
use. Amongst chordates, the arrangement of the thirty-seven mitochondrial genes is identical 
and so, as much of the mtGenome is conserved between species (Boore, 1999), the primary 
challenge when designing a qPCR assay was ensuring that it is human-specific. It is also 
preferable to amplify a target outside of the control region, which is required for sequencing, 
in order to minimalise the risk of laboratory contamination (Kavlick et al., 2011). Finally, as 
previously discussed, mtDNA is more usually targeted for DNA analysis in samples that are 
expected to contain degraded DNA and as such, the target fragment size should be less than 
200bp to aid mtDNA detection in these sample types.  
Cytochrome C oxidase is a transmembrane enzyme involved in the electron transport chain 
activity (Capaldi, 1990). It is a protein made up of thirteen subunits, the three largest of 
which COX1-3, are encoded for by the mtGenome (Kadenbach et al., 1983). The inter- and 
intra-species variability in the sequences of these subunits, predominately COX1 (Hebert et 
al., 2003) but also COX3 (Voigt, 2012), has been exploited for the DNA barcoding of 
species allowing rapid identification. 
Sequences for the COX1-3 regions of the mtGenome were obtained from Genbank and 
aligned with the Homo sapiens sequence using the web-based version of Clustal Omega 
(v1.2.1) (McWilliam et al., 2013). A comparison was first carried out between the sequence 
for Homo sapiens and the genetically closely related higher primates (accession numbers 
listed in Table 5-2), looking for two clusters of human-specific SNPs separated by no more 
than 150 bases, over which human-specific primers could be designed. One such example 
was identified in the COX3 sequence as a possible target for amplification, shown in Figure 
5.3.  
Forward and reverse primers were then designed to incorporate three of the human-specific 
SNPs and checked, first manually, against eleven species, Figure 5.4, and then across all 
organisms using Primer-BLAST (Ye et al., 2012) for specificity. Only four results were 
returned from the Primer-BLAST search, three of which were extinct species closely related 
to Homo sapiens (see Figure 5.5).  
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Table 5-2 Accession numbers for sequences of species used in assay design 
Species Genbank accession number 
Homo sapiens NC_012920.1 
Gorilla gorilla NC_011120.1 
Pan troglodytes NC_001643.1 
Pan paniscus NC_001644.1 
Cervus elaphus NC_007704.2 
Lemur catta NC_004025.1 
Canis lupus AY656745.1 
Felis catus NC_001700.1 
Mus musculus NC_005089.1 
Scomberomorus semifasciatus NC_021391.1 
Xenopus laevis NC_001573.1 
Bos taurus AF492351.1 
 
Gorilla_gorilla     GGTGTCTCAATTACCTGAGCCCACCATAGCCTAATAGAAAATAACCGTAACCAAATAATT 
Human_Cyt_COX3      GGAGTATCAATCACCTGAGCTCACCATAGTCTAATAGAAAACAACCGAAACCAAATAATT 
Pan_troglodytes     GGAGTATCAATTACTTGAGCCCATCACAGCTTAATAGAAAATAACCGAAACCAAATAATT 
Pan_paniscus        GGAGTATCAATTACTTGAGCCCATCACAGCTTAATAGAAAATAACCGAAACCAAATAATT 
                    ** ** ***** ** ***** ** ** **  ********** ***** ************ 
 
Gorilla_gorilla     CAAGCACTACTTATCACAATTTTACTGGGCCTCTACTTCACCCTCCTACAAGCCTCAGAG 
Human_Cyt_COX3      CAAGCACTGCTTATTACAATTTTACTGGGTCTCTATTTTACCCTCCTACAAGCCTCAGAG 
Pan_troglodytes     CAAGCACTGCTTATTACGATTCTACTAGGTCTTTATTTTACCCTCCTACAAGCCTCAGAA 
Pan_paniscus        CAAGCACTACTCATTACAATTTTACTAGGTCTCTATTTCACCCTCCTACAAGCCTCAGAA 
                    ******** ** ** ** *** **** ** ** ** ** ********************  
 
Gorilla_gorilla     TACTTTGAAGCCCCCTTTACCATTTCCGATGGTATCTATGGCTCAACATTTTTTGTAGCC 
Human_Cyt_COX3      TACTTCGAGTCTCCCTTCACCATTTCCGACGGCATCTACGGCTCAACATTTTTTGTAGCC  
Pan_troglodytes     TATTTCGAATCCCCTTTTACCATTTCCGATGGCATCTACGGCTCAACATTCTTTGTAGCC 
Pan_paniscus        TACTTCGAATCCCCTTTTACCATTTCCGATGGCATCTACGGCTCAACATTCTTTGTAGCC 
                    ** ** **  * ** ** *********** ** ***** *********** ********* 
 
Figure 5.3 Clustal Omega (v1.2.1) alignment of the Homo sapiens mtGenome COX3 
region with three higher primates; human-specific SNPs are highlighted in grey with a 
distance of 139 bases between the two furthest positions                        
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Scom_semifasciatus  GGAGTTACAGTTACCTGAGCTCACCACAGCATTATAGAAGGCAATCGAAAAGAAGCAATC 
Xenopus_laevis      GGAGTTACAGTTACCTGAGCTCACCACAGCATTATAGAAGGCAATCGAAAAGAAGCAATC 
Mus_musculus        GGTGTTTCAATTACATGAGCTCATCATAGCCTTATAGAAGGTAAACGAAACCACATAAAT 
Lemur_catta         GGCGTATCCATCACCTGAGCTCACCATAGCCTAATAGAAGGAAACCGAGTACAAATACTC 
Gorilla_gorilla     GGTGTCTCAATTACCTGAGCCCACCATAGCCTAATAGAAAATAACCGTAACCAAATAATT 
Human_Cyt_COX3      GGAGTATCAATCACCTGAGCTCACCATAGTCTAATAGAAAACAACCGAAACCAAATAATT 
Pan_troglodytes     GGAGTATCAATTACTTGAGCCCATCACAGCTTAATAGAAAATAACCGAAACCAAATAATT 
Pan_paniscus        GGAGTATCAATTACTTGAGCCCATCACAGCTTAATAGAAAATAACCGAAACCAAATAATT 
Canis_familiaris    GGAGTATCTATTACTTGAGCCCATCATAGTTTAATAGAAGGTAATCGCAAACATATACTT 
Felis_catus         GGAGTATCAATCACCTGAGCTCACCACAGTTTGATGGAGGGAAATCGAAAACACATGCTT 
Cervus_elaphus      GGAGTTTCTATCACCTGAGCCCATCATAGCCTTATAGAAGGAAACCGCAACCATATACTA 
Bos_taurus          GGAGTTTCTATTACCTGAGCCCATCATAGTTTAATAGAAGGGGACCGAAAGCATATATTA 
                    ** **  *  * ** ***** ** ** **  * ** **     * **     *       
  
Scom_semifasciatus  CAGTCTCTAGCACTGACAATTCTCCTCGGTTTCTACTTCACCTTCCTTCAAGCTATAGAA 
Xenopus_laevis      CAGTCTCTAGCACTGACAATTCTCCTCGGTTTCTACTTCACCTTCCTTCAAGCTATAGAA 
Mus_musculus        CAAGCCCTACTAATTACCATTATACTAGGACTTTACTTCACCATCCTCCAAGCTTCAGAA 
Lemur_catta         CAAGCTCTACTCATCACTATTACCCTAGGTCTCTATTTCACACTCCTCCAAGCCTCAGAA 
Gorilla_gorilla     CAAGCACTACTTATCACAATTTTACTGGGCCTCTACTTCACCCTCCTACAAGCCTCAGAG 
Human_Cyt_COX3      CAAGCACTGCTTATTACAATTTTACTGGGTCTCTATTTTACCCTCCTACAAGCCTCAGAG 
Pan_troglodytes     CAAGCACTGCTTATTACGATTCTACTAGGTCTTTATTTTACCCTCCTACAAGCCTCAGAA 
Pan_paniscus        CAAGCACTACTCATTACAATTTTACTAGGTCTCTATTTCACCCTCCTACAAGCCTCAGAA 
Canis_familiaris    CAAGCCTTATTCATTACAATCTCCTTAGGCGTATATTTTACGCTATTACAGGCCTCCGAA 
Felis_catus         CAAGCACTATTTATTACAATCTCTTTAGGGGTCTACTTTACACTCCTCCAAGCCTCCGAA 
Cervus_elaphus      CAAGCCTTATTTATTACTATCGCACTAGGCGTCTATTTTACACTACTACAAGCCTCAGAA 
Bos_taurus          CAAGCCCTATTTATCACCATCACATTAGGAGTCTACTTCACACTACTACAAGCCTCAGAA 
                    **  *  *     * ** **     * **  * ** ** **  *  * ** **    **  
 
Scom_semifasciatus  TACTATGAAGCTCCCTTTACAATCGCAGACGGAGTCTACGGTTCCACATTCTTTGTAGCC 
Xenopus_laevis      TACTATGAAGCTCCCTTTACAATCGCAGACGGAGTCTACGGTTCCACATTCTTTGTAGCC 
Mus_musculus        TACTTTGAAACATCATTCTCCATTTCAGATGGTATCTATGGTTCTACATTCTTCATGGCT 
Lemur_catta         TATTTTGAAACATCCTTTACAATCTCAGACGGCGTGTATGGTTCTACATTCTTTATGGCA 
Gorilla_gorilla     TACTTTGAAGCCCCCTTTACCATTTCCGATGGTATCTATGGCTCAACATTTTTTGTAGCC 
Human_Cyt_COX3      TACTTCGAGTCTCCCTTCACCATTTCCGACGGCATCTACGGCTCAACATTTTTTGTAGCC 
Pan_troglodytes     TATTTCGAATCCCCTTTTACCATTTCCGATGGCATCTACGGCTCAACATTCTTTGTAGCC 
Pan_paniscus        TACTTCGAATCCCCTTTTACCATTTCCGATGGCATCTACGGCTCAACATTCTTTGTAGCC 
Canis_familiaris    TACTATGAGACATCTTTTACAATCTCCGATGGGGTGTACGGATCTACCTTTTTTATAGCC 
Felis_catus         TACTATGAAACATCATTCACGATCTCGGACGGAGTATACGGATCTACCTTCTTCATGGCC 
Cervus_elaphus      TACTATGAAGCACCCTTTACCATTTCAGACGGAGTTTATGGCTCAACCTTCTTTGTAGCT 
Bos_taurus          TACTATGAAGCACCTTTTACTATCTCCGACGGAGTTTACGGCTCAACTTTTTTTGTAGCC 
                    ** *  **  *  * **  * **  * ** **  * ** ** ** ** ** **  * **  
 
Figure 5.4 Clustal Omega (v1.2.1) alignments of the target fragment of the mtGenome 
COX3 region for a variety of species. Sequences were obtained from Genbank for 
comparison, the accession numbers for which are listed in Table 5-2. Proposed human-
specific primer hybridisation sites are highlighted in grey and nucleotides which differ from 
this sequence are highlighted in pale grey.   
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Figure 5.5 Screenshot of Primer-BLAST (Ye et al., 2012) page showing four results 
returned from a search against all organisms. Homo sapiens neanderthalensis, Homo 
heidelbergensis and Homo sapiens Altai are now extinct, and so this assay is highly modern 
human-specific, allowing for an accurate quantification of the human mtDNA within a 
sample. Both primers are 21 nucleotides in length with a GC content of approximately 52% 
and a Tm of 58-59 ºC. 
5.3.5.2 Standards 
A 200 bp synthetic gene fragment was used to generate qPCR standards containing a known 
copy number of the COX3 target so that the mtDNA copy number in each sample could be 
determined. The DNA fragment was ordered as two single-stranded complementary 
oligonucleotides (Integrated DNA Technologies, Coralville, IA, USA), which were each 
resuspended to a concentration of 10 µM in primer resuspension buffer as described in 
Section 2.8.1.1 . 
The following calculations were utilised to determine the mtDNA copy number of synthetic 
standard.  
Forward strand 
1 copy MW = 61095.6 g/mol (provided by IDT) 
1 copy = 
61095.6 𝑔/𝑚𝑜𝑙
6.022× 1023 𝑚𝑜𝑙
   (divide by mol) 
1 copy = 1.01*10-19 g (1.01*10-10 ng)    
Total amount of oligo = 90,000 ng  (provided by IDT) 
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Total number of copies = 
90000 𝑛𝑔
1.01×10−10 𝑛𝑔
 (mass of total amount of oligo/mass of 1 copy) 
Total number of copies = 8.91 *1014 
Resuspended to 10 µM in 153.1 µl of primer resuspension buffer 
1 µl = 
8.91×1014 𝑐𝑜𝑝𝑖𝑒𝑠
153.1 µ𝑙
 
1 µl = 5.82*10
12
 copies in a 10 µM stock 
A working solution was prepared with a concentration of 2 µM, by adding 10 µl of 10 µM 
stock, containing total of 5.82*1013 copies of the DNA fragment, to 40 µl of MBG water and 
mixed briefly by vortex. 
Theoretical no. of copies in 1 µl = 
5.82×1013 𝑐𝑜𝑝𝑖𝑒𝑠
50 µ𝑙
 
Theoretical no. of copies in 1 µl of a 2 µM solution = 1.16*10
12   
The 2 µM oligonucleotide solution was quantified using the NanoDrop® Spectrophotometer 
ND-1000 with software ND-1000 V3.8.1 as described in Section 2.7.2, in order to determine 
the actual number of copies of the fragment in this diluted solution.  
Average DNA concentration = 103.7 ng/µl 
Actual no. of copies in 1µl = 
103.7 𝑛𝑔
1.01×10−10 𝑛𝑔
 
Actual no. of copies in 1 µl of 2 µM solution = 1.03*10
12 
Complimentary strand 
1 copy MW = 62345.4 g/mol 
1 copy = 
62345.4 𝑔/𝑚𝑜𝑙
6.022× 1023 𝑚𝑜𝑙
 
1 copy = 1.04*10-19 g (1.04*10-10 ng) 
Total amount of oligo = 30,000 ng  
Total number of copies = 
30000 𝑛𝑔
1.04×10−10 𝑛𝑔
 
Total number of copies = 2.90 *1014 
Resuspended to 10 µM in 50.1 µl of primer resuspension buffer 
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1 µl = 
2.90×1014 𝑐𝑜𝑝𝑖𝑒𝑠
50.1 µ𝑙
 
1 µl = 5.79*10
12
 copies in a 10 µM stock 
A working solution of the oligonucleotide was again prepared with a concentration of 2 µM, 
by adding 10 µl of 10 µM stock, containing total of 5.79*1013 copies of the DNA fragment, 
to 40 µl of MBG water and mixing briefly by vortex. 
Theoretical no. of copies in 1 µl = 
5.79×1013 𝑐𝑜𝑝𝑖𝑒𝑠
50 µ𝑙
 
Theoretical no. of copies in 1 µl of a 2 µM solution = 1.16*10
12   
The 2µM oligonucleotide solution was quantified using the NanoDrop® Spectrophotometer 
as previously described in order to determine the actual number of copies of the fragment in 
this diluted solution.  
Average DNA concentration = 116.0 ng/µl 
Actual no. of copies in 1µl = 
116.0 𝑛𝑔
1.04×10−10 𝑛𝑔
 
Actual no. of copies in 1 µl of 2 µM solution = 1.12*10
12 
Both oligonucleotides were then diluted to a concentration of 1*1010 as shown below: 
Forward strand – stock = 1.03*1012 copies/µl 
Dilution factor = 
(1.03×1012 𝑐𝑜𝑝𝑖𝑒𝑠/µ𝑙) × 1µ𝑙
1×1010 𝑐 𝑜𝑝𝑖𝑒𝑠
 
Dilution factor = 103 
1 µl of 2 µM oligonucleotide solution was added to 102µl of MBG water and centrifuged 
briefly to mix.  
Complimentary strand – stock = 1.12*1012 copies/µl 
Dilution factor = 
(1.12×1012 𝑐𝑜𝑝𝑖𝑒𝑠/µ𝑙) × 1 µ𝑙
1×1010 𝑐𝑜𝑝𝑖𝑒𝑠
 
Dilution factor = 112 
1 µl of 2 µM oligonucleotide solution was added to 111µl of MBG water and centrifuged 
briefly to mix.  
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Both oligonucleotides were transferred to a fresh tube in a 1:1 ratio to give a concentration 
of 1*109 copies/µl. The tube was heated to 95 ºC for 3 minutes and then left to cool slowly at 
room temperature.  
All stock and working solutions of both oligonucleotides were stored at -80 ºC.  
5.3.5.3 Optimisation 
The primer annealing temperature was tested between 55-60 ºC using the thermal gradient 
feature on the CFX96 Touch™ Real-Time PCR Detection System and although it was 
marginal, 60 ºC was determined to be the optimum. The specificity of the primer set was 
demonstrated by the single melt peak observed for all samples tested indicating the presence 
of one PCR product only as shown in Figure 5.6. 
 
Figure 5.6 Single melt peak generated post PCR cycling steps, demonstrating the 
presence of just one PCR product. Extremely low levels of primer dimer were also 
observed, falling well below the Ct detection threshold, thus having no impact upon the Ct 
values.  
As can be seen in Figure 5.7, although mtDNA was amplified down to the lowest DNA 
input of 50 copies/µl, the linear range of the assay was determined to be 5*103 – 5*109 
copies/µl as the linear relationship between the quantity of DNA and the Ct value was lost 
below this value. Whilst samples with an mtDNA DNA copy number below 5000 will be 
detected, the copy number cannot be accurately determined.  
The assay performance can be measured through comparison with the theoretical number of 
cycles (n) between Ct values for adjacent standards, expected for a perfect doubling reaction 
using the equation 2n = X, where X is the dilution factor used in generating the standard 
curve. The theoretical value for this assay was calculated as 3.32 cycles and the actual value 
as an average of 3.34 cycles with a standard deviation of 0.7, indicating that the assay is 
highly optimised. This is supported by both the amplification efficiency value of 96%, i.e.  
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Figure 5.7 Standard curve generated for the mtDNA synthetic standard using a 1 in 10 
serial dilution of the stock concentration for the range of 5*109–5*101 copies/µl (3XA) or 
5*109–5*103 copies/µl (3XB). The linear relationship is lost below 5*103 copies/µl as 
demonstrated by the plateau in the Ct (Cq) detection threshold for lower values and high 
amplification efficiency value of 134%. Copy number values calculated using the standard 
curve equation shown in 3XA would be inaccurate. The linear relationship is demonstrated 
for the standards 5*109 – 5*103 copies/µl in 3XB.  
96% of the DNA template was amplified at the end of each cycle, and the R2 value of 0.99.  
The sensitivity of the assay was tested using samples with a known DNA concentration by 
preparing a serial dilution (1 in 10) using Quantifiler Trio standard DNA with DNA input 
concentrations of 5000 pg/µl, 500 pg/µl, 50 pg/µl and 5 pg/µl. As shown in Figure 5.8, 
amplified mtDNA was detected for all samples within the linear range of the assay thus 
demonstrating its robustness at low levels of DNA. 
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Figure 5.8 Sensitivity test results for mtDNA qPCR assay showing the amplification 
curves for a 1 in 10 serial dilution at DNA inputs of approximately 5000 pg/µl, 500 pg/µl, 50 
pg/µl and 5 pg/µl (blue). All samples were quantified within the range of the mtDNA 
standards (red).  
 
5.3.5.4 Species specificity test 
In order to check for non-human mtDNA amplification, DNA extracts from eight species; 
fox, pig, hedgehog, deer, dog, cat pseudomonas aeruginosa, mc and fungus, were tested 
using the qPCR assay. 007 Control DNA was used at an input of 50 pg/µl as a point of 
comparison against the species tested. All species had an average Ct value of < 28, and so 
low level amplified product was detected. However the extraction negative control had a Ct 
value of 29, suggesting very low level human contamination may be present in all samples; 
if compared with the human control of just 50 pg/µl, this must be equivalent to only several 
pg/µl DNA. As can be seen in Figure 5.9 the Ct values for all species tested falls below that 
of even the last standard, equating to only a few copies of mtDNA/µl. As all species DNA 
was freshly extracted, if amplification was of a non-specific product/target then a greater Ct 
value would have been observed. The results therefore demonstrate the human-specific 
nature of this assay.  
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Figure 5.9 Human specificity test results. Standards at 10
9
- 10
1
 copies (green). Human 
control 007 DNA used as a positive control at an input of 0.5 pg/µl (black), extraction 
negative control (red) and all species samples (blue) 
 
5.3.5.5 Reaction set-up for mtDNA assay 
Each of the Brazil bone and tooth samples, alongside a fresh set of mtDNA standards, were 
set-up for qPCR using the in-house mtDNA assay in a 10 µl volume and amplified using a 
CFX96 Touch™ Real-Time PCR Detection System as described in Section  2.8.4. 
 
5.3.6 DNA amplification, visualisation and data analysis 
 
5.3.6.1 AmpFℓSTR® NGM™ PCR Amplification Kit 
The AmpFℓSTR® NGM™ PCR Amplification Kit was used to amplify each of the 
Vindolanda DNA extracts, Brazil samples 001B–020B and 002T and all control samples. 
Reactions were set-up using 10 µl of DNA extract in a 25 µl reaction volume as described in 
Table 2-7 and amplified on a Veriti thermal cycler for 30 cycles according to manufacturer’s 
instructions as shown in Table 2-8. Two amplification reactions were set-up for each DNA 
extract to enable consensus DNA profile interpretation. The exception to this was with the 
Vindolanda femur extracts, which were compared with one another to generate a consensus 
profile. Reference samples were set-up using 5 µl of DNA extract in a 12.5 µl reaction as 
described in Table 2-7, and amplified using the 28-cycle program described in Table 2-8. 
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1 µl of PCR product was used, together with Hi-Di™ Formamide and GeneScan™ 500 
LIZ™ dye Size Standard for visualisation using the 3130 Genetic Analyzer as described in 
Section 2.13.2.1. Results were analysed as described in Section 2.13.3.1, using GeneMapper 
ID v3.2, with either standard or ltDNA guidelines followed for reference or bone/tooth 
samples respectively.  
5.3.6.2 AmpFℓSTR® Yfiler® PCR Amplification Kit 
10 µl of each of the Vindolanda extracts was used to set-up amplification AmpFℓSTR® 
Yfiler® PCR Amplification Kit reactions for a 34-cycle PCR. The tooth extract was set-up 
in duplicate so that a consensus profile could be generated, whilst the femur results were 
compared with one another to generate the consensus profile. Reaction volumes of 25 µl 
were used for each reaction as shown in Table 2-7 and amplification was carried out on a 
Veriti thermal cycler as instructed by the manufacturer, outlined in Table 2-8.    
1 µl of PCR product was used, together with Hi-Di™ Formamide and GeneScan™ 500 
LIZ™ dye Size Standard for visualisation using the 3130 Genetic Analyzer as described in 
Section 2.13.2.1. Results were analysed as described in Section 2.13.3.1, using GeneMapper 
ID v3.2, with either standard or ltDNA guidelines followed for reference or bone/tooth 
samples respectively.  
5.3.6.3 ForenSeq™ DNA Signature Kit 
20 µl of DNA extract from each of the Vindolanda femur and tooth samples, along with 
Brazil samples 002T, 005B, 007B, 009B, 011B, 012B, 013B, 017B & 020B and an operator 
reference sample, were sent to the Illumina Inc. laboratory (Little Chesterford, Essex, UK) 
for amplification using the ForenSeq™ DNA Signature Prep Kit and sequencing on the 
MiSeq FGx Forensic Genomics System (see appendix 8.20 for workflow details). The Brazil 
samples were amplified using the database compatible primer set A, whilst primer set B was 
used for the Vindolanda samples, which includes additional phenotypic and ancestry 
markers.  
5.3.6.4 mtDNA amplification for Sanger sequencing for York results 
comparison 
In order to support the authenticity of the DNA obtained from the Vindolanda femur sample, 
5 µl of the two DNA extracts was used for each of the two primer sets listed in Table 2-18 
covering regions of HVSII (primer set H) and HVSIII (primer set J) of the mtGenome, 
which had previously been sequenced by York University. Following the extraction of DNA 
from a section of the femur sample using a silica based method, as described in            
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Rohland et al. (Rohland et al., 2010), researchers at York University then amplified the 
control region of the mtGenome using nine overlapping primer sets (Gonzalez Fortes, 2014) 
Reactions were set-up as described in Table 2-12 in a total volume of 20 µl and amplified on 
a Veriti thermal cycler following the 35-cycle program outlined in Table 2-21 and Table 
2-22. Reference profiles for all mtDNA work were set-up using all of the primer sets listed 
in Table 2-18 in the same way as above, for sequencing on the 3130 Genetic Analyzer.  
To prepare amplicons for sequencing by the 3130 Genetic Analyzer, PCR product was first 
cleaned using the QuickStep™ 2 PCR Purification Kit as described in Section 2.10.1. 2 µl of 
the purified PCR product was then used to set-up the sequencing reaction with the BigDye® 
Terminator v1.1 Cycle Sequencing Kit as explained in Section 2.11.1. Reaction product was 
then cleaned prior to sequencing using PERFORMA® DTR Gel Filtration Cartridges as 
outlined in Section 2.12.1.  
5.3.6.5 Illumina D-loop protocol amplification of HVSI/HVSII regions of the 
mtGenome 
Samples 004B, 008B, 009T, 019B, 013B and 014B were each set-up for amplification of 
four overlapping DNA fragments (two for each HVSI/II region) using the primer set mixes 
listed in Table 2-20, as described by the Illumina D-loop protocol. Reactions were set-up in 
a 20 µl volume using optimised volumes as described in Table 2-14 to Table 2-17 using 5 µl 
of DNA extract per primer mix. PCR was carried out using a Veriti thermal cycler using the 
parameters outlined in Table 2-21 and Table 2-22. Control DNA 007 was used as a PCR-
positive control for each primer set with a total DNA input of 50 pg. PCR product was 
visualised on a 3% (w/v) agarose gel as described in Section 2.13.1.2. 
5.3.6.6 Amplification of HVSII set E of the mtGenome  
Samples 004B, 008B, 009T, 019B, 013B and 014B were each set-up for amplification of 
one fragment of the mtGenome HVSII region using Edson primer set E, the sequence for 
which is listed in Table 2-18. The amplification of this 125 bp target was used to 
demonstrate the presence of mtDNA in samples that had failed PCR using the Illumina 
suggested primer sets. Reactions were set-up using 5 µl of DNA extract per primer set, in a 
total reaction volume of 20 µl as outlined in Table 2-12 and amplified on a Veriti thermal 
cycler using the parameters outlined in Table 2-21 and Table 2-22. AmpFlSTR® Control 
DNA 007 was used as a PCR positive control for each primer set with a total DNA input of 
50 pg. PCR products were visualised on a 3% (w/v) agarose gel as described in Section 
2.13.1.2 
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Data produced by sequencing using the 3130 Genetic Analyzer were analysed as described 
in Section 2.13.3.2. 
5.3.6.7 mtDNA in-house HVSI amplification for MiSeq sequencing  
To allow for the MPS of DNA from extremely degraded samples using a one-step PCR 
process, the protocol developed by Kozich et al. (Kozich et al., 2013) has been adapted for 
use amplifying fragments of mtDNA. Rather than fragmenting the DNA library and adding 
the platform-specific adaptors and sample indices in a second PCR step, all the required 
components are added to the primers, see Figure 5.10, for incorporation into the amplicon 
during target amplification. This has the dual advantage of decreasing the number of sample 
manipulations, and therefore time taken for sample preparation, and should also simplify 
sequence alignment during data analysis.     
 
Figure 5.10 Design of modified Edson (Edson, 2004) primer sets, adapted for direct 
sequencing using the Illumina MiSeq MPS platform. Each modified primer has a flow 
cell adapter attachment enabling the amplified DNA fragment to hybridise to the flow cell, a 
unique barcode for amplicon identification, a pad sequence to allow the melting temperature 
of the amplicon to be manipulated, a linker sequence to attach the additional sections to the 
primer, and the primer to target the specific region of DNA to be amplified.  
 
There are two types of oligo adaptors that are used to hybridise the DNA strands to the flow 
cell surface of the MiSeq platform (see Figure 5.11), the sequences for which were released 
by Illumina in 2014 (Illumina, 2014a). One version of the oligo adaptor is attached to the 
forward primer and the second version is incorporated with the reverse primer. Five 
nucleotide index sequences were designed using the online tool COMAIWIKI Barcode 
Generator (Comai, 2012), one for each of the forward and reverse primer sequences that 
together make up a unique sample identifier. The design of these barcodes took into 
consideration the following factors: that the detection of individual clusters on the flowcell 
occurs within the first four sequencing cycles and therefore there needs to be enough 
diversity between these bases to enable cluster detection (Mitra et al., 2015); that at least one 
of the two nucleotides for detection by each of the red (A/C) and green (G/T) lasers is 
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included for each sequencing cycle in order to ensure correct registration, and that there 
should be an approximately 25% distribution of each nucleotide across the index (Kozich et 
al., 2013). The following design parameters were entered into the barcode generator: a 
length of five nucleotides, a minimum of two nucleotides genetic difference between indices 
and a GC content of 20-80%. The suggested indices sequences with the associated primers 
are listed in appendix 8.21 and for the index combinations utilised for each sample see Table 
5-3.  
Two, 10-nt pad sequences were designed to manipulate the melting temperature (Tm) of the 
sequencing primers (see below), so that they fall within the required annealing temperature 
of 65-70 °C for the Illumina platform. Two linker nucleotides, which are not complementary 
to the two bases immediately prior to the primer, are used to link the primer with flanking 
sequences (Kozich et al., 2013). The target-specific primers are taken from the paper of 
Edson et al. (Edson, 2004), which are designed to target and amplify degraded HVSI 
mtDNA in four overlapping fragments, with a maximum amplicon size of 132-169 bp.  
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Figure 5.11 Diagram depicting the use of the modified primers for PCR, and the key 
stages during the sequencing of the resulting amplicons on the Illumina MiSeq 
platform. 
A 
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Table 5-3 List of all primer/index combinations to identify each amplicon and its 
source. Prior to use with samples, all primer/index combinations were tested using 20 µl 
reactions with 0.5 ng of 007 control DNA as described in Section 2.9.3. PCR product was 
visualised using gel electrophoresis as described in Section 2.13.1.2. 
 
mtGenome HVS I region 
Sample AMPLICON A AMPLICON B AMPLICON C AMPLICON D 
005B AF1/AR1 BF1/BR1 CF1/CR1 DF1/DR1 
007B AF2/AR1 BF2/BR1 CF2/CR1 DF2/DR1 
013B AF3/AR1 BF3/BR1 CF3/CR1 DF3/DR1 
017B AF1/AR2 BF1/BR2 CF1/CR2 DF1/DR2 
020B AF2/AR2 BF2/BR2 CF2/CR2 DF2/DR2 
EXT Neg A AF3/AR2 BF3/BR2 CF3/CR2 DF3/DR2 
 
Table 5-4 Table listing the sequences and Tm of each sequencing read 1 (SR1) and read 
2 (SR2) primers for each target fragment (denoted by letters A-D). Read 1 primers consist 
of the pad-link-forward primer sequence used in the amplification of each of the target 
sequences whilst Read 2 is the same but utilises the reverse primer rather than the forward 
primer.  
 
Table 5-5 Table listing the sequencing index primer (SIP) for each target fragment 
(denoted by letters A-D). This primer is the reverse complement of the Read 2 sequencing 
primer and is used to read the index which was originally incorporated with the forward 
primer during amplification.  
 
Samples 005B, 007B, 013B, 017B, 020B & Batch 1 Negative A were each set-up for 
amplification of four overlapping fragments of mtGenome HVSI region using the 
primers, which had been adapted for use on the MiSeq Benchtop sequencer, as listed in  
Table 2-19. Reactions were set-up using 5 µl of DNA extract per primer set, in a total 
reaction volume of 20 µl as outlined in Table 2-12 and Table 2-13, and amplified on a Veriti 
 
ID PAD LINK PRIMER  Tm oC 
R
E
A
D
 1
 SR1A ATTCATGCAT TG CCCAAAGCTAAGATTCTAAT 68.09 
SR1B ATTCATGCAT AT CACCATGAATATTGTACGGT 66.96 
SR1C ATTCATACAT AG CCCCATGCTTACAAGCAAGT 68.83 
SR1D ATTCATGCAT AT CACTAGGATACCAACAAACC 66.14 
R
E
A
D
 2
 SR2A ACCTGAGTCG TG TACTACAGGTGGTCAAGTAT 66.48 
SR2B ACTTGAATAT CC GGAGTTGCAGTTGATGT 67.16 
SR2C ACCTGAGTCG CC  TGGCTTTATGTACTATGTAC 67.36 
SR2D ACTTGAATAT AT GAGGATGGTGGTCAAGGGAC 68.65 
  ID PRIMER  LINK PAD Tm oC 
IN
D
E
X
  SIPA ATACTTGACCACCTGTAGTA CA CGACTCAGGT 66.48 
SIPB ACATCAACTGCAACTCC GG ATATTCAAGT 67.16 
SIPC GTACATAGTACATAAAGCCA  GG CGACTCAGGT 67.36 
SIPD GTCCCTTGACCACCATCCTC AT ATATTCAAGT 68.65 
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thermal cycler using the parameters outlined in Table 2-21 and Table 2-22. AmpFlSTR® 
Control DNA 007 was used as a PCR positive control for each primer set with a total DNA 
input of 50 pg.  
On completion of the first amplification step, samples were transferred to the NUomics 
sequencing facility at Northumbria University. Briefly, PCR product was cleaned-up using a 
Sequal Prep normalisation plate and then DNA fragment size was checked using the Agilent 
High Sensitivity DNA Kit and 2100 Bioanlayzer (Agilent, Santa Clara, CA, USA). Samples 
were then pooled into four groups, following which the DNA of each pool was quantified 
using Kapa qPCR library quantification kit. Samples were then normalised to the lowest 
concentration of the four pools and then combined to make a single pool prior to diluting to 
3.5 pM and denaturing the samples. The pool was then spiked with 5% PhiX to provide 
greater variation in the sample pool, thus ensuring that the lasers can distinguish between the 
clusters during the sequencing reads. A MiSeq Reagent Kit V2, 2 x 250 cycle cartridge was 
utilised for sequencing which was spiked with the required read 1 read 2 and index matching 
for the mitochondrial primers used, the run then took approximately forty hours to complete 
(G. Holt, NUomics, 2015 pers. comm. 05.08.2015). 
5.3.7 Data analysis 
5.3.7.1 Statistics tests  
The Kruskal-Wallis test was selected to determine if a statistical difference existed in the 
DNA yield between extraction methods as it is a non-parametric test, thus allowing for 
several independent and randomly selected samples to be compared. This test was conducted 
using R version 3.1.2 (2014-10-31) -- "Pumpkin Helmet".  
5.3.7.2 Analysis of data generated by the MiSeq MPS platform 
Following sequencing using the MiSeq platform, samples could not be demultiplexed and 
consequently just the two read data files were available for analysis. Fortunately due to the 
short fragment length of the mtDNA regions amplified, the 250 sequencing read cycles also 
included the sequence data of the modified primers, including the unique barcode identifiers. 
Using a number of different bioinformatics tools it was possible to trim each of the 
sequences to remove additional bases such as the flowcell attachment site and then 
manipulate the files so that the forward and reverse sequences were in the same file. It was 
then possible to demulitplex the samples using the unique barcodes included in the sequence. 
Once demulitplexed the forward and reverse reads were then separated and all of the barcode, 
pad and linker sequences were removed to leave just the mtDNA target sequences. Finally 
the trimmed sequences were aligned against the Hg38 reference genome. A number of 
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bioinformatics tools were utilised for this analysis the details of which, along with a step-by-
step guide to the manipulations carried out, can be found in appendix 8.23. 
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5.4 Results 
5.4.1 Extraction technique comparison 
Five bone samples were selected at random from the Brazilian sample set and each was 
extracted with three different methods, using an equivalent mass of pulverised sample. 
Extraction method one is a phenol-chloroform based protocol outlined by Kemp et al. 
(Kemp et al., 2007), method 2 utilises a silica column for DNA purification as described by 
Yang et al. (Yang et al., 1998), and method 3 relies on the use of a silica suspension as 
described by Rohland and Hofreiter (Rohland and Hofreiter, 2007). The nDNA and mtDNA 
in each extract was quantified using the Quantifiler Trio Kit or mtDNA qPCR assay 
respectively. The quantity of nDNA in sample 13B2 was an order of magnitude greater than 
the nDNA results for any other sample; a mixed nDNA profile was observed in subsequent 
DNA profiling of this sample, thus demonstrating that a contamination event had occurred 
and so this value was excluded from analysis. In order to determine if any one of the three 
extraction methods statistically resulted in a consistently higher quantity of DNA, the results 
shown in Table 5-6 were subjected to a Kruskal-Wallis test using R. This test is a non-
parametic test, which allows for the comparison of more than two groups for an independent 
variable (Kruskal and Wallis, 1987). In order to use this test, four assumptions must be met: 
the dependant variable must be measured at the ordinal or continuous level (mass of DNA in 
ng/µl was measured in the extracted samples in this data-set); the independent variable must 
be two or more groups (three extraction methods were tested in this stu); there should be no 
relationship between the results of each group (each extraction method was tested 
independently) and each group should be expected to have a normal distribution. 
The null hypothesis for this test is that there is no difference in the yield of either nDNA or 
mtDNA between extraction methods, which was accepted in both cases P = 0.74 and P = 
0.29 (see appendix 8.22 for details). 
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Table 5-6 Summary of Quantifiler Trio and mtDNA qPCR assay results for the comparison of three different extraction methods; method 1- phenol-
chloroform-based, method 2 – silica-column-based and method 3 – silica-suspension-based. Each sample was quantified in triplicate and the average and 
standard deviation of the results is given. A negative result is denoted by (-) 
 
Method 1 Method 2 Method 3 
Sample 
Quant mean 
(ng/µl) 
Quant SD 
mtDNA        
copy number 
Quant 
mean 
(ng/µl) 
Quant SD 
mtDNA        
copy number 
Quant mean 
(ng/µl) 
Quant SD 
mtDNA        
copy number 
005B1 0.0232 0.0015 8.00E+00 0.0400 0.0126 1.15E+06 0.0493 0.0003 3.12E+05 
007B1 0.0010 0.0006 3.84E+04 0.0005 0.0003 9.55E+04 0.0011 0.0004 4.02E+04 
011B1 0.0012 0.0006 - 0.0079 0.0034 - 0.0066 0.0009 1.00E+02 
013B1 0.0497 0.0093 3.20E+05 0.4657 0.0319 4.00E+05 0.0690 0.0139 1.48E+05 
020B1 0.0014 0.0007 9.71E+03 0.0436 0.0030 1.50E+05 0.0081 0.0011 4.19E+04 
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5.4.2 Brazilian samples 
5.4.2.1 Quantifiler Trio and mtDNA assay results  
All submitted samples were quantified in triplicate using both the Quantifiler Trio kit and 
the in-house mtDNA qPCR assay; for a summary of results see Table 5-7. Amplification of 
DNA was detected for all samples with an average of 0.1 ng/µl with a range of 0.0008-0.54 
ng/µl. Of the eighteen samples that could be categorised by DI value as described in Section 
5.3.4, three samples showed no degradation, four samples mild degradation, nine samples 
were grouped as degraded and two samples as severely degraded. Six samples did not have 
DI values assigned, one of which, 006B, showed a sign of PCR inhibition as a high IPC Ct 
value was observed. Sex was assigned to eighteen of the twenty-four samples; fourteen 
males, one female, four potential mixes and five unassigned. Mitochondrial amplification 
was observed in eleven of the twenty-four samples with an average of 1.31 x 105 and 
minimum and maximum values of 1.89 x 103 and 4.40 x 105 copies of mtDNA respectively. 
Two-extraction negative controls were processed alongside each batch of bone samples, a 
negative deer bone control (Neg A) and a reagent blank control (Neg B), in addition to 
which a no template control (NTC) was included during quantification. Nuclear DNA was 
amplified in six of the twelve samples (see Table 5-8), the quantification value was < 1 pg/µl 
in all cases with the exception of Method 2 Neg A, for which a value of < 2 pg/µl was 
observed. mtDNA was amplified in ten samples, the remaining two being NTC samples., 
with an average of 8.28 x 103 and minimum and maximum values of 1.31 x 103 and 1.21 x 
104 copies of mtDNA respectively.  
 
185 
 
Table 5-7 Summary of Quantifiler Trio results for Brazilian skeletal samples. In cases where multiple extractions were tested, the highest short fragment 
quantity was selected. The short autosomal target is 80 bp in length, the long autosomal is 214 bp and the Y target is 75 bp. A negative result is denoted by (-) 
Sample 
Extraction 
method 
Short autosomal 
 
Long autosomal Y target 
  
Internal 
positive control 
mtDNA 
 
 
Quant 
mean 
(ng/µl) 
Quant 
SD 
Quant 
mean 
(ng/µl) 
Quant 
SD 
Quant 
mean 
(ng/µl) 
Quant 
SD 
DI Sex 
Ct 
value 
Ct 
mean 
Copy number 
001B 3 0.0433 0.0048 0.0050 0.0010 0.0346 0.0039 8.6 M 27.25 0.81 - 
002B 3 0.0443 0.0033 0.0071 0.0013 0.0348 0.0051 6.2 M 28.01 0.58 - 
002T 1 0.0236 0.0091 - - 0.0299 0.0051  M 26.00 1.90 - 
003B 3 0.1054 0.0234 0.0236 0.0044 0.0716 0.0101 4.5 M 28.34 0.16 - 
004B 3 0.3959 0.0662 0.0749 0.0121 0.2416# 0.0143 5.3 M/F 28.59 0.19 3.04E+04 
005B 3 0.0493 0.0003 0.0195 0.0024 0.0331 0.0023 2.5 M/F 27.69 0.30 3.12E+05 
006B 3 0.0015 0.0003 - - 0.0042 0.0040  - 38.11^ - - 
007B 3 0.0011 0.0004 0.0009 0.0007 - - 1.2 - 27.84 0.10 4.02E+04 
007T 1 0.0008# 0.0007 -* - - -  - 27.00 0.39 1.40E+04 
008B 3 0.5359 0.0099 0.546 0.0094 0.4952 0.0127 1.0 M 27.46 0.58 - 
009B 1 0.0030 0.0018 0.0005 0.0004 0.0036 0.0025 5.7 M 26.18 1.01 1.74E+04 
009T 1 0.0017# 0.0006 - - 0.0016 0.0005  - 26.13 1.34 1.89E+03 
010B 3 0.1175 0.0062 0.0315 0.0003 0.1004 0.0078 3.7 M 28.18 0.06 - 
011B 2 0.0079 0.0034 0.0012 0.0010 0.0055 0.0030 6.8 M 27.52 0.51 - 
011T 2 0.0037 0.0011 - - 0.0011 0.0006  M/F 27.33 0.20 - 
012B 1 0.0015# 0.0006 - - - -  - 26.60 0.97 1.20E+04 
013B 2 0.4657 0.0319 0.1041 0.0070 0.4745 0.0374 4.5 M 26.62 0.62 4.00E+05 
014B 3 0.4257 0.0557 0.0475 0.0087 0.2045 0.0747 9.0 M/F 28.19 0.53 - 
015B 3 0.0368 0.0048 0.0159 0.0023 - - 2.3 F 28.13 0.09 - 
016B 3 0.0118 0.0026 0.0037 0.0015 0.0084 0.0021 3.2 M 27.69 0.61 1.80E+04 
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017B 1 0.0351 0.0033 0.0030 0.0025 0.0269 0.0021 11.8 M 26.67 0.75 4.40E+05 
018B 3 0.0831 0.0096 0.0086 0.0040 0.0667 0.0026 9.7 M 27.74 0.49 - 
019B 3 0.0261 0.0043 0.0015# 0.0006 0.0231 0.0042 17.3 M 27.97 0.05 - 
020B 2 0.0436 0.0030 0.0342 0.0025 0.0541 0.0081 1.3 M 27.28 0.04 1.50E+05 
*only one result recorded #two results out of three  ^inhibited sample  
 
Table 5-8 Quantifiler Trio results for all negative control samples Brazil samples. A negative result is denoted by (-)  
Sample Short autosomal Long autosomal Y target mtDNA 
 Quant mean 
(ng/µl) 
Quant SD Quant mean 
(ng/µl) 
Quant SD Quant mean 
(ng/µl) 
Quant SD Copy number 
Method 1 Neg A 0.0008 0.00001 - - - - 6.77E+03 
Method 1 Neg B - - - - - - 8.38E+03 
Method 2 Neg A 0.0017 0.00064 - - - - 1.21E+04 
Method 2 Neg B - - - - - - 9.11E+03 
Method 1/2 NTC 0.0002 0.00003 - - - - - 
Method 3a Neg A 0.0005 0.00032 - - - - 1.29E+04 
Method 3a Neg B - - - - 0.0003 0.0001 8.35E+03 
Method 3a NTC - - - - - - 1.31E+03 
Method 3b Neg A 0.0006 0.00014 - - - - 8.47E+03 
Method 3b Neg B1 - - - - 0.0008 0.0002 8.79E+03 
Method 3b NegB2 0.0005 0.00008 0.0003 0.000001 - - 6.64E+03 
Method 3b NTC - - - - - - - 
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5.4.2.2 Illumina protocol 
The Illumina protocol was optimised for each primer mix using 250 pg 007 control DNA 
including the primer annealing temperature (56 – 62 ˚C), MgCl2 concentration (4 – 8 mM), 
primer concentration (0.03 – 0.06 µM) and the use of a PCR additive (0.5X Qiagen Q 
Solution), and the sensitivity of each primer set was then demonstrated down to 
approximately 16 pg of DNA as shown in Figure 5.12. The band intensity for Primer mix 
MIII was relatively less than the other three sets; however, amplified product is present 
down to the lowest DNA input. Although assay optimisation has reduced the presence of 
secondary PCR product, faint bands can still be observed for primer mixes MI, MII and MIV 
as shown Figure 5.12. Having discussed this with the NUomics team, it was decided due to 
the relatively larger fragment size of this product, it could be bioinformatically removed 
post-sequencing and thus should not impact downstream analyses.  
Following this six of the Brazil sample DNA extracts were selected, representing the range 
of DNA quantification values obtained using the Quantifiler Trio Kit, for amplification using 
the optimised protocol. As the electrophoresis gel image shown in Figure 5.13, no amplified 
product was observed for any of these samples.  
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Figure 5.12 Sensitivity tests for Illumina suggested primer sets using a 1 in 2 serial 
dilution of 007 control DNA with the following approximate DNA inputs; 500 pg (1), 250 
pg (2), 125 pg (3), 63 pg (4), 32 pg (5), 16 pg (6) and a negative control (7). DNA 
HyperladderTM 25bp was used to to measure approximate DNA fragment size. The two 
values provided for expected band size represent the duplex tagged primers within each 
amplicon mix. Amplified DNA was visible down to a DNA input of approximately 16 pg of 
input DNA for all primer mixes, whilst no band was visible in any of the negative controls. 
A secondary PCR product can be observed (examples circled in red) for primer mixes MI, 
MII and MIIV, particularly at the higher DNA inputs. 
 
Figure 5.13 Example of results for the amplification of samples 004B, 008B, 009T, 
019B, 013B, 014B and the PCR positive controls amplified using Illumina’s suggested 
primer sets. There was no amplified DNA visible for any of the samples tested.  
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5.4.2.3 Edson primer set 
In order to test the theory that the DNA extracted from the Brazil bone samples was too 
degraded for amplification using the Illumina primer mixes, the same sample set of 009T, 
019B, 004B, 014B, 013B and 008B were amplified using Edson primer set E (Edson, 2004) 
which has a smaller target fragment size of 125 bp. As shown in Figure 5.14, amplified 
DNA of the expected size is present for samples 009T, 004B and 013B. Faint bands were 
also visible for sample 014B and the ‘A’ negative control for extraction 1, the latter 
indicating the presence of contaminating DNA. These results reflect the qPCR results and 
demonstrate that the use of a shorter target fragment size is apposite for degraded samples.   
 
Figure 5.14 Results for the amplification of samples 004B, 008B, 009T, 019B, 013B and 
014B, using primer set E from (Edson, 2004). PCR product of the expected 125 bp 
fragment size is observed for samples 009T, 004B and 013B. Faint bands are also visible for 
sample 014B and the method 1 extraction negative A control sample.  
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5.4.2.4 MiSeq results 
The HVSI region of samples 005B, 007B, 013B, 017B, 020B and Method 1 Neg A were 
sequenced using the MiSeq platform. Samples could not be demultiplexed and consequently 
just the two read data files were available for analysis. These were analysed as described in 
section 5.3.7.2 and appendix 8.23.  
Once demultiplexed, the number of indexed and unmatched reads for each amplicon was 
plotted using Microsoft Excel 2010 as shown in Figure 5.15. A total of 287,446 single reads 
were obtained in this MiSeq run, of which 234,283 were indexed and 53,163 were 
unmatched. The unmatched reads represented 10-25% of the total read count for each 
amplicon, whilst the average number of single indexed reads per amplicon is 58,571 ± 
29,556.  
Following the trimming of data to remove the barcodes, pad sequences etc. as previously 
described in section 5.3.7.2, > 98% of the raw sequence reads were utilised for alignment of 
amplicons A, C and D with the human mtGenome reference and 0.6% of the raw sequence 
reads generated for amplicon B as shown in Figure 5.16.  
BWA-MEM files were opened using the Integrative Genomics Viewer program (v2.3.57) 
(Robinson et al., 2011, Thorvaldsdottir et al., 2013) and aligned against the human (hg38) 
mtGenome as the reference sequence. An example of the Viewer is shown in Figure 5.17. 
This was a proof of concept study to demonstrate the use of the adapted primer set method 
for the amplification of degraded DNA using MPS. As such, individual sequences and 
heteroplasmy were not considered at this point, but all DNA fragments were successfully 
aligned to the human mtDNA rCRS.  
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Figure 5.15 Stacked column chart showing the indexed and unmatched read counts 
obtained for each amplicon post demulitplexing 
 
 
Figure 5.16 Stacked column chart showing the number of reads that were utilised for 
alignment as a percentage of the total reads generated for each amplicon 
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Figure 5.17 Example of Integrative Genomics Viewer showing all for amplicons for sample 020B aligned to the human mtGenome. Differences from 
the reference sequence are shown in a base-dependent colour while conserved bases are shown in grey. 
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5.4.3 Vindolanda samples 
5.4.3.1 Quantifiler Trio results 
The DNA extracts from the Vindolanda samples, including both femur DNA extracts, were 
quantified in triplicate using the Quantifiler Trio kit, the results for which are summarised in 
Table 5-9. Nuclear DNA was amplified in all three DNA extracts with 35 pg/µl and 71 pg/µl 
recorded for the femur sample from extracts 1 and 2 respectively, and a DNA concentration 
of 56 pg/µl for the tooth extract. Male DNA was amplified in both of the femur DNA 
extracts and the DI values, calculated as described in Section 5.3.4, were consistent with one 
another with values of 9.1 and 9.3, indicating the DNA is in a degraded state. The sex of the 
tooth sample was also recorded as male, however the DI value of 2.5 indicates that the 
extracted DNA is in a mildly degraded state, and thus of better quality than the femur sample.  
Two extraction negative controls were processed alongside each sample, a negative deer 
bone control (Neg A) and a reagent blank control (Neg B). Nuclear DNA was detected in the 
Femur 1 DNA extract to a concentration of <0.5 pg/µl, whilst no DNA was detected in the 
Femur 2 negative controls.  DNA was amplified in both of the tooth negative controls at 
concentrations of 6 pg/µl and 1 pg/µl for Neg A and Neg B respectively.  
The IPC values for all samples were within the expected range and so no indication of PCR 
inhibition was observed.  
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Table 5-9 Summary of Vindolanda Quantifiler Trio results 
 
Short autosomal target Long autosomal target Y target   IPC 
Sample 
Quant mean 
(ng/µl) 
Quant SD 
Quant mean 
(ng/µl) 
Quant SD 
Quant mean 
(ng/µl) 
Quant SD DI Sex Ct value Ct SD 
Femur 1 0.0349 0.0020 0.0038 0.0019 0.0420 0.0020 9.1 Male 27.62 0.61 
F1NA 0.0003 0.0001 0.0001 0.00002 - -   27.41 0.81 
F1NB - - - - - -   27.66 0.07 
Femur 2 0.0711 0.0115 0.0076 0.0029 0.0753 0.0096 9.3 Male 27.62 0.21 
F2NA - - - - - -   27.15 0.88 
F2NB - - - - - -   27.88 0.16 
Tooth 0.0562 0.0030 0.0226 0.0035 0.0617 0.0048 2.5 Male 28.29 0.02 
TNA 0.0062 0.0022 0.0036 0.0002 0.0066 0.0031   28.03 0.30 
TNB 0.0013 0.0006 0.0010 0.0002 0.0015 0.0001   28.02 0.13 
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5.4.3.2 AmpFℓSTR® NGM™ PCR amplification kit 
NGM™ DNA profiles shown in Table 5-10 for both the tooth and femur samples were 
generated through consensus using a minimum peak amplitude of 25 RFU; for example 
EPGs of both samples see Figure 5.18 and Figure 5.19. Twenty-seven alleles were amplified 
from the tooth DNA extract and fifteen alleles from the femur extract. In addition to this, 
XY was present at Amelogenin in both samples, confirming the biological sex as male. In 
both samples a decrease in peak height was observed as the amplicon size of the amplified 
allele increased (Figure 5.20). The decline in peak height is more severe in the femur sample 
which, along with a maximum amplified amplicon size of approximately 250 bp, is 
reflective of the degraded quality of DNA observed with the Quantifiler Trio kit. An outlier 
was removed from tooth results at locus D8 (peak height 544 RFU); this allele had an 
increased peak height relative to the other alleles in both amplifications of the DNA extract 
and indicates that this locus may be homozygous.  
Table 5-10 Vindolanda samples NGM™ consensus DNA profiles. ‘F’ denotes alleles for 
which consensus was not attained or no amplification was observed 
Locus Tooth Femur 
AMEL X Y X Y 
D10S1248 13 15 13 14 
vWA 17 18 17 F 
D16S539 9 12 11 F 
D2S1338 20 25 F F 
D8S1179 14 F 11 16 
D21S11 28 F 29 30 
D18S51 16 20 F F 
D22S1045 11 16 15 17 
D19S433 13 14 F F 
THO1 9.3 F 8 F 
FGA 20 24 F F 
D2S441 10 14 10 11.3 
D3S1358 15 16 15 18 
D1S1656 14.3 17.3 F F 
D12S391 17 19 F F 
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Figure 5.18 EPG for Vindolanda tooth DNA (amplified product a) profile generated 
using NGM™ amplification kit 
 
 
Figure 5.19 EPG for Vindolanda femur (extract 2) DNA profile generated using 
NGM™ amplification kit 
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Figure 5.20 Relationship between size of amplified STR alleles and peak height (RFU) 
for both tooth and femur samples. It can be seen that preferential amplification of the 
lower molecular weight alleles has occurred with higher rfu values for loci with a molecular 
weight of <125 bp. A decrease in the peak height is observed as the molecular weight of the 
amplicons increases. 
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5.4.3.3 ForenSeq™ DNA Signature Kit 
The ForenSeq™ DNA Signature Kit (ForenSeq™)  results provided by Illumina Inc. for the 
amplification of each marker type observed in the DNA profile from the Vindolanda tooth 
DNA extract are summarised in Table 5-11. A total of 58% of all possible loci were 
observed to have amplified, of which 72% were <150 bp in fragment size. Of all the markers 
amplified the highest proportion present (44%) were identity SNPs as shown in Figure 5.21. 
No DNA amplification was observed in either of the two femur DNA extracts.  
Table 5-11 Summary of ForenSeq
TM 
result for Vindolanda tooth 
Marker Type Number of loci observed  Percentage of total possible 
loci amplified (%) 
Autosomal STRs 15 56 
X-STRs 3 43 
Y-STRs 5 21 
Identity SNPs 59 62 
Ancestry SNPs 35 56 
Phenotypic SNPs 18 82 
 
 
Figure 5.21 Marker types amplified in tooth sample in ascending order of amplicon 
size. It can be seen that the read count is relatively consistent across all amplicon sizes. 
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5.4.3.4 Biogeographic results for Vindolanda samples 
To obtain an indication of biogeographic ancestry, both the tooth and femur DNA extracts 
were amplified using the AmpFℓSTR® Yfiler® PCR Amplification Kit. A consensus 
haplotype for each sample was generated using alleles with a minimum peak height of 25 
rfu, which were observed in each of the amplified profiles but not in the consensus negative 
controls as described in the guidelines set by Gill et al. (Gill et al., 2000b). The resulting 
consensus haplotype for the femur, shown in  
 
Table 5-12, and the combined YFiler® and ForenSeq™ kits Y-STR haplotypes, Table 5-13, 
were entered into the Haplogroup Predictor (Athey, 2015) 
(http://www.hprg.com/hapest5/index.html, accessed on 18/07/2015). This is an online tool 
that can be used to indicate the haplogroup of the individual based on their Y-STR DNA 
profile. This tool calculates a ‘goodness of fit’ score (Athey, 2005) and a probability using a 
Bayesian approach (Athey, 2006) across twenty-one haplogroups, which >98% of the 
Western European population fall into (Athey, 2005). Allele frequencies for STRs associated 
with these haplogroups have been calculated using public databases, and are used as a point 
of comparison to see which group the unknown sample best fits into.   
As only three alleles are available for analysis from the femur sample the probability of the 
individual belonging to a particular haplogroup is spread across a number of different 
haplogroups with the highest probability of 38% assigned to group I2a1. The tooth however 
has been assigned to haplogroup R1b with a probability of 97% based on the seven alleles 
combined using both YFiler® and ForenSeq™ results (see Table 5.13). 
 ForenSeq™ Primer Set B contains fifty-six ancestry informative SNP markers, 63% of 
which were successfully amplified from the tooth DNA extract. Principal component 
analysis was utilised by Illumina Inc. to evaluate the results as shown in Figure 5.22. This 
involves reducing the overall complexity of the dataset whilst retaining the most variation 
between samples that is possible. This way several inter-correlated variables can be assessed 
using patterns of similarity to extract pertinent information from the data (Wold et al., 1987).  
In order to generate accurate PCA plots, the relevance, in terms of the populations sample, 
and quality of the data is of vital importance. Illumina generate their PCA plots using data 
from the 1000 genomes project, which ran between 2008-2015 to create a catalogue of 
human genetic variation and genotype data (The Genomes Project, 2015, Sudmant et al., 
2015). Data has been collected from 26 populations from within Africa, Europe, East Asia, 
South Asia and the Americas, sampling approximately 500 individuals per continental 
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group. Each continental group contained approximately five subpopulations, the number of 
samples from those in within Europe are 180 British individuals in England and Scotland 
(GBR), 192 Finnish in Finland (FIN), 121 individuals from Iberian populations in Spain 
(IBS), 205 Toscani in Italia (TSI) and 184 UTAH residents (CEPH) with Northern and 
Western European ancestry (The Genomes Project, 2015). Whilst there are gaps in the data 
for populations such as Native Australian, North Africa and Southeast Asian (Phillips, 
2015), it is the GBR and TSI populations that are of direct relevance to this study.  
The biogeographic origin of the individual from which the tooth sample was taken was 
estimated to be European, with the distance to the nearest centroid (the weighted mean of the 
data set) given as 2.40. The closest reference samples were from the TSI (Toscani in Italia) 
grouping, indicating that the individual is more closely related to samples in this region than 
other reference samples within the centroid.  
 
Table 5-12 Consensus profiles generated for both the tooth and femur DNA extracts 
using the AmpFℓSTR® Yfiler® PCR Amplification Kit. Loci included in the minimal 
haplotype for ancestry analysis are denoted by an asterisk. 
 
 
Table 5-13 Y-STR haplotypes generated from the tooth DNA extract using either the 
AmpFℓSTR® Yfiler® PCR Amplification Kit or the ForenSeq™ DNA Signature Kit. 
Loci included in the minimal haplotype for ancestry analysis are denoted by an asterisk. 
 
 
 
 
 
Consensus 
haplotype 
DYS389I* DYS393* DYS391* DYS635 DYS437 
Tooth 13 - 11 23 15 
Femur - 13 10 - 15 
Amplification 
Kit used 
DYS389
I* 
DYS391
* 
DYS63
5 
DYS43
7 
DYS43
8 
DYS57
0 
DYS57
6 
Yfiler 13 11 23 15    
ForenSeq 13 11   12 17 19 
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Table 5-14 Results of the Haplogroup Predictor online tool (Athey, 2015) for both the 
femur sample (left) and tooth (right) Y-STR haplotypes. The femur is predicted to belong 
to haplogroup I2a1 (38%) followed by I2a (11.9%) and R1b (10.5%), whilst the results for 
the tooth are more conclusive with a probability of 99.7% that the indivdiual is in 
haplogroup R1b.  
 Femur sample Tooth sample 
Haplogroup Fitness score Probability 
(%) 
Fitness score Probability 
(%) 
E1b1a 50 1.9 20 0.0 
E1b1b 27 0.6 7 0.0 
G2a 29 0.7 5 0.0 
G2c 21 0.5 0 0.0 
H 6 0.0 1 0.0 
I1 38 2.0 3 0.0 
I2a (xI2a1) 87 11.9 23 0.0 
I2a1 100 38.0 3 0.0 
I2b (xI2b1) 68 10.1 1 0.0 
I2b1 37 0.8 11 0.0 
J1 11 0.1 2 0.0 
J2a1b 41 2.1 8 0.0 
J2a1h 11 0.0 1 0.0 
J2a1 x J2a1-bh 40 1.9 3 0.0 
J2b 21 0.3 1 0.0 
L 39 1.0 19 0.0 
N 9 0.0 10 0.0 
Q 69 8.4 28 0.2 
R1a 26 0.4 18 0.0 
R1b 73 10.5 57 97.0 
T 67 8.6 4 0.0 
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Figure 5.22 PCA plot of biogeographical results for tooth sample as provided by Illumina using the ForenSeq™ Signature Prep Kit
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5.4.3.5 Authentication of results 
Two fragments of the mtGenome were targeted; nucleotide positions 220-389 and 403-569 
which cover substitutions 185A and 228A, and 462T, 482C and 489C respectively. Both the 
forward and reverse strands for each of the amplified fragments in both femur extract 1 and 
femur extract 2 were sequenced, resulting in a minimum of X2 and a maximum of X4 
coverage for each substitution, and the consensus haplotype was recorded as shown in Table 
5-15. The two sets of results agree as all five substitutions recorded by York University were 
found to be present in both of the femur DNA extracts, as well as an additional substitution 
of 263G as shown in Figure 5.23. 
Table 5-15 Substitutions in the control region of the mtGenome as recorded by both 
the previous work by York University and as part of this study. Positions 73G, 295T 
and 16076T were not tested (n/t) as part of this study. 
 mtGenome Positions 
York University 73G 185A 228A - 295T 462T 482C 489C 16076T 
Current study n/t 185A 228A 263G n/t 462T 482C 489C n/t 
 
 
Figure 5.23 Image of the electropherogram for the mtDNA sequence amplified from 
Femur extract 1 (forward strand) as an example to show the presence of substitution 263G, 
indicated by arrrow, as compared with the rCRS.  
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5.5 Discussion 
5.5.1 Brazilian sample set 
Due to the expected degraded state of the DNA in the Brazilian sample set it was determined 
that the use of a more specialised extraction protocol would help maximise the DNA yield 
from the samples and so methods utilised for ancient DNA work, which is also subject to 
degradation, were reviewed. Three well documented methods were selected for comparison; 
a phenol-chloroform-based extraction, a silica-column-based extraction and a silica-
suspension-based extraction. A selection of five bone samples were randomly chosen from 
the Brazilian set of remains and extracted using each of the three methods to determine if 
any one protocol consistently yielded a higher quantity of mtDNA or nDNA. Using the 
Kruskal-Wallis test; the null hypothesis that there was no difference between DNA 
extraction methods was accepted for both mtDNA (p=0.3) and nDNA (p=0.7). It is difficult 
to assess the different methods in terms of DNA recovery given the low average DNA 
quantification value of 20 pg/µl (sd 0.02) for all samples across the three methods. It was 
decided that method 3 would be used for further extractions due to a very marginal increase 
in quantification values in three of the five tested samples, along with ease of handling 
during the extraction protocol.  
Over half of the samples for which the DI value could be calculated were categorised as 
degraded or severely degraded which, given that the post mortem interval (PMI) on these 
samples is only eight to fourteen years, demonstrates the detrimental effects of a hostile 
environment. The environmental conditions in Brazil are such that the rate of putrefaction 
and skeletisation will be rapid, creating a limited timeframe for the binding and 
mineralisation of both DNA and mtDNA within the bone infrastructure (Campos et al., 
2012, Jans et al., 2004). As an exponential increase in microbial activity with increasing 
temperature has been demonstrated, it is also likely that microbial activity and bioerosion 
will have played a significant role in the degradation of DNA within this sample set 
(Campos et al., 2012, Child, 1995, Jans et al., 2004).    
All four of the tooth samples tested in this sample set had no detected amplification of the 
LA marker using the Quantifiler Trio kit and therefore do not have DI values assigned. As 
previously discussed, it has been demonstrated that DNA in teeth samples is usually 
preserved better than in femur bone and so it is possible that the LA target was not amplified 
in these samples, along with 012B, due to the low DNA concentration rather than an 
accurate representation of the quality of the contained DNA. Having said this, however, all 
four of the tooth samples were prepared by removing the inner material without destroying 
the tooth casing and whilst this approach has been successfully demonstrated, the 
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combination of a low mass of tooth powder, together with the expected DNA degradation 
suggests that this approach may not be effective under these circumstances.  
The use of quantification values as low as those observed in many of the Brazilian sample to 
assign sex presents a difficulty for interpretation, for example, if 10 pg of total DNA and 6 
pg of male DNA was recorded, this could be interpreted as a mixture or attributed to 
stochastic variation, but it is difficult to determine at what values the results can be accepted 
as reliable. It was decided to err on the side of caution for this study and so the sex was not 
assigned to any sample containing <2 pg/µl total DNA concentration, which accounted for 
five samples. Sex was only assigned as single source if an overlap was observed between the 
SA quantification value mean ± SD and the Y quantification value mean ± SD. Of the 
remaining nineteen samples, fourteen were determined to be male, one was assigned as 
female (zero quantification value for the Y marker) and four were tentatively assigned as 
M/F mixtures. The information submitted with the Brazilian sample set included the sex for 
each individual, sixteen males and four females, based on anthropological examination for 
comparison with the DNA results. Sample 015 was confirmed as female, with a zero 
quantification result for the Y marker, whilst amplification of the Y target in sample 019 
resulted in a male designation thus contradicting the paperwork. It should be noted however, 
that whilst the total and Y quantification values were 26 pg/ µl  and 23 pg/ µl respectively, 
the DI value for this sample was 17.3 indicating extreme degradation and no amplification 
was observed using the NGM amplification kit. Although no Y target amplification was 
observed for the remaining two samples that had been designated female, 007 and 012, both 
had total quantification values of <2 pg/µl (both had a zero quantification value for the Y 
marker) and so no sex was assigned.  
It had been originally planned to use the Illumina suggested protocol for D-loop 
amplification (Illumina, 2013) to prepare the DNA library for sequencing of the mtGenome 
control region on the MiSeq platform. However, despite the demonstrated sensitivity of the 
assay down to an approximate DNA input of 16 pg, no amplified product was observed for 
any of the tested sample DNA extracts. The DNA in this sample set has been shown to be 
moderately-severely degraded as reflected in the low quantification values for the long 
autosomal marker, a 214 bp target, amplified during qPCR, therefore the 236-256 bp target 
range of the Illumina proposed primer sets was not attainable for these samples. The 
presence of mtDNA albeit in a degraded state, was demonstrated in four of these six samples 
using the Edson primer set, which were designed for degraded DNA samples (Edson, 2004) 
having a target of just 125 bp. 
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Following the success of the Edson primer set, an ‘in-house’ assay was developed through 
adaptation of the 16S protocol ustilsed by Kozich et al. (Kozich et al., 2013), whereby 
primers were extended to include all the necessary attachments for MPS on the Illumina 
MiSeq platform. Five samples and one extraction negative control were selected for analysis 
using the in-house assay. Following sequencing, Illumina’s integrated software ‘Basespace’ 
should demulitplex samples based on the index reads, but due to software issues the six 
samples in this study could not be automatically demultiplexed. Fortunately, the sequencing 
method and amplicon design enabled the entire target sequence and the reverse index to be 
sequenced during read 1, and the target sequence plus the forward index to be sequenced in 
read 2, which allowed for samples to be manually demultiplexed as described in appendix 
8.23.  
The total number of reads generated during this run was 287,446, 82% of which were an 
exact match for one of the utilised index sequences. The remaining 18% are unmatched 
reads, resulting from the stringent filtering process applied during demulitplexing, which did 
not allow for any mismatches to be accepted within the index sequence. Amplicon C had 
twice the number of associated reads relative to the other amplicons, which could be the 
effects of preferential amplification and sequencing as this had the smallest target amplicon 
size of 132 bp. Whilst over 34,000 indexed reads were obtained for Amplicon B, just 0.6% 
of these could be aligned against the rCRS. The drop in read number occurred during the 
combining of the paired end reads that was carried out as described in step four of appendix 
8.23 as part of the DNA fragment identification process. This most likely due to either an 
inconsistency in the primer set-up during preparation for loading to the MiSeq flowcell, or a 
homopolymorphic region between positions 16185-16194 (CCCCCTCCCC) in the template 
sequence, which has caused strand bias during amplification, and therefore the subsequent 
loss of reads as only those combined in pairs were advanced through the process. Despite the 
requirement for further optimisation in order to better balance the coverage across the four 
amplicons, all paired reads were successfully aligned against the human rCRS. This method 
has many advantages over the commonly used two-step PCR method; the potential for 
further exacerbating amplification bias within the sample is reduced, DNA fragments are 
indexed in the first PCR reducing the risk of sample confusion, a lower number of required 
manipulations minimises the potential for sample loss or contamination and there are also 
associated time and cost efficiency gains. This method will prove particularly useful for 
degraded DNA, as a high number of primers can be multiplexed to amplify the required 
target region in a number of short fragments, thereby increasing the chance of success.  
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5.5.2 Vindolanda sample set 
The human skull, from which the tooth submitted for DNA analysis was extracted, was 
excavated from a ditch dated to the Severan period, circa 208-212 CE based on associated 
coin evidence (Birley, 2009). The individual had suffered severe peri mortem injury, with 
evidence of at least three blows to the head with a sharp weapon as well as decapitation and 
mounted on a pole, possibly as a trophy (Birley, 2009) or warning to others. There are two 
conflicting theories on the origins of this individual; firstly that that he was a native Briton, 
possibly one of the revolting Maeatae killed at the hands of the imperial expedition who had 
been deployed to eradicate them, or secondly that he was a disgraced member of the Roman 
army (A. Birley 2015 pers. comm. 16th, April).  
The femur bone was recovered as part of a partial skeleton, excavated from one of the 
earliest fort ditches dated circa 110 AD. The skeletal remains were found strewn along a 
section of the ditch suggesting that the body may have been in flowing water at some point 
post mortem (A. Birley/T. Buck 2015 pers. comm. 16th, April). It was highly unusual for the 
Romans during this period to bury their dead so the discovery of remains from this era is 
very rare. Aside from this, the presence of general debris in the area suggested that this 
individual had been left without a burial of any kind, once again raising questions about 
whether this individual was a native who died at the hands of the army or perhaps a 
disgraced Roman (A. Birley 2015 pers. comm. 16th April). In lieu of the skull or pelvis, 
anthropologist Dr Trudi Buck had tentatively assigned female sex to the remains based on 
the size of the femur bone, although this was complicated by the open ends of the bone, as 
whilst the length was on the larger size for a female, it was on the short size for a Roman 
soldier, who would be expected to have a height over 6 ft (T. Buck 2015 pers. comm. 16th, 
April).  
Previous analysis by York University had already established the presence of mtDNA within 
the femur sample through the amplification and sequence of the control region. The resulting 
haplotype was then used to predict the individual’s mitochondrial haplogroup as J1c1, which 
is not very common in Europe, with an observed frequency of approximately 9% for the 
whole of haplogroup J (http://www.mitomap.org/MITOMAP/GBFreqInfo, last accessed 
28/05/2016). Although relatively uncommon, this group is widely dispersed across Europe 
(Gonzalez Fortes, 2014) and therefore not highly informative in this case. 
In order to address the questions associated with both of these samples, particularly in terms 
of sex confirmation for the femur sample, and specific biogeographic ancestry data along 
with the potential for additional phenotypic information for both samples, the decision was 
taken to pursue the amplification of DNA markers.   
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The immediate environment in which the sample is situated post mortem does have a 
demonstrable impact on the persistence of DNA within the sample (Gilbert et al., 2003, 
Lamers et al., 2009, Bollongino et al., 2008, Burger et al., 1999). Clarifying the extent to 
which different variables influence DNA persistence is problematic due to the small sample 
sets available from each environment, contamination issues and the lack of taphonomic 
information available in most cases. Nuclear DNA was however detected in both of the 
femur and tooth DNA extracts with values of 35 pg/µl, 71 pg/µl and 56 pg/µl respectively. 
The persistence of DNA in these two specimens is likely due to both the anaerobic 
environment in which both samples were kept and the temperate nature of the UK weather. 
An anaerobic environment, such as that described in the some strata of the Vindolanda site, 
will reduce the rate of DNA degradation though chemical modifications due to oxidation and 
hydrolysis, particularly depurination which can lead to further fragmentation of the DNA 
(Briggs et al., 2007, Ginolhac et al., 2012) as well as limiting bioerosion due to microbial 
activity (Campos et al., 2012, Child, 1995), thus better preserving the integrity of the DNA 
relative to an aerobic environment. This is in stark contrast to the severe degradation 
observed in the Brazilian sample set, thus demonstrating the effects of the environment are 
more influential on the rate of degradation than PMI.    
Considering that the tooth sample is eighteen hundred years in age, the DNA within this 
sample was remarkably well preserved, showing signs of only mild degradation, whereas the 
nineteen hundred year old femur sample yielded DNA that only just fell short of the severely 
degraded DNA category (Vernarecci et al., 2015). Aside from the approximate one hundred 
year difference in specimen age, it is well documented that tooth samples contain a higher 
quality of DNA than bone samples, due to the enamel coating of the tooth sample and 
encasement of the root section within the jaw bone, both of which facilitate the preservation 
of DNA through limiting access to it by the surrounding microbiome, oxygen and water.  
Interestingly, the Quantifiler® Trio result indicated that the femur sample, which had a 
female sex assigned anthropologically, actually originated from a male individual. This was 
supported with the amplification of Amelogenin using the AmpFℓSTR® NGM™ PCR Kit 
(NGM™) in each of the femur DNA extracts and also through amplification of Y-STRs 
using the AmpFℓSTR® Yfiler® PCR Kit (YFiler®). Two negative controls were processed 
for each of the femur extractions; of these four, amplified DNA was only detected in one 
control with a Quantifiler® value of <0.5 pg/µl, thus indicating that the DNA amplified in 
each of the extracts was endogenous to the sample and not from a foreign source. On further 
discussion with Dr Buck, the possibility was raised that due to the shorter stature of this 
individual, he may in fact have been a slave brought in to serve the garrison officers. The 
biogeographic ancestry of this individual may shed further light on this proposal, however 
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unfortunately no DNA amplification was observed using the ForenSeq™ DNA Signature 
Kit (ForenSeq™) for this sample. Given the demonstrated amplification of DNA using 
Quantifiler® Trio, in addition to consensus amplification using both the NGM™ and 
YFiler® amplification kits, the most likely explanation for this is there is a PCR inhibitor 
present in the DNA extract which did not affect the Thermo Scientific kits, but which 
prevented amplification using the ForenSeq™ chemistry. This may be due to a difference in 
the polymerase used during the PCR or that the complexity of a multiplex this size is unable 
to tolerate inhibitors as well as the smaller PCR-CE assays (N. Oldroyd, Illumina Inc. 2015 
pers. comm. 24th June). 
PCR inhibitors associated with skeletal remains include calcium and collagen from the 
remains themselves, and humic acid absorbed from the surrounding soil; it is possible that 
one or more of these may have been co-extracted with the sample DNA. A paper by Opel et 
al. (Opel et al., 2010) used qPCR to demonstrate that each of these molecules utilises 
differing mechanisms of inhibition; calcium competes with the magnesium ions thereby 
reducing the efficacy of the PCR polymerase, collagen binds with the DNA template 
hindering the progress of the polymerase as it extends the primers, whilst humic acid acts to 
bind with sequence-specific areas of the DNA strand, thus restricting access to the template 
by the polymerase. It is not possible to determine the extent to which these inhibitors may be 
affecting PCR using the ForenSeq™ kit, as the degraded nature of the DNA within the 
femur sample is already subject to stochastic effects resulting from amplification.   
It is worth noting at this point that although DNA was extracted from both the tooth and 
femur extracts using the same protocol, DNA from the tooth extract was successfully 
amplified using ForenSeq™. This may be down to the fact that the better quality of DNA in 
the tooth sample made it more amenable to amplification in the presence of the same 
inhibitors that prevented the degraded femur DNA from undergoing PCR. As the two 
samples were excavated from differing locations and strata at the Vindolanda site, however, 
they may consequently have had different types or quantities of inhibitors co-extracted with 
the samples. Alternatively, as less collagen is present in teeth than in bone, along with the 
possibility that the enamel layer of the tooth sample may have offered protection against the 
imbibing of humic acid from the surrounding environment, this may have resulted in less of 
these inhibitors being present compared with the femur extract. A greater mass of the 
powdered femur sample (1.5 g) was also used for the extraction process than the tooth 
sample (1.1 g) which, together with one or more of the aforementioned possibilities, may 
also account or the difference in amplification success between the two samples.  
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Optimisation of the PCR assay can facilitate DNA amplification in the presence of 
inhibitors; however, in this case the ForenSeq™ the reaction components are already finely 
balanced in order to accommodate the large number of loci in the multiplex and so it would 
be preferable to remove the inhibitors from the DNA extract itself. Although a second 
attempt to amplify the femur sample using the ForenSeq™ kit will be carried out, it will not 
be completed within the time frame of this study.  
As expected, the results of the Quantifiler® Trio and NGM™/YFiler® kits confirmed the 
presence of male DNA in the tooth sample. As previously discussed, the biogeographical 
ancestry of this sample is of particular interest and so both Y-STRs and aSNPs were 
employed to draw conclusions about the individual in question.  
The Y-STR haplotype determined by combining both the YFiler® and ForenSeq™ Y-STR 
results, was entered into both the YHRD (Willuweit and Roewer, 2015) (release 50) and the 
online Haplogroup Predictor tool (Athey, 2015). The ancestry analysis performed on the 
YHRD website is based on a minimal haplotype, made up of eight loci, of which only two 
were amplified in each of the tooth and femur samples and so no meaningful information 
could be obtained from these results. The online Haplogroup predictor tool takes into 
account all of the available loci which enabled the assignment of haplogroup R1b to the 
tooth sample with a 99.7% probability (Athey, 2015). One of two major sub-clades of the 
haplogroup R1, R1b is found predominately in Western Europe (Myres et al., 2011), which 
supports the theory that the individual was either native to the UK or had travelled from 
Europe. The results for the femur sample are inconclusive given that only three consensus 
alleles were amplified and available for analysis. 
Illumina’s ForenSeq™ Universal Analysis Software utilises principal component analysis 
(PCA) to determine the biogeographical ancestry based on the generated aSNP profile. 
Amplification of the tooth DNA extract resulted in 63% of the aSNPs being successfully 
amplified with the individual being placed as European with the distance to the nearest 
centroid given as 2.40. The closest reference samples were from the TSI (Toscani in Italia) 
grouping, indicating that the individual is more closely related to samples in this region than 
other reference samples within the centroid. The statistical calculations utilised for these 
projections are not yet published for further analysis (L. Devesse 2105 pers. comm. 23 rd 
October).  
Wherever possible, it is good practice to carry out DNA analyses on ancient samples in two 
independent laboratories in order to support the authentication of any DNA results obtained. 
Due to the precious nature of these aged samples, the quantity of sample available for testing 
was limited to one tooth from the skull and a small section of the femur, and so it was not 
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possible to carry out independent tests in this manner. However, as previously mentioned, 
DNA was extracted from this same femur sample by York University for mtDNA 
sequencing of the control region and, although no attempt was made to amplify DNA on this 
occasion, this represented results from an independent laboratory. Two sections of the 
mtGenome were consequently amplified to enable comparison with five out of the eight 
differences from the rCRS that were recorded by York University (Gonzalez Fortes, 2014); 
all five of these substitutions were confirmed in each of the femur extracts. An additional 
substitution of 263G was identified in both femur extracts which was not included in the 
report. This was queried with Dr Gloria Gonzalez Fortes who carried out the original 
mtDNA sequencing work at York University, who reported that there was a gap in her 
consensus sequence between positions 247 and 267 and consequently position 263 was not 
reported (G. Gonzalez 2015 pers. comm. 24th February).  
It is expected that the increased mtGenome copy number per cell along with its inherent 
resistance to degradation relative to nDNA, would result in detection of mtDNA in all 
samples for which DNA was detected. However in this study the presence of DNA was 
detected in all twenty-four of the submitted Brazilian samples, whilst the mtDNA target was 
only amplified in eleven of these. As discussed for the ForenSeq kit above, the most 
probable explanation for this is that the in-house mtDNA qPCR assay is less tolerant to the 
presence of inhibitors than the Quantifiler® Trio chemistry. Signs of inhibition were 
detected in only one of the samples using the Quantifiler® Trio internal positive control 
which had a Ct value or 38.11, well above the calculated flag threshold of 30.71 for this run. 
If this in indeed the case then given that the internal positive control values did not indicate 
any additional samples as showing signs of inhibition, then it can be concluded that the 
Quantifiler® Trio results accurately represent the quantity of DNA within the samples, but 
the mtDNA copy numbers may be significantly under-represented in this study.  
Sample 013B was extracted using three different methods; the Quantifiler® Trio value for 
the silica-column-based method was an order of magnitude higher than for the other two 
methods, whereas the variation within other samples was very limited. Subsequent DNA 
profiling using both the NGM and ForenSeq™ kits demonstrated the presence of a DNA 
mixture that could be attributed to the operator. Although the quantity of DNA was elevated, 
there was no indication of a male/female mix in this sample as the quantification value for 
both the Y and short autosomal targets was 0.47 ng/µl. It is possible that the sample was 
contaminated post-quantification, however with a male/female mix the ratio of X:Y DNA is 
3:1 and therefore an increased representation of the X markers would be expected. 
Conversely both of the consensus NGM profiles and the ForenSeq™ data, the Y marker had 
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the higher RFU (Hb = 0.66 and 0.42) or read count (Hb = 0.36). This serves to highlight the 
stochastic effects that can be observed when working with low level of DNA template.  
As discussed in Section 5.1, one of the advantages of MPS is the sequence data obtained for 
each STR as it allows for the detection of isolalleles. An example of this was seen in the 
results of the ForenSeq™ amplification on the Vindolanda tooth DNA extract. The low read 
counts obtained for this sample means that the designation of locus D13S317 allele 11, 
would have been recorded as a possible heterozygote with allelic dropout. The sequence data 
however indicates the presence of two distinct sequences, with a read count of thirty-nine for 
the expected ‘TATC’ repeat and forty-two copies of ‘AATC’, a SNP variant in the flaking 
region immediate to the 3ʹ end of the repeating unit.  
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5.6 Conclusions 
Of the three DNA extraction methods selected, there was not one that consistently yielded a 
higher quantity or quality of DNA relative to the other two tested.  
The removal of dentin/cementum from tooth samples in order to preserve the casing is 
unlikely to yield amplifiable DNA in sub-optimal samples, due to the low mass of material 
produced using this method.  
Nuclear DNA was detected in all of twenty of the Brazilian samples and both the 
Vindolanda femur and tooth samples. The detrimental effects of a hot and humid 
environment on buried skeletal remains is clear as the samples from Brazil were observed to 
be of low quantity and poor quality despite a post mortem interval of just 8 -14 years. 
Endogenous DNA is believed to have been extracted and amplified from both the 
Vindolanda tooth and femur samples, demonstrating that the anaerobic conditions at the 
Vindolanda site favour DNA preservation. When compared with the Brazilian sample set, 
this also shows that given good preservation conditions, the age of the sample, in this case 
1800 – 1900 years, is of less consequence in terms of the quantity and quality of extracted 
DNA, than temperature, humidity and an aerobic environment.   
Although Quantifiler Trio is sensitive to <1 pg/µl DNA, assigning sex at this level should be 
treated with caution. The results from this study suggest that the Quantifiler Trio assay 
chemistry is highly tolerant of PCR inhibitors, and so may not be reflective of likelihood of 
obtaining a PCR result if using assays, either developed in-house or commercially available, 
which rely on other chemistries that may be less tolerant to the presence of PCR inhibitors.  
The Illumina suggested protocol for amplification of mtGenome D-loop region was shown 
to be unsuitable for amplification of moderately-severely degraded DNA, presumably owing 
to the relatively large target fragment size of >230 bp.  
Adapting primers for a one-step amplification reaction in which all components necessary 
for direct flowcell attachment were added to the target fragment, proved a sensitive and 
time/cost effective method of targeted sequencing on the MiSeq MPS platform.  
The multi-marker ForenSeq™ Signature Preparation Kit enables a more comprehensive 
evaluation of DNA than any other assay currently available on the forensic market. The 
inclusion of identity SNPs alongside the STR markers ensures a greater chance of 
amplification of degraded forensic material. The capability to amplify the ancestry and 
phenotypic SNPs are particularly useful in its application to bioarchaeological investigations 
that would benefit from a forensic approach.   
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6. Conclusions 
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The overall aim of this thesis was to explore the use of enhanced experimental strategies for 
the analysis of sub-optimal biological material that is encountered during forensic 
investigations. In order to fulfil this aim two main areas of research were selected, namely 
ltDNA analysis, using single-cell DNA analysis as an example of an underexploited source 
of DNA in forensic casework, and severely degraded DNA samples, in this instance 
obtained through analysis of bone/teeth samples, which are aged or have been subjected to 
hostile environmental conditions.   
The first area of research focusing on single-cell DNA analysis was further separated into 
two sections; the initial part aimed to investigate the analysis and interpretation of DNA 
derived from individual single-cells in order to determine their efficacy for use in forensic 
casework, whilst the second section then considered a novel application of this work for use 
in forensic casework.  
The difficulties associated with single-cell DNA analysis has resulted in the under-
exploitation of this sample type within a forensic context, however, given the development 
in our knowledge on the processing and interpretation of ltDNA samples, alongside the 
increased sensitivity of the commercially available assays, a reinvestigation of this 
potentially valuable source of DNA is warranted. In order to address the aim of the first part 
of this study it was first necessary to develop a method by which individual single-cells 
could be detected and transferred from a surface to a PCR tube without sample loss. This 
was vital to ensure that any generated DNA data could be confidently attributed to a single-
cell as the developed protocol included a visual check of the sample under the microscope 
immediately prior to transfer into the PCR tube. J-LAR adhesive tape and a 1 µl volume of 
Sticky Stuff Remover were found to be compatible with downstream PCR, whilst the use of 
the ForensicGEM® Tissue extraction reagents facilitated direct amplification of DNA using 
the AmpFℓSTR® SGM Plus® PCR Amplification Kit. Following development, this 
protocol for the detection, recovery and amplification was utilised to generate DNA profiles 
for fifty individual single-cells, enabling an assessment of the effects of artefacts associated 
with DNA profiling at this low quantity of starting template. Overall, the results for this data 
set demonstrate that the frequency and intensity of artefacts resulting from the stochastic 
effects of PCR are comparable with those observed using DNA extracted from any ltDNA 
samples and can, therefore, be interpreted using the same parameters. Therefore, although a 
consensus DNA profile cannot be generated from a single-cell, the move towards computer-
based statistical likelihood data analysis and evaluation for all ltDNA samples should 
facilitate the increased use of single-cells as a source of DNA in forensic casework. An 
overall drop-in rate of <1% demonstrates that provided good DNA anti-contamination 
practice is used, the impact of this unavoidable artefact is minimal. Finally an initial trial of 
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several recently developed, and purportedly more sensitive, amplification assays were tested 
using individual single-cells as a source of DNA. Of these kits Promega’s ESX-16 
amplification assay, used in conjunction with ForensicGEM extraction reagents, appears to 
be particularly effective for amplification of DNA from individual single-cells. 
 As an application of the aforementioned single-cell DNA analysis work, the second section 
of this area of research tested the hypothesis that when textile fibres are transferred from a 
garment to a second surface, they are also acting as a vector for the wearer’s own DNA, via 
cells that have adhered to the fibre surfaces. This would offer forensic scientists a method by 
which transferred fibres could be targeted on fibre tapings, in order to obtain a DNA profile. 
Rather than the use of DNA evidence at the expense or destruction of the fibre evidence, as 
so often happens in forensic casework. The intention of this work was that the two evidence 
types should be examined with causing detrimental effects to the other so that both could be 
utilised alongside one another in forensic casework.  
It was quickly established that the use of a DAPI-based fluorescent stain, in place of the 
previously used haematoxylin and eosin, was an effective method for the visualisation of 
cells on the surface of textile fibres without staining the fibre itself, thereby showing no 
detrimental effect on the MSP spectral profile. Furthermore it was demonstrated that the 
DAPI stain did not cause PCR inhibition and so was compatible with downstream DNA 
analyses. Prior to testing of the hypothesis, it was deemed necessary to first establish the 
frequency with which nucleated cells are likely to be present on the outside front surface of 
an individual’s garment, in order to inform expectations on the availability of cells for 
transfer to a second surface. It was demonstrated through the staining of entire fibre tapes 
that the garments sampled for this study had on average over one thousand nucleated cells 
present and as such represent a source of DNA for possible transfer to a recipient surface. Of 
particular interest, was the presence of clusters of nucleated cells in addition to the 
individual cells, which were often observed, wrapped around the fibre surface therefore 
representing a high chance of transfer. A total of ten fibre/cell transfer experiments were 
then conducted in order to test the previously stated hypothesis, during which time a number 
of developments to the protocol established in the previous chapter were made in order to 
account for the extended length of time required for the examination, staining, searching and 
recovery of fibres relative to the initial single-cell experiments. Whilst it has been 
demonstrated that nucleated cells can be visualised in situ on fibre tapes and recovered for 
DNA analysis without adversely affecting subsequent fibre analysis, the results of this study 
suggest that if fibres are in fact acting as a vector for the transfer of DNA then they do so 
rarely and as such, specifically targeting transferred fibres for an associated DNA profile is 
unlikely to yield a result.  
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The second area of research is focused on DNA contained within human skeletal remains 
that has severely degraded as a result of temporal or environmental factors, and therefore 
represents a significant challenge for forensic DNA analysis. The aim of this part of the 
thesis is to investigate the efficacy of novel and emerging MPS techniques in the targeted 
sequencing of degraded DNA samples, using existing laboratory strategies as a point of 
comparison. In order to address the aims of this section, two distinct sample sets were 
obtained; twenty samples (8-14 years PMI) excavated from a site in Brazil, which had been 
subjected to extremely hostile environmental conditions, and two samples from the 
Vindolanda Roman archaeological dig site, which are over 1800 years in age.  
The starting point for this work was a comparison of commonly used methods used for the 
extraction of DNA from skeletal material. Of the three DNA extraction methods selected, 
there was not one that consistently yielded a higher quantity or quality of DNA relative to 
the other two tested.  
Quantifiler® Trio, a recently introduced real-time PCR quantification assay, was utilised to 
quantify the DNA in all samples. Nuclear DNA was detected in all of twenty of the Brazilian 
samples although the detrimental effects of a hot and humid environment on buried skeletal 
remains is clear, as the samples from Brazil were observed to be of low quantity and poor 
quality despite a post mortem interval of just 8 -14 years. DNA was also detected in both of 
the Vindolanda samples. This DNA is believed to be endogenous to the samples, 
demonstrating that the anaerobic conditions at the Vindolanda site favour DNA preservation. 
When compared with the Brazilian sample set, this also shows that given good preservation 
conditions, the age of the sample, in this case 1800 – 1900 years, is of less consequence in 
terms of the quantity and quality of extracted DNA, than temperature, humidity and an 
aerobic environment. Quantifiler® Trio purports to be sensitive to <1 pg/µl DNA, assigning 
sex at this level should be treated with caution. The results from this study suggest that the 
Quantifiler® Trio assay chemistry is highly tolerant of PCR inhibitors, and so may not be 
reflective of likelihood of obtaining a PCR result if using assays, either developed in-house 
or commercially available, which rely on other chemistries that may be less tolerant to the 
presence of PCR inhibitors.  
Following DNA extraction and quantification, a variety of strategies were tested for the 
amplification and targeted sequencing of the degraded samples. Initially the Illumina 
suggested protocol for amplification of mtGenome D-loop region was to be used for the 
amplification of the Brazilian samples, however this method was shown to be unsuitable for 
amplification of moderately-severely degraded DNA, owing to the relatively large target 
fragment size of >230 bp. It was decided to adapt a number of primers that amplified a 
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shorter fragment length, thus facilitating the amplification of the degraded samples, for 
direct flowcell attachment by adding all the necessary components to the target fragment in a 
one-step PCR. This method, which has not been used in a forensic context at the time of 
writing, was successful and proved to be a sensitive and time/cost effective method of 
targeted sequencing on the MiSeq MPS platform. The Vindolanda samples were amplified 
using AmpFℓSTR® NGM™ and Yfiler® PCR Amplification Kits, which are existing PCR-
CE methods as well as the newly released ForenSeq™ Signature Preparation Kit. This multi-
marker assay enabled a more comprehensive evaluation of DNA than any other assay 
currently available on the forensic market. The inclusion of identity SNP alongside the STR 
markers ensures a greater chance of amplification of degraded forensic material. The 
capability to amplify the ancestry and phenotypic SNPs is particularly useful in its 
application to bioarchaeological investigations that would benefit from a forensic approach.   
There are many advantages to support the introduction of MPS into routine forensic 
casework. The ability to multiplex different forensic markers of interest offers the 
opportunity to obtain more information from a smaller quantity of DNA, running one rather 
than multiple reactions, also saving time and potentially cost in the process. Removing the 
restriction on the number of dye lanes associated with the use of CE, enables an increased 
number of STR loci to be included for analysis; including loci in use around the world to 
facilitate global crime fighting efforts in areas such as terrorism, drug trafficking and 
paedophilia, and also miniSTRs /identity SNPs to aid detection of low template and 
degraded DNA samples. Phenotypic SNPs for hair, eye and skin tone have the potential use 
for intelligence purposes when trying to identify an unknown offender; although this is of 
course somewhat limited in that artificial change can be made to these features. Ancestry 
information can also be utilised to infer the ethnicity of an individual using ancestry SNPs, 
Y-STRs and mtDNA. In addition to the number of markers used, the generation of actual 
sequence information for STRs rather than fragment size only as used with CE, increases the 
ability to distinguish between two seemingly homozygote alleles as well as identifying the 
proportion of a peak that may be stutter of the subsequent allele, both of which enables a 
better resolution of mixed DNA samples.  
However, rather than a simple extension of current techniques, as the introduction of DNA 
17 in England and Wales in recent years was, MPS is a complete deviation from current 
methods, with the interpretation process almost unrecognisable. The platforms used for MPS 
are expensive and unfamiliar to many forensic scientists, requiring a huge investment in 
terms of equipment and staff training by forensic providers for successful implementation, 
which may not be desirable or feasible given the current state of the forensic market within 
the UK. In addition to this, extensive validation processes will be required in order to 
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properly accredit all the new methods used, which again are expensive in terms of time and 
cost. Discussions around the need for the additional information that could be obtained from 
MPS will be essential, particularly with respect to at what point in the investigation 
phenotypic and ancestry information should be generated, how this information should be 
stored and who should have access to it? Changes to the National DNA Database will also 
be required in order to utilise the additional STR and identity SNP data obtained from every 
sample submitted.  
Even with obvious advantages over current techniques, completing all the validation 
processes and developing a good level of expertise for use within the criminal Justice 
System, along with the understanding and trust of the public, police and other interested 
parties,  means that the introduction of MPS into routine casework will be a long process. 
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6.1 Further work 
Following the completion of this study there are a number of suggested topics of research, 
which would further contribute to knowledge and understanding in the areas focused on 
during this thesis: 
 As computer-based statistical programmes are being developed with increasing 
capabilities, an investigation into the statistical evaluation of single-cell DNA 
profiles is essential for use in forensic casework. 
 As discussed in Section 4.4, it would be interesting to carry out RNA work on 
clusters of cells detected on the outside surface of garments, in order to determine 
the body fluid of origin. 
 Further detailed investigation into DNA extraction methods for degraded skeletal 
material would be beneficial for both forensic and bioarchaeological fields. 
 Primer sets adapted for the MiSeq platform should be extended to enable 
amplification of the entire control region of the mtGenome, all of which will require 
optimisation in order to maximise results. 
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8. Appendices  
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8.1 Identifying mtDNA haplotype 
In a simple point mutation, the nucleotide position and the nucleotide base that differ from 
the rCRS are recorded, i.e. at position 263 the rCRS nucleotide is adenine (A), if the queried 
sequence has guanine (G) at that same position then the designation for that position is 
written 263G. Insertions are shown through the use of a decimal place after the preceding 
nucleotide positon, i.e. a thymine (T) insertion after nucleotide position 267 is depicted as 
267.1T. If there is a two-base insertion of TT, then the second insertion is shown as 267.2T 
and so on. In the case of homopolymeric stretches such as the common C stretch at positions 
311-315, then the highest number possible is used as the preceding nucleotide position, i.e. 
315.1C [58]. A nucleotide position followed by the letters ‘DEL’ is used to represent a 
deleted nucleotide, i.e. 389DEL [57] and an ‘N’ is utilised to denote an ambiguous base call 
where all four bases are observed [57]. In the case of heteroplasmy, mixed base sites are 
represented by a standardised letter as set out by the International Union of Biochemistry 
(IUB). For example, if a mixture of adenine and guanine is observed at position 678, then 
the notation 678R is used [59]. Upper case letters should be used as standard, with lower 
cases letters used to denote heteroplasmic events that include an insertion or deletion [57]. 
RS nucleotide is adenine (A), if the queried sequence has guanine (G) at that same position 
then the designation for that position is written 263G. Insertions are shown through the use 
of a decimal place after the preceding nucleotide positon, i.e. a thymine (T) insertion after 
nucleotide position 267 is depicted as 267.1T. If there is a two base insertion of TT, then the 
second insertion is shown as 267.2T and so on. In the case of homopolymeric stretches such 
as the common C stretch at positions 311-315, then the highest number possible is used as 
the preceding nucleotide position, i.e. 315.1C (Carracedo et al., 2000). A nucleotide position 
followed by the letters ‘DEL’ is used to represent a deleted nucleotide, i.e. 389DEL (Parson 
et al., 2014) and an ‘N’ is utilised to denote an ambiguous base call where all four bases are 
observed (Parson et al., 2014).  
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8.2 Allele frequencies for ltDNA assay loci (Section 3.3.6) 
PENTA E D12S391 D10S1248 
Allele Amplicon 
size 
Allele Amplicon 
size 
Allele Amplicon 
size 
5 73 15 145 8 79 
6 78 16 149 9 83 
7 83 17 153 10 87 
8 88 17.3 156 11 91 
9 93 18 157 12 95 
9.1 94 18.3 160 13 99 
9.4 97 19 161 14 103 
10 98 19.3 164 15 107 
10.2 100 20 165 16 111 
11 103 21 169 17 115 
11.4 107 22 173 18 119 
12 108 23 177 19 123 
12.1 109 24 181   
12.2 110 25 185   
12.3 111 26 189   
13 113 27 193   
13.2 115 27.2 195   
13.4 117     
14 118     
14.4 122     
15 123     
15.2 125     
15.4 127     
16 128     
16.4 132     
17 133     
17.4 137     
18 138     
18.4 142     
19 143     
19.4 147     
20 148     
20.2 150     
20.3 151     
21 153     
22 158     
23 163     
23.4 167     
24 168     
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8.3 Inhibition test data 
Table 8-1 Average peak area (RFU) data for alleles amplified during inhibition tests for J-LAR Tape, Sellotape, Sticky stuff remover (SSR) and 
Adhesive Off (AO). Peak areas for control DNA also recorded. (-) denotes no observed amplification (Figure 3.4 and Figure 3.5) 
  
Sample D3 VWA D16 D2 AMEL D8 
  CONTROL 24382 20866 47579 35598 27972 26307 5895 15119 12534 19140 22930 31310 
T
ap
e J-LAR TAPE 14257 9447 62327 32929 30605 25436 15963 10303 21849 37404 41702 17143 
SELLOTAPE 8081 11458 10294 22332 8164 13258 3708 2201 16028 16318 8794 12157 
A
d
h
es
iv
e 
re
m
o
v
er
 
SSR 1 µl 17726 13917 37075 26336 15222 10008 5843 11378 21623 20871 17945 19389 
SSR 2 µl - - - - - - - - - - - - 
SSR 3 µl - - - - - - - - - - - - 
AO  1 µl - - - - - - - - - - - - 
AO  2 µl - - - - - - - - - - - - 
AO  3 µl - - - - - - - - - - - - 
 
               Sample D21 D18 D19 THO1 FGA 
    CONTROL 17440 14867 11773 10134 20276 17665 17413 25802 12138 8154 
  
T
ap
e J-LAR TAPE 32635 31399 10587 13944 23948 23012 27078 20944 21285 14171 
  SELLOTAPE 8241 7776 5884 3340 8104 5884 3721 12221 6487 4688 
  
A
d
h
es
iv
e 
re
m
o
v
er
 
SSR 1 µl 11530 14038 7728 9264 18429 16426 13442 17716 8516 6192 
  SSR 2 µl - - - - - - - - - - 
  SSR 3 µl - - - - - - - - - - 
  AO  1 µl - - - - - - - - - - 
  AO  2 µl - - - - - - - - - - 
  AO  3 µl - - - - - - - - - - 
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8.4 Amplification reaction volume trial data (Figure 3.6) 
Table 8-2 Alleles observed using five different reaction volumes for the amplification of DNA from a single-cell (in triplicate) 
  AMEL D3 VWA D16 D2 D8 D21 D18 D19 THO1 FGA 
Single_cell_5µL_1 - - - - 17 - - - - - - - - - - - - - - - -  
Single_cell_5µL_2 - - - - - - - - - - - - - - - - - - - - -  
Single_cell_5µL_3  - -   - -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  
Single_cell_10µL_1 - - - - - - - - - - - - - - - - - - - - -  
Single_cell_10µL_2 X Y - 17 - - - - - 12 - - 32 12 - 13 15 - - - 21 
Single_cell_10µL_3 X  - 16 17 17 -  -  16 20 -  15 -  -  -   -  - -  8 -  -  -  
Single_cell_15µL_1 X Y 16 17 17 - 12 - 20 - 15 30 32 12 18 13 15 8 9 19 21 
Single_cell_15µL_2 - - - 17 17 - - - - 12 - 30 - - - - - - - - -  
Single_cell_15µL_3 X Y -  -  -  8 12 -  -  -  -  -  -  -  18 -  -  8 -  -  -  
Single_cell_20µL_1 X - - - 17 - - - - 12 - - - - - - - - - - -  
Single_cell_20µL_2 - - - - - - - - - - - - - - - - - - - - -  
Single_cell_20µL_3 X Y 16 17 17 -  12 16 -  12 -  30 32 -  -  13 15 8 9  - 21 
Single_cell_25µL_1 X - 16 - 17 - - 16 20 12 15 30 32 12 18 13 15 8 9 - -  
Single_cell_25µL_2 X Y - - 17 - - - - - - - - 12 - - 15 - 9 - 21 
Single_cell_25µL_3 - - - 17 - - - - - - - - - - - - - - - - - 
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8.5 Single-cell overall results summary data (Figure 3.7) 
Table 8-3 Summary data for the number of alleles amplified and profile type obtained for single-cell tests using a standard CE injection time 
Standard CE injection time 
 
Standard CE injection time 
 
Standard CE injection time 
Profile 
type 
Number of 
alleles 
present 
Total 
number 
of alleles 
possible 
Alleles 
amplified 
(%) 
 
Profile 
type 
Number 
of alleles 
present 
Total 
number 
of alleles 
possible 
Alleles 
amplified 
(%) 
 
Profile 
type 
Number 
of alleles 
present 
Total 
number 
of alleles 
possible 
Alleles 
amplified 
(%) 
NP 0 19 0 
 
P 5 19 26 
 
P 11 19 58 
NP 0 19 0 
 
P 13 19 68 
 
P 11 19 58 
NP 0 19 0 
 
NP 0 19 0 
 
P 10 19 53 
P 1 19 5 
 
P 2 19 11 
 
P 14 19 74 
P 2 19 11 
 
P 8 19 42 
 
P 0 19 0 
P 1 19 5 
 
P 3 19 16 
 
NP 0 19 0 
P 13 19 68 
 
P 9 19 47 
 
P 9 19 47 
NP 0 19 0 
 
P 4 19 21 
 
NP 0 19 0 
P 1 19 5 
 
NP 0 19 0 
 
P 13 19 68 
P 5 19 26 
 
P 1 19 5 
 
P 4 19 21 
P 4 19 21 
 
P 10 19 53 
 
P 3 19 16 
NP 0 19 0 
 
P 2 19 11 
 
P 13 19 68 
P 9 19 47 
 
P 10 19 53 
 
P 16 19 84 
P 5 19 26 
 
P 11 19 58 
 
P 5 19 26 
P 7 19 37 
 
P 13 19 68 
 
P 17 19 89 
NP 0 19 0 
 
P 2 19 11 
     NP 0 19 0 
 
P 3 19 16 
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8.6 Summary data for alleles amplified at each locus (Figure 3.8) 
Table 8-4 Summary data for the number of alleles amplified at each of the heterozygous loci 
  AMEL D19 D3 D8 THO1 D21 FGA D16 D18 D2 
Total number of observed alleles 
at each locus 
42 41 41 35 28 21 23 24 21 11 
Total number of alleles possible 98 98 98 98 98 98 98 98 98 98 
Percentage of alleles amplified 
for each locus (standard injection) 
(%) 
43 42 42 36 29 21 23 24 21 11 
Percentage of alleles amplified 
for each locus (increased 
injection) (%) 
45 44 42 39 31 24 26 27 23 11 
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8.7 Summary data for relationship between fragment size and allele peak height (Figure 3.9) 
Table 8-5 Peak height (Ht in RFU) and fragment size (Fs in bp) for each amplified peak at all locus for each cell, using a standard CE injection time 
  D3 D16 D2 AMEL D8 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
5 - - - - - - - - - - - - - - - - - - 79 152.48 
6 35 126.18 - - - - - - - - - - - - - - - - - -  
7 200 126.60 349 130.64 - - 142 256.73 - - 132 312.33 666 102.79 447 108.37 82 137.73 43 152.77 
9 443 126.83 - - - - - - - - - - - - - - - - - -  
10 721 126.78 - - - - - - - - - - 250 102.95 - - 146 139.50 419 153.36 
11 169 126.67 - - - - - - - - - - - - 130 108.48 - - - -  
13 395 126.72 118 130.87 - - 145 257.02 - - 108 312.52 656 102.97 415 108.49 - - 236 152.58 
14 248 126.69 - - - - - - - - - - 244 102.95 230 108.46 152 139.30 - -  
15 467 126.52 - - - - - - - - - - 579 102.80 187 108.40 - - - -  
                       D21 D18 D19 THO1 FGA 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
5 - - - - - - - - - - - - 266 174.33 - - - - - -  
6 - - - - - - - - - - - - - - - - - - - -  
7 299 208.16 371 216.02 - - 207 308.85 261 116.24 384 124.17 - - - - 270 220.07 - -  
9 - - - - - - - - - - - - - - - - - - - -  
10 - - - - - - - - - - - - - - - - 168 220.49 - -  
11 - - 90 216.09 - - - - 27 124.15 - - - - - - - - - -  
13 - - - - - - - - 272 116.32 179 124.27 - - 288 182.41 - - - -  
14 - - - - - - 66 309.21 200 116.34 - - 500 178.48 - - - - -  - 
15 181 208.12 - - - - - - 164 116.30 302 124.17 - - 364 182.36 - - 294 228.34 
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  D3 D16 D2 AMEL D8 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
19 72 126.00 - - - - - - - - - - 150 102.66 230 108.30 - - - - 
20 54 126.47 37 130.52 391 240.4 111 256.56 188 294.56 - - 270 102.73 367 108.26 - - 255 152.87 
22 - - - - - - - - - - - - 247 102.6 - - - - 122 152.70 
23 135 126.44 106 130.53 - - 81 256.41 - - - - 159 102.59 169 108.16 124 139.00 - - 
24 - - - - - - - - - - - - - - 253 108.21 - - - - 
25 417 126.48 155 130.50 - - - - - - - - 284 102.6 312 108.12 144 139 87 152.82 
26 680 126.49 - - - - - - - - - - - - - - - - 132 152.73 
28 - - - - - - - - - - - - - - - - - - - - 
29 264 126.48 - - - - 220 256.63 - - 102 312.03 267 102.61 279 108.25 - - - - 
30 - - - - - - - - - - - - 279 102.69 205 108.32 125 139.1 - - 
                     
                       D21 D18 D19 THO1 FGA 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
19 - - - - - - - - 335 116.32 - - 88 178.18 323 182.22 - - - - 
20 276 208.01 - - - - 106 308.64 194 116.25 110 124.20 - - 307 182.22 100 219.99 - - 
22 - - - - - - - - - - - - - - - - - - - - 
23 - - - - 89 282.51 - - 151 116.22 - - - - 109 182.20 - - 277 227.90 
24 - - - - - - - - - - 159 124.15 - - - - - - 124 227.92 
25 - - - - 188 282.45 - - 213 116.21 351 124.19 - - 317 182.48 - - 127 227.96 
26 - - - - - - - - 708 116.32 - - - - - - - - - - 
28 - - - - - - - - 43 116.21 - - - - - - - - - - 
29 240 208.05 427 216.00 - - 106 308.28 - - 382 124.26 346 178.36 262 182.27 - - - - 
30 - - 193 215.97 - - - - - - - - - - - - - - - - 
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  D3 D16 D2 AMEL D8 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
31 - - - - 84 240.32 249 256.5 - - 96 312.13 - - 388 108.27 151 139.00 141 152.72 
32 201 126.55 180 130.67 48 240.49 187 256.60 - - - - - - - - 100 139.10 - - 
33 445 126.54 526 130.60 - - 174 256.69 182 294.56 - - 310 102.71 353 108.30 - - 111 152.75 
34 - - - - - - - - - - - - 303 102.61 - - - - 105 152.42 
35 355 126.42 - - - - - - - - - - - - - - - - 151 152.73 
36 376 126.68 676 130.72 - - 125 256.78 - - 140 312.53 600 102.78 656 108.43 - - 216 152.42 
37 498 126.65 385 130.77 - - - - 256 294.73 76 312.34 - - 258 108.40 - - 170 153.02 
38 409 126.58 609 130.69 - - - - - - - - - - - - 126 139.20 101 153.00 
39 519 126.56 735 130.64 499 240.64 464 256.77 - - - - - - - - 414 139.20 - - 
40 - - - - - - - - - - - - 233 102.85 - - - - - - 
                     
                       D21 D18 D19 THO1 FGA 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
31 - - 125 215.98 - - - - 377 124.22 - - - - 309 182.33 101 219.81 - - 
32 - - - - - - 115 308.41 227 116.32 - - 374 178.26 - - 134 219.94 157 227.99 
33 - - 216 216.01 261 282.62 105 308.67 - - 305 124.22 229 178.31 613 182.35 - - 350 228.00 
34 - - - - - - - - - - 170 124.08 - - - - - - - - 
35 - - - - - - - - - - 242 124.20 - - - - - - - - 
36 314 208.13 - - - - - - 414 116.33 538 124.28 - - 267 182.37 147 220.10 - - 
37 - - - - 175 282.83 51 308.71 395 116.27 353 124.26 - - - - - - 229 228.26 
38 - - - - - - 79 309.04 447 116.15 260 124.20 297 178.35 399 182.34 - - - - 
39 265 208.16 - - - - 117 308.87 92 116.26 276 124.27 447 178.38 250 182.44 88 220.12 292 228.29 
40 - - - - - - - - - - - - - - - - - - - - 
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  D3 D16 D2 AMEL D8 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
41 - - - - - - - - - - - - 398 102.83 - - - - - - 
42 - - 151 130.73 142 240.65 117 256.77 - - 90 312.46 - - - - 70 139.20 53 153.10 
44 - - - - 108 240.60 368 256.76 53 294.65 - - 287 102.80 1248 108.40 110 139.16 - - 
45 548 126.56 315 130.61 - - - - - - - - - - - - - - - - 
46 - - - - - - - - - - - - 343 102.55 - - - - - - 
47 266 126.44 - - 265 240.47 477 256.57 - - - - 521 102.57 808 108.19 344 139.00 53 152.48 
48 464 123.51 259 130.64 294 240.36 129 256.42 - - - - 511 102.64 489 108.25 112 138.54 224 152.77 
49 278 126.40 - - - - - - - - - - - - - - 147 138.91 - - 
50 252 126.56 593 130.61 1260 240.48 1109 256.61 - - - - 1072 102.66 981 108.29 588 139.00 296 152.87 
                     
                       D21 D18 D19 THO1 FGA 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
41 - - - - - - - - - - - - 149 178.32 - - - - - - 
42 83 208.04 35 215.88 34 282.72 - - - - - - - - - - 93 220.17 - - 
44 262 207.98 269 215.87 198 282.64 - - 598 116.29 156 124.08 463 178.29 356 182.37 - - 87 227.89 
45 256 207.99 - - - - - - - - - - - - - - - - 102 227.95 
46 - - 179 215.93 - - - - 315 116.22 - - - - - - - - - - 
47 260 208.08 190 215.97 165 282.54 - - 403 116.19 339 124.17 305 178.24 228 182.27 - - - - 
48 285 207.96 - - 340 282.55 78 308.47 532 116.22 295 124.16 632 178.23 294 182.33 386 219.87 281 227.95 
49 - - - - - - 143 308.52 - - 223 124.15 - - - - 217 219.87 - - 
50 1166 208.01 798 216.01 136 282.62 268 308.56 715 116.31 208 124.29 2325 178.24 373 182.18 680 219.90 481 228.01 
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Table 8-6 Peak height (Ht in RFU) and fragment size (Fs in bp) for each amplified peak at all locus for each cell, using a increased CE injection time 
  D3 D16 D2 AMEL D8 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
5 - - - - - - - - - - - - - - - - - - 271 152.24 
6 114 126.25 - - - - - - - - - - - - - - - - - - 
7 574 125.36 1286 129.53 - - 437 256.6 - - 366 311.98 937 102.48 913 107.99 373 138.18 157 152.22 
8 - - - - - - - - - - - - - - - - 41 140.21 - - 
9 740 125.53 - - - - - - - - - - - - - - - - - - 
10 1152 125.53 - - - - - - - - - - 403 102.74 - - 374 138.17 911 152.20 
11 198 125.48 - - - - - - - - - - - - 361 108.06 - - - - 
13 1102 125.49 419 129.6 - - 477 256.51 - - 350 311.97 1102 102.48 1287 108.06 - - 1038 152.00 
14 606 125.49 - - - - - - - - - - 494 102.48 462 108.06 430 138.18 - - 
15 1228 125.51 - - - - - - - - - - 1211 102.37 376 107.98 - - - - 
                       D21 D18 D19 THO1 FGA 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
5 - - - - - - - - - - - - 850 174.09 - - - - - - 
6 - - - - - - - - - - - - - - - - - - - - 
7 902 208.01 1117 215.92 - - 626 308.82 687 115.03 1043 123.06 - - - - 802 219.72 - - 
8 - - - - - - - - - - - - - - - - - - - - 
9 - - - - - - - - - - - - - - - - - - - - 
10 - - - - - - - - - - - - - - - - 527 220.11 - - 
11 - - 286 215.96 - - - - 92 124.10 - - - - - - - - - - 
13 - - - - - - - - 804 116.20 443 124.02 - - 1030 182.28 84 219.79 - - 
14 - - - - - - 233 308.44 606 116.10 - - 1827 178.23 - - - - - - 
15 565 207.95 - - - - - - 661 116.19 1154 124.13 - - 1273 182.13 - - 1045 227.67 
 
 
256 
 
  D3 D16 D2 AMEL D8 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
19 133 125.99 - - - - - - - - - - 328 102.32 474 107.88 - - - - 
20 73 125.80 134 129.85 1367 240.17 406 256.37 660 294.25 - - 601 102.38 821 107.90 - - 975 152.17 
22 - - - - - - - - - - - - 498 102.35 - - - - 418 152.17 
23 444 125.51 418 129.65 - - 347 256.44 - - - - 428 102.42 459 108.02 606 138.22 - - 
24 - - - - - - - - - - - - - - 804 108.01 - - - - 
25 1237 125.59 494 129.72 - - - - - - - - 569 102.37 498 107.99 552 138.24 335 152.18 
26 1637 125.60 - - - - - - - - - - - - - - - - 478 152.28 
28 - - - - - - - - - - - - - - - - - - - - 
29 701 125.63 - - - - 782 256.32 - - 333 311.71 1072 102.29 1087 107.86 - - - - 
30 - - - - - - - - - - - - 1045 102.27 776 107.89 470 138.27 - - 
                     
                       D21 D18 D19 THO1 FGA 
  Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
19 - - - - - - - - 1343 116.22 - - 322 178.14 1134 182.16 - - - - 
20 933 207.90 - - - - 375 308.13 813 116.18 446 124.13 - - 1118 182.04 367 219.57 50 227.57 
22 - - - - - - - - - - - - - - - - - - - -  
23 - - - - 406 282.54 - - 603 116.11 - - - - 519 182.25 - - 1228 227.79 
24 - - - - - - - - - - 507 124.09 - - - - - - 437 227.74 
25 - - - - 627 282.44 36 308.25 532 116.11 925 124.15 - - 1071 182.11 37 219.56 398 227.68 
26 - - - - - - - - 1663 116.16 - - - - - - - - - - 
28 - - - - - - - - 115 116.07 - - - - - - - - - - 
29 798 207.86 1412 215.79 - - 379 308.09 - - 923 123.93 1162 178.02 847 181.98 - - - - 
30 - - 613 215.81 - - - - - - - - - - - - - - - - 
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  D3 D16 D2 AMEL D8 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
31 - - - - 288 240.26 878 256.32 - - 290 311.72 - - 1237 107.93 649 138.28 560 152.18 
32 559 125.68 631 129.80 134 240.27 592 256 - - - - - - - - 382 138.29 - - 
33 1245 125.70 1620 129.78 - - 591 256.38 555 294.21 - - 1199 102.24 1402 107.86 - - 471 152.21 
34 - - - - - - - - - - - - 1373 102.23 - - - - 524 152.23 
35 903 125.64 - - - - - - - - - - - - - - - - 556 152.26 
36 1048 125.67 2042 129.83 - - 411 256.36 - - 407 311.68 2200 102.26 2497 107.9 163 138.28 930 152.16 
37 850 125.66 1252 129.80 - - - - 777 194.20 225 311.83 - - 821 107.89 
  
742 152.30 
38 1164 125.68 1863 129.77 - - - - - - - - - - - - 553 138.29 458 152.19 
39 931 125.60 1477 129.71 1763 240.08 1640 256.31 - - - - - - - - 950 138.29 - - 
40 - - - - - - - - - - - - 895 102.31 - - - - - - 
                     
                       D21 D18 D19 THO1 FGA 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
31 - - 392 215.83 - - - - 904 123.89 - - - - 1000 182.05 339 219.36 - - 
32 - - - - - - 375 308.19 491 115.70 - - 1178 177.93 - - 399 219.34 447 227.49 
33 - - 678 215.74 895 282.39 379 308 - - 672 123.64 753 177.96 2000 181.92 - - 1079 227.38 
34 - - - - - - - - - - 476 123.61 - - - - - - - - 
35 - - - - - - - - - - 476 123.62 - - - - - - - - 
36 927 207.83 - - - - - - 882 115.65 1175 123.60 - - 790 182.06 428 219.35 - - 
37 - - - - 615 282.46 189 308 874 115.57 843 123.69 - - - - - - 784 227.51 
38 - - - - - - 297 308.33 1054 115.41 617 123.51 1015 177.98 1307 181.96 - - - - 
39 830 207.87 - - - - 397 308.33 244 115.52 732 123.5 1553 178.03 841 182.02 305 219.36 954 227.5 
40 - - - - - - - - - - - - - - - - - - - - 
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  D3 D16 D2 AMEL D8 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
41 - - - - - - - - - - - - 1737 102.29 - - - - - - 
42 - - 485 129.80 522 240.35 453 256.54 45 294.25 319 311.87 - - - - 297 138.37 234 152.35 
44 - - - - 325 240.16 1068 256.38 483 294.24 - - 919 102.26 3980 107.88 229 138.22 - - 
45 1681 125.68 1053 129.78 - - - - - - - - - - - - - - - - 
46 - - - - - - - - - - - - 1163 102.32 - - - - - - 
47 639 125.65 - - 782 240.39 1414 256.51 - - - - 1845 102.41 2885 108.01 1266 138.27 163 152.36 
48 1196 125.78 708 129.92 887 240.33 400 256.51 - - - - 1850 102.40 1779 108.04 400 138.37 770 152.28 
49 755 125.71 - - - - - - - - - - - - - - 553 138.38 - - 
50 538 125.78 1471 129.83 3317 240.41 2879 256.58 - - - - 3368 102.37 3205 107.03 1972 138.36 973 152.30 
                     
                       D21 D18 D19 THO1 FGA 
Id Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs Ht Fs 
41 - - - - - - - - - - - - 517 177.93 - - - - - - 
42 284 207.94 123 215.87 130 282.51 71 308.31 - - 59 123.49 - - - - 323 219.46 - - 
44 788 207.87 803 215.82 676 282.47 - - 1916 115.41 504 123.45 1391 177.94 1070 181.98 - - 266 227.54 
45 923 207.89 60 215.86 - - - - - - - - - - - - - - 368 227.54 
46 - - 497 215.91 - - - - 677 115.44 - - - - - - - - - - 
47 754 207.95 550 215.97 508 282.58 - - 844 115.45 737 123.48 919 178.00 667 181.99 - - - - 
48 865 207.89 - - 1114 282.59 238 308.51 1176 115.21 659 123.55 1886 178.02 878 182.05 1121 219.45 862 227.6 
49 - - - - - - 510 308.56 - - 502 123.44 - - - - 648 219.50 - - 
50 2857 208.02 2012 215.94 374 282.61 742 308.46 1427 115.48 432 123.51 6010 178.02 975 181.97 1646 219.53 1180 227.72 
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8.8 Summary of heterozygous balance data (Figure 3.10 and Figure 
3.11) 
 
Table 8-7 Heterozygous balance values for loci with both alleles present using a 
standard CE injection time. Hb = LMW area/ HMW area 
Id D3 D16 D2 AMEL D8 D21 D18 D19 THO1 FGA 
7 0.60 - - 0.68 0.58 0.78 - 0.64 - - 
10 - - - - 0.33 - - - - - 
13 - - - 0.64 - - - 0.67 - - 
14 - - - 0.98 - - - - - - 
15 - - - 0.34 - - - 0.50 - - 
19 - - - 0.59 - - - - 0.27 - 
20 0.45 0.29 - 0.71 - - - 0.60 - - 
23 0.65 - - 0.94 - - - - - - 
24 - - - - - - - - - - 
25 0.32 - - 0.87 0.65 - - 0.58 - - 
29 - - - 0.97 - 0.54 - - 0.74 - 
30 - - - 0.74 - - - - - - 
31 - 0.34 - - 0.81 - - - - - 
32 0.80 0.30 - - - - - - - 0.83 
33 0.87 - - 0.86 - - 0.42 - 0.37 - 
36 0.59 - - 0.93 - - - 0.75 - - 
37 0.85 - 0.29 - - - 0.32 0.96 - - 
38 0.73 - - - 0.76 - - 0.57 0.75 - 
39 0.72 0.93 - - - - - 0.32 0.55 0.29 
42 - 0.82 - - 0.73 0.37 - - - - 
44 - 0.29 - 0.23 - 0.96 - 0.26 0.77 - 
45 0.54 - - - - - - - - - 
47 - 0.58 - 0.65 0.14 0.75 - 0.85 0.73 - 
48 0.51 0.46 - 0.95 0.56 - 0.23 0.55 0.47 0.76 
50 0.46 0.90 - 0.92 0.49 0.69 0.49 0.29 0.16 0.71 
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Table 8-8 Heterozygous balance values for loci with both alleles present using an 
increased CE injection time. Hb = LMW area/ HMW area 
Id D3 D16 D2 AMEL D8 D21 D18 D19 THO1 FGA 
7 0.41 - - 0.97 0.52 0.79 - 0.66 - - 
10 - - - - 0.37 - - - - - 
13 - - - 0.85 - - - 0.56 - - 
14 - - - 0.92 - - - - - - 
15 - - - 0.31 - - - 0.56 - - 
19 - - - 0.72 - - - - 0.28 - 
20 0.54 0.30 - 0.77 - - - 0.55 - 0.15 
23 0.94 - - 0.94 - - - - - - 
24 - - - - - - - - - - 
25 0.40 - - 0.85 0.63 - - 0.57 - 12.06 
29 - - - 0.97 - 0.57 - - 0.74 - 
30 - - - 0.74 - - - - - - 
31 - 0.32 - - 0.93 - - - - - 
32 0.90 0.22 - - - - - - - 0.87 
33 0.77 - - 0.84 - - 0.44 - 0.37 - 
36 0.52 - - 0.88 0.14 - - 0.77 - - 
37 0.68 - 0.30 - - - 0.30 0.93 - - 
38 0.62 - - - 0.94 - - 0.56 0.76 - 
39 0.63 0.94 - - - - - 0.34 0.54 0.31 
40 - 0.86 0.12 - 0.91 0.42 0.54 - - - 
44 - 0.30 - 0.23 - 0.96 - 0.26 0.77 - 
45 0.62 - - - - 0.06 - - - - 
47 - 0.55 - 0.65 0.13 0.73 - 0.86 0.73 - 
48 0.57 0.46 - 0.96 0.47 - 0.23 0.54 0.47 0.77 
50 0.36 0.88 - 0.96 0.50 0.71 0.49 0.30 0.16 0.72 
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8.9 Summary of alleles observed at each locus (Figure 3.12 and Figure 3.15) 
Table 8-9 Summary of alleles amplified at each locus using a standard CE injection time (-) denotes no observed amplification 
Id D3 VWA D16 D2 AMEL D8 D21 D18 D19 THO1 FGA 
4 - - 17 - - - - - - - - - - - - - - - - - - 
5 - - - - - - - - - - 15 - - - - - - - - - - 
6 16 - - - - - - - - - - - - - - - - - - - - 
7 16 17 17 - 12 - 20 X Y 12 15 30 32 - 18 13 15 - - 19 - 
9 16 - - - - - - - - - - - - - - - - - - - - 
10 16 - 17 - - - - X - 12 15 - - - - - - - - 19 - 
11 16 - 17 - - - - - Y - - - 32 - - - 15 - - - - 
13 16 17 17 - 12 - 20 X Y - 15 - - - - 13 15 - 9 - - 
14 16 - - - - - - X Y 12 - - - - 18 13 - 8 - - - 
15 16 - 17 - - - - X Y - - 30 - - - 13 15 - 9 - 21 
19 16 - 17 - - - - X Y - - - - - - 13 - 8 9 - - 
20 16 17 17 8 12 16 - X Y - 15 30 - - 18 13 15 - 9 19 - 
22 - - 17 - - - - X - - 15 - - - - - - - - - - 
23 16 17 - - 12 - - X Y 12 - - - 12 - 13 - - 9 - 21 
24 - - 17 - - - - - Y - - - - - - - 15 - - - 21 
25 16 17 - - - - - X Y 12 15 - - 12 - 13 15 - 9 - 21 
26 16 - 17 - - - - - - - 15 - - - - 13 - - - - - 
28 - - - - - - - - - - - - - - - 13 - - - - - 
29 16 - 17 - 12 
 
20 X Y - - 30 32 - 18 - 15 8 9 - - 
30 - - - - - - - X Y 12 - - 32 - - - - - - - - 
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Id D3 VWA D16 D2 AMEL D8 D21 D18 D19 THO1 FGA 
31 - - 17 8 12 - 20 - Y 12 15 - 32 - - - 15 - 9 19 - 
32 16 17 17 8 12 - - - - 12 - - - - 18 13 - 8 - 19 21 
33 16 17 17 - 12 16 - X Y - 15 - 32 12 18 - 15 8 9 - 21 
34 - - - - - - - X - - 15 - - - - - 15 - - - - 
35 16 - - - - - - - - - 15 - - - - - 15 - - - - 
36 16 17 17 - 12 - 20 X Y - 15 30 
 
- - 13 15 - 9 19 - 
37 16 17 17 - - 16 20 - Y - 15 - - 12 18 13 15 - - - 21 
38 16 17 17 - - - - - - 12 15 - - - 18 13 15 8 9 - - 
39 16 17 17 8 12 - - - - 12 - 30 - - 18 13 15 8 9 19 21 
41 - - - - - - - X - - - - - - - - - 8 - - - 
42 - 17 17 8 12 - 20 - - 12 15 30 32 12 - - - - - 19 - 
44 - - 17 8 12 16 - X Y 12 - 30 32 12 - 13 15 8 9 - 21 
45 16 17 - - - - - - - - - 30 - - - - - - - - 21 
46 - - 17 - - - - X - - - - 32 - - 13 - - - - - 
47 16 - 17 8 12 - - X Y 12 15 30 32 12 - 13 15 8 9 - - 
48 16 17 17 8 12 - - X Y 12 15 - - 12 18 13 15 8 9 19 21 
49 16 - - - - - - - - 12 - - - - 18 - 15 - - 19 - 
50 16 17 17 8 12 - - X Y 12 15 - 32 12 18 13 15 8 9 19 21 
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Table 8-10 Summary of alleles amplified at each locus using an increased CE injection time (-) denotes no observed amplification 
Id D3 VWA D16 D2 AMEL D8 D21 D18 D19 THO1 FGA 
4  - -  17 - - - - - - - - - -  - - - - - - - -  
5 - - - - - - - - - - 15 - - - - - - - - - -  
6 16 - - - - - - - - - -  - - - - - - - - - -  
7 16 17 17 - 12 - 20 X Y 12 15 30 32 - 18 13 15 - - 19 -  
8 - - - - - - - - - 12 - - - - - - - - - - -  
9 16 - - - - - - - - - - - - - - - - - - - -  
10 16 - 17 - - - - X - 12 15 - - - - - - - - 19  - 
11 16 - 17 - - - - - Y - - - 32 - - - 15 - - -  - 
13 16 17 17 - 12 - 20 X Y - 15 - - - - 13 15 - 9 19  - 
14 16 - - - - - - X Y 12 - - - - 18 13 - 8 - -  - 
15 16 - 17 - - - - X Y - - 30 - - - 13 15 - 9 - 21 
19 16 - 17 - - - - X Y - - - - - - 13 - 8 9 -  - 
20 16 17 17 8 12 16 - X Y - 15 30 - - 18 13 15 - 9 19 21 
22 - - 17 - - - - X - - 15 - - - - - - - - -  - 
23 16 17 - - 12 - - X Y 12 - - - 12 - 13 - - 9 - 21 
24 - - 17 - - - - - Y - - - - - - - 15 - - - 21 
25 16 17 - - - - - X Y 12 15 - - 12 18 13 15 - 9 19 21 
26 16 - 17 - - - - - - - 15 - - - - 13 - - - -  - 
28 - - - -- - - - - - - - - - - - 13 - - - -  - 
29 16 - 17 - 12 - 2 X Y - - 30 32 - 18 - 15 8 9 -  - 
30 - - - - - - - X Y 12 - - 32 - - - - - - -  - 
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Id D3 VWA D16 D2 AMEL D8 D21 D18 D19 THO1 FGA 
31 - - 17 8 12 - 20 - Y 12 15 - 32 - - - 15 - 9 19 -  
32 16 17 17 8 12 - - - - 12 - - - - 18 13 - 8 - 19 21 
33 16 17 17 - 12 16 - X Y - 15 - 32 12 18 - 15 8 9 - 21 
34 - - - - - - - X - - 15 - - - - - 15 - - - -  
35 16 - - - - - - - - - 15 - - - - - 15 - - - -  
36 16 17 17 - 12 - 20 X Y 12 15 30 - - - 13 15 - 9 19  - 
37 16 17 17 - - 16 20 - Y - 15 - - 12 18 13 15 - - - 21 
38 16 17 17 - - - - - - 12 15 - - - 18 13 15 8 9 -  - 
39 16 17 17 8 12 - - - - 12 - 30 - - 18 13 15 8 9 19 21 
40 - - - - - - - X - - - - - - - - - - - -  - 
41 - - - - - - - X - - - - - - - - - 8 - -  - 
42 - 17 17 8 12 16 20 - - 12 15 30 32 12 18 - 15 - - 19  - 
44 - - 17 8 12 16 - X Y 12 - 30 32 12 - 13 15 8 9 - 21 
45 16 17 - - - - - - - - - 30 32 - - - - - - - 21 
46 - - 17 - - - - X - - - - 32 - - 13 - - - -  - 
47 16 - 17 8 12 - - X Y 12 15 30 32 12 - 13 15 8 9 -  - 
48 16 17 17 8 12 - - X Y 12 15 - - 12 18 13 15 8 9 19 21 
49 16 - - - - - - - - 12 - - - - 18 - 15 - - 19  - 
50 16 17 17 8 12 - - X Y 12 15 - 32 12 18 13 15 8 9 19 21 
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8.10 Summary of stutter (%) observed at each locus (Figure 3.16 
and Figure 3.17 and Figure 3.18)  
 
Table 8-11 Percentage of stutter observed for each locus per sample using a standard 
CE injection time 
Id D3 VWA D16 D8 D21 D18 D19 THO1 FGA 
7 - 15 - - - - - 12 8 - 13 23 11 - - -  - 
10 - 6 8 - - - - - - - - - - - - -  - 
13 - 5 8 - - - - - - - - 18 - - - -  - 
15 - 7 12 - - - - 11 - - - - 11 - - - 9 
20 - - 6 - - - - - - - - - - - - -  - 
25 - 9 - - - - - - - - - - 12 - - -  - 
26 - 13 - - - - - - - - - - - - - -  - 
29 - 13 10 - 12 - - - 16 - - - - - - -  - 
31 - - 7 - - - - - - - - 29 - - - -  - 
32 - - 9 - - - - - - - - - - - - -  - 
33 - 6 7 - - - - - 11 - - - - - - - 8 
35 - - - - - - - - - - - - 15 - - -  - 
36 - 12 8 - - - - 16 - - - - 9 - - -  - 
37 - 19 - - - - - - - - - - 10 - - - 10 
38 - 4 14 - - - - - - - - - 11 - - -  - 
39 - - 8 - 6 - - - - - 33 - - - - -  - 
42 - - 7 - 
 
- - - - - - - - - - -  - 
44 - - 9 - 7 - - - 15 - - 8 20 - - -  - 
45 - 3 - - - - - - - - - - - - - -- -  
46 - - 7 - - - - - - - - - - - - - -  
47 - - 7 - 9 8 - - 16 - - - 11 - - -  - 
48 - 6 10 - - - - 7 - - - - 9 - - 7 8 
50 - - 7 3 6 9 - 8 14 - 13 - - 3 - 5 7 
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Table 8-12 Percentage of stutter observed for each locus per sample using an increased 
CE injection time 
Id D3 VWA D16 D8 D21 D18 D19 THO1 FGA 
7 - 21 - - - - - 10 9 - 13 19 10 - - - - 
10 - 2 7 - - - - - - - - - - - - - - 
13 - 29 12 - - - - - - - - 2 - - - - - 
15 - 20 14 - - - - 9 - - - - 13 - - - 8 
20 - - 7 - - - - - - - - - - - - - - 
25 - 6 - - - - - - - - - - 10 - - - - 
26 - 13 - - - - - - - - - - - - - - - 
29 - 13 11 - 11 - - - 14 - - - - - - - - 
31 - - 6 - - - - - - - - 28 - - - - - 
32 - - 9 - - - - - - - - - - - - - - 
33 - 4 6 - - - - - 10 - - - - - - - 8 
35 - - - - - - - - - - - - 15 - - - - 
36 - 10 7 - - - - 16 - - - - 10 - - - - 
37 - 24 - - - - - - - - - - 11 - - - 10 
38 - 3 13 - - - - - - - - - 10 - - - - 
39 - - 8 - 7 - - - - - 30 - - - - - - 
42 - - 7 - - - - - - - - - - - - - - 
44 - - 9 - 6 - - - 14 - - 8 20 - - - - 
45 - 3 - - - - - - - - - - - - - - - 
46 - - 7 - - - - - - - - - - - - - - 
47 - - 8 - 9 7 - - 14 - - - 11 - - - - 
48 - 3 8 - - - - 6 - - - - 9 - - 5 7 
50 - - 6 2 6 8 - 7 13 - 12 - - 3 - 5 6 
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8.11 Summary of observed amplified alleles for assay trial (Figure 3.19) 
Table 8-13 DNA profiles from single-cells (SC) amplified using the Promega ESI 16 assay 
ESI AMEL D3 D19 D2S1338 D22 D16 D18 D1 D10 D2S441 THO1 vWA D21 D12 D8 FGA 
ESI_SC_b - - 16 - -   - - - - - - - -  -  - - - - - - - - - - -  -  -  -  -  -  
ESI_SC_c X Y 16 17 - - - - - - - 12 - - 11 - - - - 8 9 17 30 32 - - - - -  - 
ESI_SC_d - Y 16 17 - 15 - - - - - - 12 18 - - - - 11 8 - - - - - 23 - - -  - 
ESI_SC_e - - - - 13 - - - - 16 - - - - - - - - - - - 17 - - - - - - -  - 
ESI_SC_f - - - - - - - - 13 - - - - - - - - - - - - 17 - - - - - - -  - 
ESI_SC_g - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  - 
ESI_SC_h - Y - - - - - - - - 8 12 12 18 - - - - - - 9 17 - - - - - - 19 21 
ESI_SC_i X Y 16 - 13 15 16 - - - 8 12 12 18 11 - - 16 11 8 9 17 - - 16 23 - - 19 21 
ESI_SC_j - Y 16 17 13 - - - - - 8 12 - - 11 15 - - - 8 9 17 - 32 - - - - 19 21 
 
Table 8-14 DNA profiles from single-cells (SC) amplified using the Promega ESX 16 assay 
ESX AMEL D3 THO1 D21 D18 D10 D1 D2S1338 D16 D22 vWA D8S1179 FGA D2S441 D12 D19 
ESX_SC_a X Y 16 17 8 9 30  - 12 18 13 16 11 15 16 20 8 12 13 16 17 12 15 19 21 11 16 23  - 15 
ESX_SC_b X Y 16 17 8 9 30 32 12 18 13 16 11 15 16 20 8 12 13 16 17 12 15 19 21 11 - 23 13 15 
ESX_SC_c X Y 16 17 8 9 - - 12 - - 16 11 - 16 - - - 13 16 17 - - 19 21 11 - 23 13 15 
ESX_SC_e X Y 16 17 8 9 30 32 - 18 13 16 - 15 16 - 8 12 13 16 17 12 - 19 21 11 16 23 13 15 
ESX_SC_f - Y 16 17 8 9 30 32 - 18 13 16 - - 16 20 8 12 - 16 17 - 15 - - 11 - 23 -  - 
ESX_SC_g - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
ESX_SC_h - - - 17 - - 30 32 12 18 - - 11 15 - - - - 13 16 17 - - - 21 11 - 23 -  - 
ESX_SC_i X Y 16 17 8 9 30 32 - 18 13 16 11 15 16 20 8 12 13 16 17 12 15 19 - 11 16 23 13 15 
ESX_SC_j X Y 16 - 8 - 30 32 12 18 13 16 11 - - 20 8 12 13 - 17 - 15 19 - 11 16 - 13 15 
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Table 8-15 DNA profiles from single-cells (SC) amplified using the Applied Biosystems SGM Plus assay 
SGM PLUS D3 VWA D16 D2 AMEL D8 D21 D18 D19 THO1 FGA 
SGM_SC_a 15 16 18 19 - - - 23 X 10 11 28 30 14 20 14 15 - 9 22 24 
SGM_SC_b 15 16 - 19 11 14 - 23 X - 11 - - - 20 14 15 - 9 - - 
SGM_SC_c - - - - - - - - - - - - - - - - - - - - - 
SGM_SC_d - 16 18 - - 14 - 23 X 10 11 - 30 14 - - 15 - 9 - 24 
SGM_SC_e 15 16 - - 11 14 - - X - 11 - - 14 - 14 - 7 9 22 24 
SGM_SC_f - - - - - - - - - - - - - - - - - - - - - 
SGM_SC_g - - - 19 - - - - X - - - 30 - - 14 - 7 9 22 - 
SGM_SC_h - - 18 - - - - - X - - - - - - - 15 - - - - 
SGM_SC_i - - 18 - - - - 23 X - 11 - - - - 14 15 - - - - 
SGM_SC_j 15 16 - - 11 - 19 23 - - 11 28 - - 20 - 15 7 9 22 - 
 
Table 8-16 DNA profiles from single-cells (SC) amplified using the Applied Biosystems NGM assay 
NGM D10 VWA D16 D2 AMEL D8 D21 D18 D22 D19 THO1 FGA D2S441 D3 D1S1656 D12S391 
NGM_SC_a 14 18 19 - 14 - - X 10 11 28 - - - 15 17 14 - 7 9 - 24 12 14 15 - 11 17 18 -  
NGM_SC_b 14 - 19 - 14 19 - X 10 11 - - 14 20 15 17 14 15 7 9 22.2 - 12 14 15 - 11 17 18 -  
NGM_SC_c - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
NGM_SC_d - - - - - - - X - - - - - - - - - - - - - - - - - - - - - -  
NGM_SC_e 14 18 - 11 - 19 23 X 10 - 28 30 - - - 17 - 15 7 9 - - 12 14 15 - - 17 18 19 
NGM_SC_f - 18 19 - - - 23 X 10 11 28 - - - 15 - 14 - - 9 22.2 - 12 14 15 16 - - - 19 
NGM_SC_g 14 - - - 14 - - X 10 11 - 30 14 - - - - - 7 - - 24 12 14 - 16 - - - -  
NGM_SC_h - 18 - - 14 - - - 10 11 - 30 - - 15 - - - - - - - - 14 15 - 11 - 18 19 
NGM_SC_i - - - - - - - - - - - - - - 15 17 - - - - - - 12 14 - - - - - -  
NGM_SC_j 14 18 19 - - - 23 X 10 11 - - - - 15 17 - - - 9 - 24 12 14 - - - - - -  
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Table 8-17 DNA profiles from single-cells (SC) amplified using the 'in-house' ltDNA assay. Alleles defined using size as no ladder available 
ltDNA assay Penta E D12S391 D10S1428 Amelogenin 
ltDNA_SC_1 - 113.06 162.62 182.61 99.11 - - 113.24 
ltDNA_SC_2 - - - - 99.06 - - - 
ltDNA_SC_3 103.90 - - - 99.19 - 107.73 - 
ltDNA_SC_4 - 113.30 - - 99.20 - - - 
ltDNA_SC_5 103.68 - 162.41 - 99.03 - - - 
ltDNA_SC_6 - - - - 
 
- - - 
ltDNA_SC_7 103.83 - 162.46 - 99.16 - 107.64 - 
ltDNA_SC_8 - - 162.47 182.39 99.12 - 107.68 113.11 
ltDNA_SC_9 103.67 113.04 - - 99.02 - - 112.98 
ltDNA_SC_10 - - - - 99.09 102.96 - - 
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8.12 Statistics carried out in Chapter 3 
Fisher’s exact test for count data was carried out using R version 3.1.2 (2014-10-31) -- 
"Pumpkin Helmet". Copyright (C) 2014 The R Foundation for Statistical Computing. 
Locus dropout 
Null hypothesis: extending the CE injection time does not significantly reduce locus dropout 
 Locus amplified Locus dropped out 
Standard CE injection 
time 
229 200 
Extended CE injection 
time 
231 198 
 
> Locus.dropout <- read.csv("E:/Locus dropout.csv") 
>   View(Locus.dropout) 
> challenge.df = matrix(c(229,200,231,198), nrow = 2) 
> fisher.test(challenge.df) 
data:  challenge.df 
p-value = 0.9454 
alternative hypothesis: true odds ratio is not equal to 1 
95 percent confidence interval: 
 0.7436232 1.2952325 
sample estimates: 
odds ratio  
  0.981445 
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Allele dropout 
Null hypothesis: extending the CE injection time does not significantly reduce allele drop 
out 
 
Alleles 
amplified 
Alleles dropped out 
Standard CE 
injection time 
311 529 
Extended CE 
injection time 
322 518 
 
> Allele.dropout <- read.csv("E:/Allele dropout.csv") 
>   View(Allele.dropout) 
> challenge.df = matrix(c(311,529,322,518), nrow = 2) 
> fisher.test(challenge.df) 
data:  challenge.df 
p-value = 0.6146 
alternative hypothesis: true odds ratio is not equal to 1 
95 percent confidence interval: 
 0.7725123 1.1578405 
sample estimates: 
odds ratio  
 0.9458113 
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Heterozygous balance 
Null hypothesis: extending the injection time does not significantly reduce heterozygous 
imbalance of peaks 
 Balance Imbalance 
Standard CE injection 
time 
42 41 
Extended CE injection 
time 
47 47 
 
> Hb.Imbalance <- read.csv("E:/Hb Imbalance.csv") 
>   View(Hb.Imbalance) 
> challenge.df = matrix(c(42,41,47,47), nrow = 2) 
> fisher.test(challenge.df) 
data:  challenge.df 
p-value = 1 
alternative hypothesis: true odds ratio is not equal to 1 
95 percent confidence interval: 
 0.5441173 1.9287896 
sample estimates: 
odds ratio  
  1.024259 
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Presence of stutter peaks 
Null hypothesis: extending the CE injection time does not significantly reduce the number of 
stutter peaks 
 Stutter No stutter 
Standard CE injection 
time 
74 198 
Extended CE injection 
time 
110 281 
 
> Stutter.peaks <- read.csv("E:/Stutter peaks.csv") 
>   View(Stutter.peaks) 
> challenge.df = matrix(c(74,198,110,281), nrow = 2) 
> fisher.test(challenge.df) 
data:  challenge.df 
p-value = 0.8601 
alternative hypothesis: true odds ratio is not equal to 1 
95 percent confidence interval: 
 0.6640974 1.3684288 
sample estimates: 
odds ratio  
 0.9547822 
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Presence of stutter peaks over under the 15% threshold 
Null hypothesis: extending the CE injection time does not significantly reduce the peak 
height to below the 15% threshold 
 Under 15% 
threshold 
Over 15% threshold 
Standard CE injection time 240 32 
Extended CE injection 
time 
259 22 
 
> Stutter.peaks.over.threshold <- read.csv("E:/Stutter peaks over threshold.csv", 
header=FALSE) 
>   View(Stutter.peaks.over.threshold) 
> challenge.df = matrix(c(240,32,259,22), nrow = 2) 
> fisher.test(challenge.df) 
data:  challenge.df 
p-value = 0.1514 
alternative hypothesis: true odds ratio is not equal to 1 
95 percent confidence interval: 
 0.3425962 1.1677407 
sample estimates: 
odds ratio  
 0.6375896 
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8.13 Participant information and consent forms 
 
Participant Information sheet  
Project title: Visualisation, recovery & DNA profiling of human cells deposited onto a 
surface through contact with skin 
Investigator: Victoria Barlow      Email victoria.barlow@northumbria.ac.uk 
Principle supervisor: Dr Eleanor Graham  Email eleanor.graham@northumbria.ac.uk 
In order to decide whether or not you would like to participate in this study, please read all 
the information provided very carefully and raise any questions that you may have with the 
investigator. 
Project Introduction & Objectives 
In forensic science we often use the evidence left at the scene or on a victim/suspect to help 
identify the individual(s) involved. This evidence is often so small as to be invisible to the 
naked eye and consequently research has to be done to find ways that allow the scientists to 
‘see’ this evidence and interpret it for use in court. One type of such evidence is fibres which 
are often transferred between the clothes of the victim, suspect and also to/from the scene 
(i.e. carpets) and can help investigators link these items together. What fibres currently don’t 
help us work out is who was wearing the clothes or has been in contact with the fibres. 
Fibres are generally collected by placing adhesive tape over an area and pulling it off which 
should then have any fibres that have been transferred captured on it, known as fibre taping.  
What this project aims to do is look at cells under a microscope that have been transferred to 
the surface of the fibres and to see if a DNA profile can be obtained from them.  Factors that 
may affect the transfer of cells to fibres will also be investigated, for example whether the 
chemistry of the fibre or the amount of time skin is in contact with the fibres. By 
investigating these factors and obtaining a DNA profile from these cells will hopefully mean 
that investigators can use the evidence in court to help in the conviction of criminals.  
We use DNA profiling in forensic science to help identify who a particular biological 
sample came from. In order to do this we target a number of small regions of DNA that are 
known to vary between individuals called short tandem repeats (STR’s). Each repeat is made 
up of the same short DNA code, and it is the number of repeats that are present at each target, 
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which allows us to build up your DNA profile. As DNA is inherited from both mother and 
father, there are two versions of each target. 
For example, DNA target 1 – 6, 9   
ATAT ATAT ATAT ATAT ATAT ATAT     Number of repeats = 6 
 ATAT ATAT ATAT ATAT ATAT ATAT ATAT ATAT ATAT   Number of repeats = 9 
The areas of DNA targeted in this study cannot provide us with any additional information 
such as hair/eye colour, height etc., and will only be used to check that we get the expected 
profile result during our tests, so that we can rule out any contamination of the samples. 
What you will be required to do 
You are invited to take part in this study by volunteering to provide samples of cells 
transferred from the surface of your skin using the method outlined below. This method will 
not cause any pain or discomfort.   
 You will be asked to sign a consent form before participating and fill out a very brief 
questionnaire detailing very briefly your activities during the time the garment was 
worn, i.e. 3 hours spent in library, lunch with friends etc.  
 You will be given and asked to wear a cotton long sleeved top as part of your 
normal daily clothing which will allow your cells to transfer naturally to the outside 
of the fabric. You will then be asked to meet in Ellison building lab A316 and hug a 
second volunteer for two minutes (one minute with arms around the shoulders and 
one minute with arms around the side). Once the two minutes is completed you 
will be asked to deposit the top in a bag and hand back to the investigator. Fibre 
tapes from the top will then be searched for cells adhered to the surface of the 
transferred fibres, which will then be recovered for DNA profiling. This part of the 
study  will also require you to provide a buccal swab which is swabbed from the 
inside of your cheek, which will then be used to compare against the results from 
the cells taken from the fibres to check that they match.  Please note that no 
personal information other then gender will be determined with your DNA profile.  
This will take no longer then 10 minutes to complete. 
At the time of sampling you will be given a unique reference number and this is the number 
which will be linked to any data produced to ensure that you remain anonymous at all times. 
Your personal information will be kept in a secure cabinet which only people directly 
involved with this project will have access to. Any data that is published in a scientific 
journal or presented at a conference will use the reference number only. All tissue samples 
will be kept in a secure freezer and disposed of in accordance with University guidelines 
once this project has been completed, which is expected to be in October 2015. 
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Who can participate? 
Please only volunteer in this study if you are over the age of 18 years and do not have an 
allergy to cotton or have any skin conditions which could cause any discomfort during the 
sampling methods as described above. 
What if you change your mind? 
If you have any concerns regarding the methods used during these tests or use of your results 
then you please feel free to raise them with the investigator who will do their best to address 
your concerns. Should you wish to withdraw from the study at any point however, you are 
able to do so without providing a reason and without prejudice.  
If you have read al the information carefully and would like to participate in this study 
please contact Victoria Barlow using the email address at the top of the page. 
This study has been approved by the Northumbria University Chemical and Forensic 
Science Department Ethics Committee.  
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General consent form 
 
       School of Life Sciences 
 
                    INFORMED CONSENT FORM 
 
 
Project Title: ____________________________________________ 
 
Principal Investigator: _______________________ 
 
Participant Number: ______ 
 
                 please tick  
            where applicable 
I have read and understood the Participant Information Sheet.  
 
I have had an opportunity to ask questions and discuss this study and I have 
received satisfactory answers. 
 
 
I understand I am free to withdraw from the study at any time, without having 
to give a reason for withdrawing, and without prejudice. 
 
 
I agree to take part in this study.  
 
I would like to receive feedback on the overall results of the study at the email 
address given below.   
 
Email address…………………………………………………………………… 
 
 
 
 
 
Signature of participant.......................................................    Date.....……………….. 
 
(NAME IN BLOCK LETTERS)....................................................………………………. 
 
 
Signature of researcher.......................................................    Date.....……………….. 
 
(NAME IN BLOCK LETTERS)....................................................………………………. 
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Human tissue consent form 
     School of Life Sciences 
 
Consent Form for Tissue which is being removed and stored  
Principal Investigator: _______________________________________ 
Participant Number: __________ 
 
I agree that the following tissue or other bodily material may be taken and used for the study:  
 
Tissue/Bodily material Purpose Removal Method 
Skin cells 
 
 
 
 
 
 
 
 
 
 
Saliva 
 
 
To view under microscope attached to 
fibres and to recover a DNA profile 
 
 
 
 
 
 
 
 
To obtain a reference DNA profile for 
interpreting data 
-Swabbing a non-intimate area of the skin, 
i.e. hands 
  
-Fabric rubbed against non-intimate area of 
skin, i.e. hands 
 
-T-shirt worn for period of time for cells to 
transfer naturally 
 
-Swab of inside of cheek 
 
I understand that if the material is required for use in any other way than that explained to me, then my consent to this will be 
specifically sought. I understand that I will not receive specific feedback from any assessment conducted on my samples.  
 
I understand that the University may store this tissue in a Licensed Tissue Bank only for the duration of the study, it will 
then be destroyed. 
Method of disposal:    
Clinical Waste               
Other                             
If other please specify...........................................................  
 
Signature of participant.......................................................    Date.....………………..  
Signature of researcher.......................................................    Date.....………………..  
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8.14 Summary of data for DNA profiles obtained during two-way cell transfer test (Figure 4.10) 
 
Table 8-18 Table summarising DNA profiles obtained from cells recovered from the surface of textile fibres during two-way transfer test 
  Vol 1 Vol 2 Vol 3 Vol 4 Vol 5 Vol 6 Total 
  
 
  
 
  
 
    
No. of cell samples recovered 8 17 6 8 4 2 45 
No. of wearer profiles 1 7 2 3 3 0 16 
No. of non-wearer profiles 0 0 0 1 0 0 1 
No. of  failed samples 7 10 4 4 1 2 28 
  
 
  
 
  
 
    
No. of full profiles obtained 0 1 0 0 0 0 1 
Partials with 4+ alleles 1 5 2 1 1 0 10 
Partials with less than 4 alleles 0 1 0 1 2 0 4 
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8.15 Summary of data for the effect of increased SSR exposure (Figure 4.14) 
 
Table 8-19 Peak height (RFU) for amplified alleles following increasing exposure (hrs) to sticky stuff remover (SSR) 
Exposure (hrs) D3 VWA D16 D2 D8 D21 D18 D19 THO1 FGA 
5 458 386 688 386 398 222 215 456 245 532 249 244 379 517 335 353 173 173 
4 318 379 1284 701 371 230 165 402 471 592 340 99 167 489 441 444 165 89 
3 749 692 1317 838 69 216 127 380 331 245 215 85 439 656 502 354 140 83 
2 1091 991 1587 201 972 897 258 395 231 1161 344 559 461 373 542 650 457 407 
1 1300 958 1880 1298 901 371 407 1337 1088 566 717 597 701 1185 1325 1521 484 430 
0 1469 1286 2952 2038 749 724 1512 1112 836 1201 519 685 1270 1327 1231 1313 564 336 
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8.16 Summary of data showing the effectiveness of FAST™ minitapes with MBG water (Figure 4.15) 
 
Table 8-20 Alleles amplified at locus from a single-cell (in triplicate) using different tape and adhesive removers 
Sample id D3 VWA D16 D2 AMEL D8 D21 D18 D19 TH01 FGA 
FAST_TAPE_SSR_a - 16 14 - - 12 - X 11 13 - - - 13.2 15 - - 20 - 
FAST_TAPE_SSR_b 15 - - 16 - 12 - - - - - 30 - - 15 - 9.3 - - 
FAST_TAPE_SSR_c - - - - - - - - - 13 - - - - - - - - - 
FAST_TAPE_SDW_a - - - - - - - - - - - - - - - - - - - 
FAST_TAPE_SDW_b - - - 16 - - - - - - - - - - 15 - - - - 
FAST_TAPE_SDW_c 15 16 - - 9 - - X - - 27 - - 13.2 15 - - - - 
JLAR_TAPE_SSR_a 15 16 14 16 9 12 - X 11 13 - 30 12 13.2 15 7 - - - 
JLAR_TAPE_SSR_b 15 - - - - - - X - - - - - - - - - - - 
JLAR_TAPE_SSR_c - - - - - - - - - - - - - - - - - 20 - 
JLAR_TAPE_SDW_a 15 - - - - - - X 11 - - - - - - - - - 23 
JLAR_TAPE_SDW_b - - - - - - - - 11 - - - - - - - - - - 
JLAR_TAPE_SDW_c - - 14 16 9 12 - X 11 - 27 30 12 - 15 7 742 20 23 
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8.17 Summary of data demonstrating the persistence of single-cells in fibre tapes (Figure 4.19) 
 
Table 8-21 Peak heights for alleles amplified from single-cells following a 24 month period in storage on fibre tapes 
Sample id Amel D19 D3 D8 VWA TH01 D21 FGA D16 D18 D2 
24_months_a 
  
1973 2394 9371 11153 
            
1095     
24_months_b 4959 
 
2605 2604 9364 7387 2028 
   
3960 
   
911 4158 
    
  
24_months_c 410 3617 
 
3400 
   
2622 
       
3600 
    
  
24_months_d 
  
1500 
  
4704 
  
4585 
 
3967 
         
  
24_months_e 
 
5670 2853 3778 2438 1486 1226 1292 
  
2088 
         
  
24_months_f 
 
6247 
 
3276 1383 3606 
 
1344 
  
3898 
 
3288 
 
2975 
   
2929 
 
  
24_months_h 9861 14400 11866 4018 21281 11080 1877 2396 14188 4625 8160 1380 6844 2166 
 
2642 926 
 
2122 982 1145 
24_months_i 3645 5695 2284 5998 7219 4392 1876 807 5724 4260 6669 
 
1492 1253 2068 1849 1295 
   
790 
24_months_j 8911 5979 4731 9629 9551 5860 6648 
 
11668 3564 
 
2853 
 
2309 
 
3815 868 
   
1914 
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8.18 Ethical approval for Brazil samples 
 
Sao Paulo 
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Northumbria University ethics approval 
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8.19 Permission for sample destruction - Vindolanda 
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8.20 Illumina ForenSeq™ Signature Prep Kit Workflow 
Information taken directly from the ForenSeq™ DNA Signature Prep Reference Guide 
(Illumina, 2015c). 
1. Amplify and tag targets 
This process amplifies and tags the gDNA using a ForenSeq oligonucleotide primer mix 
with regions specific to DNA sequences upstream and downstream of STRs and SNPs. 
2. Enrich targets  
This process amplifies the DNA and adds Index 1 (i7) adapters, Index 2 (i5) adapters, and 
sequences required for cluster amplification. The index adapters tag DNA with a unique 
combination of index sequences, which allow data from each tagged library to be separated 
during later analysis. 
3. Purify libraries  
This process uses SPB (Sample Purification Beads) to purify the amplified libraries from the 
other reaction components. 
4. Normalize libraries  
This process prepares DNA libraries for cluster generation to make sure that libraries of 
varying yields are equally represented within the sequencing run. This process assures that 
samples with varying input amounts or sample types achieve consistent cluster density to 
optimize the resolution of individual samples when pooled together. By normalizing the 
concentration of the libraries, while preserving the content of each library, post-PCR 
quantification and individual PCR product normalization are not necessary. 
5. Pool libraries  
This process combines equal volumes of normalized library to create a pool of libraries that 
are sequenced together on the same flow cell. 
6. Denature and dilute libraries  
This process dilutes the libraries in HT1 (hybridization buffer), adds HSC (Human 
Sequencing Control), and heat denatures the libraries in preparation for sequencing.
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8.21 Primer design for adapted Edson primer sequences 
The colour coding of the difference parts of the sequence correspond with the diagrams shown in Figure 5.10 and Figure 5.11 
Primer ID FLOW ATTACHMENT SITE BARCODE PAD LINKER PRIMER 
AF1 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC CGCTG ATTCATGCAT TG CCC AAA GCT AAG ATT CTA AT 
AF2 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC AGGCG ATTCATGCAT TG CCC AAA GCT AAG ATT CTA AT 
AF3 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC GCGGT ATTCATGCAT TG CCC AAA GCT AAG ATT CTA AT 
AR1 CAA GCA GAA GAC GGC ATA CGA GAT AATAC ACCTGAGTCG TG TAC TAC AGG TGG TCA AGT AT 
AR2 CAA GCA GAA GAC GGC ATA CGA GAT TTTTC ACCTGAGTCG TG TAC TAC AGG TGG TCA AGT AT 
BF1 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC GTGAC ATTCATGCAT AT CAC CAT GAA TAT TGT ACG GT 
BF2 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC CCCTA ATTCATGCAT AT CAC CAT GAA TAT TGT ACG GT 
BF3 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC AGGTC ATTCATGCAT AT CAC CAT GAA TAT TGT ACG GT 
BR1 CAA GCA GAA GAC GGC ATA CGA GAT CACTT ACTTGAATAT CC GGA GTT GCA GTT GAT GT 
BR2 CAA GCA GAA GAC GGC ATA CGA GAT ATGCT ACTTGAATAT CC GGA GTT GCA GTT GAT GT 
CF1 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC CCTGT ATTCATACAT AG CCC CAT GCT TAC AAG CAA GT 
CF2 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC CGATC ATTCATACAT AG CCC CAT GCT TAC AAG CAA GT 
CF3 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC GTCCA ATTCATACAT AG CCC CAT GCT TAC AAG CAA GT 
CR1 CAA GCA GAA GAC GGC ATA CGA GAT GGTAA ACCTGAGTCG CC TGG CTT TAT GTA CTA TGT AC 
CR2 CAA GCA GAA GAC GGC ATA CGA GAT GATTC ACCTGAGTCG CC TGG CTT TAT GTA CTA TGT AC 
DF1 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC CTGGT ATTCATGCAT AT CAC TAG GAT ACC AAC AAA CC 
DF2 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC GCATC ATTCATGCAT AT CAC TAG GAT ACC AAC AAA CC 
DF3 AAT GAT ACG GCG ACC ACC GAG ATC TAC AC GGAAC ATTCATGCAT AT CAC TAG GAT ACC AAC AAA CC 
DR1 CAA GCA GAA GAC GGC ATA CGA GAT ATTCC ACTTGAATAT AT GAG GAT GGT GGT CAA GGG AC 
DR2 CAA GCA GAA GAC GGC ATA CGA GAT AAGGA ACTTGAATAT AT GAG GAT GGT GGT CAA GGG AC 
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8.22 Kruskal Wallis test for DNA extraction methods 
Kruskal Wallis test conducted using R version 3.1.2 (2014-10-31) -- "Pumpkin Helmet" 
Copyright (C) 2014 The R Foundation for Statistical Computing 
Platform: i386-w64-mingw32/i386 (32-bit) 
> BrazilSA <- read.csv("C:/Users/vicki/Desktop/BrazilSA.csv", header=FALSE) 
>   View(BrazilSA) 
> r = c(t(as.matrix(BrazilSA))) 
> f = c("V1", "V2", "V3") 
> k = 3 
> n = 5 
> tm = gl(k, 1, n*k, factor(f)) 
> kruskal.test(r ~tm) 
 
Kruskal-Wallis rank sum test 
data:  r by tm 
Kruskal-Wallis chi-squared = 0.5914, df = 2, p-value = 0.744 
> BrazilmtDNA <- read.csv("C:/Users/vicki/Desktop/BrazilmtDNA.csv", header=FALSE) 
>   View(BrazilmtDNA) 
> r = c(t(as.matrix(BrazilmtDNA))) 
> f = c("V1", "V2", "V3") 
> k = 3 
> n = 5 
> tm = gl(k, 1, n*k, factor(f)) 
> kruskal.test(r ~tm) 
 Kruskal-Wallis rank sum test 
data:  r by tm 
Kruskal-Wallis chi-squared = 2.4394, df = 2, p-value = 0.2953 
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8.23 Steps utilised to analyse raw MiSeq data 
Following sequencing using the MiSeq platform, samples (005B, 007B, 013B, 017B, 020B 
and Method 1 Neg A) could not be demultiplexed and consequently just the two read data 
files were available for analysis.  The following steps were carried out to analyse the data: 
1. Both read files were uploaded to Galaxy (www.usegalaxy.org) using the Upload File 
tool (Blankenberg et al., 2010) 
Sample files converted to Galaxy compatible fastqsanger files using FASTQ Groomer 
(Blankenberg et al., 2010) 2098148 sanger reads were converted for each read file (1.1 GB). 
An example of the data is shown in Figure 8.1. 
TTAAACTATTCTCTGTTCTTTCATGGGGAAGCAGATTTGGGTACCACCCAAGTATTGACTCACCCATC
AACAACCGCTATGTATTTCGTACATTACTGCCAGCCACCATGAATATTGTACGGTACCATAAATACTT
GACCACCTGTAGTACACGACTCAGGTGTATTATCTCGTATGCCGTCTTCTGCTTGTCAAATTACACTC
TATTACCACATCCTTCCTCTTCCTTCCCTCCTATTTTTAACACCCC 
TTATGGTACCGTACAATATTCATGGTGGCTGGCAGTAATGTACGAAATACATAGCGGTTGTTGATG
GGTGAGTCAATACTTGGGTGGTACCCAAATCTGCTTCCCCATGAAAGAACAGAGAATAGTTTAAAT
TAGAATCTTAGCTTTGGGCAATGCATGAATCAGCGGTGTAGATCTCGGTGGTCGCCGTATCATTAAT
ACAAATAAACAAAAGAGTTTGGGTGTTCGTTTCGCGGTATGCATAGGTCGAT 
Figure 8.1 The fastqsanger format R1 data contains the target DNA sequence 
(highlighted blue) and the reverse complement of the reverse primer/ linker/ pad/ index/ and 
flow cell adaptor. The fastqsanger format R2 data contains the target DNA sequence 
(highlighted blue) and the reverse complement of the forward primer/ linker/ pad/ index and 
flow cell adaptor. Additional bases (not highlighted) were present at the end of each read 
after the flow cell adaptor sequence.  
 
2. Illumina adapters were removed from the end of every read in each file using Clip 
(based on the FASTX-Toolkit by Assaf Gordon) as shown in Figure 8.2. 
TATGGTACCGTACAATATTCATGGTGGCTGGCAGTAATGTACGAAATACATAGCGGTTGTTGATGG
GTGAGTCAATACTTGGGTGGTACCCAAATCTGCTTCCCCATGAAAGAACAGAGAATAGTTTAAATT
AGAATCTTAGCTTTGGGCAATGCATGAATCAGCG 
Figure 8.2 Sequence with Illumina adapters and additional bases removed 
 
3. In order for the two reads to be joined, the index for the reverse read (R2) needed to 
be positioned at the 5’ end of the sequence for identification at a later stage, which 
was accomplished using the Reverse-Complement tool (FASTX-Toolkit) 
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4. The paired end reads in both R1 and R2 files were then combined using FASTQ 
joiner (Blankenberg et al., 2010) in order to place the forward and reverse indexes in 
the sample sequence for sample identification and demulitplexing, shown in Figure 
8.3.   
CGCTGATTCATGCATTGCCCAAAGCTAAGATTCTAATTTAAACTATTCTCTGTTCTTTCATGGGGAAG
CAGATTTGGGTACCACCCAAGTATTGACTCACCCATCAACAACCGCTATGTATTTCGTACATTACTGC
CAGCCACCATGAATATTGTACGGTACCATAATTAAACTATTCTCTGTTCTTTCATGGGGAAGCAGAT
TTGGGTACCACCCAAGTATTGACTCACCCATCAACAACCGCTATGTATTTCGTACATTACTGCCAGCC
ACCATGAATATTGTACGGTACCATAAATACTTGACCACCTGTAGTACACGACTCAGGTGTATT 
Figure 8.3 The reverse complement of the R2 file reads were joined with the R1 files so 
that both indexes were present for sample identification and demulitplexing 
 
5. A text file containing the reverse indexes (in reverse complement) was uploaded to 
Galaxy using Upload File  
6. The Barcode Splitter tool (FASTX-Toolkit) was selected to split the joined file by 
the reverse index at the 3ʹ sequence end and the number of allowed mismatches was 
set to zero 
7. This produced two files, i.e. AR1 and AR2, now in FASTQ txt format which were 
downloaded and extracted 
8. The AR1 file was uploaded using Upload File and then the format converted for 
later use with the barcode splitter tool using FASTQ to FASTA (Blankenberg et al., 
2010)  
9. A text file for each of the forward indexes, AF1, AF2 and AF3, was uploaded to 
Galaxy using Upload File  
10. The Barcode Splitter tool was then utilised to split the converted AR1 file by the 
three forward indexes at the 5ʹ sequence end and the number of allowed mismatches 
was set to zero 
11. Steps 9-11 were then repeated for the AR2 file resulting in a total of six FASTQ txt 
8) files, one for each sample, which were all downloaded and renamed; AF1/AR1, 
AF2/AR1, AF3/AR1, AF1/AR2, AF2/AR2, AF3/AR2.  
12. The AF1/AR1 FASTQ txt file was uploaded using Upload File and the format 
converted using FASTQ to FASTA  
13. Combine FASTA and QUAL (Blankenberg et al., 2010) was used to convert the 
AF1/AR1 file once again into the FASTQ sanger format required for the following 
steps 
14. FASTQ splitter (Blankenberg et al., 2010) was utilised to separate the still-joined 
paired end reads back into the forward (LHS) and reverse (RHS) reads for alignment 
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15. The Reverse-Complement of the RHS read file was obtained to position the barcode 
once again at the 3ʹsequence end (previously changed in step 4) 
16. FASTQ Trimmer (Blankenberg et al., 2010) was used to remove seventeen bases 
(barcode + pad + link) from the 3ʹ end of each read in both the LHS and RHS files 
17. The reads in each file were then aligned to the Human reference sequence (hg38) 
using BWA-MEM (Li, 2013, Li and Durbin, 2009, Li and Durbin, 2010) which 
produces a BAM format file 
18. Steps 13-18 was repeated for each of the six sample files generated in step 12 
19. Steps 6-18 were repeated for each of the remaining three amplicons 
20. Flagstat (Li, 2011b, Li, 2011a, Li et al., 2009) was used to tabulate the descriptive 
statistics for the BAM dataset for each individual sample file 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
